名称（Title） 2016-N M0301: M0403 M0402 M0302 D0031

M0301 [2016-N]
ＮＥＳ日産技術標準規格
規格番号変番区分承認日ﾌｧｲﾙ分類番号

M0301 2016-N 改正 16-07-22 M-6-01
名称（Title）
特定物質の使用に関する制限
Substance Use Restrictions
概要
自動車に使用される材料、部品、製品に関する使用禁止物質と使用制限物質を記載した。
キーワード
有害物質、環境負荷物質、特定物質、使用制限、有害物、毒
制定日最新変番の承認日重保重要識別英訳ﾗﾝｸ分類(製造)

94-09-08 16-07-22 - A
ｺﾓﾝｽﾀﾝﾀﾞｰﾄﾞ日産自動車株式会社 NES 委員会

Type2 開発部会部会長
承認者１福井孝之分科会材料技術(高分専門委員会環境材料

子)
承認者２服部直樹
承認者３分科会長福井孝之専門委員会長服部直樹
地区課ｺｰﾄﾞ作成者 TEL(内線）

X XD1 曽根里枝 6411-3815
引用／関連規格社内規格
関 D0031 関 M0302 関 M0402 関 M0403
引用／関連規格社外規格
GADSL(2016 Version 1.0)
表紙
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
RENAULT NISSAN ENGINEERING STANDARD
(RNES)
Material engineering
RNES-B00027 v1.0
RENAULT STANDARD NISSAN ENGINEERING
(GDNormes) STANDARD
MATERIAL REFERENCE NES
SHEET M0301 [2016-N]
00-10-050 / - - N
Issued: 2015-12-15
IMPORTANT PART SYMBOL
______________________________________________________________________________________
Title: Prohibited or restricted substances in parts – List and

declaration modes
Signature (Alliance Single Technical Leader)

Daniel COURATIN
Signature (Renault validator) Signature (Nissan validator)

Ana FERNANDEZ Takayuki FUKUI
1/298
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Revisions
Philippe
DEA-TC
Daniel ROLLAND 2015
2016.06.08 Newly established 1.0 N
COURATIN Naoki -N
XD1
HATTORI
APPROVED APPROVED CHG Ver CHG
AUTHOR SECT ALTERATION
BY DATE RNES GDNormes NES
RENAULT-NISSAN
2
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Important Notices and Disclaimers
 "This document is a compilation of RENAULT document No 00-10-050 and Nissan document No

NES_M0301 with the addition of Alliance Specifications (AS).
It complies with the agreement reached between RENAULT and NISSAN in 2016-04-08.
Any revision or alteration of this document is subject to prior approval by the secretariat of RENAULT and
NISSAN.
 This document was translated from French or Japanese originals. In case of any discrepancies, the
English original shall take precedence over any other language translation.
Copyright notice
©RENAULT 2016
©NISSAN 2016
No duplication permitted without the consent of the issuing department.
Alliance Document
The players concerned by this document are Materials Engineering Team from Renault & Nissan.
3
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Issued by : Philippe ROLLAND
Renault
Validated by : Ana Fernandez
Issued by : Naoki HATTORI
NISSAN
Validated by : Takayuki FUKUI
Renault Nissan Internal

4
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Contents
Introduction ........................................................................................................................................................ 6
1 Scope .............................................................................................................................................................. 7
1.1 SCOPE (Field of application) ....................................................................................................................... 7
1.1.1. PHYSICAL FIELD OF APPLICATION ..................................................................................................... 7
1.1.2. GEOGRAPHIC FIELD OF APPLICATION............................................................................................... 7
1.1.3 .DRAWING NOTATION ............................................................................................................................ 7
2 Normative and informative references............................................................................................................ 7
3 Terms and definitions: ..................................................................................................................................... 8
4 Symbols and abbreviations: ........................................................................................................................... 9
5 Substance classification: ................................................................................................................................ 9
5.1 P / R / D substances .................................................................................................................................... 9
5.1.1 P: Prohibited SUBSTANCES .................................................................................................................... 9
5.1.2. R: Restricted SUBSTANCES ................................................................................................................... 9
5.1.3. D: Declarable SUBSTANCES .................................................................................................................. 9
5.2. SPECIFIC CASES ...................................................................................................................................... 9
5.2.1. Action for REACh authorization ............................................................................................................... 9
5.2.2 Action for European Biocidal Products Regulation active substances ................................................... 10
6 Requirements ............................................................................................................................................... 10
6.1. COMPLIANCE .......................................................................................................................................... 10
6.2. MANDATORY DECLARATION & PROHIBITION TRESHOLDS ............................................................... 11
7. DECLARATION PROCESS .......................................................................................................................... 11
7.1. DECLARATION PROCESS TO BE FULFILL BY SUPPLIER ................................................................... 11
7.2. PARTS MODIFICATION IN PROJECT DEVELOPMENT AND DURING PRODUCTION LIFECYCLE ... 11
8. LIST PRESENTATION .................................................................................................................................. 11
9. FUNCTIONING OF THE SUBSTANCE LIST .............................................................................................. 13

5
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Introduction
This document concerns the substances used in the parts supplied to Renault or Nissan to be assembled in
vehicle.
This document lists the substances to be declared, that are restricted or that are banned by Renault/Nissan in
the parts.
FOREWORD
RENAULT and NISSAN have set themselves the objective of minimizing the impact of their activities and their
products on health and the environment by drafting this standard.
As active supporter of sustainable development, RENAULT and NISSAN aim to take into account increasing
environmental challenges that automotive sector has to face through reducing continuously the use of
substances identified as having potential impacts on health and environment (in the present state of our
knowledge).
Today, REANULT and NISSAN reaffirm their commitment to enhance their brand values to be innovative
companies, close to people, that make sustainable mobility accessible to all.
Within the framework of their environmental and health global approaches, RENAULT and NISSAN reaffirm
their willing to increase the protection of people exposed to substances used in vehicles , more particularly
with an anticipation policy of the REACh regulation.

6
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Prohibited or restricted substances in parts
List and declaration modes
1 Scope
The purpose of this common specification is to:
- Make the suppliers aware of the list of substances or families prohibited or restricted substances so that they
can ban or restrict their use accordingly.
- Set the conditions for the "mandatory declaration" by the Supplier to RENAULT and NISSAN for all listed
substances and families.
- Allow to apply these interdictions or restrictions.
1.1 SCOPE (Field of application)

1.1.1. PHYSICAL FIELD OF APPLICATION
The Standard established requirements are applicable for :

- All articles used for the manufacture of vehicles, parts, sub-assemblies, components, including spare parts
and accessories,
The Standard established requirements are not applicable :
- Chemical mixtures
- Cases subject to regulatory derogations (see Observations column in the Annex 1).
- Exceptional and justified uses for which no substitute is currently possible and for which case-by case
exceptions such as those provided for in paragraph 5.1.1 must be granted.
1.1.2. GEOGRAPHIC FIELD OF APPLICATION

The Standard is applicable throughout the world. In other words, in any countries where RENAULT s.a.s and
NISSAN Motor or one of its subsidiaries companies already in operation or consider doing it.
1.1.3 .DRAWING NOTATION

“RNES-B00027” shall be described in the drawing
2 Normative and informative references

These normative references apply the latest version.
― International Standards
GADSL: Global Automotive Declarable Substance List. List of prohibited (P) and declarable (D)
substances for automotive industry, set up by the Global Automotive Stakeholders Group (GASG).
Last version of the list could be found in GADSL website (http://www.gadsl.org).
― Renault Standards
7
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
80-00-044 IMDS documentation rules for Renault suppliers
00-10-050 PROHIBITED OR RESTRICTED SUBSTANCES LIST AND DECLARATION MODES
― Nissan Standards
NES-M0302 Substance data input standard by IMDS
3 Terms and definitions:

For the purpose of this standard, the following terms and definitions apply.
Chemical compound: elementary body with an organic, metallic, or mineral nature, which is characterized
by constant physical and chemical properties.
Examples of elementary bodies:
- Organic: vinyl chloride, ethyl alcohol, …
- Metallic: iron, lead, copper, …
- Mineral: water, silica, titanium oxide, …
Chemical mixture: Mixture or solution composed of two or more substances. The term "chemical mixture"
mainly applies to paints, adhesives, mastics, and automotive fluids, together with the products used in the
industrial processes.
CMR: Carcinogenic, Mutagenic or toxic to Reproduction.
Articles/Parts/Component: constituent of a Bought Out Parts, In-House Parts. The structured assembly of
all the components of a part forms the parts list.
Family: Group of substances with the following common point, either:
- chemical element. E.g: lead, copper, nickel …,
- a chemical function. E.g: glycol ether, phthalate…,
- a type of action or use. E.g: biocide, azo dye …,
- a regulatory risk for health or the environment. E.g: allergenic substances H317, substances dangerous for
the environment H400 or H410/411/412/413.
GADSL: Global Automotive Declarable Substance List. See paragraph 2 “normative references” for more
details.
Homogenous material: uniform material in space consisting of items all of which are similar and all parts of
which are identical and perceived as such.
Examples:
- PA 6.6,
- PP-GF30
- Steel 16NC6,
- Side window glass
- A part protected by a zinc-based anti-corrosion coat is generally made of four homogenous materials:
Part made of metal
Zinc-based electroplated layer (pure zinc or alloyed zinc)
Passivation layer (based on chromium III for example)
Possible finishing layer (also known as top coat).
Homogenous material component: constituent item of part made from a homogenous material.
List: corresponds to the substances list describes in Annex 1
8
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Material: mixture of organic, metal, or mineral chemical compounds. The term "material" mainly applies to
vehicle parts.
REACh authorization list: List of the substances included in the Annex XIV of the REACH European
regulation, N°1907/2006
Substance: Chemical element and its compounds in the natural state or obtained by any manufacturing process,
including any additive necessary to preserve its stability and any impurity deriving from the process used. But
excluding any solvent which may be separated without affecting the stability of the substance or changing its
composition.
Supplier: any company connected to RENAULT and/or NISSAN by a purchasing contract or a contract for
the provision of services or products: this term also applies to any sector in the manufacturer's company
having supplier customer relationships with other sectors at a different site.
4 Symbols and abbreviations:

They are defined in the previous paragraph
5 Substance classification:
The substances are divided into three categories such as Prohibited, Restricted and Declarable in the List
which is presented in Annex 1.
5.1 P / R / D substances
5.1.1 P: Prohibited SUBSTANCES
Relates to substances whose use is prohibited:
- by regulation, or
- by the voluntary commitment of RENAULT and NISSAN. It is based on pre-established criteria such as the
anticipation of future regulations, the potential risk for the health and/or the environment.
5.1.2. R: Restricted SUBSTANCES
Relates to substances which particular uses or presence in certain parts are prohibited by a regulation
Refers to column “observation”.
5.1.3. D: Declarable SUBSTANCES
Relates to substances to be monitored due to possible future restrictions or prohibitions (medium or long
term).
5.2. SPECIFIC CASES

5.2.1. Action for REACh authorization
Priority substance column of Annex 1 table gives the list of substances which should be eliminated in parts of
new vehicle projects from given date, especially because of their addition in the REACh authorization list that
means a short term prohibition (are targeted the substances that are in the REACh authorization list, and the
substances that are recommended to enter the REACh authorization list)
From inclusion date, each new part conception must take the substitution into account.

9
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
5.2.2 Action for European Biocidal Products Regulation active substances
The following requirements under Biocidal Products Regulation (EU) No5282012 shall be met
• Final products can only be treated with Active Substances which are approved for the relevant Product
Types for the purpose of biocidal functions*.
*Biocidal functions/properties: Disinfectants (e.g. antibacterial, sterilization etc.), Preservatives (e.g. corrosion protection, fungicide,
degradation protection etc.), Pest repellent (e.g. bug repellent, pesticide, rodenticide etc.)
• The labelling requirements have to be complied with when a claim regarding the biocidal properties of the
treated article is made, or when the conditions for the approval of the active substance(s) so require.
Substances regulated according to the European Biocidal Products Regulation (BPR), biocidal coatings
/biocidal additives have been added into Annex 1 as group “Biocidal coatings / biocidal additives, selected” ,
in the column Number 2.
It is allowed to use substances as biocide only when they are approved for target product type Product-type 7,
8 and 9 is applied for automotive application.
Even though the substance listed in biocidal product family, it is accepted if it is not used as biocide.
Product-type 7: Typical IMDS Material Categories
Film preservatives *1) 6.1 , 9.7
Product-type 8: Typical IMDS Material Categories:
Wood preservatives *1) 7.1 , 9.7
Product-type 9: Typical IMDS Material Categories:
Fiber, leather, rubber and polymerized 5.x, 6.1, 7.1, 9.7
materials preservatives *1)
*1) For insecticide and to prevent to growth of microbes or algae.
Observation column on biocidal family in Annex 1 describes approval status as biocidal product.
Authorization required： It has not been approved as biocidal use yet. Prohibit to use as biocide until approval
acquisition.
D：Approved as biocidal use.
P：Prohibited as biocidal use
6 Requirements
6.1. COMPLIANCE
This Standard is drafted taking into account current regulations applicable on the date of its publication: it
reiterates prohibitions and mandatory declarations of the applicable regulations.
Therefore, this Standard is based on:
- Applicable regulatory texts,
- GADSL requirements,
- RENAULT and NISSAN specific requirements.

10
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
With which the Supplier shall fully comply.
This Standard is not intended in a way to substitute for official regulation or any changes there to. However,
where the law is less restrictive than this standard, the latter shall prevail.
In addition, the present standard covers only parts. Please refer to mixture specification for substances in
mixtures.
6.2. MANDATORY DECLARATION & PROHIBITION TRESHOLDS

The Supplier shall guarantee that no Prohibited and Restricted substances are present in the products
delivered to RENAULT and NISSAN, at a threshold exceeding the prohibition threshold.
Any “P”: Prohibited and “R”: Restricted substances, present at a threshold lower than the prohibition threshold
in a product, shall be the subject of a quantitative declaration if its content is equal to or greater than the
specified declaration threshold.
Any “D”: Declarable substances shall be the subject of a quantitative declaration if its content is equal to or
greater than the specified declaration threshold.
If there is no threshold, the substance shall be declared regardless of its quantity.
7. DECLARATION PROCESS
7.1. DECLARATION PROCESS TO BE FULFILL BY SUPPLIER
The supplier should provide Material Data Sheets (MDS) via the IMDS system referring to Renault Nissan
guideline “IMDS documentation guideline for RENAULT and NISSAN suppliers”
The substances declaration must be done all along the supply chain, according to Annex 1 of the present
standard. List and declaration threshold associated.
7.2. PARTS MODIFICATION IN PROJECT DEVELOPMENT AND DURING PRODUCTION
LIFECYCLE
In the event of a change in the chemical composition of the part or material weight, the approval and
codification process described in the chapter 7.1 is reinitialized.
8. LIST PRESENTATION
The List includes fourteen different columns in which twelve parameters for each substance are indicated:
Colum 1: Group number
The first column indicates number of substance or substance family
Colum 2: Group of substances
The second column indicates name of chemical substance family
Colum.3: Substance name
The third column indicates the chemical name of the substance
Colum 4: CAS N°
The forth column specifies the CAS (Chemical Abstract Service) number of the substance. The CAS number
is an international codification which precisely and rigorously identifies the substance.

11
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Column 5 : EINECS or ELINCS
The fifth column specifies the EINECS number (European Inventory of Existing Commercial chemical
Substances) or ELINCS number (European List of Notified Chemical Substances) when it exists. This number
precisely and rigorously identifies the substance.
Column 6: Classification Renault Nissan
The sixth column specifies classification of Renault and Nissan based on section 5.1.1, 5.1.2 and 5.1.3.
It is this classification that the supplier has contractually to comply with.
Column 7: GADSL classification
The seventh column describes GADSL classification.
Column 8: Comparison with GADSL
The eighth column describes difference with GADSL. Category A is same classification with GADSL.
Category B is a specific requirement by Renault and Nissan.
Column 9: Priority substances
The ninth column indicates priority substances from REACh regulation. See paragraph 5.2.1 for more detail.
Column 10: Prohibition threshold
The tenth column indicates the prohibition threshold associated to the substance for parts.
For the substances that have a defined prohibition threshold, this is the threshold at which the substance is
prohibited. The threshold is expressed either as a weight percentage, or in PPM (parts per million), or as a
weight per unit area for each substance. It is applicable to homogenous materials.
A dash (-) means the substance is prohibited regardless of its quantity.
Column 11: Declaration threshold
For the substances having a defined declaration threshold, this is the threshold at which it is required to
declare the substance. The threshold is expressed either as a weight percentage, or in PPM (parts per
million), or as a weight per unit area for each substance. It is applicable to homogenous materials.
A dash (-) means the substance should be declared regardless of its quantity.
Column 12 Example of use
The twelfth column lists examples of uses for this substance. They are not exhaustive and just provided as an
indication.
Column 13 Hazard (for information)
The thirteenth column indicate toxicity of some chemical substances.
Column 14 Regulation
Indicates relevant regulation
Column 15 indicates applicable date by regulation or specific requirement (i.e Sunset date by Annex XIV of
REACh)
Column 16 Observations
Specific characteristics such as use restrictions, specific prohibition are indicated in the fifteenth column.

12
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
9. FUNCTIONING OF THE SUBSTANCE LIST
Table of Annex 1 presents the list of Prohibited, Restricted and Declarable substances specified by Renault
and Nissan.
Annex 1: List of substances with P / R / D classification
See file “RNES-B00027_V1.0_Annex1.xlsx” included below
RNES-B00027_Anne
x1.xlsx

13
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Annex 2: Exemption list, for information
Table 1 Materials and components exempted from EU Directive on end-of-life vehicles (No. 1)
Please, see European directive: 2000/53/CE, and the last update of its annex II
4 Heavy metals are banned. It is this exemption scheme that is applied at a world level. If local regulations are stricker, it is them who
apply.
To be labeled or made identifiable using

Scope and expiry date
Materials and components another method in accordance with
of the exemption
Article 4 (2) (b) (iv)
[Lead as an alloying element]

1(a). Steel for machining purposes and
batch hot dip galvanised steel components No expiry set
containing up to 0,35 % lead by weight
1(b). Continuously galvanised steel sheet Vehicles whose model was and will be
containing up to 0.35 % lead by weight certified before Jan. 1, 2016 and spare
parts for those vehicles
2(a). Aluminum for machining purposes with a Spare parts for vehicles introduced on the
lead content up to 2% by weight market before Jul. 1, 2005
2(b). Aluminum with a lead content up to 1.5% Spare parts for vehicles introduced on the
by weight market before Jul. 1, 2008
2(c). Aluminum with a lead content up to 0.4%
*(1)
by weight
3. Copper alloy containing up to 4% lead by
*(1)
weight
4(a). Bearing shells and bushes Spare parts for vehicles introduced on the
market before Jul. 1, 2008
4(b). Bearing shells and bushes in engines, Up to Jul. 1, 2011. Spare parts for
transmissions and air conditioning compressors vehicles introduced on the market before
Jul. 1, 2011 after the expiry date of the
exemption
[Lead and lead compounds in components]

5. Batteries *(1) X
6. Vibration dampers Vehicles whose model was and will be
certified before Jan. 1, 2016 and spare X
7(a). Vulcanising agents and stabilisers for
elastomers in brake hoses, fuel hoses, air Spare parts for vehicles introduced on the
ventilation hoses, elastomer/metal parts in the market before Jul. 1, 2005
chassis applications, and engine mountings
7(b). VVulcanising agents and stabilisers for
elastomers in brake hoses, fuel hoses, air
Spare parts for vehicles introduced on the
ventilation hoses, elastomer/metal parts in the
chassis applications, and engine mountings
containing up to 0,5 % lead by weight
7(c). Bonding agents for elastomers in
powertrain applications containing up to 0.5%
lead by weight
[Lead and lead compounds in components] continued

8(a). Lead in solders to attach electrical and
electronic components to electronic circuit
boards and lead in finishes on terminations of Vehicles whose model was and will be
components other than electrolyte aluminum certified before Jan. 1, 2016 and spare X*(3)
capacitors, on component pins and on parts for those vehicles
electronic circuit boards
8(b). Lead in solders in electrical applications Vehicles whose model was and will be
other than soldering on electronic circuit boards certified before Jan. 1, 2011 and spare X*(3)
or on glass parts for those vehicles
8(c). Lead in finishes on terminals of electrolyte Vehicles whose model was and will be
X*(3)
aluminums capacitors certified before Jan. 1, 2013 and spare

14
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
8(d). Lead used in soldering on glass in mass Vehicles whose model was and will be
airflow sensors certified before Jan. 1, 2015 and spare X*(3)
8(e). Lead in high melting temperature type
solders (i.e. lead-based alloys containing 85% *(3) X*(3)
by weight or more lead)
8(f).(a) Lead in compliant pin connector Vehicles type-approved before 1 January
X*(3)
systems 2017 and spare parts for these vehicles
8(f).(b) Lead in compliant pin connector
systems other than the mating area of vehicle *(3) X*(3)
harness connectors
8(g). Lead in solders to complete a viable
electrical connection between semiconductor
*(3) X*(3)
die and carrier within integrated circuit flip chip
packages
8(h). Lead in solder to attach heat spreaders to
the heat sink in power semiconductor
Vehicles type-approved before 1 January
assemblies with a chip size of at least 1 cm² of X*(3)
2016 and spare parts for these vehicles
projection area and a nominal current density of
at least 1 A/mm2 of silicon chip area
8(i). Lead in solders in electrical glazing Vehicles whose model was and will be
applications on glass except for soldering in certified before Jan. 1, 2016 and spare
X*(3)
laminated glazing parts for those vehicles
The beginning issue schedule of 2013
8(j). Lead in solders for soldering in laminated Vehicles type-approved before 1 January
X*(3)
glazing 2020 and spare parts for these vehicles
9. Valve seats Spare parts for engines developed before
Jul. 1, 2003

10(a). Electrical and electronic components
which contain lead in a glass or ceramic, in a
glass or ceramic matrix compound, in a X*(4)
glass-ceramic material, or in a glass-ceramic (Except the piezo parts in engine)
matrix compound. This exemption does not No expiry set
cover the use of lead in: — glass in bulbs and
glaze of spark plugs, — dielectric ceramic
materials of components listed under 10(b),
10(c) and 10(d).
10(b). Lead in PZT based dielectric ceramic
materials of capacitors being part of integrated No expiry set
circuits or discrete semiconductors
10(c). Lead in dielectric ceramic materials of Vehicles whose model was and will be
capacitors with a rated voltage of less than 125 certified before Jan. 1, 2016 and spare
V AC or 250 V DC parts for those vehicles
10(d). Lead in the dielectric ceramic materials of
capacitors compensating the Vehicles type-approved before 1 January
temperature-related deviations of sensors in 2017 and spare parts for these vehicles
ultrasonic sonar systems
11. Pyrotechnic initiators Vehicles whose model was certified before
Jul. 1, 2006 and their spare parts
12. Lead-containing thermoelectric materials in Vehicles whose model was and will be
automotive electrical applications to reduce CO certified before Jan. 1, 2019 and spare X
2 emissions by recuperation of exhaust heat parts for those vehicles
[Hexavalent chromium]
13(a). Corrosion preventive coatings Spare parts for vehicles introduced on the
13(b). Corrosion preventive coatings related to
bolt and nut assemblies for chassis applications Spare parts for vehicles introduced on the
14. As an anti-corrosion agent of the carbon

steel cooling system in absorption refrigerators
in motorcaravans
up to 0,75 weight -% in the cooling solution
except where the use of other cooling
technologies is practicable (i.e. available on the
market for the application in motor caravans)
and does not lead to negative environmental,
health and/or consumer safety impacts

15
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
[Mercury]
15(a). Discharge lamps for headlight application Vehicles whose model was and will be
certified before Jul. 1, 2012 and their spare X
parts
15(b). Fluorescent tubes used in instrument Vehicles whose model was and will be
panel displays certified before Jul. 1, 2012 and their spare X
parts
[Cadmium]
16. Batteries for electrical vehicles As spare parts for vehicles put on the
market before 31 December 2008
(1) This exemption shall be reviewed in 2015.

(2) This exemption shall be reviewed in 2019.
(3) Dismantling if, in correlation with entry 10(a), an average threshold of 60 grams per vehicle is exceeded. For the application of this
clause electronic devices not installed by the manufacturer on the production line shall not be taken into account.
(4) Dismantling if, in correlation with entries 8(a) to 8(j), an average threshold of 60 grams per vehicle is exceeded. For the application
of this clause electronic devices not installed by the manufacturer on the production line shall not be taken into account.
2. Note
- A maximum concentration value up to 0.1 wt% per homogeneous material for lead, hexavalent chromium and mercury and up to 0.01 wt%
per homogeneous material for cadmium are tolerated.
- The reuse of parts of vehicles that were already on the market at the date of expiry of an exemption item is allowed without limitation since it
is not covered by 2000/53/EC Article 4 (2) (a).
- Service parts introduced on the market after Jul. 1, 2003 that are used for vehicles introduced on the market before Jul. 1, 2003 are excluded
from application of 2000/53/EC Article 4 (2) (a).
* Wheel balance weight, carbon brushes for electric motor and brake linings are excluded.

16
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Table 2 Materials and components exempted from South Korean recycling law:
Please see, the last revision of Presidential Decree (No.25046). the table is appendix table
EXHAUSTIVE LIST OF EXEMPTIONS

Ranges and expiry dates of Changes from
Materials and components
exemption previous version
A. Lead
1) Lead as an alloying element
a) Steel for machining purposes and galvanized

steel
(1) Steel for machining purposes containing up to
Steels are divided into
0.35 % lead by weight
3 sub-categories
(2) batch hot dip galvanised steel components
containing up to 0,35 %lead by weight
New type whose dimension
New expiry date for (3)
(3) Continuously galvanised steel sheet management No. is newly given or
containing up to 0,35 % lead by weight revised before Jan. 1, 2016 and
spare parts for those vehicles
Deleted an exemption on
b) Aluminium with a lead content up to 0,4 % by “Aluminium with a lead
weight content up to 1,5 % by
weight”
Deleted an exemption on
c) Bearing shells and bushes in engines, Spare parts for vehicles put on the
“Bearing shells and
transmissions and air conditioning compressors market before Jul. 1, 2011
bushes other than c)”
d) Copper alloy containing up to 4 % lead by
weight
2) Lead and lead compounds in components
a) Battery

management No. is newly given or
b) Vibration dampers New expiry date
revised before Jan. 1, 2016 and
c) Bonding agents for elastomers in P/T Spare parts for vehicles put on the
applications containing up to 0,5 % lead by weight market before Jul. 1, 2009
d) Lead in solders to attach electrical and Solders are divided into
electronic components to electronic circuit boards 10 sub-categories
and lead in finishes on terminations of from d) to m)
components other than electrolyte aluminium
capacitors, on component pins and on electronic New expiry dates for d),

17
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
circuit boards e), f), g) and l)
e) Lead in solders in electrical applications other
than soldering on electronic circuit boards or on
revised before Jul. 1, 2013 and spare
glass*

f) Lead in finishes on terminals of electrolyte management No. is newly given or
aluminium capacitors* revised before Jan. 1, 2014 and
g) Lead in finishes on terminals of electrolyte management No. is newly given or
aluminium capacitors revised before Jan. 1, 2015 and
h) Lead in high melting temperature type solders
(i.e. lead-based alloys containing 85 % by weight
or more lead) Solders are divided into
10 sub-categories
i) Lead in compliant pin connector systems
from d) to m)
j) Lead in solders to complete a viable electrical
connection between semiconductor die and
New expiry dates for d),
carrier within integrated circuit flip chip packages
e), f), g) and l)
k) Lead in solder to attach heat spreaders to the
heat sink in power semiconductor assemblies [in
cases of a chip size of at least 1 cm 2 of projection
area and a nominal current density of at least 1
A/mm 2 of silicon chip area]
l) Lead in solders in electrical glazing applications management No. is newly given or
on glass except for soldering in laminated glazing revised before Jan. 1, 2016 and
m) Lead in solders for soldering in laminated
glazing
n) Electrical and electronic components which Lead in ceramic and
contain lead in the cases below glass are divided into 4
a) a glass or ceramic sub-categories
b) a glass or ceramic matrix compound Frim n) to q)
c) a glass-ceramic material

18
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
d) a glass-ceramic matrix compound
This exemption does not cover the use of lead in New expiry dates for p)
glass in bulbs and glaze of spark plugs, and
dielectric ceramic materials of components listed
under O, P, and Q
o) Lead in PZT based dielectric ceramic materials
of capacitors being part of integrated circuits or
discrete semiconductors
p) Lead in dielectric ceramic materials of
capacitors with a rated voltage of less than 125 V
AC or 250 V DC
q) Lead in the dielectric ceramic materials of
capacitors compensating the temperature-related
deviations of sensors in ultrasonic sonar systems

r) Lead-containing thermoelectric materials in
automotive electrical applications to reduce CO 2 January 1, 2019 New exemption
emissions by recuperation of exhaust heat
B. Mercury (Hg)

1) Discharge lamps for headlight application
management No. are newly given or
2) Fluorescent tubes used in instrument panel revised before July 1, 2012 and spare
displays parts for those vehicles
C. Hexavalent Chromium (Cr6+)
As an anti-corrosion agent of the carbon steel

cooling system in absorption refrigerators in
motorcaravans up to 0.75 weight -% in the cooling
solution except where the use of other cooling
technologies is practicable (limited to the case that
no negative environmental, health and/or
consumer safety impacts were taken place)
D. Cadmium (Cd)
Spare parts for vehicles put on the

Batteries for electric vehicles
market before Dec. 31, 2008
Other generals

19
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Motor vehicles whose dimension
E. The parts and components as repair parts of management No. were given before
motor vehicles July 1, 2008 and manufactured by
December 31, 2010
The parts and components exempted
under sub-para E and used
F. The parts and components as repair parts of commonly to motor vehicles whose
motor vehicles dimension management No. were
newly given or revised after July 1,
2008
Motor vehicles introduced on the
G. The parts and components under sub-para. A
market before the expiry dates set
and D as repair parts for motor vehicles
above
H. The parts and components under sub-para. B
management No. are newly given or
as repair parts of motor vehicles
revised before July 1, 2012

20
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Table 3 Materials and components exempted from voluntary regulation by Taiwan scrap vehicle recycling
Scope and expiry date

of the exemption
[Lead as an alloying element]
1. Steel or galvanized steel for processing containing up to 0.35 wt% No expiry set
2. a) Aluminum alloy for processing with a lead content up to 2 wt% Spare parts for vehicles introduced on the
2. b) Aluminum alloy for processing with a lead content up to 1.5 wt% Spare parts for vehicles introduced on the
2. c) Aluminum alloy for processing with a lead content up to 0.4 wt% No expiry set
3. Copper alloy with a lead content up to 4 wt% No expiry set
4. a) Bearing shells and bearing cylinders (bushings) Spare parts for vehicles introduced on the
4. b) Bearing shells and bushings for engines, transmissions and air conditioning Up to Jul. 1, 2013. Spare parts for vehicles
compressors introduced on the market before Jul. 1,
2013 after the expiry date of the
exemption
[Lead and lead compounds in components]
5. Lead acid batteries No expiry set
6. Vibration dampers No expiry set
7. a) Vulcanizing agents and stabilizers for elastomers used in brake hoses, fuel hoses, air Spare parts for vehicles introduced on the
ventilation hoses, elastomeric/metallic components for chassis and engine mountings market before Jul. 1, 2008
7. b) Vulcanizing agents and stabilizers with a lead content up to 0.5 wt% for elastomer
used in brake hoses, fuel hoses, air ventilation hoses, elastomeric/metallic components for
chassis and engine mountings
7. c) Elastomeric adhesive with a lead content up to 0.5 wt% used in power trains
8(a). Leaded solder for mounting electronic or electric units, except aluminum electrolytic New models that were and will be
capacitor terminals, on electric circuit boards, and leaded solder on the surface of terminals introduced before Jan. 1, 2018 and spare
of electronic units or on the surface of electric circuit boards parts for those vehicles
8(b). Leaded solder used for anything other than mounting of electronic or electric units on New models that were and will be
electric circuit boards or on glass <leaded solder excluding those stipulated in 8(a) and in introduced before Jan. 1, 2013 and spare
8(c) to 8(j)> parts for those vehicles
8(c). Leaded solder on terminals of aluminum electrolytic capacitors New models that were and will be
introduced before Jan. 1, 2015 and spare
8(d). Leaded solder on glass in airflow sensors New models that were and will be
introduced before Jan. 1, 2017 and spare

8(e). Leaded solder with a high melting point (i.e. lead alloy with a lead content of 85% or Shall be studied in accordance with the
more) latest version of EU directive
8(f). Lead in compliant pin connector systems Shall be studied in accordance with the
latest version of EU directive
8(g). Leaded solder for connecting semiconductor chips in integrated circuits in flip chip Shall be studied in accordance with the
packages with carriers latest version of EU directive
8(h). Leaded solder for bonding heat spreaders in assembly pats of power semiconductors
Shall be studied in accordance with the
to heat sinks with the chip projection area of at least 1 cm2 and the nominal current density
at least 1 A/mm2 of the silicon chip
8(i). Leaded solder used for welding on glass of electric units, except for soldering in New models that were and will be
laminated glazing introduced before Jan. 1, 2015 and spare
(Shall be studied in accordance with the
latest version of EU directive)
8(j). Leaded solder for bonding in laminated glazing Shall be studied in accordance with the
9. Valve seats
Spare parts for engines developed before
Jul. 1, 2009
10. Leaded electronic components in glass or ceramic substrates, excluding glass of light
bulb glass and glaze of spark plugs No expiry set
11. Initiators
Vehicles whose model was certified
before Jul. 1, 2008 and their spare parts

21
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
12. a) Anti-rust coating
market before July, 1, 2009
12. b) Anti-rust coating for bolts and nuts for use in assembling of chassis components
market before July, 1, 2010
13. Heat absorption refrigerators for camping trailers No expiry set

[Mercury]
14. a) Discharge headlamps
New models that were and will be
introduced before July 1, 2014 and spare
14. b) Fluorescent tubes for instrument panel displays

New models that were and will be
introduced before July. 1, 2014 and spare
[Cadmium]
15. Batteries for electrical vehicles Spare parts for vehicles introduced on the
market before Dec., 31, 2010
Note
1. A maximum concentration value up to 0.1 wt% per homogeneous material for lead, hexavalent chromium and mercury and up to 0.01
wt% per homogeneous material for cadmium are tolerated.
2. This application exemption parts list applies to the new model vehicles released after Jan. 1, 2008 and the spare parts for those
vehicles.
It does not apply to the vehicles released and sold before Jan. 1, 2008.
3. This application exemption parts list is based on Europe ELV: 2005/673/EC, 2008/689/EC, and 2010/115/EU.
The numbers in the list correspond to those in Annex II of EU directive.

22
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Table 4 Materials and components exempted from mandatory standard of prohibited/restricted-use substances for
road vehicles of China
The standard GB/T 30512-2014 specifies prohibited substances in automobile complete vehicles and their
components. Scope of prohibited substances: 4 heavy metals (lead, hexavalent chromium, cadmium and Mercury,
and two kinds of flame retardants (polybrominated diphenyl and polybrominated diphenyl ether).
Range of exemption
New models Current models
[Lead alloy]
1. Steel materials for machine processing or galvanized steel (lead ≦
No expiry set No expiry set
0.35%)
2. Aluminum materials (lead ≦0.4%) No expiry set No expiry set
3. Copper alloy (lead ≦4%) No expiry set No expiry set
4 (a). Bearing bush and axle bush Jan. 30, 2015 Jun. 30, 2017
4(b). Engine, transmission and air conditioner compressor bearing bush
Jun. 30, 2016 Jun. 30, 2018
and axle bush
[Lead and lead compound for parts]
5. Batteries No expiry set No expiry set
6. Shock absorber No expiry set No expiry set
7. Vulcanizing preparations and stabilizer for elastomer used in brake
hose, fuel hose, ventilation hose, chassis/elastomer used in metal parts Jan. 30, 2015 Jun. 30, 2017
and engine suspension (lead≦0.5%)
8. Elastomer adhesive on power train (lead ≦0.5%) Jan. 30, 2015 Jun. 30, 2017
9. Welding material for circuit board and other electric parts No expiry set No expiry set
10. Valve seat Jan. 30, 2015 Jun. 30, 2017
11. Electric module composed of lead glass or ceramic based compound
No expiry set No expiry set
materials, excluding glazing layer of glass of light bulb and spark plug
12. Initial explosive Jan. 30, 2015 Jun. 30, 2017
13. Lead-plated plate used for automobile fuel tank Jan. 30, 2015 Jun. 30, 2017
14. Wheel balance weight Jan. 30, 2014 Jun. 30, 2016
15. Carbon brushes for motors Jan. 30, 2015 Jun. 30, 2017
16. Contained in brake lining abrasion material (lead ≦0.5%) Jan. 30, 2014 Jun. 30, 2016
17. Preservative paint (corrosion preventive coatings) Jan. 30, 2014 Jun. 30, 2016
18. Preservative coating for parts such as bolt/nut for chassis assembly Jan. 30, 2014 Jun. 30, 2016
19. Endothermic type air conditioner in caravan No expiry set No expiry set
[Mercury]
20. Discharge lamp for headlamp No expiry set No expiry set
21. Dashboard display fluorescent tube No expiry set No expiry set
[Cadmium]
22. Nickel cadmium battery for electric vehicle Repair vehicle parts Repair vehicle parts
put on the market put on the market
before the effective before the effective
date date
[Brominated flame retardant]
23. Decabromodiphenylether No expiry set No expiry set
Notes:
1. The limit of concentration in the parenthesis denotes a fraction by mass.
2. Exemption time limit in the table is the exemption time limit of newly approved vehicle type, exemption time limit
of in-production vehicle will be postponed by 2 years

23
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Common spec. format (RNES)
Comparison
with GADSL
Classification Prohibition
EINECS / GADSL A: Following Priority Declaration Sunset date /
Group No. Groupe of substances Substance name CAS No RENAULT threshold Example of Use Hazard (for information) Regulation Observation
ELINCS Classification GADSL substance threshold (wt%) Effective date
NISSAN (wt%)
B: Specific
requirement
Flam. Liq. 1
Adhesive, antiseptic, Carc. 2
1 Acetaldehyde 75-07-0 200-836-8 D D A 0.01% Reg. (EC) No 1272/2008
for photo development Eye Irrit. 2
STOT SE 3
Plasticizer,
2 Acetamide 60-35-5 200-473-5 P - B 0.1% 0.01% Carc. 2 Reg. (EC) No 1272/2008
stabilizer
Dye material, synthetic organic REACH SVHC

3 Acetamide, N-methyl- 79-16-3 201-182-6 P D B 0.3% 0.01% Repr. 1B
intermediate body Reg. (EC) No 1272/2008
Flam. Liq. 2
Acute Tox. 4 *
Vitamin B1,
4 Acetonitrile 75-05-8 200-835-2 D D A 0.01% Acute Tox. 4 * Reg. (EC) No 1272/2008
Butadiene extraction
Acute Tox. 4 *
Eye Irrit. 2
Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 3 *
STOT RE 1 REACH Annex XVII, SVHC
5 Acrylamide 79-06-1 201-173-7 P D B X 0.001% 0.001% Adhesive, paint
Acute Tox. 4 * Reg. (EC) No 1272/2008
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Flam. Liq. 2
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * PACT
6 Acrylonitrile 107-13-1 203-466-5 D D A 0.01% Plastic
STOT SE 3 Reg. (EC) No 1272/2008
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
Acute Tox. 4 *
Amines, which can form polyurethane foams, corrosion
STOT RE 2 * Regulated according to German
7 carcinogenic Nitrosamines, N,N-Diethanolamine 111-42-2 203-868-0 D D A 0.01% inhibitors, lubricants, rubber,
Skin Irrit. 2 TRGS 615
selected colourants, herbicides
Eye Dam. 1
Flam. Liq. 2
Amines, which can form Acute Tox. 4 * See 1st line of "Amines, which can
7 carcinogenic Nitrosamines, N,N-Diethylamine 109-89-7 203-716-3 D D A 0.01% Acute Tox. 4 * form carcinogenic Nitrosamines,
selected Acute Tox. 4 * selected"
Skin Corr. 1A
Flam. Liq. 2
Amines, which can form See 1st line of "Amines, which can
Acute Tox. 4 *
7 carcinogenic Nitrosamines, N,N-Di-i-propylamine 108-18-9 203-558-5 D D A 0.01% form carcinogenic Nitrosamines,
Acute Tox. 4 *
selected selected"
Skin Corr. 1B
Flam. Gas 1
Press. Gas
Acute Tox. 4 *
7 carcinogenic Nitrosamines, N,N-Dimethylamine 124-40-3 204-697-4 D D A 0.01% form carcinogenic Nitrosamines,
STOT SE 3
selected selected"
Skin Irrit. 2
Eye Dam. 1
24
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Flam. Liq. 2
7 carcinogenic Nitrosamines, N,N-Di-n-propylamine 142-84-7 205-565-9 D D A 0.01% Acute Tox. 4 * form carcinogenic Nitrosamines,
Skin Corr. 1A
Flam. Liq. 3
Acute Tox. 4 *
7 carcinogenic Nitrosamines, N,N-Di-n-butylamine 111-92-2 203-921-8 D D A 0.01% form carcinogenic Nitrosamines,
Acute Tox. 4 *
selected selected"
Acute Tox. 4 *
Acute Tox. 3 *
Acute Tox. 3 *
7 carcinogenic Nitrosamines, N,N-Ethylphenylamine 103-69-5 203-135-5 D D A 0.01% form carcinogenic Nitrosamines,
Acute Tox. 3 *
selected selected"
STOT RE 2 *
7 carcinogenic Nitrosamines, N,N-Methylethylamine 624-78-2 210-862-1 D D A 0.01% form carcinogenic Nitrosamines,
selected selected"
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
7 carcinogenic Nitrosamines, N-Methyl-N-phenylamine 100-61-8 202-870-9 D D A 0.01% form carcinogenic Nitrosamines,
STOT RE 2 *
selected selected"
Aquatic Acute 1
Aquatic Chronic 1
Flam. Liq. 3
7 carcinogenic Nitrosamines, Morpholine 110-91-8 203-815-1 D D A 0.01% Acute Tox. 4 * form carcinogenic Nitrosamines,
Skin Corr. 1B
Flam. Liq. 2
Acute Tox. 3 *
7 carcinogenic Nitrosamines, Piperidine 110-89-4 203-813-0 D D A 0.01% form carcinogenic Nitrosamines,
Acute Tox. 3 *
selected selected"
Skin Corr. 1B
7 carcinogenic Nitrosamines, Pyrrolidine 123-75-1 204-648-7 D D A 0.01% form carcinogenic Nitrosamines,
selected selected"
Dye intermediate for natural

REACH Annex XVII, SVHC
fabric and leather
Carc. 1A Reg. (EC) No 1272/2008
8 4-Aminobiphenyl and its salts, 4-Aminobiphenyl 92-67-1 202-177-1 P P A 0.1% 0.01% Oxidation inhibitor for
Acute Tox. 4 * Industrial Safety and Health Law:
all members lubrication oil, rubber, latex
Production prohibited substances
and plastic
Dye intermediate for natural

fabric and leather restricted as "4-Aminobiphenyl
8 4-Aminobiphenyl and its salts, p-aminobiphenyl hydrochloride 2113-61-3 P P A 0.1% 0.01% Oxidation inhibitor for Carc. 1A xenylamine and its salts" by
all members lubrication oil, rubber, latex REACH Annex XVII
and plastic
Carc. 2
Muta. 2
Acute Tox. 3 *
Aniline and its salts,
9 Aniline 62-53-3 200-539-3 R D B 0.1% 0.01% Dye, hardening accelerator Acute Tox. 3 * PACT Prohibit in North America
all members
STOT RE 1 TSCA Article 5
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aniline and its salts, Pigments, sulfonamides,

9 Aniline chloride 142-04-1 205-519-8 D D A 0.01% Reg. (EC) No 1272/2008
all members isocyanate - plastics
25
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

9 Anilinetrifluoroboron 660-53-7 211-539-8 D D A 0.01% Reg. (EC) No 1272/2008
all members isocyanate - plastics

9 Benzenamine sulfate (2:1) 542-16-5 D D A 0.01% Reg. (EC) No 1272/2008
all members 208-805-0 isocyanate - plastics
Polymer cross-linking agent, Carc. 1B

Aniline and its salts, Salts from 2,2'-Dichloro-4,4'- synthetic raw materials Acute Tox. 4 * REACH ANNEX XIV
9 101-14-4 202-918-9 P - B X 0.01% 0.01% 2017/11/22
all members methylendianilin Azo dye synthesis, weed-killer, Aquatic Acute 1 Reg. (EC) No 1272/2008
antioxidant Aquatic Chronic 1
Acute Tox. 4 *
Aniline and its salts, 3,5-Dichloro-4-(1,1,2,2- Pigments, sulfonamides,
9 104147-32-2 401-790-3 D D A 0.01% Aquatic Acute 1 Reg. (EC) No 1272/2008
all members Tetrafluroethoxy)Aniline isocyanate - plastics
Aquatic Chronic 1
9,10-Anthracenedione, 1-[(5,7-dichloro-
1,9-dihydro-2-methyl-9- Carcinogenic, Reg. (EC) No 1272/2008
10 74336-60-0 277-824-4 D D A 0.01% Azo dye
oxopyrazolo[5,1-b]quinazolin-3-yl)azo]- genotoxicity
(Pigment Red 251)
Canada Gazette Vol. 140, No. 49 -

9,10-Anthracenedione, 1,8-dihydroxy-4- Pigment, tinting, dye, ink, and Carcinogenic,
11 20241-76-3 243-632-4 D - B 0.01% December 9, 2006 (Canadian
nitro-5-(phenylamino)- fabric genotoxicity
Challenge)
Flame retardant synergist for

Acute Tox. 4 *
plastics and rubber/latex,
12 Antimonytrioxide (Diantimonytrioxide) 1309-64-4 215-175-0 D D A 0.01% Acute Tox. 4 * Reg. (EC) No 1272/2008
opacifier, friction material
Aquatic Chronic 2
component
Impurities in fabric and leather Carc. 2

stainer; Eye Irrit. 2
13 Aromatic amines, selected N-Phenyl-2-naphthylamine 135-88-6 205-223-9 D D A 0.01% oxidation inhibitor for Skin Irrit. 2 Reg. (EC) No 1272/2008
lubrication oil, rubber/latex, Skin Sens. 1
and plastic Aquatic Chronic 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
13 Aromatic amines, selected Diethylmethylbenzenediamine 68479-98-1 270-877-4 D D A 0.01% Reg. (EC) No 1272/2008
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
Skin Sens. 1
13 Aromatic amines, selected Bis(methylthio)toluenediamine 106264-79-3 403-240-8 D D A 0.01% Reg. (EC) No 1272/2008
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
13 Aromatic amines, selected Diphenylamine 122-39-4 204-539-4 D D A 0.01% Lubricant, explosive Reg. (EC) No 1272/2008
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
1,3-benzenediamine, 4,6-diethyl-2- STOT RE 2 *
13 Aromatic amines, selected 2095-01-4 218-255-3 D D A 0.01% Reg. (EC) No 1272/2008
methyl- Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
26
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Acute Tox. 4 *
Acute Tox. 4 *
1,3-benzenediamine, 2,4-diethyl-6- STOT RE 2 *
13 Aromatic amines, selected 2095-02-5 218-256-9 D D A 0.01% Reg. (EC) No 1272/2008
methyl- Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
Muta. 2
Acute Tox. 3 *
13 Aromatic amines, selected O-toluidine, 4-chloro-, hydrochloride 3165-93-3 221-627-8 P D B 0.1% 0.01% Acute Tox. 3 * Reg. (EC) No 1272/2008
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
Muta. 2
13 Aromatic amines, selected Anisole, 2,4-diamino-, sulphate 39156-41-7 254-323-9 D D A 0.01% Reg. (EC) No 1272/2008
Acute Tox. 4 *
Aquatic Chronic 2
Carc. 2
Acute Tox. 3 *
Benzenamine, 2-methyl-5-nitro-,
13 Aromatic amines, selected 51085-52-0 256-960-8 D D A 0.01% Acute Tox. 3 * Reg. (EC) No 1272/2008
monohydrochloride
Acute Tox. 3 *
Aquatic Chronic 3
[4-[[4-anilino-1-naphthyl][4-
(dimethylamino)phenyl]methylene]cyclo Reg. (EC) No 1272/2008
13 Aromatic amines, selected 2580-56-5 219-943-6 D D A 0.01% Ink component for labels
hexa-2,5-dien-1-ylidene] REACH SVHC
dimethylammonium chloride (C.I. Basic
Blue 26)
Carc. 2
Methanaminium, n-[4-[bis[4-
Acute Tox. 4 *
(dimethylamino)phenyl]methylene]-2,5- Reg. (EC) No 1272/2008
13 Aromatic amines, selected 548-62-9 208-953-6 D D A 0.01% Ink component on labels. Eye Dam. 1
cyclohexadien-1-ylidene]-n-methyl-, REACH SVHC
Aquatic Acute 1
chloride: C.I. Basic Violet 3
Aquatic Chronic 1
Benzenamine, 4-[(4-aminophenyl) Reg. (EC) No 1272/2008

13 Aromatic amines, selected (4-imino-2,5-cyclohexadien-1-ylidene) 569-61-9 209-321-2 D D A 0.01% Dye Carc. 1B Registry of Intension List for
methyl]-,monohydrochloride REACH Annex XIV
Paints, leather and textile Acute Tox. 3 * REACH Annex XIV

Arsenic and its compounds, finishes, glasses, pyrotechnic Acute Tox. 3 * REACH Annex XVII
14 Arsenic pentoxide 1303-28-2 215-116-9 P D/P B X 0.01% 0.01% 2015/5/21
all members objects, metal finishes, Aquatic Acute 1 Reg. (EC) No 1272/2008
electronics Aquatic Chronic 1 Reg. (EU) No 528/2012
Acute Tox. 3 *
REACH Annex XVII
Arsenic and its compounds, Acute Tox. 3 *
14 Diphenoxarsin-10-yloxid 58-36-6 200-377-3 D D/P B 0.01% Reg. (EC) No 1272/2008
all members Aquatic Acute 1
Reg. (EU) No 528/2012
Aquatic Chronic 1
REACH ANNEX XVII

Arsenic and its compounds, 2,6-Dimethyl-4-(1-naphthyl)pyrylium Reg. (EC) No 1272/2008
14 84282-36-0 282-682-1 D D A 0.01%
all members hexafluoroarsenate Gefsto ff V Annex IV
No. 3, No. 5
Arsenic and its compounds, 2,6-Dimethyl-4-phenylpyrylium REACH ANNEX XVII

14 84304-15-4 282-700-8 D D A 0.01%
all members hexafluoroarsenate Reg. (EC) No 1272/2008
Arsenic and its compounds, 4-Cyclohexyl-2,6-dimethylpyrylium REACH ANNEX XVII

14 84304-16-5 282-701-3 D D A 0.01%
all members hexafluoroarsenate Reg. (EC) No 1272/2008
27
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Arsenic and its compounds, 6,6'-Dihydroxy-3,3'-diarsene-1,2- REACH ANNEX XVII

14 139-93-5 205-386-6 D D A 0.01%
all members diyldianilinium dichloride Reg. (EC) No 1272/2008
Arsenic and its compounds, REACH ANNEX XVII

14 Aluminum arsenide (AlAs) 22831-42-1 245-255-0 D D A 0.01%
all members Reg. (EC) No 1272/2008
Acute Tox. 3 *
231-901-9
Arsenic and its compounds, Acute Tox. 3 * REACH ANNEX XVII
14 Aluminum gallium arsenide ((Al,Ga)As) 37382-15-3 231-547-5 D D A 0.01%
all members Aquatic Acute 1 Reg. (EC) No 1272/2008
231-904-5
Aquatic Chronic 1

14 Ammonium arsenate 7784-44-3 232-067-9 D D A 0.01%

14 Ammonium-magnesium-arsenat 14644-70-3 D D A 0.01%

14 Antimony arsenate 28980-47-4 249-347-1 D D A 0.01%

14 Antimony arsenic oxide 64475-90-7 264-904-9 D D A 0.01%

14 Antimony arsenide (Sb3As) 12255-36-6 235-505-7 D D A 0.01%

14 Arsenargentite (Ag3As) 12417-99-1 235-652-7 D D A 0.01%

14 Arsenate(1-), hexafluoro-, hydrogen 17068-85-8 241-128-9 D D A 0.01%

14 Arsenate(1-), hexafluoro-, lithium 29935-35-1 249-963-0 D D A 0.01%

14 Arsenate(1-), hexafluoro-, potassium 17029-22-0 241-102-7 D D A 0.01%

14 Arsenenous acid, lithium salt 72845-34-2 D D A 0.01%

14 Arsenic acid 1327-52-2 231-901-9 D D A 0.01%
Acute Tox. 3 *
Arsenic and its compounds, Acute Tox. 3 * REACh Annex XIV, Annex XVII
14 Arsenic acid 7778-39-4 231-901-9 P D B X 0.01% 0.01% 2017/8/22
Aquatic Chronic 1
Arsenic and its compounds, Arsenic acid (H3AsO4), REACH ANNEX XVII
14 32680-29-8 251-151-6 D D A 0.01%
all members ammonium copper(2+) salt (1:1:1) Reg. (EC) No 1272/2008
REACH ANNEX XVII

Reg. (EC) No 1272/2008
Arsenic and its compounds, Arsenic acid (H3AsO4), barium salt
14 13477-04-8 236-762-8 D D A 0.01% Gefsto ff V Annex IV
all members (2:3)
No. 3, No. 5
1907/2006
28
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Arsenic and its compounds, Arsenic acid (H3AsO4), bismuth salt REACH ANNEX XVII
14 13702-38-0 D D A 0.01%
all members (1:1) Reg. (EC) No 1272/2008

14 Arsenic acid (H3AsO4), copper salt 10103-61-4 233-286-2 D D A 0.01%
Arsenic and its compounds, Arsenic acid (H3AsO4), copper(2+) salt REACH ANNEX XVII
14 7778-41-8 D D A 0.01%
Arsenic and its compounds, Arsenic acid (H3AsO4), dipotassium REACH ANNEX XVII
14 21093-83-4 D D A 0.01%
all members salt Reg. (EC) No 1272/2008
Arsenic and its compounds, Arsenic acid (H3AsO4), magnesium REACH ANNEX XVII
14 102110-21-4 310-019-9 D D A 0.01%
all members salt, manganese-doped Reg. (EC) No 1272/2008
Arsenic and its compounds, Arsenic acid (H3AsO4), REACH ANNEX XVII
14 13462-93-6 236-667-1 D D A 0.01%
all members monoammonium salt Reg. (EC) No 1272/2008
Arsenic and its compounds, Arsenic acid (H3AsO4), strontium salt REACH ANNEX XVII
14 13464-68-1 236-684-4 D D A 0.01%

14 Arsenic acid (H3AsO4), trilithium salt 13478-14-3 236-773-8 D D A 0.01%

14 Arsenic acid (H3AsO4), trisilver(1+) salt 13510-44-6 236-841-7 D D A 0.01%

14 Arsenic acid, trisodium salt 13464-38-5 236-682-3 D D A 0.01%
REACH ANNEX XVII

Arsenic and its compounds, Reg. (EC) No 1272/2008
14 Arsenic bromide 64973-06-4 265-296-8 D D A 0.01%
all members Gefsto ff V Annex IV
No. 3, No. 5
Acute Tox. 3 *
14 Arsenic bromide 7784-33-0 232-057-4 D D A 0.01%
Aquatic Chronic 1

14 Arsenic chloride 37226-49-6 D D A 0.01%

14 Arsino thioxo 12044-79-0 D D A 0.01%

14 Arsenic disulfide 56320-22-0 D D A 0.01%

14 Arsenic sulfide 12612-21-4 235-720-6 D D A 0.01%

14 Arsenic sulfide (As2S4) 12344-68-2 D D A 0.01%

14 Arsenic telluride (As2Te3) 12044-54-1 234-955-1 D D A 0.01%
29
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

14 Arsenic trichloride 60646-36-8 D D A 0.01%
Acute Tox. 3 *
Arsenic and its compounds, Acute Tox. 3 * REACH Annex XIV, Annex XVII
14 Arsenic trioxide 1327-53-3 215-481-4 P D/P B X 0.01% 0.01% 2015/5/21
Aquatic Chronic 1

14 Arsenic trisulfide 1303-33-9 215-117-4 D D A 0.01%
Acute Tox. 3 *
14 Arsenic, elemental 7440-38-2 231-148-6 D D A 0.01%
Aquatic Chronic 1

14 Arsenous acid, trisodium salt 13464-37-4 236-681-8 D D A 0.01%
Acute Tox. 3 *
14 Arsenous trichloride 7784-34-1 232-059-5 D D A 0.01%
Aquatic Chronic 1

14 Arsenous triiodide 7784-45-4 232-068-4 D D A 0.01%
REACH ANNEX XVII

14 Barium arsenide (Ba3As2) 12255-50-4 235-508-3 D D A 0.01%
No. 3, No. 5
Benzenediazonium,
14 3-methyl-4-(1-pyrrolidinyl)-, 27569-09-1 248-532-4 D D A 0.01%
hexafluoroarsenate(1-)
Benzenediazonium,
14 4-(diethylamino)-2-ethoxy-, 63217-33-4 264-027-1 D D A 0.01%
Arsenic and its compounds, Benzenediazonium,4-(ethylamino)-2- REACH ANNEX XVII

14 63217-32-3 264-026-6 D D A 0.01%
all members methyl-, hexafluoroarsenate(1-) Reg. (EC) No 1272/2008

14 Benzenesulfonic acid, 4-arsenoso- 71130-51-3 D D A 0.01%
Arsenic and its compounds, Benzenesulfonic acid, 4-arsenoso-, REACH ANNEX XVII
14 71130-50-2 D D A 0.01%
all members sodium salt Reg. (EC) No 1272/2008
Arsenic and its compounds, Boron(1+), bis(2,4-pentanedionato- REACH ANNEX XVII

14 68892-01-3 272-591-5 D D A 0.01%
all members O,O')-, (T-4)-, hexafluoroarsenate(1-) Reg. (EC) No 1272/2008

14 Calcium arsenate 10103-62-5 233-287-8 D D A 0.01%
Acute Tox. 3 *
14 Calcium arsenate 7778-44-1 231-904-5 D D A 0.01%
Aquatic Chronic 1
30
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

14 Calcium arsenide (Ca3As2) 12255-53-7 235-509-9 D D A 0.01%

14 Calcium arsenite 52740-16-6 258-147-3 D D A 0.01%

14 Calcium arsenite (2:1) 15194-98-6 D D A 0.01%

14 Calcium arsenite (2:3) 27152-57-4 248-266-9 D D A 0.01%
REACH ANNEX XVII

14 Copper acetoarsenite 12002-03-8 D D A 0.01%
No. 3, No. 5

14 Copper arsenate 29871-13-4 249-916-4 D D A 0.01%
Arsenic and its compounds, Copper arsenate hydroxide REACH ANNEX XVII
14 12774-48-0 D D A 0.01%
all members (Cu2(AsO4)(OH)) Reg. (EC) No 1272/2008
Acute Tox. 3 *
14 Copper arsenide (Cu3As) 12005-75-3 234-472-6 D D A 0.01%
Aquatic Chronic 1

14 Copper arsenite 10290-12-7 233-644-8 D D A 0.01%

14 Copper arsenite 33382-64-8 D D A 0.01%

14 Copper diarsenite 16509-22-1 240-574-1 D D A 0.01%

14 Diarsenic acid 13453-15-1 D D A 0.01%

14 Diphenyldiarsenic acid 4519-32-8 224-845-1 D D A 0.01%

14 Disodium hydrogen arsenate 10048-95-0 D D A 0.01%

14 Disodium hydrogen arsenate 7778-43-0 231-902-4 D D A 0.01%

14 Dysprosium arsenide (DyAs) 12005-81-1 234-473-1 D D A 0.01%

14 Erbium arsenide (ErAs) 12254-88-5 235-501-5 D D A 0.01%

14 Europium arsenide (EuAs) 32775-46-5 251-206-4 D D A 0.01%
31
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

14 Ferric arsenate 10102-49-5 233-274-7 D D A 0.01%

14 Ferric arsenite 63989-69-5 D D A 0.01%

14 Ferrous arsenate 10102-50-8 233-275-2 D D A 0.01%

14 Gadolinium arsenide (GdAs) 12005-89-9 234-475-2 D D A 0.01%
Repr. 1B
Arsenic and its compounds, Carc. 1B REACH ANNEX XVII
14 Gallium arsenide 1303-00-0 215-114-8 D D A 0.01%
all members STOT RE 1 Reg. (EC) No 1272/2008
Acute Tox. 3 *
231-901-9
14 Gallium arsenide phosphide 106097-61-4 231-547-5 D D A 0.01%
231-904-5
Aquatic Chronic 1
Acute Tox. 3 * REACH ANNEX XVII

Arsenic and its compounds, Acute Tox. 3 * Reg. (EC) No 1272/2008
14 Gallium arsenide phosphide 12044-20-1 234-948-3 D D A 0.01%
all members Aquatic Acute 1 Gefsto ff V Annex IV
Aquatic Chronic 1 No. 3, No. 5

14 Gallium zinc triarsenide 98106-56-0 308-577-3 D D A 0.01%

14 Germanium arsenide (GeAs) 12271-72-6 235-547-6 D D A 0.01%

14 Holmium arsenide (HoAs) 12005-92-4 234-476-8 D D A 0.01%

14 Indium arsenide (InAs) 1303-11-3 215-115-3 D D A 0.01%
Arsenic and its compounds, Iodonium, diphenyl-, REACH ANNEX XVII

14 62613-15-4 263-638-0 D D A 0.01%
all members hexafluoroarsenate(1-) Reg. (EC) No 1272/2008

14 Iron arsenide (Fe2As) 12005-88-8 234-474-7 D D A 0.01%

14 Iron arsenide (FeAs) 12044-16-5 234-947-8 D D A 0.01%

14 Iron arsenide (FeAs2) 12006-21-2 234-485-7 D D A 0.01%

14 Lanthanum arsenide (LaAs) 12255-04-8 235-502-0 D D A 0.01%

14 Lithium arsenide (Li3As) 12044-22-3 234-950-4 D D A 0.01%
32
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

14 Lutetium arsenide (LuAs) 12005-94-6 234-477-3 D D A 0.01%
Acute Tox. 3 *
14 Magnesium arsenate 10103-50-1 233-285-7 D D A 0.01%
Aquatic Chronic 1

14 Magnesium arsenide (Mg3As2) 12044-49-4 234-954-6 D D A 0.01%
Acute Tox. 3 *
231-901-9
14 Manganese arsenide (Mn2As) 12005-96-8 231-547-5 D D A 0.01%
231-904-5
Aquatic Chronic 1

14 Manganese arsenide (MnAs) 12005-95-7 234-478-9 D D A 0.01%

14 Manganese hydrogenarsenate 7784-38-5 232-063-7 D D A 0.01%

14 Metaarsenic acid 10102-53-1 D D A 0.01%
REACH ANNEX XVII

Arsenic and its compounds, Methylium, triphenyl-, Reg. (EC) No 1272/2008
14 437-15-0 207-111-5 D D A 0.01%
all members hexafluoroarsenate(1-) Gefsto ff V Annex IV
No. 3, No. 5
Arsenic and its compounds, N-(p-Arsenosophenyl) REACH ANNEX XVII

14 21840-08-4 244-612-8 D D A 0.01%
all members -1,3,5-triazine-2,4,6-triamine Reg. (EC) No 1272/2008

14 Neodymium arsenide (NdAs) 12255-09-3 235-504-1 D D A 0.01%

14 Niobium arsenide (NbAs) 12255-08-2 235-503-6 D D A 0.01%

14 Platinum arsenide (PtAs2) 12044-52-9 D D A 0.01%
Acute Tox. 3 *
14 Potassium arsenate 7784-41-0 232-065-8 D D A 0.01%
Aquatic Chronic 1

14 Potassium arsenide (K3As) 12044-21-2 234-949-9 D D A 0.01%
Acute Tox. 3 *
14 Potassium arsenite 10124-50-2 233-337-9 D D A 0.01%
Aquatic Chronic 1

14 Potassium arsenite 13464-35-2 236-680-2 D D A 0.01%
33
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

14 Praseodymium arsenide (PrAs) 12044-28-9 234-953-0 D D A 0.01%

14 Samarium arsenide (SmAs) 12255-39-9 235-506-2 D D A 0.01%
Arsenic and its compounds, Silicic acid (H4SiO4), tetraethyl ester, REACH ANNEX XVII
14 68957-75-5 D D A 0.01%
all members polymer with arsenic oxide(As2O3) Reg. (EC) No 1272/2008
Silicon(1+), tris(2,4-pentanedionato-
14 O,O')-,(OC-6-11)-, 67251-38-1 266-621-6 D D A 0.01%
REACH ANNEX XVII

14 Silver arsenide (Ag2As) 70333-07-2 274-573-2 D D A 0.01%
No. 3, No. 5
Acute Tox. 3 *
14 Silver arsenite 7784-08-9 232-048-5 D D A 0.01%
Aquatic Chronic 1

14 Sodium arsenate 7631-89-2 231-547-5 D D A 0.01%

14 Sodium arsenide (Na3As) 12044-25-6 234-952-5 D D A 0.01%

14 Sodium arsenite 7784-46-5 232-070-5 D D A 0.01%

14 Sodium metaarsenate 15120-17-9 239-171-3 D D A 0.01%

14 Strontium arsenide (Sr3As2) 39297-24-0 254-407-5 D D A 0.01%

14 Strontium arsenite 15195-06-9 D D A 0.01%

14 Strontium arsenite 91724-16-2 D D A 0.01%

14 Strychnidin-10-one, arsenite (1:1) 100258-44-4 309-388-9 D D A 0.01%

14 Strychnine arsenate 10476-82-1 233-970-0 D D A 0.01%
Arsenic and its compounds, Sulfonium, triphenyl-, REACH ANNEX XVII

14 57900-42-2 261-009-5 D D A 0.01%
all members hexafluoroarsenate(1-) Reg. (EC) No 1272/2008

14 Terbium arsenide (TbAs) 12006-08-5 234-479-4 D D A 0.01%

14 Thallium arsenide (TlAs) 12006-09-6 234-481-5 D D A 0.01%
34
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

14 Thallium triarsenide 84057-85-2 281-902-3 D D A 0.01%

14 Thulium arsenide (TmAs) 12006-10-9 234-482-0 D D A 0.01%

14 Triammonium arsenate 24719-13-9 246-428-3 D D A 0.01%
231-901-9 Tox. 3 *
REACH SVHC
Arsenic and its compounds, 427-700-2 Acute Tox. 3 *
14 Triethyl arsenate 15606-95-8 D D A 0.01% REACH Annex XVII
all members 231-547-5 Aquatic Acute 1
Reg. (EC) No 1272/2008
231-904-5 Aquatic Chronic 1

14 Triethyl arsenite 3141-12-6 221-543-1 D D A 0.01%

14 Trimanganese arsenide 61219-26-9 262-667-6 D D A 0.01%
Arsenic and its compounds, Tris[(8a)-6'-methoxycinchonan-9(R)-ol] REACH ANNEX XVII

14 94138-87-1 303-002-2 D D A 0.01%
all members arsenite Reg. (EC) No 1272/2008
REACH ANNEX XVII

Arsenic and its compounds, Tris[(8a,9R)-6'-methoxycinchonan-9-ol] Reg. (EC) No 1272/2008
14 549-59-7 208-971-4 D D A 0.01%
all members bis(arsenate) Gefsto ff V Annex IV
No. 3, No. 5

14 Vanadium(4+) diarsenate (1:1) 99035-51-5 308-917-0 D D A 0.01%

14 Ytterbium arsenide (YbAs) 12006-12-1 234-483-6 D D A 0.01%

14 Yttrium arsenide (YAs) 12255-48-0 235-507-8 D D A 0.01%
Arsenic and its compounds, Zinc arsenenate oxide REACH ANNEX XVII
14 1303-39-5 D D A 0.01%
all members (Zn5(AsO3)4O3), tetrahydrate Reg. (EC) No 1272/2008

14 Arsenic acid (H3AsO4), zinc salt (2:3) 13464-44-3 236-683-9 D D A 0.01%

14 Zinc arsenide (Zn3As2) 12006-40-5 234-486-2 D D A 0.01%

14 Zinc arsenide (ZnAs2) 12044-55-2 234-956-7 D D A 0.01%

14 Zinc arsenite 10326-24-6 D D A 0.01%

14 Zirconium arsenide (ZrAs) 60909-47-9 262-524-8 D D A 0.01%
35
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Acute Tox. 3 *
231-901-9
14 Arsorous acid 13464-58-9 231-547-5 D D A 0.01%
231-904-5
Aquatic Chronic 1
Acute Tox. 3 *
14 Arsin 7784-42-1 232-066-3 D D A 0.01%
Aquatic Chronic 1
Carc. 1B
Arsenic and its compounds, Skin Sens. 1 REACH ANNEX XVII
14 Chromium arsenide (Cr2As) 12254-85-2 235-499-6 P D B 0.01% 0.01%
Aquatic Chronic 1
REACH ANNEX XVII

14 Arsenic selenide (As2Se3) 1303-36-2 215-119-5 D D A 0.01%
all members Waste Disposal and Public
Cleaning Law
Arsenic and its compounds, Arsenic acid (H3AsO4), cobalt(2+) salt REACH ANNEX XVII
14 24719-19-5 246-429-9 D D A 0.01%
Acute Tox. 3 *
231-901-9
14 Arsenopyrite, cobaltoan 12414-94-7 231-547-5 D D A 0.01%
231-904-5
Aquatic Chronic 1

14 Cobalt arsenide (CoAs) 27016-73-5 248-168-6 D D A 0.01%

14 Cobalt arsenide (CoAs2) 12044-42-7 D D A 0.01%

14 Cobalt arsenide (CoAs3) 12256-04-1 D D A 0.01%
REACH ANNEX XVII

Asbestos Fibres, Friction material, gasket, Carc. 1A
15 Asbestos, actinolite 77536-66-4 P P A - - Industrial Safety and Health Law in
all members insulation material STOT RE 1
Japan
Asbestos Fibres, Carc. 1A See 1st line of "Asbestos Fibres,

15 Asbestos, amosite 12172-73-5 P P A - -
all members STOT RE 1 all members"

15 Asbestos, anthophylite 77536-67-5 P P A - -

15 Asbestos, chrysotile 12001-29-5 P P A - -

15 Asbestos, crocidolite 12001-28-4 P P A - -

15 Asbestos, Tremolite 77536-68-6 P P A - -
Industrial Safety and Health Law in

Asbestos Minerals, Friction material, gasket, Fibroid lung,
16 Asbestos 1332-21-4 P D B - - Japan
all members heat insulating material carcinogenic
Potential to form Asbetos fibers
36
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Asbestos Minerals, See 1st line of "Asbestos Minerals,

16 Actinolite 13768-00-8 P D B - -
all members all members"

16 Tremolite 14567-73-8 P D B - -

16 Anthophyllite 17068-78-9 P D B - -

16 Actinolite 12172-67-7 P D B - -
Asbestos Minerals, Carc. 1A

16 Chrysotile 132207-32-0 P P A - - REACH ANNEX XVII
all members STOT RE 1

16 Crocidolite 132207-33-1 P D B - -
Carc. 1B
Amines, carcinogenic, Acute Tox. 3 * REACH Annex XVII
In dyes for textiles and leather
17 which are formed from 2,4,5-Trimethylaniline 137-17-7 205-282-0 P - B 0.1% 0.01% Acute Tox. 3 * German TRGS 614
articles
Azo-dyes, selected Acute Tox. 3 * Reg. (EC) No 1272/2008
Aquatic Chronic 2
See 1st line of "Amines,

Amines, carcinogenic,
carcinogenic,
17 which are formed from C.I. Acid Black 29 12217-14-0 P D/P B 0.1% 0.01%
which are formed from
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Acid Black 94, C.I.30336 6358-80-1 228-784-1 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Acid Brown 415 97199-27-4 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Acid Orange 45, C.I.22195 2429-80-3 219-389-5 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"
37
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
17 which are formed from C.I. Acid Red 4, C.I.14710 5858-39-9 227-490-0 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Acid Red 24, C.I.16140 5858-30-0 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Acid Red 119:1 90880-75-4 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"
38
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Acid Red 167 61901-41-5 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Acid Violet 12, C.I.18075 6625-46-3 229-584-7 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Basic Brown 4, C.I.21010 5421-66-9 226-541-4 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Basic Red 42 12221-66-8 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Basic Red 76, C.I.12245 68391-30-0 269-941-4 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

Amines, carcinogenic, STOT RE 2 *
carcinogenic,
17 which are formed from C.I. Basic Red 111 118658-98-3 408-000-6 P D/P B 0.1% 0.01% Skin Sens. 1
Azo-dyes, selected Aquatic Chronic 3
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Basic Yellow 82 12227-67-7 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"
39
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
17 which are formed from C.I. Basic Yellow 103 54060-92-3 258-946-7 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Black 29, C.I.22580 3626-23-1 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Black 154 37372-50-2 259-355-7 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Blue 1, C.I.24410 2610-05-1 220-026-8 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Blue 9, C.I.24155 6428-98-4 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"
40
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Blue 160 12222-02-5 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Brown 1:2, C.I.30110 2586-58-5 219-965-6 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Brown 25, C.I.36030 33363-87-0 251-466-9 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Brown 33, C.I.35520 1324-87-4 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"
41
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Brown 223 76930-14-8 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Green 8:1 76012-70-9 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Green 85, C.I.30387 72390-60-4 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Orange 1, C.I.22370 54579-28-1 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Orange 6 6637-88-3 229-639-5 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Orange 10, C.I.23370 6405-94-3 229-024-1 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"
42
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Red 2, C.I.23500 992-59-6 213-594-3 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Red 17, C.I.22150 2769-07-5 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"
43
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Violet 1, C.I.22570 2586-60-9 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Direct Yellow 1, C.I.22250 6472-91-9 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"
44
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Disperse Orange 60 12270-44-9 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Disperse Orange 149 151126-94-2 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Disperse Red 151, C.I.26130 61968-47-6 274-405-8 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Disperse Red 221 64426-35-3 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Disperse Yellow 7, C.I.26090 67701-38-6 228-587-0 P - B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Disperse Yellow 23, C.I.26070 6250-23-3 228-370-0 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Disperse Yellow 56 54077-16-6 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Disperse Yellow 218 83929-90-2 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Mordant Yellow 16 8003-87-0 232-327-1 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"
45
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
17 which are formed from C.I. Solvent Red 1, C.I.12150 1229-55-6 214-968-9 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Solvent Red 68 61813-90-9 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Solvent Red 164 71819-51-7 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Solvent Red 215 85203-90-3 286-282-8 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Solvent Yellow 72 4645-07-2 225-074-3 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"
Trisodium bis(6-(4-anisidino)-3- See 1st line of "Amines,

sulfonato-2-(3,5-dinitro-2- carcinogenic,
17 which are formed from 118685-33-9 P P A 0.1% 0.01%
oxidophenylazo)-1- which are formed from
Azo-dyes, selected
naphtholato)chromate(1-) Azo-dyes, selected"
46
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
17 which are formed from C.I. Direct Brown 27, C.I.31725 6360-29-8 228-826-9 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from C.I. Disperse Yellow 7, C.I.26090 6300-37-4 228-587-0 P D/P B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"

carcinogenic,
17 which are formed from 4,4'-Methylenedi-o-toluidine 838-88-0 212-658-8 P - B 0.1% 0.01% Carc. 1B
Azo-dyes, selected
Azo-dyes, selected"
Carc. 1B
Muta. 1B
Amines, carcinogenic, Repr. 2
carcinogenic,
17 which are formed from 4,4'-Oxydianiline 101-80-4 202-977-0 P - B 0.1% 0.01% Acute Tox. 3 *
Azo-dyes, selected Acute Tox. 3 *
Azo-dyes, selected"
Acute Tox. 3 *
Aquatic Chronic 2

Amines, carcinogenic, Carc. 1B
carcinogenic,
17 which are formed from 4,4'-Thiodianiline 139-65-1 205-370-9 P - B 0.1% 0.01% Acute Tox. 4 *
Azo-dyes, selected Aquatic Chronic 2
Azo-dyes, selected"
Carc. 1B
Acute Tox. 3 *
Amines, carcinogenic, Acute Tox. 3 *
carcinogenic,
17 which are formed from 4-Chloraniline 106-47-8 203-401-0 P - B 0.1% 0.01% Acute Tox. 3 *
Azo-dyes, selected Skin Sens. 1
Azo-dyes, selected"
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
Muta. 2
carcinogenic,
17 which are formed from 4-Chloro-o-toluidine 95-69-2 202-441-6 P - B 0.1% 0.01% Acute Tox. 3 *
Azo-dyes, selected"
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B See 1st line of "Amines,

Muta. 2 carcinogenic,
17 which are formed from 4-Methoxy-m-phenylenediamine 615-05-4 210-406-1 P - B 0.1% 0.01%
Acute Tox. 4 * which are formed from
Azo-dyes, selected
Aquatic Chronic 2 Azo-dyes, selected"
Carc. 1B
Muta. 2
Repr. 2 See 1st line of "Amines,
Acute Tox. 3 * carcinogenic,
17 which are formed from 4-Methyl-m-phenylendiamine 95-80-7 202-453-1 P - B 0.1% 0.01%
Azo-dyes, selected
STOT RE 2 * Azo-dyes, selected"
Skin Sens. 1
Aquatic Chronic 2
Carc. 2
carcinogenic,
17 which are formed from 5-Nitro-o-toluidine 99-55-8 202-765-8 P - B 0.1% 0.01% Acute Tox. 3 *
Azo-dyes, selected"
Aquatic Chronic 3
47
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

carcinogenic,
17 which are formed from o-Aminoazotoluene 97-56-3 202-591-2 P - B 0.1% 0.01% Carc. 1B
Azo-dyes, selected
Azo-dyes, selected"
Carc. 1B See 1st line of "Amines,

Amines, carcinogenic, Muta. 2 carcinogenic,
17 which are formed from o-Anisidine 90-04-0 201-963-1 P - B 0.1% 0.01% Acute Tox. 3 * which are formed from
Azo-dyes, selected Acute Tox. 3 * Azo-dyes, selected"
Acute Tox. 3 *

Carc. 1B carcinogenic,
17 which are formed from p-Cresidine 120-71-8 204-419-1 P - B 0.1% 0.01%
Azo-dyes, selected
Azo-dyes, selected"
200-453-6
Amines, carcinogenic, 222-530-3 Carc. 1B
carcinogenic,
17 which are formed from 4-Aminoazobenzene 60-09-3 226-789-3 D - B 0.01% Aquatic Acute 1
Azo-dyes, selected 202-199-1 Aquatic Chronic 1
Azo-dyes, selected"
252-984-8
222-530-3 See 1st line of "Amines,

226-789-3 carcinogenic,
17 which are formed from [1,1'-Biphenyl]-2,4,4'-triamine 2835-69-0 P - B 0.1% 0.001% Carc. 1B
202-199-1 which are formed from
Azo-dyes, selected
252-984-8 Azo-dyes, selected"
tetrasodium 5-benzamido-3-(5-(4-
Amines, carcinogenic, fluoro-6-(1-sulphonato-2- Eye Irrit. 2
carcinogenic,
17 which are formed from naphthylamino)-1,3,5-triazin-2- 85665-97-0 400-790-0 P - B 0.1% 0.001% Skin Irrit. 2
Azo-dyes, selected ylamino)-2-sulphonatophenylazo)-4- Skin Sens. 1
Azo-dyes, selected"
hydroxynaphthalene-2,7- disulphonate

Amines, carcinogenic, 202-080-4
N-(4-(1,1,3,3-tetramethylbutyl))phenyl- carcinogenic,
17 which are formed from 4572-51-4 209-030-0 P - B 0.1% 0.001%
1-naphthylamine which are formed from
Azo-dyes, selected 210-313-6
Azo-dyes, selected"

carcinogenic,
17 which are formed from 2-aminonaphthalene-1-sulphonic acid 81-16-3 201-331-5 P - B 0.1% 0.001%
Azo-dyes, selected
Azo-dyes, selected"

3,3'-dimethoxybiphenyl-4,4'- carcinogenic,
17 which are formed from 20325-40-0 243-737-5 P - B 0.1% 0.01% Carc. 1B
ylenediammonium dichloride which are formed from
Azo-dyes, selected
Azo-dyes, selected"
Carc. 2 See 1st line of "Amines,

C.I. Solvent Yellow 14; 1-Phenylazo-2- Muta. 2 carcinogenic,
17 which are formed from 842-07-9 212-668-2 D - B 0.01%
naphthol Skin Sens. 1 which are formed from
Azo-dyes, selected
Aquatic Chronic 4 Azo-dyes, selected"

Amines, carcinogenic, Acetamide, N-(2-((2-bromo-4,6-
carcinogenic,
17 which are formed from dinitrophenyl)azo)-5- 52697-38-8 258-110-1 D - B 0.01%
Azo-dyes, selected (diethylamino)phenyl)-
Azo-dyes, selected"
amitrol Repr. 2
18 (3-amino-1,2,4-triazole ; 1,2,4-triazole- 61-82-5 200-521-5 D - B 0.01% Weed-Killer STOT RE 2 * Reg. (EC) No 1272/2008
3-ylamine) Aquatic Chronic 2
Repr. 1B
Skin Corr. 1B
19 2-(2-aminoethylamino)ethanol 111-41-1 203-867-5 D - B 0.01% Reg. (EC) No 1272/2008
Skin Sens. 1
48
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Reg. (EC) No 1272/2008

Barium compounds Colour pigments, stabilizers for Acute Tox. 4 *
20 Barium 7440-39-3 231-149-1 D D A 0.01% Poisonous and Deleterious
(organic or water soluble) PVC,lubricant additives Acute Tox. 4 *
Substances Control Law in Japan
selected
Barium 2-
Barium compounds (2-hydroxy-3,6-disulphonato-1- Acute Tox. 4 * See 1st line of "Barium compounds
20 15782-06-6 239-880-8 D D A 0.01%
(organic or water soluble) naphthyl) Acute Tox. 4 * (organic or water soluble) selected"
selected azo benzoate (3:2)
Barium 4-
Barium compounds Acute Tox. 4 * See 1st line of "Barium compounds
20 (5-chloro-4-methyl-2-sulphonatophenyl) 7585-41-3 231-494-8 D D A 0.01%
(organic or water soluble) Acute Tox. 4 * (organic or water soluble) selected"
azo-3-hydroxy-2-naphthoate
selected

20 Barium 4-(1,1-dimethylethyl)benzoate 10196-68-6 233-490-1 D D A 0.01%
selected
Barium bis 5-chloro-4-ethyl-2-

20 (2-hydroxy-1-naphthyl)azo 67801-01-8 267-122-6 D D A 0.01%
benzenesulp...
selected

20 Barium bis(2-ethylhexanoate) 2457-01-4 219-535-8 D D A 0.01%
selected
Barium compounds Barium Acute Tox. 4 * See 1st line of "Barium compounds
20 25619-56-1 247-132-7 D D A 0.01%
(organic or water soluble) bis(dinonylnaphthalenesulphonate) Acute Tox. 4 * (organic or water soluble) selected"
selected

20 Barium bis(nonylphenolate) 28987-17-9 249-359-7 D D A 0.01%
selected

20 Barium distearate 6865-35-6 229-966-3 D D A 0.01%
selected
Barium compounds Barium oxide, obtained by calcining Acute Tox. 4 * See 1st line of "Barium compounds
20 1304-28-5 215-127-9 D D A 0.01%
(organic or water soluble) witherite Acute Tox. 4 * (organic or water soluble) selected"
selected
Barium(2+) hydrogen 2- (2-hydroxy-3,

20 6-disulphonato-1-naphthyl)azo 1325-16-2 215-388-9 D D A 0.01%
benzoate
selected
Ox. Sol. 1
20 Barium-chlorate 13477-00-4 236-760-7 D D A 0.01%
selected Aquatic Chronic 2

20 Barium-chloride 10361-37-2 233-788-1 D D A 0.01%
selected

20 Barium-cyanide 542-62-1 208-822-3 D D A 0.01%
selected
49
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

20 Barium-dilaurate 4696-57-5 225-167-9 D D A 0.01%
selected

20 Barium-dioleate 591-65-1 209-726-4 D D A 0.01%
selected

20 Barium-fluoride 7787-32-8 232-108-0 D D A 0.01%
selected

20 Barium-hydroxide 17194-00-2 241-234-5 D D A 0.01%
selected

20 Barium-hydroxide-octahydrate 12230-71-6 D D A 0.01%
selected

20 Barium-neodecanoate 55172-98-0 259-509-3 D D A 0.01%
selected

20 Barium-nitrate 10022-31-8 233-020-5 D D A 0.01%
selected

20 Barium-permanganate 7787-36-2 232-110-1 D D A 0.01%
selected
Ox. Sol. 2
Barium compounds See 1st line of "Barium compounds
20 Barium-peroxide 1304-29-6 215-128-4 D D A 0.01% Acute Tox. 4 *
(organic or water soluble) (organic or water soluble) selected"
Acute Tox. 4 *
selected

20 Barium-sebacate 19856-32-7 243-380-5 D D A 0.01%
selected

20 Naphthenic acid, Barium salts 61789-67-1 263-077-1 D D A 0.01%
selected
Ox. Sol. 1
Barium compounds See 1st line of "Barium compounds
20 Barium-perchlorate 13465-95-7 236-710-4 D D A 0.01% Acute Tox. 4 *
(organic or water soluble) (organic or water soluble) selected"
Acute Tox. 4 *
selected
50
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Flam. Liq. 2
Carc. 1A
REACH ANNEX XVII
Muta. 1B
Synthetic rubber, resin, Reg. (EC) No 1272/2008
21 Benzene 71-43-2 200-753-7 P P A 0.1% 0.01% STOT RE 1
plasticizer, solvent Industrial Safety and Health Law in
Asp. Tox. 1
Japan
Eye Irrit. 2
Skin Irrit. 2
Benzenamine, N-phenyl-, reaction Canada Gazette Vol. 140, No. 49 -

22 products with styrene and 2,4,4- 68921-45-9 272-940-1 R D/P A 0.1% 0.01% Rubber, Lubricant December 9, 2006 (Canadian Prohibit in North America
trimethylpentene (BNST) Challenge).
PACT
1,4-Benzenediamine, N,N' -mixed Ph Dye material, synthetic organic Canada Gazette Vol. 140, No. 49 -
23 68953-84-4 273-227-8 D D A 0.01%
and tolyl derivs intermediate body December 9, 2006 (Canadian
Challenge).
Carc. 2
Muta. 2
Adhesive, paint, Acute Tox. 4 * Reg. (EC) No 1272/2008
24 1,4 Benzenediol (Hydroquinone) 123-31-9 204-617-8 D D A 0.01%
car oil, fuel Eye Dam. 1 Canada SNAC
Skin Sens. 1
Aquatic Acute 1
REACH ANNEX XVII

Benzidine and its salts, all Dyes for cloth, paper, and Reg. (EC) No 1272/2008
25 Benzidine 92-87-5 202-199-1 P P A 0.01% 0.001% Carc. 1B
members leather. Industrial Safety and Health Law
Published in Canada Gazette
Carc. 1A
Benzidine and its salts, all Acute Tox. 4 * See 1st line of "Benzidine and its
25 Benzidine acetate 36341-27-2 252-984-8 P P A 0.01% 0.001%
members Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Benzidine and its salts, all See 1st line of "Benzidine and its
25 Benzidine salt 531-86-2 208-520-1 P P A 0.01% 0.001% Carc. 1B
members salts, all members"
25 Benzidine sulphate 21136-70-9 244-236-4 P P A 0.01% 0.001% Carc. 1B
Benzidine and its salts, all [1,1'-Biphenyl]-4,4'-diamine, See 1st line of "Benzidine and its
25 531-85-1 208-519-6 P P A 0.01% 0.001% Carc. 1B
members dihydrochloride salts, all members"
Benzidine and its salts, all [1,1'-Biphenyl]-4,4'-diamine, See 1st line of "Benzidine and its
25 70146-07-5 274-338-4 P P A 0.01% 0.001%
members 2,2'-dichloro-,sulfate (1:1) salts, all members"
25 3,3'-Dichlorobenzidine dihydrochloride 612-83-9 210-323-0 P P A 0.01% 0.001% Carc. 1B
25 3,3'-Dimethylbenzidine dihydrochloride 612-82-8 210-322-5 P P A 0.01% 0.001% Carc. 1B
Benzidine and its salts, all 4,4'-Diaminodiphenyl-2,2'-disulfonic See 1st line of "Benzidine and its
25 27336-24-9 P P A 0.01% 0.001%
members acid disodium salt salts, all members"
25 Acid Black 7 8004-59-9 P P A 0.01% 0.001%
25 Direct Orange 1 13164-93-7 236-106-0 P P A 0.01% 0.001%
51
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Benzidine and its salts, all Dipotassium O,O'-(4,4'-diaminobipheny See 1st line of "Benzidine and its
25 74220-10-3 277-771-7 P P A 0.01% 0.001%
members l-3,3'-ylene)diglycollate salts, all members"
25 3,3'-Dichlorbenzidine 91-94-1 202-109-0 P P A 0.01% 0.001% Carc. 1B
25 3,3'-Dimethoxybenzidine 119-90-4 204-355-4 P P A 0.01% 0.001% Carc. 1B
25 3,3'-Dimethylbenzidine 119-93-7 204-358-0 P P A 0.01% 0.001% Carc. 1B
25 Salts from 3,3'-Dimethoxybenzidine P - B 0.1% 0.01%
25 C.I. Acid Red 85, C.I.22245 3567-65-5 222-655-3 P P A 0.01% 0.001%
222-530-3
217-710-3
25 C.I. Direct Black 38, C.I.30235 1937-37-7 226-789-3 P P A 0.01% 0.001% Carc. 1B
202-199-1
252-984-8
25 C.I. Direct Black 4, C.I.30245 2429-83-6 219-392-1 P P A 0.01% 0.001%
222-530-3
220-012-1
25 C.I. Direct Blue 6, C.I.22610 2602-46-2 226-789-3 P P A 0.01% 0.001% Carc. 1B
202-199-1
252-984-8
25 C.I. Direct Blue 2, C.I.22590 2429-73-4 219-384-8 P P A 0.01% 0.001%
25 C.I. Direct Brown 1, C.I.30045 3811-71-0 223-294-4 P P A 0.01% 0.001%
Benzidine and its salts, all C.I. Direct Brown 31, C.I.35660; See 1st line of "Benzidine and its
25 2429-81-4 219-390-0 P P A 0.01% 0.001%
members tetrasodium salt salts, all members"
25 C.I. Direct Brown 95, C.I.30145 16071-86-6 240-221-1 P P A 0.01% 0.001% Carc. 1B
52
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
25 C.I. Direct Green 1, C.I.30280 3626-28-6 222-835-1 P P A 0.01% 0.001%
25 C.I. Direct Red 1, C.I.22310 2429-84-7 219-393-7 P P A 0.01% 0.001%
222-530-3
209-358-4
25 C.I. Direct Red 28, C.I.22120 573-58-0 226-789-3 P P A 0.01% 0.001% Carc. 1B
202-199-1
252-984-8
25 C.I. Direct Red 37, C.I.22240 3530-19-6 222-560-7 P P A 0.01% 0.001%
25 C.I. Direct Violet 22, C.I.22480 6426-67-1 P P A 0.01% 0.001%
Benzoic acid, 5-[[4'-[(1-amino-4-sulfo-2-

Benzidine and its salts, all naphthalenyl)azo][1,1'-biphenyl]-4- See 1st line of "Benzidine and its
25 2429-79-0 219-387-4 P P A 0.01% 0.001%
members yl]azo]-2-hydroxy-, disodium salt; C.I. salts, all members"
Direct Orange 8, C.I.22130
25 Trypan blue (C.I. Direct Blue 14) 72-57-1 200-786-7 P P A 0.01% 0.001%
Benzoic acid, 3,3'-[(3,7-disulfo-1,5-

naphthalenediyl)bis[azo(6-hydroxy-
3,1-phenylene)azo[6(or 7)-sulfo-4,
25 1-naphthalenediyl]azo[1,1'-biphenyl] 8014-91-3 232-397-3 P P A 0.01% 0.001%
-4,4'-diylazo]]bis[6-hydroxy-,
hexasodium salt; C.I. Direct Brown 74,
C.I.36300
25 Benzidine, Ni(2+) salt 67632-50-2 P P A 0.01% 0.001%
222-530-3
Benzidine and its salts, all 226-789-3 See 1st line of "Benzidine and its
25 N,N'-dimethylbenzidine 2810-74-4 P - B 0.1% 0.001% Carc. 1B
members 202-199-1 salts, all members"
252-984-8
Carc. 1B
Acute Tox. 3 *
benzyl chloride Production of quaternary Acute Tox. 4 *
PACT
26 (alpha-chlorotoluene ; 100-44-7 202-853-6 D - B 0.01% ammoniums, benzylic alcohol, STOT RE 2 *
Reg. (EC) No 1272/2008
chloromethylbenzene) phthalate … STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Benzothiazolesulphenamide, N, N- Persistent, PACT

27 4979-32-2 225-625-8 D D A 0.01% Vulcanizing accelerator
dicyclohexyl- high-accumulation JPN CSCL
2-(2H-benzotriazol-2-yl)-4,6- Dye material, synthetic organic

28 25973-55-1 247-384-8 D D A 0.01% vPvB REACH SVHC
ditertpentylphenol (UV-328) intermediate body
53
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Beryllium and its compounds, Coughing, shortness of breath,

29 Beryl ore 1302-52-9 215-101-7 D D A 0.01% Additive for alloy Reg. (EC) No 1272/2008
all members pharynngalgia
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Beryllium and its compounds, See 1st line of "Beryllium and its
29 Beryllate(2-), tetrafluoro-, diammonium 14874-86-3 238-948-4 D D A 0.01% Eye Irrit. 2
all members compounds, all members"
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1 See 1st line of "Beryllium and its
Beryllium and its compounds,
29 Beryllium 7440-41-7 231-150-7 D D A 0.01% Eye Irrit. 2 compounds, all members"
all members
STOT SE 3 PACT
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium aluminum alloy 12770-50-2 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium boride (Be2B) 12536-51-5 235-694-6 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium boride (Be4B) 12536-52-6 235-695-1 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium boride (BeB2) 12228-40-9 235-443-0 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
54
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium boride (BeB6) 12429-94-6 235-657-4 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium bromide (BeBr2) 7787-46-4 232-115-9 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium carbide (Be2C) 506-66-1 208-050-7 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium carbonate 13106-47-3 236-030-8 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium carbonate 66104-24-3 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium chloride 7787-47-5 D D A 0.01% Eye Irrit. 2
all members 232-116-4 compounds, all members"
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium di(acetate) 543-81-7 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
55
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
29 Beryllium fluoride 12323-05-6 232-118-5 D D A 0.01%
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium fluoride 7787-49-7 232-118-5 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium hydroxide 13327-32-7 236-368-6 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium iodide (BeI2) 7787-53-3 232-119-0 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium nitride (Be3N2) 1304-54-7 215-132-6 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium oxide 1304-56-9 215-133-1 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium phosphate 13598-15-7 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
56
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium phosphide 58127-61-0 261-137-1 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
29 Beryllium phosphide (BeP2) 57620-29-8 D D A 0.01%
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium sulfate 13510-49-1 236-842-2 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium sulfate tetrahydrate 7787-56-6 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium sulfide (BeS) 13598-22-6 237-064-6 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium telluride (BeTe) 12232-27-8 235-451-4 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
29 Beryllium zinc silicate 25638-88-4 247-151-0 D D A 0.01%
29 Beryllium zinc silicate 39413-47-3 D D A 0.01%
57
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Bis(pentane-2,4-dionato-O,O')beryllium 10210-64-7 233-513-5 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Diethylberyllium 542-63-2 208-823-9 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
29 Disodium tetrafluoroberyllate 13871-27-7 237-630-2 D D A 0.01%
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Beryllium and its compounds, Hexakis[.mu.-(acetato-O:O')]-.mu. See 1st line of "Beryllium and its
29 19049-40-2 242-785-4 D D A 0.01% Eye Irrit. 2
all members 4-oxotetraberyllium compounds, all members"
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Phosphoric acid, beryllium salt 35089-00-0 252-356-3 D D A 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
29 Phosphoric acid, beryllium salt (2:3) 13598-26-0 D D A 0.01%
Beryllium and its compounds, Silicic acid (H4SiO4), beryllium salt See 1st line of "Beryllium and its
29 15191-85-2 239-251-8 D D A 0.01%
all members (1:2) compounds, all members"
29 Silicic acid, beryllium salt 58500-38-2 261-293-0 D D A 0.01%
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
29 Beryllium nitrate 13597-99-4 237-062-5 D - B 0.01% Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
29 Beryllium nitrate trihydrate 7787-55-5 D - B 0.01%
58
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
29 Nitric acid, beryllium salt, tetrahydrate 13510-48-0 D - B 0.01%
29 Beryllium selenide (BeSe) 12232-25-6 235-450-9 D D A 0.01%
Acute Tox. 4 *
Skin Irrit. 2 P: Forbidden use as biocide in product-type : 7
Biocidal coatings / biocidal Reg. (EC) No 1272/2008
30 1,2-Benzisothiazoline-3-one 2634-33-5 220-120-9 R D/P A 0.1% 0.01% Polymer, herbicide Eye Dam. 1 Authorisation as biocide needed for product-type 8
additives, selected Reg. (EU) No 528/2012
Skin Sens. 1 D: Allowed use as biocide in product-type : 9
Aquatic Acute 1
Carc. 2
Acute Tox. 4 * Reg. (EC) No 1272/2008 D: Allowed use as biocide in product-type : 7
Biocidal coatings / biocidal
30 Diuron 330-54-1 206-354-4 R D B 0.1% 0.001% Weed-Killer STOT RE 2 * Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Aquatic Acute 1 PACT Authorisation as biocide needed for product-type 9
Aquatic Chronic 1
Biocidal coatings / biocidal REACH Annex XVII

30 Dimethylfumarate 624-49-7 210-849-0 P P A 0.1% 0.00001% Anti-mold
Biocidal and biostatic

30 5-chloro-2-methyl-4-thiazoline-3-ketone 26172-55-4 247-500-7 P P A 0.1% 0.001% treatments of polymers, Reg. (EU) No 528/2012
additives, selected
textiles, and other components
Acute Tox. 3 *
Acute Tox. 3 *
3(2h)-Isothiazolone, 5-chloro-2-methyl-, Acute Tox. 3 * P: Forbidden use as biocide in product-type : 7
30 mixture. With 2-methyl-3(2h)- 55965-84-9 R D/P A 0.1% 0.001% Skin Corr. 1B Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
isothiazolone Skin Sens. 1 P: Forbidden use as biocide in product-type : 9
Aquatic Acute 1
Aquatic Chronic 1
P: Forbidden use as biocide in product-type : 7

Biocidal coatings / biocidal Reg. (EU) No 528/2012
30 2-methyl-4-thiazoline-3-ketone 2682-20-4 220-239-6 R D/P A 0.1% 0.001% Polymer, herbicide Inflammation in skin and eyes Authorisation as biocide needed for product-type 8
additives, selected PACT
REACH ANNEX XIV

Biocidal coatings / biocidal Insecticide, insect repellent, RECOMMENDATION
30 Diboron trioxide 1303-86-2 215-125-8 P D B X 0.01% 0.01% Repr. 1B
additives, selected analysis reagent Reg. (EC) No 1272/2008
Reg. (EU) No 528/2012
Muta. 1B
carbendazim Allowed use as biocide in product-type : 7
Biocidal coatings / biocidal Repr. 1B Reg. (EC) No 1272/2008
30 (1H-benzimidazole-2-carbamic acid, 10605-21-7 234-232-0 R D B 0.01% 0.01% Biocide, fungicide Authorisation as biocide needed for product-type 8
additives, selected Aquatic Acute 1 Reg. (EU) No 528/2012
methyl ester) Allowed use as biocide in product-type : 9
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
Reg. (EC) No 1272/2008 P: Forbidden use as biocide in product-type 7
Biocidal coatings / biocidal 2-bromo-2-nitropropan-1,3-diol STOT SE 3
30 52-51-7 200-143-0 R D/P A 0.1% 0.01% Preservative Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected (bronopol) Skin Irrit. 2
D: Allowed use as biocide in product-type 9
Eye Dam. 1
Aquatic Acute 1
Acute Tox. 3 *
STOT RE 2 * Authorisation as biocide needed for product-type 7
30 Alpha-cypermethrin 67375-30-8 257-842-9 R D/P A 0.1% 0.01% STOT SE 3 P: Forbidden use as biocide in product-type : 8
Aquatic Acute 1 P: Forbidden use as biocide in product-type : 9
Aquatic Chronic 1
Benzalkonium chloride; Quaternary P: Forbidden use as biocide in product-type : 7

30 ammonium compounds, 8001-54-5 R D/P A 0.1% 0.01% Biocide surfactant Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type: 8
additives, selected
alkylbenzyldimethyl, chlorides P: Forbidden use as biocide in product-type : 9
59
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

30 Benzododecinium chloride 139-07-1 205-351-5 R D/P A 0.1% 0.01% Bactericide biocide Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected

Biocidal coatings / biocidal Benzyldimethyl(octadecyl)ammonium
30 122-19-0 204-527-9 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected chloride

30 Benzyldimethyloleylammonium chloride 37139-99-4 253-363-4 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
D: Allowed use as biocide in product-type : 9

Biocidal coatings / biocidal Benzyldodecyldimethylammonium
30 7281-04-1 230-698-4 R D/p A 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected bromide

30 Cetalkonium chloride 122-18-9 204-526-3 R D/P A 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected

30 Decyldimethyloctylammonium chloride 32426-11-2 251-035-5 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected

30 Didecyldimethylammonium bromide 2390-68-3 219-234-1 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected

30 Dimethyldioctylammonium chloride 5538-94-3 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected

30 Miristalkonium chloride 139-08-2 205-352-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected

Biocidal coatings / biocidal Quaternary ammonium compounds,
30 68989-00-4 273-544-1 R D/P A 0.1% 0.01% Biocide surfactant Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected benzyl-C10-16-alkyldimethyl, chlorides
Quaternary ammonium compounds,

Biocidal coatings / biocidal benzyl-C12-16-alkyldimethyl, chlorides;
additives, selected Alkyl (C12-16) dimethylbenzyl
ammonium chloride; C12-16-ADBAC


additives, selected benzyl-C8-18-alkyldimethyl, bromides

30 61789-71-7 263-080-8 R D/P A 0.1% 0.01% Bactericide biocide Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected benzylcoco alkyldimethyl, chlorides
Quaternary ammonium compounds, P: Forbidden use as biocide in product-type : 7

30 bis(hydrogenated tallow alkyl)dimethyl, 61789-80-8 263-090-2 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
chlorides P: Forbidden use as biocide in product-type : 9
60
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

Biocidal coatings / biocidal Quaternary ammonium compounds, di-
additives, selected C6-12-alkyldimethyl, chlorides

30 73398-64-8 277-453-8 R D/P A 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8

additives, selected dicoco alkyldimethyl, chlorides
(+/-)-1-(.beta.-allyloxy-2,4- Authorisation as biocide needed for product-type 7

30 dichlorophenylethyl)imidazole; 73790-28-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected
Technical grade imazalil Authorisation as biocide needed for product-type 9
Authorisation as biocide needed for product-type 7

Biocidal coatings / biocidal .alpha.,.alpha.',.alpha.'-trimethyl-1,3,5-
30 25254-50-6 246-764-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected triazine-1,3,5(2H,4H,6H)-triethanol

30 1,3-bis(hydroxymethyl)urea 140-95-4 205-444-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

Biocidal coatings / biocidal 1,3-didecyl-2-methyl-1H-imidazolium
additives, selected chloride
1-[1,3-bis(hydroxymethyl)-2,5-
Biocidal coatings / biocidal dioxoimidazolidin-4-yl]-1,3-
30 78491-02-8 278-928-2 R D/P A 0.1% 0.01% Polymer, herbicide Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected bis(hydroxymethyl)urea;
Diazolidinylurea

Biocidal coatings / biocidal 2,2',2''-(Hexahydro-1,3,5-triazine-1,3,5- Acute Tox. 4 *
additives, selected triyl)triethanol Skin Sens. 1
P: Forbidden use as biocide in product-type 9

30 2,2'-dithiobis[N-methylbenzamide] 2527-58-4 219-768-5 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 2,4-dichlorobenzyl alcohol 1777-82-8 217-210-5 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

Biocidal coatings / biocidal 2-bromo-1-(4-hydroxyphenyl)ethan-1-
additives, selected one

Biocidal coatings / biocidal 2-Bromo-2-
30 35691-65-7 252-681-0 R D/P A 0.1% 0.01% Bactericide biocide Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected (bromomethyl)pentanedinitrile
Repr. 2 P: Forbidden use as biocide in product-type : 7

30 2-Chloroacetamide 79-07-2 201-174-2 R D/P A 0.1% 0.01% Acute Tox. 3 * Authorisation as biocide needed for product-type 8
Skin Sens. 1 P: Forbidden use as biocide in product-type : 9
Skin Corr. 1B
Biocidal coatings / biocidal Skin Sens. 1
30 2-n-butyl-benzo[d]isothiazol-3-one 4299-07-4 420-590-7 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected Aquatic Acute 1
Aquatic Chronic 1
61
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

Biocidal coatings / biocidal Acute Tox. 4 *
30 2-Phenoxyethanol 122-99-6 204-589-7 R D/P A 0.1% 0.01% Bactericide biocide Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected Eye Irrit. 2
Eye Irrit. 2
Biocidal coatings / biocidal 2-Phenylphenol; Biphenyl-2-ol; 2- STOT SE 3
30 90-43-7 201-993-5 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected Hydroxybiphenyl Skin Irrit. 2
Aquatic Acute 1
Acute Tox. 3
Acute Tox. 4
STOT RE 1 D: Allowed use as biocide in product-type : 7
Biocidal coatings / biocidal 3-Iodo-2-propynyl butylcarbamate; 3-
30 55406-53-6 259-627-5 R D B 0.1% 0.01% Biocide, fungicide Eye Dam. 1 Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected Iodo-2-propynylbutylcarbamate (IPBC)
Aquatic Acute 1
Aquatic Chronic 1
4,5-Dichloro-2-octyl-2H-isothiazol-3- D: Allowed use as biocide in product-type : 7

30 one; 4,5-Dichloro-2-octylisothiazol- 64359-81-5 264-843-8 R D B 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
3(2H)-one (DCOIT) D: Allowed use as biocide in product-type : 9

30 4,5-dichloro-3H-1,2-dithiol-3-one 1192-52-5 214-754-5 R D/P A 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Eye Dam. 1 Authorisation as biocide needed for product-type 7

Biocidal coatings / biocidal 5-Chloro-2-(4-chlorophenoxy)-phenol
30 3380-30-1 429-290-0 R D/P A 0.1% 0.01% Aquatic Acute 1 Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected (DCPP)
Aquatic Chronic 1 P: Forbidden use as biocide in product-type : 9
Water-react. 1
Aluminium phosphide; Aluminium Acute Tox. 2 Authorisation as biocide needed for product-type 7
30 phosphide releasing phosphine (under 20859-73-8 244-088-0 R D/P A 0.1% 0.01% Acute Tox. 3 P: Forbidden use as biocide in product-type : 8
BPR) Acute Tox. 1 Authorisation as biocide needed for product-type 9
Aquatic Acute 1

Biocidal coatings / biocidal Aluminium sodium silicate-silver
30 130328-18-6 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected complex; Silver zeolite
D: Allowed as biocide needed for product-type 9

Biocidal coatings / biocidal Amines, n-C10-16-alkyltrimethylenedi-,
additives, selected reaction products with chloroacetic acid

30 Ammonium bromide 12124-97-9 235-183-8 R D/P A 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Skin Sens. 1 P: Forbidden use as biocide in product-type : 7

Biocidal coatings / biocidal Benzothiazole-2-thiol; 2-
30 149-30-4 205-736-8 R D/P A 0.1% 0.01% Aquatic Acute 1 Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected Mercaptobenzothiazole

30 Benzoxonium chloride 19379-90-9 243-008-1 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Acute Tox. 4 *
Acute Tox. 4 * Authorisation as biocide needed for product-type 7
30 Beta-cypermethrin 52315-07-8 257-842-9 R D/P A 0.1% 0.01% STOT SE 3 Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type 8
additives, selected
Aquatic Acute 1 P: Forbidden use as biocide in product-type 9
Aquatic Chronic 1
62
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 2
Acute Tox. 3
Acute Tox. 2 Authorisation as biocide needed for product-type 7
30 Bifenthrin 82657-04-3 617-373-6 R D B 0.1% 0.01% STOT RE 1 D: Allowed use as biocide in product-type : 8
Skin Sens. 1B Aquatic Acute 1
Aquatic Chronic 1
Bis(2-sulfidopyridin-1-olato)copper; Authorisation as biocide needed for product-type 7

30 bis(1-hydroxy-1H-pyridine-2-thionato- 14915-37-8 238-984-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
O,S)copper P: Forbidden use as biocide in product-type : 9

30 Bis(trichloromethyl) sulphone 3064-70-8 221-310-4 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

Biocidal coatings / biocidal Bromochloro-5,5-dimethylimidazolidine-
30 32718-18-6 251-171-5 R D/P A 0.1% 0.01% Germicide, fungicide Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected 2,4-dione
Acute Tox. 3 *
C8-18alkylbis(2- Skin Corr. 1B P: Forbidden use as biocide in product-type : 7
30 hydroxyethyl)ammonium bis(2- 68132-19-4 404-690-8 R D/P A 0.1% 0.01% Skin Sens. 1 Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
ethylhexyl)phosphate Aquatic Acute 1 P: Forbidden use as biocide in product-type : 9
Aquatic Chronic 1
P: Forbidden use as biocide in product-type: 7

30 Calcium dihexa-2,4-dienoate 7492-55-9 231-321-6 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type: 8
additives, selected
Carc. 2
Acute Tox. 3 * P: Forbidden use as biocide in product-type: 7
Biocidal coatings / biocidal Captan; 1,2,3,6-tetrahydro-N- Fungicide, bactericide, plastic, Reg. (EC) No 1272/2008
30 133-06-2 205-087-0 R D/P A 0.1% 0.01% Eye Dam. 1 P: Forbidden use as biocide in product-type: 8
additives, selected (trichloromethylthio)phthalimide leather and paint preservative Reg. (EU) No 528/2012
Skin Sens. 1 P: Forbidden use as biocide in product-type: 9
Aquatic Acute 1
Acute Tox. 3 *
Chlorfenapyr; 4-Bromo-2-(4- P: Forbidden use as biocide in product-type : 7
30 chlorophenyl)-1-ethoxymethyl-5- 122453-73-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
trifluoromethylpyrrole-3-carbonitrile P: Forbidden use as biocide in product-type : 9
Aquatic Chronic 1
Acute Tox. 4 *
Biocidal coatings / biocidal Chlorocresol; 4-chloro-m-cresol; 4-
30 59-50-7 200-431-6 R D B 0.1% 0.01% Eye Dam. 1 Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected chloro-3-methylphenol
Aquatic Acute 1
Lact. P: Forbidden use as biocide in product-type: 7

Biocidal coatings / biocidal Chlorothalonil; Reg. (EC) No 1272/2008
30 1897-45-6 217-588-1 R D/P A 0.1% 0.01% Fungicide Aquatic Acute 1 P: Forbidden use as biocide in product-type: 8
additives, selected Tetrachloroisophthalonitrile Reg. (EU) No 528/2012
Aquatic Chronic 1 P: Forbidden use as biocide in product-type: 9
Carc. 2
Biocidal coatings / biocidal Chlorotoluron; 3-(3-chloro-p-tolyl)-1,1- Repr. 2 Reg. (EC) No 1272/2008
30 15545-48-9 239-592-2 R D/P A 0.1% 0.01% Authorisation as biocide needed for product-type 8
additives, selected dimethylurea Aquatic Acute 1 Reg. (EU) No 528/2012
Aquatic Chronic 1
Repr. 2
Biocidal coatings / biocidal Cis-4-[3-(p-tert-butylphenyl)-2- Acute Tox. 4 * Reg. (EC) No 1272/2008
30 67564-91-4 266-719-9 R D/P A 0.1% 0.01% Polymer, herbicide D: Allowed use as biocide in product-type : 8
additives, selected methylpropyl]-2,6-dimethylmorpholine Skin Irrit. 2 Reg. (EU) No 528/2012
Aquatic Chronic 2
63
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

30 Clothianidin; IFMB 210880-92-5 433-460-1 R D B 0.1% 0.01% Aquatic Acute 1 Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
Aquatic Chronic 1 Authorisation as biocide needed for product-type 9

Biocidal coatings / biocidal Copolymer of 2-propenal and propane-
additives, selected 1,2-diol
Copper carbonate hydroxide; Basic Authorisation as biocide needed for product-type 7

30 Copper carbonate; Copper (II) 12069-69-1 235-113-6 R D B 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
carbonate--copper (II) hydroxide (1:1) Authorisation as biocide needed for product-type 9

Biocidal coatings / biocidal Copper dihydroxide; Copper (II)
30 20427-59-2 243-815-9 R D B 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected hydroxide; Copper hydroxide

30 Copper oxide; Copper (II) oxide 1317-38-0 215-269-1 R D B 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
Acute Tox. 4 *
Eye Irrit. 2 Authorisation as biocide needed for product-type 7
30 Copper sulphate 7758-98-7 231-847-6 R D/P A 0.1% 0.01% Skin Irrit. 2 Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected
Aquatic Acute 1 Authorisation as biocide needed for product-type 9
Aquatic Chronic 1

Biocidal coatings / biocidal Polymer, herbicide, Wood Reg. (EC) No 1272/2008
30 Creosote 8001-58-9 232-287-5 R D B 0.1% 0.01% Carc. 1B D: Allowed use as biocide in product-type : 8
additives, selected treatment Reg. (EU) No 528/2012
Cu-HDO; Bis(N-cyclohexyl- diazenium-

Biocidal coatings / biocidal dioxy)-copper); Bis[1-cyclohexyl-1,2-
30 312600-89-8 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected di(hydroxy-.kappa.O)diazeniumato(2-)]-
copper
Cybutryne; N'-tert-butyl-N-cyclopropyl- P: Forbidden use as biocide in product-type : 7

30 6-(methylthio)-1,3,5-triazine-2,4- 28159-98-0 248-872-3 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
diamine P: Forbidden use as biocide in product-type : 9

Biocidal coatings / biocidal Cyclohexylhydroxydiazene 1-oxide,
30 66603-10-9 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected potassium salt
Cyfluthrin; beta-cyfluthrin; a-cyano-4- Acute Tox. 2 *

Biocidal coatings / biocidal fluoro-3-phenoxybenzyl-3-(2,2- Acute Tox. 3 *
30 68359-37-5 269-855-7 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected dichlorovinyl)-2,2- Aquatic Acute 1
dimethylcyclopropanecarboxylate Aquatic Chronic 1
Repr. 2
Cyproconazole; (2RS,3RS; 2RS,3SR)- Authorisation as biocide needed for product-type 7
Biocidal coatings / biocidal Acute Tox. 4 * Reg. (EC) No 1272/2008
30 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H- 94361-06-5 R D B 0.1% 0.01% D: Allowed use as biocide in product-type : 8
1,2,4-triazol-1-yl)butan-2-ol Authorisation as biocide needed for product-type 9
Aquatic Chronic 1
Acute Tox. 4 *
Biocidal coatings / biocidal Dazomet; Tetrahydro-3,5-dimethyl- Eye Irrit. 2
additives, selected 1,3,5-thiadiazine-2-thione Aquatic Acute 1
Aquatic Chronic 1
DDACarbonate; LZ 34000; Reaction

Biocidal coatings / biocidal mass of N,N-didecyl-N,N-dimethyl-
30 894406-76-9 451-900-9 R D B 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected ammonium carbonate and N,N-didecyl-
N,N-dimethyl-ammonium bicarbonate
64
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Deltamethrin; (S)-a-cyano-3- Acute Tox. 3 *

Biocidal coatings / biocidal phenoxybenzyl (1R, 3R)-3-(2,2- Acute Tox. 3 *
additives, selected dibromovinyl)-2,2- Aquatic Acute 1
dimethylcyclopropanecarboxylate Aquatic Chronic 1
Acute Tox. 4 *
Dichlofluanid; N- D: Allowed use as biocide in product-type : 7
Biocidal coatings / biocidal Eye Irrit. 2
30 [(Dichlorofluoromethyl)thio]-N',N'- 1085-98-9 214-118-7 R D B 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected Skin Sens. 1
dimethyl-N-phenylsulfamide Authorisation as biocide needed for product-type 9
Aquatic Acute 1
Acute Tox. 4 *
Biocidal coatings / biocidal Eye Irrit. 2
30 Dichlorophene; dichlorophen 97-23-4 202-567-1 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
Aquatic Chronic 1

30 Dicopper oxide 1317-39-1 215-270-7 R D/P A 0.1% 0.01% Polymer, herbicide Aquatic Acute 1 Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected

Biocidal coatings / biocidal Didecyldimethylammonium chloride Acute Tox. 4 *
additives, selected (DDAC) Skin Corr. 1B
Didecylmethylpoly(oxyethyl)ammonium
propionate; Poly(oxy-1,2-ethanediyl), Authorisation as biocide needed for product-type 7
30 .alpha.-[2- 94667-33-1 619-057-3 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
(didecylmethylammonio)ethyl]- P: Forbidden use as biocide in product-type : 9
.omega.-hydroxy-, propanoate (salt)
Dimethyloctadecyl[3- D: Allowed use as biocide in product-type : 7

30 (trimethoxysilyl)propyl]ammonium 27668-52-6 248-595-8 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
chloride D: Allowed use as biocide in product-type : 9

Biocidal coatings / biocidal Dimethyltetradecyl[3-(trimethoxysilyl)-
30 41591-87-1 255-451-8 R D B 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected propyl]ammonium chloride

30 Dipotassium disulphite 16731-55-8 240-795-3 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 Dipyrithione 3696-28-4 223-024-5 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 Disodium disulphite; Disodium disulfite 7681-57-4 231-673-0 R D/P A 0.1% 0.01% Reg. (EC) No 1272/2008 Authorisation as biocide needed for product-type 8
additives, selected Eye Dam. 1
Disodium octaborate tetrahydrate; P: Forbidden use as biocide in product-type : 7

30 Boron sodium oxide (B8Na2O13), 12280-03-4 234-541-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
tetrahydrate P: Forbidden use as biocide in product-type : 9

30 Dodecylguanidine monohydrochloride 13590-97-1 237-030-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected
Flam. Sol. 2
Repr. 2
Biocidal coatings / biocidal DOWICIL* 150 PRESERVATIVE; Acute Tox. 4 *
30 51229-78-8 426-020-3 R D/P A 0.1% 0.01% Reg. (EC) No 1272/2008 Authorisation as biocide needed for product-type 8
additives, selected DOWICIL* 200 PRESERVATIVE Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
65
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Acute Tox. 3 *
Esfenvalerate; (S)-a-cyano-3- Acute Tox. 3 * Authorisation as biocide needed for product-type 7
30 phenoxybenzyl-(S)-2-(4-chlorophenyl)- 66230-04-4 R D/P A 0.1% 0.01% Skin Sens. 1 Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected
3-methylbutyrate Aquatic Acute 1 Authorisation as biocide needed for product-type 9
Aquatic Chronic 1
Lact.
Etofenprox; Ethofenprox; 3- Authorisation as biocide needed for product-type 7
Biocidal coatings / biocidal Aquatic Acute 1
30 Phenoxybenzyl-2-(4-ethoxyphenyl)-2- 80844-07-1 407-980-2 R D B 0.1% 0.01% Reg. (EC) No 1272/2008 D: Allowed use as biocide in product-type : 8
additives, selected Aquatic Chronic 1
methylpropylether Authorisation as biocide needed for product-type 9

Biocidal coatings / biocidal Fenitrothion; O,O-dimethyl O-4-nitro-m- Reg. (EC) No 1272/2008
30 122-14-5 204-524-2 R D/P A 0.1% 0.01% Polymer, herbicide Aquatic Acute 1 P: Forbidden use as biocide in product-type : 8
additives, selected tolyl phosphorothioate Reg. (EU) No 528/2012
Carc. 2 Authorisation as biocide needed for product-type 7

Biocidal coatings / biocidal Fenoxycarb; Ethyl [2-(4- Reg. (EC) No 1272/2008
30 72490-01-8 276-696-7 R D B 0.1% 0.01% Aquatic Acute 1 D: Allowed use as biocide in product-type : 8
additives, selected phenoxyphenoxy)ethyl]carbamate Reg. (EU) No 528/2012
Acute Tox. 3 *
Fipronil; 5-Amino-1-[2,6-dichloro-4- Acute Tox. 3 *
Biocidal coatings / biocidal (trifluoromethyl)phenyl]-4- Acute Tox. 3 *
additives, selected [(trifluoromethyl)sulfinyl]-1H-pyrazole-3- STOT RE 1
carbonitrile Aquatic Acute 1
Aquatic Chronic 1
Flufenoxuron; 1-[4-(2-Chloro-
Lact. Authorisation as biocide needed for product-type 7
Biocidal coatings / biocidal alpha,alpha,alpha-trifluoro-para- Reg. (EC) No 1272/2008
30 101463-69-8 417-680-3 R D B 0.1% 0.01% Biocide Aquatic Acute 1 D: Allowed use as biocide in product-type : 8
additives, selected tolyloxy)-2-fluorophenyl]-3-(2,6- Reg. (EU) No 528/2012
difluorobenzoyl)urea

30 Fluometuron 2164-17-2 218-500-4 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Carc. 2
Acute Tox. 4 * D: Allowed use as biocide in product-type : 7
Biocidal coatings / biocidal Folpet; N- Fungicide, bactericide for Reg. (EC) No 1272/2008
30 133-07-3 205-088-6 R D B 0.1% 0.01% Eye Irrit. 2 Authorisation as biocide needed for product-type 8
additives, selected (trichloromethylthio)phthalimide varnish, paint and coating Reg. (EU) No 528/2012
Aquatic Acute 1
Acute Tox. 3 *
Acute Tox. 3 *
Biocidal coatings / biocidal Glutaral; Glutaraldehyde; Pentane-1,5- Skin Corr. 1B Reg. (EU) No 528/2012
30 111-30-8 203-856-5 R D/P A 0.1% 0.01% Polymer, herbicide Authorisation as biocide needed for product-type 8
additives, selected dial; Pentanedial Resp. Sens. 1 PACT
Skin Sens. 1
Aquatic Acute 1

30 Guazatine triacetate 115044-19-4 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected

30 Hexa-2,4-dienoic acid; Sorbic acid 110-44-1 203-768-7 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected

30 Hexaboron dizinc undecaoxide 12767-90-7 235-804-2 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected

Biocidal coatings / biocidal Homopolymer of 2-tert-butylaminoethyl
additives, selected methacrylate (EINECS 223-228-4)
66
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

30 Hydroxyl-2-pyridone 822-89-9 212-506-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Carc. 2
Biocidal coatings / biocidal Imazalil; 1-[2-(allyloxy)-2-(2,4- Reg. (EC) No 1272/2008
30 35554-44-0 252-615-0 R D/P A 0.1% 0.01% Acute Tox. 4 P: Forbidden use as biocide in product-type : 8
additives, selected dichlorophenyl)ethyl]-1H-imidazole Reg. (EU) No 528/2012
Eye Dam. 1 Authorisation as biocide needed for product-type 9
Aquatic Chronic 1
Acute Tox. 4 * P: Forbidden use as biocide in product-type 7

30 Iodine (I) 7553-56-2 231-442-4 R D/P A 0.1% 0.01% Polymer, herbicide Acute Tox. 4 * Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Carc. 2 D: Allowed use as biocide in product-type 7

Biocidal coatings / biocidal Isoproturon; 3-(4-Isopropylphenyl)-1,1- Reg. (EC) No 1272/2008
30 34123-59-6 251-835-4 R D/P A 0.1% 0.01% Aquatic Acute 1 Authorisation as biocide needed for product-type 8
additives, selected dimethylurea Reg. (EU) No 528/2012
Aquatic Chronic 1 P: Forbidden use as biocide in product-type 9

30 L-(+)-lactic acid 79-33-4 201-196-2 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected

30 Lignin 9005-53-2 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected
Water-react. 1
Biocidal coatings / biocidal Magnesium phosphide; Trimagnesium Reg. (EC) No 1272/2008
30 12057-74-8 235-023-7 R D/P A 0.1% 0.01% Acute Tox. 3 P: Forbidden use as biocide in product-type : 8
additives, selected diphosphide Reg. (EU) No 528/2012
Aquatic Acute 1

30 Margosa ext. 84696-25-3 283-644-7 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected

Biocidal coatings / biocidal Metam potassium; Potassium
additives, selected methyldithiocarbamate
Acute Tox. 4 *
Skin Corr. 1B Authorisation as biocide needed for product-type 7
Biocidal coatings / biocidal Metam-sodium; Metam; Sodium 205-293-0 Reg. (EC) No 1272/2008
30 137-42-8 R D B 0.1% 0.01% Polymer, herbicide Skin Sens. 1 Authorisation as biocide needed for product-type 8
additives, selected ethyldithiocarbamate 205-239-0 Reg. (EU) No 528/2012
Aquatic Acute 1 D: Allowed use as biocide in product-type : 9
Aquatic Chronic 1

30 Methenamine 3-chloroallylochloride 4080-31-3 223-805-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

Biocidal coatings / biocidal N-(3-aminopropyl)-N-dodecylpropane-
additives, selected 1,3-diamine
N,N,N',N'- Authorisation as biocide needed for product-type 7

30 Tetramethylethylenediaminebis(2- 31075-24-8 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
chloroethyl)ether copolymer P: Forbidden use as biocide in product-type : 9

30 N,N'-methylenebismorpholine (MBM) 5625-90-1 R D/P A 0.1% 0.01% Biocide, fungicide Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected 227-062-3
67
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Acute Tox. 4 *
STOT SE 3 Authorisation as biocide needed for product-type 7
Biocidal coatings / biocidal Nabam; Disodium ethylenebis(N,N'- Reg. (EC) No 1272/2008
30 142-59-6 205-547-0 R D/P A 0.1% 0.01% Skin Sens. 1 Authorisation as biocide needed for product-type 8
additives, selected dithiocarbamate) Reg. (EU) No 528/2012
Aquatic Chronic 1
Flam. Liq. 3
30 Naphthenic acids, copper salts 1338-02-9 215-657-0 R D/P A 0.1% 0.01% Polymer, herbicide Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
Aquatic Chronic 1
N-Didecyl-N-dipolyethoxyammonium Authorisation as biocide needed for product-type 7

30 borate; Didecylpolyoxethylammonium 214710-34-6 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
borate P: Forbidden use as biocide in product-type : 9
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 * D: Allowed use as biocide in product-type : 7
30 Octhilinone; 2-octyl-2H-isothiazol-3-one 26530-20-1 247-761-7 R D B 0.1% 0.01% Skin Corr. 1B Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
Aquatic Acute 1
Aquatic Chronic 1
Oligo(2-(2- P: Forbidden use as biocide in product-type : 7

30 ethoxy)ethoxyethylguanidinium 374572-91-5 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
chloride) P: Forbidden use as biocide in product-type : 9

30 Oxine-copper 10380-28-6 233-841-9 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected

30 P-[(diiodomethyl)sulphonyl]toluene 20018-09-1 243-468-3 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Acute Tox. 4 *
Permethrin; m-phenoxybenzyl 3-(2,2- Acute Tox. 4 * Authorisation as biocide needed for product-type 7
30 dichlorovinyl)-2,2- 52645-53-1 258-067-9 R D B 0.1% 0.0001% Skin Sens. 1 Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
dimethylcyclopropanecarboxylate Aquatic Acute 1 D: Allowed use as biocide in product-type : 9
Aquatic Chronic 1

Biocidal coatings / biocidal Poly(hexamethylendiamine
30 57028-96-3 R D/P A 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected guanidinium chloride)
Carc. 2
Acute Tox. 4
STOT RE 1 Authorisation as biocide needed for product-type 7
Biocidal coatings / biocidal Poly(hexamethylenebicyanoguanide-
30 27083-27-8 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected hexamethylenediamine) Hydrochloride
Eye Dam. 1 D: Allowed use as biocide in product-type : 9
Aquatic Chronic 1

30 Poly(hexamethylenebiguanide) 91403-50-8 R D B 0.1% 0.01% Biocide ; water disinfectant Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Carc. 2
Acute Tox. 4
STOT RE 1 Authorisation as biocide needed for product-type 7
Biocidal coatings / biocidal Poly(hexamethylenebiguanide)hydrochl
30 32289-58-0 R D B 0.1% 0.01% Biocide ; water disinfectant Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected oride
Aquatic Chronic 1
68
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

30 Polyvinylpyrrolidone iodine 25655-41-8 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 Potassium (E,E)-hexa-2,4-dienoate 24634-61-5 246-376-1 R D/P A 0.1% 0.01% Eye Irrit. 2 Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected

30 Potassium 2-biphenylate 13707-65-8 237-243-9 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 Potassium dimethyldithiocarbamate 128-03-0 204-875-1 R D B 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 Potassium sulphite 10117-38-1 233-321-1 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 Prometryn 7287-19-6 230-711-3 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Acute Tox. 4 *
Propiconazole; ()-1-[2-(2,4- D: Allowed use as biocide in product-type : 7
Biocidal coatings / biocidal Skin Sens. 1
30 dichlorophenyl)-4-propyl-1,3-dioxolan-2- 60207-90-1 262-104-4 R D B 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
ylmethyl]-1H-1,2,4-triazole D: Allowed use as biocide in product-type : 9
Aquatic Chronic 1
D: Allowed use as Biocide in Product-Type : 7

30 Pyridine-2-thiol 1-oxide, sodium salt 3811-73-2 223-296-5 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
D: Allowed use as Biocide in Product-Type : 9
Pyrithione zinc; (T-4)-Bis[2-(thioxo- D: Allowed use as biocide in product-type : 7

30 kappaS)-pyridin-1(2H)-olato- 13463-41-7 236-671-3 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
kappaO]zinc(II) D: Allowed use as biocide in product-type : 9
Quaternary ammonium compounds

(benzylalkyldimethyl (alkyl from C8-
Biocidal coatings / biocidal C22, saturated and unsaturated, tallow
30 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type 8
additives, selected alkyl, coco alkyl, and soya alkyl)
chlorides, bromides or
hydroxides)/BKC
Quaternary ammonium compounds, [2-

[[2-[(2-carboxyethyl)(2- P: Forbidden use as biocide in product-type : 7
30 hydroxyethyl)amino]ethyl]amino]-2- 100085-64-1 309-206-8 R D/P A 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
oxoethyl]coco alkyldimethyl, Authorisation as biocide needed for product-type 9
hydroxides, inner salts



30 63449-41-2 264-151-6 R D/P A 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
69
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Quaternary ammonium compounds,

Biocidal coatings / biocidal C12-14-
additives, selected alkyl[(ethylphenyl)methyl]dimethyl,
chlorides

additives, selected coco alkyltrimethyl, chlorides


30 Quaternary ammonium iodides 308074-50-2 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Acute Tox. 3 *
STOT RE 2 * P: Forbidden use as biocide in product-type : 7
Biocidal coatings / biocidal Bethoxazin/3-benzo[b]thien-2-yl-5,6-
30 163269-30-5 431-030-6 R D/P A 0.1% 0.01% Eye Dam. 1 Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected dihydro-1,4,2-oxathiazine 4-oxide
Aquatic Chronic 1

30 Silver (Ag) 7440-22-4 231-131-3 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 Silver chloride 7783-90-6 232-033-3 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Ox. Sol. 2
Biocidal coatings / biocidal Skin Corr. 1B
30 Silver nitrate 7761-88-8 231-853-9 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
Aquatic Chronic 1

30 Silver phosphate glass 308069-39-8 R D B 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

Biocidal coatings / biocidal Silver sodium zirconium Aquatic Acute 1
30 155925-27-2 422-570-3 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected hydrogenphosphate Aquatic Chronic 1

Biocidal coatings / biocidal Silver zinc zeolite; Aluminium sodium
additives, selected silicate-silver zinc complex
Silver-zinc-aluminium-boronphosphate D: Allowed use as biocide in product-type : 7

30 glass; Glass oxide, silver- and zinc- 398477-47-9 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
containing D: Allowed use as biocide in product-type : 9

30 Sodium 2,4,6-trichlorophenolate 3784-03-0 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Acute Tox. 4 *
STOT SE 3 D: Allowed use as biocide in product-type : 7
Biocidal coatings / biocidal Sodium 2-biphenylate; 2-phenylphenol,
30 132-27-4 205-055-6 R D B 0.1% 0.01% Biocide Skin Irrit. 2 Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected sodium salt
Aquatic Acute 1
70
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

30 Sodium bromide 7647-15-6 231-599-9 R D/P A 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 Sodium dimethyldithiocarbamate 128-04-1 204-876-7 R D B 0.1% 0.01% Biocide Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

Biocidal coatings / biocidal Sodium hydrogen 2,2-methylenebis[4-
additives, selected chlorophenolate]

Biocidal coatings / biocidal Sodium hydrogensulphite; Sodium Reg. (EC) No 1272/2008
30 7631-90-5 231-548-0 R D/P A 0.1% 0.01% Acute Tox. 4 * Authorisation as biocide needed for product-type 8
additives, selected bisulphite Reg. (EU) No 528/2012

30 Sodium hydroxymethylamino acetate 70161-44-3 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected 274-357-8

30 Sodium p-chloro-m-cresolate 15733-22-9 239-825-8 R D B 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 Sodium sulphite 7757-83-7 231-821-4 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Ox. Sol. 2
Acute Tox. 4 *
Biocidal coatings / biocidal Symclosene; 1,3,5-Trichloro-1,3,5- Eye Irrit. 2
additives, selected triazinane-2,4,6-trione STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 2 *
Acute Tox. 4 *
Eye Irrit. 2 P: Forbidden use as biocide in product-type : 7
Biocidal coatings / biocidal TCMTB; (benzothiazol-2-ylthio)methyl
30 21564-17-0 244-445-0 R D/P A 0.1% 0.01% Fungicide Skin Irrit. 2 Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected thiocyanate
Aquatic Acute 1
Aquatic Chronic 1
Repr. 2
Tebuconazole; 1-(4-chlorophenyl)-4,4- D: Allowed use as biocide in product-type : 7
Biocidal coatings / biocidal Acute Tox. 4 Reg. (EC) No 1272/2008
30 dimethyl-3-(1,2,4-triazol-1- 107534-96-3 403-640-2 R D B 0.1% 0.01% D: Allowed use as biocide in product-type : 8
ylmethyl)pentan-3-ol D: Allowed use as biocide in product-type : 9
Aquatic Chronic 1

30 Terbutryn 886-50-0 212-950-5 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Tetrahydro-1,3,4,6-
Biocidal coatings / biocidal tetrakis(hydroxymethyl)imidazo[4,5-
additives, selected d]imidazole-2,5(1H,3H)-dione 226-408-0

Biocidal coatings / biocidal Tetrakis(hydroxymethyl)phosphonium
additives, selected sulphate(2:1)
71
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

Biocidal coatings / biocidal Thiabendazole; Thiabendazol; 2- Aquatic Acute 1
additives, selected (Thiazole-4-yl)benzimidazole Aquatic Chronic 1

30 Thiacloprid 111988-49-9 R D B 0.1% 0.01% Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected

30 Thiamethoxam 153719-23-4 428-650-4 R D/P A 0.1% 0.01% Aquatic Acute 1 Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected

30 Tolnaftate 2398-96-1 R D/P A 0.1% 0.01% Polymer, herbicide Inflammation in skin and eyes Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Acute Tox. 2 *
STOT RE 1
Tolylfluanid; dichloro-N- Eye Irrit. 2 D: Allowed use as biocide in product-type : 7
30 [(dimethylamino)sulphonyl]fluoro-N-(p- 731-27-1 211-986-9 R D B 0.1% 0.01% STOT SE 3 Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected
tolyl)methanesulphenamide Skin Irrit. 2 Authorisation as biocide needed for product-type 9
Skin Sens. 1
Aquatic Acute 1

30 Tosylchloramide sodium 127-65-1 204-854-7 R D/P A 0.1% 0.01% Skin Corr. 1B Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Resp. Sens. 1 P: Forbidden use as biocide in product-type : 9

Biocidal coatings / biocidal Triadimefon; 1-(4-chlorophenoxy)-3,3-
30 43121-43-3 256-103-8 R D B 0.1% 0.01% Skin Sens. 1 Reg. (EU) No 528/2012 D: Allowed use as biocide in product-type : 8
additives, selected dimethyl-1-(1,2,4-triazol-1-yl)butanone

30 Tributyltetradecylphosphonium chloride 81741-28-8 279-808-2 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Eye Irrit. 2
Triclosan; 2,4,4-Trichloro-2-hydroxy P: Forbidden use as biocide in product-type : 7
Biocidal coatings / biocidal Skin Irrit. 2 Reg. (EU) No 528/2012
30 diphenyl ether; 5-Chloro-2-(2,4- 3380-34-5 222-182-2 R D/P A 0.1% 0.001% Authorisation as biocide needed for product-type 8
additives, selected Aquatic Acute 1 PACT
dichlorophenoxy)phenol P: Forbidden use as biocide in product-type : 9
Aquatic Chronic 1
Ox. Sol. 2
Acute Tox. 4 *
Biocidal coatings / biocidal Troclosene sodium; Sodium Eye Irrit. 2
30 2893-78-9 220-767-7 R D/P A 0.1% 0.01% Polymer, herbicide Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected dichloroisocyanurate dihydrate STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
Eye Irrit. 2 Authorisation as biocide needed for product-type 7
Biocidal coatings / biocidal Troclosene sodium; Sodium
30 51580-86-0 220-767-7 R D/P A 0.1% 0.01% STOT SE 3 Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected dichloroisocyanurate dihydrate
Aquatic Chronic 1
Acute Tox. 4 *
30 Zeta-cypermethrin 52315-07-8 257-842-9 R D/P A 0.1% 0.01% STOT SE 3 Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type 8
additives, selected
Aquatic Chronic 1

Biocidal coatings / biocidal Aquatic Acute 1
30 Zinc oxide; C.I. 77947 1314-13-2 215-222-5 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type : 8
additives, selected Aquatic Chronic 1
72
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

30 Zinc sulphide 1314-98-3 215-251-3 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
Reg. (EC) No 1272/2008 P: Forbidden use as biocide in product-type : 7
Biocidal coatings / biocidal STOT SE 3
30 Ziram 137-30-4 205-288-3 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected Eye Dam. 1
PACT P: Forbidden use as biocide in product-type : 9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

Biocidal coatings / biocidal 2,2-Dibromo-2-cyanoacetamide
additives, selected (DBNPA)

Biocidal coatings / biocidal Aluminium sodium silicate-silver copper
additives, selected complex; Silver Copper Zeolite

30 (benzyloxy)methanol 14548-60-8 238-588-8 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

30 Disodium cyanodithiocarbamate 138-93-2 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected

Biocidal coatings / biocidal (ethylenedioxy)dimethanol/ 1,6-
additives, selected Dihydroxy-2,5-dioxyhexane
Fludioxonil; 4-(2,2-Difluoro-1,3- D: Allowed use as biocide in product-type 7

30 benzodioxol-4-yl)-1H-pyrrole-3- 131341-86-1 R D B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected
carbonitrile D: Allowed use as biocide in product-type 9

30 Hexafluorosilicic acid 16961-83-4 241-034-8 R D/P A 0.1% 0.01% Skin Corr. 1B P: Forbidden use as biocide in product-type 8
Titanium
Reaction mass of titanium dioxide and
dioxicide D: Allowed use as biocide in product-type 7
Biocidal coatings / biocidal silver chloride individual CAS # used
30 13463-67-7 R - B 0.1% 0.01% Reg. (EU) No 528/2012 Authorisation as biocide needed for product-type 8
additives, selected none for the "reaction mass" both must
Silver chloride D: Allowed use as biocide in product-type 9
be present to report
7783-90-6
Acute Tox. 3 *
Biocidal coatings / biocidal Acute Tox. 3 * REACH Annex XVII
30 Diphenoxarsin-10-yloxid 58-36-6 200-377-3 R D/P A 0.1% 0.01% Authorisation as biocide needed for product-type 8
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 * Reg. (EC) No 1272/2008
Thioperoxydicarbonicdiamide([(H2N)C( Prohibit as product-type : 7
Biocidal coatings / biocidal Eye Irrit. 2 PACT
30 S)]2S2),tetramethyl-; Thiram; 137-26-8 205-286-2 R D/P A 0.1% 0.01% Rubber vulcanizing accelerator Authorisation needed for product-type 8
additives, selected Skin Irrit. 2 Waste management and public
Tetramethylthiuram disulphide Allowed use as biocide in product-type : 9
Skin Sens. 1 cleansing law
Aquatic Acute 1
Aquatic Chronic 1
73
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

30 Cetylpyridinium chloride 123-03-5 204-593-9 R D/P A 0.1% 0.01% Reg. (EU) No 528/2012 P: Forbidden use as biocide in product-type: 8
additives, selected
Printing ink, soluble oil, textile

adhesive, brake oil, plasticizer, Flam. Liq. 3 REACH ANNEX XIV
31 Bis(2-methoxyethyl) ether 111-96-6 203-924-4 P - B X 0.01% 0.01% 2017/8/22
softening agent for cellophane, Repr. 1B Reg. (EC) No 1272/2008
cement admixture
Flam. Liq. 2
Carc. 1A Reg. (EC) No 1272/2008
32 Bis(chloromethyl) ether (BCME) 542-88-1 208-832-8 P P A - - Methylation agent, pigments Acute Tox. 2 * Prohibition of Certain Toxic
Acute Tox. 3 * Substances Regulations
Acute Tox. 4 *
Electronics industry material

quality (Semi-
conductor),polymerization Carc. 1B
4,4'-bis(dimethylamino)benzophenone REACH SVHC
33 90-94-8 202-027-5 D - B 0.01% initiator lithographic plate, and Muta. 2
(Michler's ketone) Reg. (EC) No 1272/2008
the bond booster of the base Eye Dam. 1
plate of resist, and a resin
layer, synthetic pigment
4,4'-bis(dimethylamino)-4''-
34 561-41-1 209-218-2 D - B 0.01% Writing ink, other inks, dye Carcinogenicity REACH SVHC
(methylamino)trityl alcohol
α,α-Bis[4-(dimethylamino)phenyl]-4 Print and writing ink, paper

35 (phenylamino)naphthalene-1-methanol 6786-83-0 229-851-8 D - B 0.01% coloring, chlorofluorocarbon Carcinogenicity REACH SVHC
(C.I. Solvent Blue 4) and glass clean agent
Antiseptic, dye, tannage, raw

REACH ANNEX XIV
material for antifreeze fluid,
36 Boric acid/Orthoboric acid Boric acid 11113-50-1 234-343-4 P D/P B X 5.5% 0.01% Repr. 1B RECOMMENDATION
chemical raw material for
Reg. (EU) No 528/2012
condenser
Antiseptic, dye, tannage, raw

REACH ANNEX XIV
material for antifreeze fluid,
36 Boric acid/Orthoboric acid Boric acid crude natural) 10043-35-3 233-139-2 P D/P B X 0.01% 0.01% Repr. 1B RECOMMENDATION
chemical raw material for
Reg. (EU) No 528/2012
condenser
Flam. Gas 1
Rubber raw Press. Gas
37 Butadiene, 1,3 - 106-99-0 203-450-8 D D A 0.01% Reg. (EC) No 1272/2008
material Carc. 1A
Muta. 1B
Flam. Liq. 2
Repr. 1B
STOT RE 2 * REACH ANNEX XIV
Dye material, synthetic organic
38 1-bromopropane; n-propyl bromide 106-94-5 203-445-0 D - B 0.01% Eye Irrit. 2 RECOMMENDATION
intermediate body
STOT SE 3 Reg. (EC) No 1272/2008
Skin Irrit. 2
STOT SE 3
REACH ANNEX XVII

Irritation of eyes and airway,
Surface protection of metals, EU-D 2000/53/EEC
lung and kidney disorder,
Cadmium and its compounds, Antimony, compound with cadmium stabilizers in polymers, JAMA voluntary regulation
39 12014-29-8 234-596-0 P D/P B 0.01% 0.001% carcinogenic,
all members (2:3) pigments, in paints and Korean Recycling Law
possibility of endocrine
plastics, electronics Voluntary restraint by Taiwan scrap
disruptors
vehicle recycling industry
Cadmium and its compounds, See " Cadmium and its

39 Boric acid, cadmium salt 51222-60-7 257-067-6 P D/P B 0.01% 0.001%
74
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cadmium and its compounds, Cadmate(2-), tetrakis(cyano-C)-, See " Cadmium and its
39 14402-75-6 238-371-8 P D/P B 0.01% 0.001%
all members dipotassium, (T-4)- compounds, all members"
Acute Tox. 4 *
Acute Tox. 4 * See " Cadmium and its
Cadmium and its compounds,
39 Cadmium 7440-43-9 231-152-8 P D/P B 0.01% 0.001% Acute Tox. 4 * compounds, all members"
all members
Aquatic Acute 1 Reg. (EC) No 1272/2008
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium acetate 543-90-8 208-853-2 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

39 Cadmium acrylate 15743-19-8 239-835-2 P D/P B 0.01% 0.001%

39 Cadmium bromide 7789-42-6 232-165-1 P D/P B 0.01% 0.001%

39 Cadmium bromide, tetrahydrate 13464-92-1 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium carbonate 513-78-0 208-168-9 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
39 Cadmium chloride 10108-64-2 233-296-7 P D/P B 0.01% 0.001% Acute Tox. 4 * compounds, all members"
all members
Aquatic Chronic 1
Cadmium and its compounds, Cadmium chloride phosphate See " Cadmium and its
39 12185-64-7 235-353-1 P D/P B 0.01% 0.001%
all members (Cd5Cl(PO4)3) compounds, all members"
Cadmium and its compounds, Cadmium chloride phosphate See " Cadmium and its
39 100402-53-7 309-489-8 P D/P B 0.01% 0.001%
all members (Cd5Cl(PO4)3), manganese-doped compounds, all members"

39 Cadmium chloride, hydrate (2:5) 7790-78-5 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium cyanide (Cd(CN)2) 542-83-6 208-829-1 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
75
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

39 Cadmium diicosanoate 14923-81-0 238-994-5 P D/P B 0.01% 0.001%

39 Cadmium diricinoleate 13832-25-2 237-544-5 P D/P B 0.01% 0.001%

39 Cadmium fluoborate 14486-19-2 238-490-5 P D/P B 0.01% 0.001%
Acute Tox. 4 *
See " Cadmium and its
Acute Tox. 4 *
Cadmium and its compounds, compounds, all members"
39 Cadmium fluoride (CdF2) 7790-79-6 232-222-0 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
39 Cadmium hexafluorosilicate(2-) 17010-21-8 241-084-0 P D/P B 0.01% 0.001% Acute Tox. 4 * compounds, all members"
all members
Aquatic Chronic 1

39 Cadmium hydrogen phosphate 14067-62-0 237-920-9 P D/P B 0.01% 0.001%

39 Cadmium hydroxide (Cd(OH)2) 21041-95-2 244-168-5 P D/P B 0.01% 0.001%

39 Cadmium iodate 7790-81-0 232-224-1 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium iodide 7790-80-9 232-223-6 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Cadmium and its compounds, Cadmium molybdenum oxide See " Cadmium and its
39 13972-68-4 237-752-6 P D/P B 0.01% 0.001%
all members (CdMoO4) compounds, all members"

39 Cadmium niobium oxide (Cd2Nb2O7) 12187-14-3 235-357-3 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Cadmium nitrate Acute Tox. 4 *
Cadmium and its compounds, 231-152-8 See " Cadmium and its
39 (Nitric acid cadmium salt tetrahydrate 10022-68-1 P D/P B 0.01% 0.001% Acute Tox. 4 *
(Cd・2NO3・4H2O)) Aquatic Acute 1
Aquatic Chronic 1
76
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Acute Tox. 4 *
Cadmium nitrate Acute Tox. 4 *
39 (Nitric acid cadmium salt (2:1) (Cd・ 10325-94-7 233-710-6 P D/P B 0.01% 0.001% Acute Tox. 4 *
2NO3)) Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium oxide 1306-19-0 215-146-2 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Cadmium oxide (CdO), solid solution

39 with calcium oxide and titanium oxide 101356-99-4 309-896-0 P D/P B 0.01% 0.001%
(TiO2), praseodymium-doped
Cadmium oxide (CdO),

39 solid solution with magnesium oxide, 102110-30-5 310-029-3 P D/P B 0.01% 0.001%
tungsten oxide (WO3) and zinc oxide

39 Cadmium peroxide (Cd(O2)) 12139-22-9 P D/P B 0.01% 0.001%

39 Cadmium phosphide (Cd3P2) 12014-28-7 234-595-5 P D/P B 0.01% 0.001%

39 Cadmium propionate 16986-83-7 241-066-2 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium stearate 2223-93-0 218-743-6 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

39 Cadmium succinate 141-00-4 205-446-1 P D/P B 0.01% 0.001%
Acute Tox. 4 *
39 Cadmium sulfate 10124-36-4 233-331-6 P D/P B 0.01% 0.001% Acute Tox. 4 * compounds, all members"
all members
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
Cadmium and its compounds, 231-152-8 See " Cadmium and its
39 Cadmium sulfate, hydrate 7790-84-3 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
39 Cadmium sulfide 1306-23-6 215-147-8 P D/P B 0.01% 0.001% Acute Tox. 4 * compounds, all members"
all members
Aquatic Chronic 1
77
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

39 Cadmium sulphite 13477-23-1 236-767-5 P D/P B 0.01% 0.001%

39 Cadmium tantalum oxide (CdTa2O6) 12292-07-8 235-561-2 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium telluride (CdTe) 1306-25-8 215-149-9 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

39 Cadmium titanium oxide (CdTiO3) 12014-14-1 234-593-4 P D/P B 0.01% 0.001%

39 Cadmium tungsten oxide (CdWO4) 7790-85-4 232-226-2 P D/P B 0.01% 0.001%

39 Cadmium vanadium oxide (CdV2O6) 16056-72-7 240-203-3 P D/P B 0.01% 0.001%

39 Cadmium zinc sulfide 11129-14-9 234-372-2 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium zinc sulfide ((Cd,Zn)S) 12442-27-2 235-672-6 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

39 Cadmium zirconium oxide (CdZrO3) 12139-23-0 235-251-7 P D/P B 0.01% 0.001%

39 Cadmium-barium laurate 15337-60-7 239-371-0 P D/P B 0.01% 0.001%

39 Carbonic acid, cadmium salt 93820-02-1 298-586-8 P D/P B 0.01% 0.001%

39 Diboron tricadmium hexaoxide 13701-66-1 237-225-0 P D/P B 0.01% 0.001%
78
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

39 Dicadmium hexakis(cyano-C)ferrate(4-) 13755-33-4 237-341-1 P D/P B 0.01% 0.001%
Cadmium and its compounds, Diphosphoric acid, barium cadmium See " Cadmium and its
39 37131-86-5 P D/P B 0.01% 0.001%
all members salt compounds, all members"

39 Diphosphoric acid, cadmium salt 19262-93-2 P D/P B 0.01% 0.001%

39 Diphosphoric acid, cadmium salt (1:2) 15600-62-1 P D/P B 0.01% 0.001%

39 Dipotassium tetrachlorocadmate(2-) 20648-91-3 243-938-8 P D/P B 0.01% 0.001%
Phosphoric acid, ammonium cadmium

39 salt 14520-70-8 P D/P B 0.01% 0.001%
(1:1:1)

39 Phosphoric acid, cadmium salt 13847-17-1 237-581-7 P D/P B 0.01% 0.001%

39 Phosphoric acid, cadmium salt (2:3) 13477-17-3 236-764-9 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Acute Tox. 4 *
Cadmium and its compounds, Silicic acid (H2SiO3), cadmium salt See " Cadmium and its
39 13477-19-5 236-765-4 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

39 Sulfamic acid, cadmium salt (2:1) 14017-36-8 237-832-0 P D/P B 0.01% 0.001%
Cadmium and its compounds, Telluric acid (H2TeO3), cadmium salt See " Cadmium and its
39 15851-44-2 239-963-9 P D/P B 0.01% 0.001%
Cadmium and its compounds, Telluric acid (H2TeO4), cadmium salt See " Cadmium and its
39 15852-14-9 239-973-3 P D/P B 0.01% 0.001%
79
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

39 Tetradecanoic acid, cadmium salt 10196-67-5 233-489-6 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmiumbis(diethyldithiocarbamat) 14239-68-0 238-113-4 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
39 cadmium(+2) cation diformate 4464-23-7 224-729-0 P D/P B 0.01% 0.001% Acute Tox. 4 * compounds, all members"
all members
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium Litophone Yellow 90604-90-3 292-386-4 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium Zinc litophone Yellow 90604-89-0 292-385-9 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium Zink Sulfide Yellow 8048-07-5 232-466-8 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
39 Nonanoic acid, branched, cadmium salt 93686-40-9 297-692-1 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

39 Cadmium bis(2-ethylhexanoate) 2420-98-6 219-346-0 P D/P B 0.01% 0.001%

39 Cadmium arsenide (Cd3As2) 12006-15-4 234-484-1 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Acute Tox. 4 *
Cadmium and its compounds, C.I. Pigment Orange 20; Cadmium See " Cadmium and its
39 12656-57-4 235-758-3 P P A 0.01% 0.001% Acute Tox. 4 *
all members sulfoselenide orange compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1

39 Cadmium selenide (CdSe) 1306-24-7 215-148-3 P D/P B 0.01% 0.001%
Cadmium selenide (CdSe),

Cadmium and its compounds, solid solution with cadmium sulfide, See " Cadmium and its
39 101357-00-0 309-897-6 P D/P B 0.01% 0.001%
all members zinc selenide and zinc sulfide, compounds, all members"
aluminum and copper-doped
80
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

39 101357-01-1 309-898-1 P D/P B 0.01% 0.001%
copper and manganese-doped

39 101357-02-2 309-899-7 P D/P B 0.01% 0.001%
europium-doped

39 101357-03-3 309-900-0 P D/P B 0.01% 0.001%
gold and manganese-doped

39 101357-04-4 309-901-6 P D/P B 0.01% 0.001%
manganese and silver-doped
Acute Tox. 3 *
Acute Tox. 3 *
39 Cadmium selenide sulfide (Cd(Se,S)) 12626-36-7 235-724-8 P P A 0.01% 0.001% STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

39 Cadmium selenide sulfide (Cd2SeS) 12214-12-9 235-392-4 P D/P B 0.01% 0.001%
Cadmium and its compounds, Cadmium selenide sulfide See " Cadmium and its
39 71243-75-9 275-290-7 P D/P B 0.01% 0.001%
all members (CdSe0.53S0.47) compounds, all members"

39 Cadmium selenide sulfide, (Cd2SeS) 12213-70-6 P D/P B 0.01% 0.001%

39 Cadmium selenide sulphide 11112-63-3 234-342-9 P D/P B 0.01% 0.001%

39 Selenic acid, cadmium salt (1:1) 13814-62-5 237-481-3 P D/P B 0.01% 0.001%

39 Selenious acid, cadmium salt (1:1) 13814-59-0 237-480-8 P D/P B 0.01% 0.001%
Acute Tox. 3 *
Acute Tox. 3 *
Cadmium and its compounds, C.I. Pigment Red 108; Cadmium See " Cadmium and its
39 58339-34-7 261-218-1 P P A 0.01% 0.001% STOT RE 2
all members sulfoselenide red compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
81
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
Cadmium and its compounds, Skin Sens. 1 See " Cadmium and its
39 Cadmium chromate 14312-00-6 238-252-0 P D/P B 0.01% 0.001%
all members Aquatic Acute 1 compounds, all members"
Aquatic Chronic 1

39 Cadmium mercury telluride ((Cd,Hg)Te) 29870-72-2 249-914-3 P D/P B 0.01% 0.001%
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium Mercury Sulfide 1345-09-1 215-717-6 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 4 *
Acute Tox. 4 *
39 Cadmium dinitrite 7790-83-2 232-225-7 P D/P B 0.01% 0.001% Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

39 Cadmium sulphate 31119-53-6 233-331-6 P - B 0.01% 0.001%
REACH ANNEX XVII

Reg. (EC) No 1272/2008
Plasticizer for PVC and paint, Flam. Liq. 1
Chlorinated hydrocarbons, Montreal Protocol;
40 1,1 Dichloroethylene 75-35-4 200-864-0 P - B 0.1% 0.01% additive for adhesive and Carc. 2
selected EU Regulation
sealant Acute Tox. 4 *
(EC Regulation 2037/2000);
US EPA ODS
Acute Tox. 2 *
Chlorinated hydrocarbons,
40 1,1,2,2 Tetrachloroethane 79-34-5 201-197-8 P - B 0.1% 0.01% Acute Tox. 1 REACH ANNEX XVII
selected
Aquatic Chronic 2
Carc. 2
Chlorinated hydrocarbons, REACH ANNEX XVII
40 Pentachloroethane 76-01-7 200-925-1 P - B 0.1% 0.01% STOT RE 1
selected Reg. (EC) No 1272/2008
Aquatic Chronic 2
Carc. 2
Repr. 2
Acute Tox. 3
40 Trichloromethane (Chloroform) 67-66-3 200-663-8 P - B 0.1% 0.01% Acute Tox. 4
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
Chlorinated hydrocarbons, Carc. 2

40 Tetrachloroethylene 127-18-4 204-825-9 D - B 0.01% Reg. (EC) No 1272/2008
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Chlorinated hydrocarbons,
40 Carbon tetrachloride 56-23-5 200-262-8 P P A - - Acute Tox. 3 * Montreal Protocol
selected
STOT RE 1 Reg. (EC) No 1272/2008
Aquatic Chronic 3
Ozone
82
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
REACH ANNEX XVII

Irritation of eyes and skin;
Reg. (EC) No 1272/2008
liver, kidney
Chlorinated hydrocarbons, Montreal Protocol;
40 1,1,1,2 Tetrachloroethane 630-20-6 211-135-1 P D B 0.1% 0.01% and digestive organ disorder;
selected EU Regulation
nervous disorder;
(EC Regulation 2037/2000);
carcinogenic
US EPA ODS
Carc. 2
Chlorinated hydrocarbons, Acute Tox. 4 * REACH ANNEX XVII
40 1,1,2 Trichloroethane 79-00-5 201-166-9 P D B 0.1% 0.01%
selected Acute Tox. 4 * Reg. (EC) No 1272/2008
Acute Tox. 4 *

40 Dichloromethane 75-09-2 200-838-9 P D B 0.1% 0.01% Carc. 2
Carc. 1B
Muta. 2
Chlorinated hydrocarbons, Eye Irrit. 2 REACH ANNEX XIV
40 Trichloroethylene 79-01-6 201-167-4 P D B X 0.01% 0.01% 2016/4/21
selected Skin Irrit. 2 Reg. (EC) No 1272/2008
STOT SE 3
Aquatic Chronic 3
Chlorinated hydrocarbons, Acute Tox. 4 * Reg. (EC) No 1005/2009; Montreal

40 1,1,1 Trichloroethane 71-55-6 200-756-3 P P A - - Solvent, washing agent
selected Ozone Protocol; US EPA Class 1 ODS
Skin, central nervous,

airway, and liver disorder,
Chlorinated or brominated
carcinogenic,
41 Dibenzo-p-dioxins or 1,2,3,4,6,7,8-Heptachlorodibenzofuran 67562-39-4 P P A 10ppb 10ppb Impurities in products ChemVerbotsV
mutagen,
Dibenzofurans, all members
disruptors
Chlorinated or brominated See 1st line of "Chlorinated or

1,2,3,4,6,7,8-Heptachlorodibenzo-p-
41 Dibenzo-p-dioxins or 35822-46-9 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or
dioxin
Dibenzofurans, all members Dibenzofurans, all members"

41 Dibenzo-p-dioxins or 1,2,3,4,7,8,9-Hexachlorodibenzofuran 55673-89-7 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or

41 Dibenzo-p-dioxins or 1,2,3,4,7,8-Hexachloro dibenzofuran 70648-26-9 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or

41 Dibenzo-p-dioxins or 1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin 39227-28-6 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or




83
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

41 Dibenzo-p-dioxins or 1,2,3,7,8-Pentachloro dibenzofuran 57117-41-6 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or

41 Dibenzo-p-dioxins or 1,2,3,7,8-Pentachlorodibenzo-p-dioxin 40321-76-4 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or

41 Dibenzo-p-dioxins or 2,3,4,6,7,8-Hexachloro dibenzofurans 60851-34-5 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or

41 Dibenzo-p-dioxins or 2,3,4,7,8-Pentachloro dibenzofurans 57117-31-4 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or

41 Dibenzo-p-dioxins or 2,3,7,8-Tetrachloro dibenzofurans 51207-31-9 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or

2,3,7,8-Tetrachlorodibenzo-p-dioxin
41 Dibenzo-p-dioxins or 1746-01-6 217-122-7 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or
(TCDD)

41 Dibenzo-p-dioxins or 2,7-Dichlorodibenzo-p-dioxin 33857-26-0 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or

41 Dibenzo-p-dioxins or Hexachlorodibenzodioxin 34465-46-8 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or

41 Dibenzo-p-dioxins or Octachlorodibenzofuran 39001-02-0 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or

41 Dibenzo-p-dioxins or Octachlorodibenzo-p-dioxin 3268-87-9 P P A 10ppb 10ppb brominated Dibenzo-p-dioxins or
Chlorinated Paraffins, Flame retardant for fabric, Carc. 2 REACH ANNEX XIV
42 Short & Medium Chain Length Alkanes, C10-13, chloro 85535-84-8 287-476-5 P P A X 0.1% 0.01% rubber, paint, coating material Aquatic Acute 1 RECOMMENDATION
(SCCP, MCCP) Extreme-pressure additive Aquatic Chronic 1 Reg. (EC) No 1272/2008
Chlorinated Paraffins, Flame retardant for fabric, Lact. REACH ANNEX XIV
287-477-0
42 Short & Medium Chain Length Alkanes, C12-13, chloro 71011-12-6 P P A X 0.1% 0.01% rubber, paint, coating material Aquatic Acute 1 RECOMMENDATION
287-476-5
(SCCP, MCCP) Extreme-pressure additive Aquatic Chronic 1 Reg. (EC) No 1272/2008
MEDIUM CHAIN (MCCP), by definition:

Chlorinated Paraffins, Chloroparaffins, unbranched, Lact.
PACT
42 Short & Medium Chain Length CxH(2x-y+2)Cly, 85535-85-9 287-477-0 D D A 0.01% Aquatic Acute 1
Reg. (EC) No 1272/2008
(SCCP, MCCP) where x = 14-17 and y = 1-17 Aquatic Chronic 1
Alkanes, C14-17, chloro
Chlorinated Paraffins, Lact.

Canadian Prohibition of Certain
42 Short & Medium Chain Length Alkanes, C10-21, chloro 84082-38-2 281-985-6 P D/P B 0.1% 0.01% Aquatic Acute 1 Prohibit when contain C10-13
Toxic Substances Regulations
(SCCP, MCCP) Aquatic Chronic 1

42 Short & Medium Chain Length Alkanes, chloro; chloroparaffins 61788-76-9 263-004-3 P P A 0.1% 0.01% Aquatic Acute 1
84
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

42 Short & Medium Chain Length Paraffin waxes, chloro 63449-39-8 264-150-0 P P A 0.1% 0.01% Aquatic Acute 1

42 Short & Medium Chain Length Chlorinated n-paraffins (C6-18) 68920-70-7 272-924-4 P P A 0.1% 0.01% Aquatic Acute 1

42 Short & Medium Chain Length Alkane, C10-14-, Chloro- 85681-73-8 288-211-6 P D/P B 0.1% 0.01% Aquatic Acute 1

42 Short & Medium Chain Length Alkane, C12-14-, Chloro- 85536-22-7 287-504-6 P D/P B 0.1% 0.01% Aquatic Acute 1

42 Short & Medium Chain Length Alkane, C16-27-, Chloro- 84776-07-8 283-931-7 P D/P B - - Aquatic Acute 1

42 Short & Medium Chain Length Alkane, C16-35-, Chloro- 85049-26-9 285-195-2 R D/P A - - Aquatic Acute 1 Prohibit when contain C10-13

42 Short & Medium Chain Length Alkene, C12-24-, Chloro- 68527-02-6 271-247-1 P D/P B - - Aquatic Acute 1

Chlorowax; Paraffin waxes and 287-477-0 SCCP POPscandidate
42 Short & Medium Chain Length 51990-12-6 D D A 0.01% Aquatic Acute 1
Hydrocarbon waxes, chloro 287-476-5 UK DEFRA
Ox. Sol. 2 ****

Carc. 1B
Muta. 1B
Repr. 1B REACH ANNEX XIV
Acute Tox. 3 * EU-D 2000/53/EEC
Chromium(VI)-salts, 232-143-1 0,001% and Surface treatment for corrosion
43 Ammonium bichromate 7789-09-5 P D/P B X 0.001% STOT RE 1 JAMA voluntary regulation 2017/9/21
all members 231-157-5 0,01µg/cm2 prevention
Acute Tox. 4 * Korean Recycling Law
Skin Corr. 1B Voluntary restraint by Taiwan scrap
Resp. Sens. 1 vehicle recycling industry
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, Skin Sens. 1 See 1st line of "Chromium(VI)-
43 Ammonium chromate 7788-98-9 232-138-4 P D/P B 0.1% 0.01%
all members Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, 0,001% and Skin Sens. 1 See 1st line of "Chromium(VI)-
43 Barium chromate 10294-40-3 233-660-5 P D/P B 0.1%
all members 0,01µg/cm2 Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, 0,001% and Acute Tox. 4 * See 1st line of "Chromium(VI)-
43 Calcium chromate 13765-19-0 237-366-8 P D/P B 0.1%
Aquatic Chronic 1
85
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
Chromium(VI)-salts, Chromic acid, calcium salt, (Calcium Skin Sens. 1 See 1st line of "Chromium(VI)-
43 14307-33-6 238-243-1 P D/P B 0.1% 0.01%
all members dichromate) Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
43 Cesium chromate 13454-78-9 236-640-4 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, Chromate(1-),chlorotrioxo- Skin Sens. 1 See 1st line of "Chromium(VI)-
43 16037-50-6 240-174-7 P D/P B 0.1% 0.01%
all members ,potassium,(T-4)- Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, 231-801-5 0,001% and Skin Sens. 1 See 1st line of "Chromium(VI)-
43 Chromic acid 7738-94-5 P D/P B 0.001% 2017/9/21
all members 236-881-5 0,01µg/cm2 Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, 236-881-5 0,001% and Skin Sens. 1 See 1st line of "Chromium(VI)-
43 Chromic acid (H2Cr2O7) 13530-68-2 P D/P B 0.001% 2017/9/21
all members 231-801-5 0,01µg/cm2 Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, Chromic acid (H2CrO4), lanthanum(3+) Skin Sens. 1 See 1st line of "Chromium(VI)-
43 16565-94-9 P D/P B 0.1% 0.01%
all members salt (3:2) Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, Chromic acid (H2CrO4), magnesium Skin Sens. 1 See 1st line of "Chromium(VI)-
43 13423-61-5 236-540-0 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Chromic acid, ammonium salt 14445-91-1 238-422-4 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Chromic acid, barium potassium salt 27133-66-0 248-244-9 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Chromic acid, potassium zinc salt 41189-36-0 255-252-6 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Chromium (VI) 18540-29-9 P D/P B 0.1%
Aquatic Chronic 1
Carc. 1B
43 Chromium (VI) chloride 14986-48-2 P D/P B 0.1% 0.01%
Aquatic Chronic 1
86
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
43 Chromium hydroxide oxide silicate 68475-49-0 270-647-3 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Chromyl chloride 14977-61-8 239-056-8 P D/P B 0.1%
Aquatic Chronic 1
Carc. 1B
43 Copper chromate 13548-42-0 236-922-7 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Copper dichromate 13675-47-3 237-161-3 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
See 1st line of "Chromium(VI)-
Chromium(VI)-salts, Skin Sens. 1
43 Dithallium dichromate 13453-35-5 236-626-8 P D/P B 0.1% 0.01% salts,
all members Aquatic Acute 1
all members"
Aquatic Chronic 1
Carc. 1B
43 Lithium chromate 14307-35-8 238-244-7 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Magnesium dichromate 14104-85-9 237-959-1 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Nitric acid, barium salt, Carc. 1B

Chromium(VI)-salts, reaction products with ammonia, Skin Sens. 1 See 1st line of "Chromium(VI)-
43 99328-50-4 308-967-3 P D/P B 0.1% 0.01%
all members chromic acid (H2CrO4) diammonium Aquatic Acute 1 salts, all members"
salt and copper(2+) dinitrate, calcined Aquatic Chronic 1
Nitric acid, copper(2+) salt,

Carc. 1B
reaction products with ammonia,
43 chromic acid (H2CrO4) diammonium 100402-65-1 309-501-1 P D/P B 0.1% 0.01%
salt and manganese(2+) dinitrate,
Aquatic Chronic 1
kilned
Carc. 1B
Muta. 1B
Eye Irrit. 2
Chromium(VI)-salts, 0,001% and STOT SE 3 See 1st line of "Chromium(VI)-
43 Potassium chromate 7789-00-6 232-140-5 P D/P B 0.001% 2017/9/21
all members 0,01µg/cm2 Skin Irrit. 2 salts, all members"
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
87
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Chromium(VI)-salts, 0,001% and See 1st line of "Chromium(VI)-
43 Potassium dichromate 7778-50-9 231-906-6 P D/P B 0.001% STOT RE 1 2017/9/21
all members 0,01µg/cm2 salts, all members"
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
43 Silver chromate 7784-01-2 P D/P B 0.1% 0.01%
all members 232-043-8 Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Ox. Sol. 1
Carc. 1B
Chromium(VI)-salts, 246-356-2 0,001% and Skin Corr. 1A See 1st line of "Chromium(VI)-
43 dichromium tris(chromate) 24613-89-6 P D/P B 0.001% 2019/1/22
all members 231-157-5 0,01µg/cm2 Skin Sens. 1 salts, all members"
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
43 Sodium chromate 7775-11-3 231-889-5 P D/P B 0.001% 2017/9/21
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, 0,001% and Acute Tox. 4 * See 1st line of "Chromium(VI)-
43 Strontium chromate 7789-06-2 232-142-6 P D/P B 0.001% 2019/1/22
Aquatic Chronic 1
Carc. 1B
43 Thallium (I) chromate 13473-75-1 236-750-2 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Zinc chromate 1328-67-2 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Zinc chromate 13530-65-9 236-878-9 P D/P B 0.1%
Aquatic Chronic 1
Carc. 1B
43 Zinc chromate hydroxide 15930-94-6 P D/P B 0.1%
Aquatic Chronic 1
Carc. 1B
43 Zinc dichromate 14018-95-2 237-843-0 P D/P B 0.1%
Aquatic Chronic 1
Carc. 1B
43 Zinc potassium chromate 11103-86-9 234-329-8 P D/P B 0.01% 0.01% 2019/1/22
Aquatic Chronic 1
88
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
43 Zinc yellow (Zinc chromate pigment) 37300-23-5 P D/P B 0.1%
Aquatic Chronic 1
Carc. 1B
43 dihydroxy-dioxo-chromium 11115-74-5 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 potassium; dioxido-dioxo-chromium 12433-50-0 235-663-7 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Pentazinc chromate octahydroxide 49663-84-5 256-418-0 P D/P B 0.001% 2019/1/22
Aquatic Chronic 1
Ox. Sol. 1
Carc. 1A
Muta. 1B
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Chromium(VI)-salts, 0,001% and Oxidising agent, battery, See 1st line of "Chromium(VI)-
43 Chromium trioxide (CrO3) 1333-82-0 215-607-8 P D/P B 0.001% Acute Tox. 3 * 2017/9/21
all members 0,01µg/cm2 chromium plating salts, all members"
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
43 Sodium dichromate dihydrate 7789-12-0 234-190-3 P D/P B 0.001% 2017/9/21
Aquatic Chronic 1
Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Chromium(VI)-salts, 0,001% and See 1st line of "Chromium(VI)-
43 Sodium dichromate 10588-01-9 234-190-3 P D/P B 0.001% Acute Tox. 4 * 2017/9/21
all members 0,01µg/cm2 salts, all members"
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, Cobalt chromate (Chromic acid Skin Sens. 1 See 1st line of "Chromium(VI)-
43 13455-25-9 236-651-4 P D/P B 0.1% 0.01%
all members (H2CrO4), cobalt(2+) salt (1:1)) Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
43 C.I. Pigment Orange 21 1344-38-3 215-694-2 P D/P B 0.1% 0.01%
Aquatic Chronic 1
89
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
Chromium(VI)-salts, 0,001% and Dye material, synthetic organic Skin Sens. 1 See 1st line of "Chromium(VI)-
43 Lead chromate 7758-97-6 231-846-0 P D/P B 0.001% 2015/5/21
all members 0,01µg/cm2 intermediate body Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
43 Lead chromate oxide 18454-12-1 242-339-9 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Lead chromate silicate 11113-70-5 234-347-6 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, Lead sulfochromate yellow(C.I. 0,001% and Skin Sens. 1 See 1st line of "Chromium(VI)-
43 1344-37-2 215-693-7 P D/P B 0.001% 2015/5/21
all members Pigment Yellow 34) 0,01µg/cm2 Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, Molybdate orange (Lead chromate 0,001% and Skin Sens. 1 See 1st line of "Chromium(VI)-
43 12656-85-8 235-759-9 P D/P B 0.001% 2015/5/21
all members pigment) 0,01µg/cm2 Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
43 Chromium lead oxide 11119-70-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Dilead chromate dihydroxide 12017-86-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, Lead chromate Skin Sens. 1 See 1st line of "Chromium(VI)-
43 69011-07-0 231-100-4 P D/P B 0.1% 0.01%
all members silicate(Pb3(CrO4)(SiO4)) Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
Chromium(VI)-salts, Lead chromate Skin Sens. 1 See 1st line of "Chromium(VI)-
43 51899-02-6 231-100-4 P D/P B 0.1% 0.01%
all members sulfate(Pb9(CrO4)5(SO4)4) Aquatic Acute 1 salts, all members"
Aquatic Chronic 1
Carc. 1B
231-106-7
43 Mercury (I) chromate 13465-34-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
Aquatic Chronic 1
Carc. 1B
231-106-7
43 Mercury (II) chromate 13444-75-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
Aquatic Chronic 1
Carc. 1B
231-106-7
43 Mercury dichromate 7789-10-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
Aquatic Chronic 1
90
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
Chromium(VI)-salts, Chromic acid (H2Cr2O7), nickel(2+) Skin Sens. 1 See 1st line of "Chromium(VI)-
43 15586-38-6 239-646-5 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 Nickel chromate 14721-18-7 238-766-5 P D/P B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
43 chromium hexacarbonyl 13007-92-6 235-852-4 P - B 0.1%
Aquatic Chronic 1
Carc. 1B REACH ANNEX XVII

44 coal tar 122384-78-5 310-191-5 D - B 0.01%
Muta. 1B Reg. (EC) No 1272/2008
Carc. 1B
Cobalt and its compounds, Chromium cobalt copper iron Hard metals, galvanic Zn-Co- Skin Sens. 1 Reg. (EC) No 1272/2008
45 102262-21-5 P D B 0.1% 0.01%
all members manganese oxide plating, element in metals Aquatic Acute 1 Reg. (EC) No 1907/2006 (REACH)
Aquatic Chronic 1
Carc. 1B
Cobalt and its compounds, Chromium cobalt iron manganese Skin Sens. 1 See 1st line of "Cobalt and its
45 102262-22-6 P D B 0.1% 0.01%
all members oxide Aquatic Acute 1 compounds, all members"
Aquatic Chronic 1
Carc. 1B
Cobalt and its compounds, Skin Sens. 1 See 1st line of "Cobalt and its
45 Chromium cobalt manganese oxide 102262-19-1 P D B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
45 Chromium cobalt oxide 37382-24-4 234-613-1 P D B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
45 Chromium cobalt oxide (Cr2CoO4) 12016-69-2 234-613-1 P D B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
45 Cobalt chromium alloy 11114-92-4 P D B 0.1% 0.01%
Aquatic Chronic 1
Carc. 1B
Muta. 2
Repr. 1B See 1st line of "Cobalt and its
Cobalt and its compounds, Acute Tox. 4 * compounds, all members"
45 Sulfuric acid, cobalt(2+) salt (1:1)- 10124-43-3 233-334-2 D D A 0.001%
all members Resp. Sens. 1 REACH ANNEX XIV
Skin Sens. 1 RECOMMENDATION
Aquatic Acute 1
Aquatic Chronic 1
Sodium [4-[[6-[(4-amino-6-chloro-1,3,5-
triazin-2-yl)amino]-1-hydroxy-3-sulpho-
Cobalt and its compounds, See 1st line of "Cobalt and its
45 2-naphthyl]azo]-3-hydroxy-7- 100231-59-2 309-359-0 D D A 0.01%
nitronaphthalene-1-sulphonato(4-
)]cobaltate(1-)
91
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
(Ethylenediamine-N)(1-imino-1H-
Cobalt and its compounds, isoindol-3-aminato-N2)[29H,31H- See 1st line of "Cobalt and its
45 83898-69-5 281-281-9 D D A 0.01%
all members phthalocyaninato- compounds, all members"
N29,N30,N31,N32]cobalt
Cobalt and its compounds, [.mu.-[Carbonato(2-)-O:O']] See 1st line of "Cobalt and its
45 12069-68-0 235-112-0 D D A 0.01%
all members dihydroxydicobalt compounds, all members"
Cobalt and its compounds, [5,10,15,20-Tetraphenyl-21H,23H- See 1st line of "Cobalt and its
45 14172-90-8 238-018-8 D D A 0.01%
all members porphinato(2-)-N21,N22,N23,N24]cobalt compounds, all members"
Cobalt and its compounds, 1,2,4-Benzenetricarboxylic acid, See 1st line of "Cobalt and its
45 67801-57-4 267-177-6 D D A 0.01%
all members cobalt(2+) salt (1:1) compounds, all members"
Cobalt and its compounds, 1,4-Benzenedicarboxylic acid, cobalt See 1st line of "Cobalt and its
45 34262-88-9 251-901-2 D D A 0.01%
Cobalt and its compounds, 1,4-Benzenedicarboxylic acid, See 1st line of "Cobalt and its
45 51084-32-3 256-958-7 D D A 0.01%
all members monomethyl ester, cobalt(2+) salt compounds, all members"
Cobalt and its compounds, 2(3H)-Benzothiazolethione,cobalt(2+) See 1st line of "Cobalt and its
45 29904-98-1 249-945-2 D D A 0.01%
Cobalt and its compounds, 2-Propenoic acid, 2-methyl-, cobalt(2+) See 1st line of "Cobalt and its
45 67952-53-8 267-906-8 D D A 0.01%
45 2-Propenoic acid, cobalt(2+) salt 58197-53-8 261-161-2 D D A 0.01%
9,12-Octadecadienoic acid (Z,Z)-,

45 cobalt 14666-96-7 238-711-5 D D A 0.01%
salt
45 9-Octadecenoic acid (Z)-, cobalt salt 14666-94-5 238-709-4 D D A 0.01%
45 Acetic acid, bromo-, cobalt(2+) salt 54846-43-4 D D A 0.01%
Cobalt and its compounds, Acetic acid, cobalt(2+) salt, See 1st line of "Cobalt and its
45 6147-53-1 D D A 0.01%
all members tetrahydrate compounds, all members"
45 Acetic acid, cobalt(3+) salt 917-69-1 213-033-2 D D A 0.01%
45 Adipic acid, cobalt salt 54437-56-8 259-163-3 D D A 0.01%
45 Aluminum cobalt oxide 12672-27-4 235-762-5 D D A 0.01%
45 Aluminum cobalt oxide (Al2CoO4) 1333-88-6 215-610-4 D D A 0.01%
Ammonium bis[4-hydroxy-3-[(5-
hydroxynaphth
45 [2,1-d]-1,3-oxathiol-4-yl)azo]-N- 83847-05-6 281-081-1 D D A 0.01%
methylbenzenesulphonamide S,S-
dioxidato(2-)]cobaltate(1-)
92
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
45 Ammonium cobalt orthophosphate 36835-61-7 253-232-1 D D A 0.01%
45 Antimony, compound with cobalt (1:1) 12052-42-5 234-993-9 D D A 0.01%
45 Benzoic acid, methyl-, cobalt salt 42978-77-8 256-033-8 D D A 0.01%
Cobalt and its compounds, Bis(1,3-diphenylpropane-1,3-dionato- See 1st line of "Cobalt and its
45 14405-50-6 238-379-1 D D A 0.01%
all members O,O')cobalt compounds, all members"
Cobalt and its compounds, Bis(1-phenylbutane-1,3-dionato- See 1st line of "Cobalt and its
45 14128-95-1 237-981-1 D D A 0.01%
Cobalt and its compounds, Bis(6-methylheptane-2,4-dionato- See 1st line of "Cobalt and its
45 79215-59-1 279-115-5 D D A 0.01%
45 Bis(D-gluconato-O1,O2)cobalt 71957-08-9 276-206-1 D D A 0.01%
45 Bis(dibutyldithiocarbamato-S,S')cobalt 14591-57-2 238-636-8 D D A 0.01%
45 Bis(diethyldithiocarbamato-S,S')cobalt 15974-34-2 240-111-3 D D A 0.01%
Bis(N,N-dimethylpropane-1,3-diamine-
N')[2,3,9,10,16,17,23,24-octahydro-
45 29H,31H-tetrakis[1,4]dithiino[2,3-b:2',3'- 83863-98-3 281-146-4 D D A 0.01%
g:2'',3''-l:2''',3'''-q]porphyrazinato(2-)-
Bis(N,N-dimethylpropane-1,3-diamine-
45 N')[29H,31H-phthalocyaninato(2-)- 83863-97-2 281-145-9 D D A 0.01%
Bis[2-[(5-chloro-2-pyridyl)azo]-5-
45 (diethylamino)phenolato]cobalt(1+) 81342-98-5 279-741-9 D D A 0.01%
chloride
45 Carbonic acid, cobalt salt 7542-09-8 231-419-9 D D A 0.01%
45 Cerium, compound with cobalt (1:5) 12214-13-0 235-394-5 D D A 0.01%
45 Cerium, compound with cobalt (2:7) 12515-29-6 235-683-6 D D A 0.01%
Cobalt and its compounds, Chloro[2,2',2''-nitrilotris[ethanolato]- See 1st line of "Cobalt and its
45 36217-04-6 252-923-5 D D A 0.01%
all members N,O,O',O'']cobalt compounds, all members"
Cobalt and its compounds, Chloropentakis(methylamine)cobalt See 1st line of "Cobalt and its
45 15392-59-3 239-413-8 D D A 0.01%
all members dichloride compounds, all members"
93
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
45 Cobalt (II) chloride, hexahydrate 7791-13-1 D D A 0.001%
45 Cobalt bis(2-ethylhexanoate) 136-52-7 205-250-6 D D A 0.001%
45 Cobalt bis(nonylphenolate) 83970-30-3 281-601-7 D D A 0.01%
Cobalt and its compounds, Cobalt bis[citrato(3-)]di-.mu.- See 1st line of "Cobalt and its
45 93776-58-0 297-988-0 D D A 0.01%
all members oxodioxodimolybdate(2-) compounds, all members"
45 Cobalt boride (Co2B) 12045-01-1 D D A 0.01%
45 Cobalt boride (Co3B) 12006-78-9 D D A 0.01%
Carc. 1B
Muta. 2
See 1st line of "Cobalt and its
Repr. 1B
Cobalt and its compounds, compounds, all members"
45 Cobalt carbonate 513-79-1 208-169-4 D D A 0.001% Resp. Sens. 1
all members REACH ANNEX XIV
Skin Sens. 1
RECOMMENDATION
Aquatic Acute 1
Aquatic Chronic 1
45 Cobalt carbonyl 10210-68-1 233-514-0 D D A 0.01%
45 Cobalt chloride (CoCl3) 10241-04-0 233-574-8 D D A 0.01%
45 Cobalt chromite blue green spinel 68187-50-8 269-102-2 D D A 0.01%
45 Cobalt dilactate 16039-54-6 240-179-4 D D A 0.01%
45 Cobalt dilaurate 14960-16-8 239-034-8 D D A 0.01%
45 Cobalt dilinoleate 6401-84-9 229-013-1 D D A 0.01%
45 Cobalt dinicotinate 28029-53-0 248-788-7 D D A 0.01%
45 Cobalt dioctanoate 1588-79-0 216-452-9 D D A 0.001%
45 Cobalt dioleate 19192-71-3 242-865-9 D D A 0.01%
45 Cobalt dipalmitate 14582-18-4 238-625-8 D D A 0.01%
Cobalt and its compounds, Cobalt disodium See 1st line of "Cobalt and its
45 15137-09-4 239-198-0 D D A 0.01%
all members ethylenediaminetetraacetate compounds, all members"
94
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
45 Cobalt distearate 1002-88-6 213-694-7 D D A 0.01%
45 Cobalt disulfide 12013-10-4 D D A 0.01%
45 Cobalt fluoride (CoF3) 10026-18-3 233-062-4 D D A 0.01%
45 Cobalt glycinate 17829-66-2 241-786-7 D D A 0.01%
45 Cobalt hexafluorosilicate(2-) 12021-67-9 234-665-5 D D A 0.01%
45 Cobalt hydroxide 21041-93-0 244-166-4 D D A 0.01%
45 Cobalt hydroxide oxide (Co(OH)O) 12016-80-7 234-614-7 D D A 0.01%
45 Cobalt iodide (CoI2) 15238-00-3 239-283-2 D D A 0.01%
45 Cobalt iron oxide (CoFe2O4) 12052-28-7 234-992-3 D D A 0.001%
45 Cobalt magnesium red blue borate 68608-93-5 271-811-7 D D A 0.01%
45 Cobalt metasilicate 25139-08-6 246-649-5 D D A 0.01%
45 Cobalt naphthenate 61789-51-3 263-064-0 D D A 0.01%
45 Cobalt neodecanoate 27253-31-2 248-373-0 D D A 0.01%
45 Cobalt nitrate 10026-22-9 D D A 0.01%
45 Cobalt octoate 13586-82-8 237-015-9 D D A 0.01%
Acute Tox. 4 *
45 Cobalt oxide 1307-96-6 215-154-6 D D A 0.001%
Aquatic Chronic 1
45 Cobalt oxide (Co2O3) 1308-04-9 215-156-7 D D A 0.01%

Cobalt and its compounds,
45 Cobalt oxide (Co3O4) 1308-06-1 215-157-2 D D A 0.001% compounds, all members"
all members
PACT
95
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
45 Cobalt phosphide (Co2P) 12134-02-0 235-212-4 D D A 0.01%
45 Cobalt propionate 1560-69-6 216-333-1 D D A 0.01%
45 Cobalt silicate 26686-74-8 247-902-2 D D A 0.01%
45 Cobalt silicide (CoSi2) 12017-12-8 234-616-8 D D A 0.01%
45 Cobalt succinate 3267-76-3 221-878-3 D D A 0.01%
45 Cobalt sulfate heptahydrate 10026-24-1 D D A 0.01%
45 Cobalt sulfide (Co2S3) 1332-71-4 D D A 0.01%
45 Cobalt tallate 61789-52-4 D D A 0.01%
45 Cobalt telluride (CoTe) 12017-13-9 234-617-3 D D A 0.01%
Cobalt and its compounds, Cobalt tetra(2-ethylhexyl) See 1st line of "Cobalt and its
45 24828-46-4 246-485-4 D D A 0.01%
all members bis(phosphate) compounds, all members"
45 Cobalt tin oxide (CoSnO3) 1345-19-3 215-719-7 D D A 0.01%
45 Cobalt titanium oxide (Co2TiO4) 12017-38-8 234-618-9 D D A 0.01%
45 Cobalt titanium trioxide 12017-01-5 234-615-2 D D A 0.01%
Cobalt and its compounds, Cobalt titanium tungsten oxide See 1st line of "Cobalt and its
45 144437-67-2 D D A 0.01%
all members ((Co,Ti,W)O2) compounds, all members"
45 Cobalt zirconium oxide (CoZrO3) 69011-09-2 273-691-1 D D A 0.01%
45 Cobalt(2+) dibromate 14732-58-2 238-795-3 D D A 0.01%
45 Cobalt(2+) ethanolate 19330-29-1 242-967-3 D D A 0.01%
45 Cobalt(2+) tert-decanoate 84195-99-3 282-407-5 D D A 0.01%
Cobalt and its compounds, Cobalt(2+), bis(1,2-ethanediamine- See 1st line of "Cobalt and its
45 68958-90-7 273-380-0 D D A 0.01%
all members N,N')-, bis[bis(cyano-C)aurate(1-)] compounds, all members"
96
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobalt and its compounds, Cobalt(2+), bis(1,2-propanediamine- See 1st line of "Cobalt and its
45 67906-18-7 267-691-0 D D A 0.01%
Cobalt and its compounds, Cobalt(2+), pentaamminechloro-, See 1st line of "Cobalt and its
45 13859-51-3 237-594-8 D D A 0.01%
all members dichloride, (OC-6-22)- compounds, all members"
Cobalt and its compounds, Cobalt(3+), hexaammine-, (OC-6-11)-, See 1st line of "Cobalt and its
45 55494-92-3 259-674-1 D D A 0.01%
all members phosphate (1:1) compounds, all members"
45 59561-55-6 D D A 0.01%
all members salt with trifluoroacetic acid(1:3) compounds, all members"
45 14023-85-9 237-847-2 D D A 0.01%
all members triacetate compounds, all members"
45 10534-86-8 D D A 0.01%
all members trinitrate compounds, all members"
Cobalt and its compounds, Cobalt(3+), hexaammine-, trichloride, See 1st line of "Cobalt and its
45 10534-89-1 234-103-9 D D A 0.01%
all members (OC-6-11)- compounds, all members"
Cobalt and its compounds, Cobalt(3+), tris(1,2-ethanediamine- See 1st line of "Cobalt and its
45 13408-73-6 236-499-9 D D A 0.01%
all members N,N')-, trichloride, (OC-6-11)- compounds, all members"
Carc. 1B
Muta. 2
45 Cobalt(II) acetate 71-48-7 200-755-8 D D A 0.001% Resp. Sens. 1 RECOMMENDATION
all members
Skin Sens. 1 Reg. (EC) No 1272/2008
Aquatic Acute 1
Aquatic Chronic 1
45 Cobalt(II) fluoborate 26490-63-1 247-740-2 D D A 0.01%
45 Cobalt(II) fluoride 10026-17-2 233-061-9 D D A 0.01%
Skin Sens. 1
45 Cobalt(II) sulfide 1317-42-6 215-273-3 D D A 0.01% Aquatic Acute 1
Aquatic Chronic 1
Cobalt, ((2,2'-(1,2-
45 ethanediylbis(nitrilomethylidyne))bis(6- 62207-76-5 263-458-2 D D A 0.01%
fluorophenolato))(2-)-N,N',O,O')-
Cobalt and its compounds, Cobalt, [(2-amino-2- See 1st line of "Cobalt and its
45 68133-85-7 268-712-6 D D A 0.01%
all members oxoethoxy)acetato(2-)]- compounds, all members"
Cobalt and its compounds, Cobalt, [29H,31H-phthalocyaninato(2-)- See 1st line of "Cobalt and its
45 3317-67-7 222-012-7 D D A 0.01%
all members N29,N30,N31,N32]-, (SP-4-1)- compounds, all members"
Cobalt, [29H,31H-phthalocyanine-C,C-
45 disulfonyl dichloridato(2-)- 68189-40-2 D D A 0.01%
N29,N30,N31,N32]-
Cobalt, [29H,31H-phthalocyanine-C-
45 sulfonyl chloridato(2-)- 67875-38-1 D D A 0.01%
N29,N30,N31,N32]-
97
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobalt, [3-hydroxy-4-[[1-(p-
mercaptophenyl)-3-methyl-5-oxo-2-
45 pyrazolin-4-yl]azo]-o- 18285-21-7 D D A 0.01%
benzenesulfonanisididato(2-)]-, S-
(hydrogen sulfate), monosodium salt
Cobalt, [4-hydroxy-3-[[1-(p-
mercaptophenyl)-3-methyl-5-oxo-2-
45 pyrazolin-4-yl]azo]-o- 19052-32-5 D D A 0.01%
benzenesulfonophenetidato(2-)]-, S-
(hydrogen sulfate), monosodium salt
Cobalt,
45 [N-(carboxymethyl)glycinato(2-)- 13869-30-2 237-617-1 D D A 0.01%
N,O,ON]-
Cobalt, bis(acetato-O)(1,
45 4-diazabicyclo[2.2.2]octane-N1)-, 68239-56-5 D D A 0.01%
homopolymer
45 Cobalt, bis(D-glycero-D-ido-heptonato)- 68475-45-6 270-643-1 D D A 0.01%
Cobalt,
45 bis(dicyclohexylphosphinodithioato- 40621-10-1 D D A 0.01%
S,S')-
Cobalt and its compounds, Cobalt, bis[(2,3-butanedione dioximato) See 1st line of "Cobalt and its
45 3252-99-1 D D A 0.01%
all members (1-)-N,N']-, (SP-4-1)- compounds, all members"
Cobalt, bis[.alpha.-(1-oxo-1H-isoindol-
45 3-yl)-1H-benzimidazole-2- 60109-88-8 262-055-9 D D A 0.01%
acetonitrilato]-, (T-4)-
Cobalt, bis[2-[[2-hydroxy-5-
45 [(methylamino)sulfonyl]phenyl]azo]-3- 69178-42-3 273-904-8 D D A 0.01%
oxo-N-phenylbutanamidato(2-)]-
Cobalt and its compounds, Cobalt, bis[3-(1H-benzimidazol-2- See 1st line of "Cobalt and its
45 63287-28-5 264-072-7 D D A 0.01%
all members ylamino)-1H-isoindol-1-onato]-, (T-4)- compounds, all members"
Cobalt and its compounds, Cobalt,bis[carbonato(2- See 1st line of "Cobalt and its
45 12602-23-2 235-714-3 D D A 0.01%
all members )]hexahydroxypenta- compounds, all members"
Cobalt,
45 C4-10-fatty acid naphthenate 84066-85-3 281-920-1 D D A 0.01%
complexes
Cobalt, C5-23-branched carboxylate

45 C4-10-fatty acid naphthenate 83711-42-6 280-538-2 D D A 0.01%
complexes
Cobalt and its compounds, Cobalt, C5-23-branched carboxylate See 1st line of "Cobalt and its
45 83711-43-7 280-539-8 D D A 0.01%
all members naphthenate complexes compounds, all members"
Cobalt and its compounds, Cobalt, C5-23-branched carboxylate See 1st line of "Cobalt and its
45 83711-44-8 280-540-3 D D A 0.01%
all members naphthenate octanoate complexes compounds, all members"
45 Cobalt, compound with gadolinium (3:1) 12017-50-4 234-621-5 D D A 0.01%
98
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
45 Cobalt, compound with lanthanum (3:1) 61419-68-9 262-781-6 D D A 0.01%
Cobalt and its compounds, Cobalt, compound with neodymium See 1st line of "Cobalt and its
45 12187-43-8 235-358-9 D D A 0.01%
45 12017-65-1 234-623-6 D D A 0.01%
45 12516-51-7 235-686-2 D D A 0.01%
Cobalt and its compounds, Cobalt, compound with praseodymium See 1st line of "Cobalt and its
45 12017-67-3 234-624-1 D D A 0.01%
Cobalt and its compounds, Cobalt, compound with praseodymium See 1st line of "Cobalt and its
45 12516-52-8 235-687-8 D D A 0.01%
Cobalt and its compounds, Cobalt, compound with samarium See 1st line of "Cobalt and its
45 12052-78-7 234-997-0 D D A 0.01%
45 Cobalt, compound with samarium (2:1) 12017-43-5 234-619-4 D D A 0.01%
45 Cobalt, compound with yttrium (3:1) 12052-62-9 234-994-4 D D A 0.01%
Cobalt,dibromobis(triphenylphosphine)-
45 , 14126-32-0 237-978-5 D D A 0.01%
(T-4)-
99
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobalt and its compounds, Cobalt, dibromobis[tris(3,5- See 1st line of "Cobalt and its
45 69198-43-2 273-909-5 D D A 0.01%
all members dimethylphenyl)phosphine]-, (T-4)- compounds, all members"
Cobalt and its compounds, Cobalt, dibromobis See 1st line of "Cobalt and its
45 49651-10-7 256-410-7 D D A 0.01%
all members [tris(3-methylphenyl)phosphine]-, (T-4)- compounds, all members"
Cobalt,dichloro(1,4-
45 diazabicyclo[2.2.2]octane-N1)-, 68239-58-7 D D A 0.01%
homopolymer
Resp. Sens. 1
45 Cobalt, elemental 7440-48-4 231-158-0 D D A 0.001% Skin Sens. 1
Aquatic Chronic 4
Cobalt, tetrakis[(2,3-butanedione
45 dioximato) 25971-15-7 247-383-2 D D A 0.01%
(1-)-N,N']bis(pyridine)di-, (Co-Co)
Cobalt and its compounds, Cobalt,tris(2,4-pentanedionato-O,O')-, See 1st line of "Cobalt and its
45 21679-46-9 244-527-6 D D A 0.01%
all members (OC-6-11)- compounds, all members"
Cobalt and its compounds, Cobalt,tris(3-bromo-2,4- See 1st line of "Cobalt and its
45 15218-44-7 D D A 0.01%
all members pentanedionato-O,O')-,(OC-6-11)- compounds, all members"
45 Cobalt-acetate 5931-89-5 227-676-1 D D A 0.01%
Cobaltate (6-), [[[1,2-

ethanediylbis[nitrilobis(methylene)]]tetr
45 akis[phosphonato]](6-)- 68025-39-8 268-194-1 D D A 0.01%
N,N',O,O'',O'''',O'''''']-,pentaammonium
hydrogen, (OC-6-21)-
Cobaltate (6-), [[[1,2-

N,N',O,O'',O'''',O'''''']-,pentapotassium
Cobaltate (6-), [[[1,2-

N,N',O,O',O'''',O'''''']-,pentasodium
45 Cobaltate (CoO21-), lithium 12190-79-3 235-362-0 D D A 0.01%
Cobaltate(1-), [1-[[5-(ethylsulfonyl)-2-
hydroxyphenyl]azo]-2-
naphthalenolato(2- )][methyl[8-[(5-
45 ethylsulfonyl)-2-hydroxyphenyl]azo]-7- 103241-62-9 D D A 0.01%
hydroxy-2-
naphthalenyl]methylcarbamato(2-)]-,
sodium
Cobaltate(1-), [2,4-dihydro-4-[(2-
hydroxy-5-nitrophenyl)azo]-5-methyl-2-
Cobalt and its compounds, phenyl-3H-pyrazol-3 -onato(2-)][1-[(2- See 1st line of "Cobalt and its
45 70815-19-9 D D A 0.01%
all members hydroxyphenyl)azo]-2- compounds, all members"
naphthalenolato(2-)]-, hydrogen,
compound with 1-tridecanamine (1:1)
45 phenyl-3H-pyrazol-3-onato(2-)][1-[(2- 55668-56-9 259-746-2 D D A 0.01%
hydroxy-4-nitrophenyl)azo]-2-
naphthalenolato(2-)]-, hydrogen
100
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
naphthalenolato(2-)]-, sodium
phenyl-3H-pyrazol-3-onato(2-)][3-[(4,5-
45 dihydro-3-methyl-5-oxo-1-phenyl-1H- 73324-02-4 D D A 0.01%
pyrazol-4-yl)azo]-4-
hydroxybenzenesulfonamidato(2-)]-,
hydrogen
Cobalt and its compounds, phenyl-3H-pyrazol-3-onato(2-)][4- See 1st line of "Cobalt and its
45 72845-76-2 D D A 0.01%
all members hydroxy-3-[(2-hydroxy-1- compounds, all members"
naphthalenyl)azo]benzenesulfonamidat
o(2-)]-, hydrogen
Cobaltate(1-), [2,4-dihydro-4-[[2-
hydroxy-5-(methylsulfonyl)phenyl]azo]-
Cobalt and its compounds, 5-methyl-2-phenyl-3H-pyrazol-3- See 1st line of "Cobalt and its
45 70236-41-8 274-474-4 D D A 0.01%
all members onato(2-)][N-[7-hydroxy-8-[[2-hydroxy- compounds, all members"
5-(methylsulfonyl)phenyl]azo]-1-
naphthalenyl]acetamidato(2-)]-, sodium
Cobaltate(1-), [29H,31H-
45 phthalocyanine-C-sulfonato(3-)- 30638-08-5 250-265-3 D D A 0.01%
N29,N30,N31,N32]-, hydrogen
45 phthalocyanine-C-sulfonato(3-)- 52729-67-6 D D A 0.01%
N29,N30,N31,N32]-, sodium
Cobaltate(1-), [3-[(4,5-dihydro-3-methyl-
5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-
45 hydroxybenzenesulfonamidato(2-)][1- 72928-77-9 D D A 0.01%
[(2-hydroxy-4-nitrophenyl)azo]-2-
Cobaltate(1-), [3-[(4,5-dihydro-3-methyl-
45 hydroxybenzenesulfonamidato(2-)][1- 72928-76-8 D D A 0.01%
[(2-hydroxy-5-nitrophenyl)azo]-2-
101
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobaltate(1-), [3-[[1-(4-chlorophenyl)-
4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-
4-yl]azo]-4-hydroxy-N-
Cobalt and its compounds, methylbenzenesulfonamidato(2-)][N-[7- See 1st line of "Cobalt and its
45 68413-61-6 270-233-2 D D A 0.01%
all members hydroxy-8-[[2-hydroxy-5- compounds, all members"
[(methylamino)sulfonyl]phenyl]azo]-1-
naphthalenyl]acetamidato(2-)]-,
hydrogen
Cobaltate(1-), [3-[[1-(4-chlorophenyl)-
4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-
4-yl]azo]-4-hydroxy-N-
45 methylbenzenesulfonamidato(2-)][N-[7- 74499-63-1 277-898-8 D D A 0.01%
hydroxy-8-[[2-hydroxy-5-
[(methylamino)sulfonyl]phenyl]azo]-1-
Cobaltate(1-), [3-[4-[(5-chloro-2-
hydroxyphenyl)azo]-4,5-dihydro-3-
methyl-5-oxo-1H-pyrazol-1-
45 yl]benzenesulfonamidato(2-)][4- 72403-33-9 276-645-9 D D A 0.01%
hydroxy-3-[(2-hydroxy-1-
o(2-)]-, sodium
Cobaltate(1-), [3-[4-[(5-chloro-2-
hydroxyphenyl)azo]-4,5-dihydro-3-
methyl-5-oxo-1H-pyrazol-1-
Cobalt and its compounds, yl]benzenesulfonamidato(2-)][4- See 1st line of "Cobalt and its
45 72391-10-7 276-633-3 D D A 0.01%
naphthalenyl)azo]-N-(1-
methylethyl)benzenesulfonamidato(2-)]-
, sodium
Cobaltate(1-), [4-hydroxy-3-[(2-hydroxy-
1-
45 o(2-)][4-hydr oxy-3-[(5- 83864-24-8 310-137-0 D D A 0.01%
hydroxynaphth[2,1-d]-1,3-oxathiol-4-
yl)azo]benzenesulfonamide ,-
dioxidato(2-)]-, ammonium
1-
45 o(2-)][4-hydr oxy-3-[(5- 83817-76-9 280-978-5 D D A 0.01%
hydroxynaphth[2,1-d]-1,3-oxathiol-4-
yl)azo]benzenesulfonamide ,-
dioxidato(2-)]-, sodium
1-
45 o(2-)][4-hydroxy-3-[(2-hydroxy-1- 72403-32-8 276-644-3 D D A 0.01%
naphthalenyl)azo]-N-(1-
methylethyl)benzenesulfonamidato(2-)]-
, sodium
1-
45 o(2-)][8-[(2- hydroxyphenyl)azo]-2- 73297-17-3 D D A 0.01%
naphthalenolato(2-)]-, hydrogen,
compound with 3-[(2-ethylhexyl)oxy]-1-
propanamine (1:1)
102
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobaltate(1-), [6-amino-5-[(2-hydroxy-4-
nitrophenyl)azo]-N-(2-hydroxypropyl)-2-
45 naphthalenesulfonamidato(2-)][1-[(5- 73195-17-2 277-317-8 D D A 0.01%
chloro-2-hydroxyphenyl)azo]-2-
Cobaltate(1-), [C-(chlorosulfonyl)-
45 29H,31H-phthalocyanine-C-sulfonato(3- 68213-72-9 D D A 0.01%
)-N29,N30,N31,N32]-, hydrogen
Cobaltate(1-), [N,N-
45 bis(carboxymethyl)glycinato(3-)- 53108-50-2 258-368-5 D D A 0.01%
N,O,O',O'']-, hydrogen, (T-4)-
Cobaltate(1-), [N-[8-[[5-(aminosulfonyl)-
2-hydroxyphenyl]azo]-7-hydroxy-1-
naphthalenyl]acetamidato(2-)][3-[(4,5-
45 dihydro-3-methyl-5-oxo-1-phenyl-1H- 68239-47-4 269-444-2 D D A 0.01%
hydrogen
naphthalenyl]acetamidato(2-)][3-[(4,5-
45 dihydro-3-methyl-5-oxo-1-phenyl-1H- 68966-96-1 273-460-5 D D A 0.01%
sodium
naphthalenyl]acetamidato(2-)][3-[4,5-
45 dihydro-4-[(2-hydroxy-5- 59487-93-3 261-786-0 D D A 0.01%
nitrophenyl)azo]-3-methyl-5-oxo-1H-
pyrazol-1-yl]benzenesulfonamidato(2-)]-
, sodium
Cobaltate(1-), bis(2,4-dihydro-4-((2-
Cobalt and its compounds, hydroxy-4-nitrophenyl)azo)-5-methyl-2- See 1st line of "Cobalt and its
45 67486-73-1 D D A 0.01%
all members phen yl-3H-pyrazol-3-onato(2-)), compounds, all members"
sodium
Cobaltate(1-), bis[1-[(2-hydroxy-4-
45 nitrophenyl)azo]-2-naphthalenolato(2-)]- 64611-71-8 264-965-1 D D A 0.01%
, sodium
, hydrogen
, sodium
Cobaltate(1-), bis[1-[(2-
45 hydroxyphenyl)azo]-2- 75752-30-6 278-302-9 D D A 0.01%
Cobaltate(1-), bis[1-[(5-chloro-2-
45 hydroxyphenyl)azo]-2- 31586-68-2 D D A 0.01%
103
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
45 hydroxyphenyl)azo]-2- 18639-97-9 D D A 0.01%
Cobaltate(1-), bis[2-(3-chlorophenyl)-
2,4-dihydro-4-[[2-hydroxy-5-
(methylsulfonyl)phenyl]azo]-5-methyl-
Cobalt and its compounds, 3H-pyrazol-3-onato(2-)]-, hydrogen, See 1st line of "Cobalt and its
45 20506-24-5 243-855-7 D D A 0.01%
all members compound with [1R- compounds, all members"
(1.alpha.,4a.beta.,10a.alpha.)]-
1,2,3,4,4a,9,10,10a-octahydro-1,4a-
dimethyl-7-(1-methylethyl)-1-ph
Cobaltate(1-), bis[2-(3-chlorophenyl)-
Cobalt and its compounds, 2,4-dihydro-4-[[2-hydroxy-5- See 1st line of "Cobalt and its
45 70236-44-1 274-477-0 D D A 0.01%
all members (methylsulfonyl)phenyl]azo]-5-methyl- compounds, all members"
3H-pyrazol-3-onato(2-)]-, sodium
Cobaltate(1-), bis[2,4-dihydro-4-[(2-
Cobalt and its compounds, hydroxy-5-nitrophenyl)azo]-5-methyl-2- See 1st line of "Cobalt and its
45 52256-38-9 257-790-7 D D A 0.01%
all members phenyl-3H-pyrazol-3-onato(2-)]-, compounds, all members"
hydrogen
45 phenyl-3H-pyrazol-3-onato(2-)]-, 71566-27-3 275-628-3 D D A 0.01%
hydrogen, compound with
cyclohexanamine (1:1)
45 71839-88-8 D D A 0.01%
all members phenyl-3H-pyrazol-3-onato(2-)]-, 276-072-4 compounds, all members"
sodium
Cobaltate(1-), bis[2,4-dinitro-6-[[2-
Cobalt and its compounds, (phenylamino)-1- See 1st line of "Cobalt and its
45 125378-91-8 D D A 0.01%
all members naphthalenyl]azo]phenolato(2-)]-, compounds, all members"
sodium
Cobaltate(1-), bis[2-[(2-amino-1-
45 naphthalenyl)azo]-5-nitrophenolato(2-)]- 71566-34-2 275-633-0 D D A 0.01%
, hydrogen
Cobaltate(1-), bis[2-[(2-amino-1-
45 naphthalenyl)azo]-5-nitrophenolato(2-)]- 68966-98-3 273-462-6 D D A 0.01%
, sodium
, hydrogen
45 nitrophenyl)azo]-3-oxo-N- 81361-02-6 279-744-5 D D A 0.01%
phenylbutanamidato(2-)]-, sodium
phenylbutanamidato(2-)]-, hydrogen
Cobalt and its compounds, nitrophenyl)azo]-3-oxo-N- See 1st line of "Cobalt and its
45 72797-14-9 276-846-1 D D A 0.01%
all members phenylbutanamidato(2-)]-, hydrogen, compounds, all members"
compound with 1-butanamine (1:1)
104
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobaltate(1-), bis[2-[[2-hydroxy-5-
Cobalt and its compounds, [(phenylamino)sulfonyl]phenyl]azo]-3- See 1st line of "Cobalt and its
45 125408-78-8 D D A 0.01%
all members oxo-N-phenylbutanamidato(2-)]-, compounds, all members"
ammonium
Cobaltate(1-), bis[2-[[2-hydroxy-5-
Cobalt and its compounds, [(phenylamino)sulfonyl]phenyl]azo]-3- See 1st line of "Cobalt and its
45 71562-83-9 275-624-1 D D A 0.01%
all members oxo-N-phenylbutanamidato(2-)]-, compounds, all members"
sodium
Cobaltate(1-), bis[2-[[4-(aminosulfonyl)-
45 2-hydroxyphenyl]azo]-3-oxo-N- 66104-83-4 D D A 0.01%
45 2-hydroxyphenyl]azo]-3-oxo-N- 72928-91-7 277-099-4 D D A 0.01%
phenylbutanamidato(2-)]-, hydrogen
Cobalt and its compounds, 2-hydroxyphenyl]azo]-N-(2- See 1st line of "Cobalt and its
45 34735-28-9 D D A 0.01%
all members chlorophenyl)-3-oxobutan amidato(2-)]-, compounds, all members"
sodium
45 2-hydroxyphenyl]azo]-N-(2-ethylhexyl)- 72403-31-7 276-643-8 D D A 0.01%
3-oxobutanamidato(2-)]-, sodium
Cobaltate(1-), bis[2-[4-[(5-chloro-2-
Cobalt and its compounds, hydroxyphenyl)azo]-4,5-dihydro-3- See 1st line of "Cobalt and its
45 74082-15-8 D D A 0.01%
all members methyl-5-oxo-1H-pyrazol-1- compounds, all members"
yl]benzenesulfonamidato(2-)]-, sodium
Cobaltate(1-), bis[2-chloro-5-hydroxy-4-
[(2-hydroxy-1-naphthalenyl)azo]-N-
45 methylbenzenesulfonamidato(2-)]-, 71839-87-7 276-071-9 D D A 0.01%
hydrogen, compound with
cyclohexanamine (1:1)
Cobalt and its compounds, [(2-hydroxy-1-naphthalenyl)azo]-N- See 1st line of "Cobalt and its
45 70179-69-0 274-363-0 D D A 0.01%
all members methylbenzenesulfonamidato(2-)]-, compounds, all members"
sodium
Cobaltate(1-), bis[3-[(4,5-dihydro-3-
methyl-5-oxo-1-phenyl-1H-pyrazol-4-
45 yl)azo]-4- 68568-52-5 271-494-5 D D A 0.01%
hydrogen
45 yl)azo]-4- 34664-47-6 252-134-6 D D A 0.01%
sodium, (OC-6-22')-
105
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobalt and its compounds, yl)azo]-4-hydroxy-N-(1- See 1st line of "Cobalt and its
45 71839-74-2 276-061-4 D D A 0.01%
all members methylethyl)benzenesulfonamidato(2-)]- compounds, all members"
, hydrogen, compound with 2-
propanamine (1:1)
45 yl)azo]-4-hydroxy-N-[3-(1-thylethoxy) 72479-33-5 D D A 0.01%
propyl]benzenesulfonamidato(2-)]-,
sodium
45 quinolinyl)azo]benzenesulfonato(2-)]-, 72905-57-8 276-980-0 D D A 0.01%
sodium
Cobaltate(1-), bis[3-[[1-(2,5-
dichlorophenyl)-4,5-dihydro-3-methyl-5-
45 oxo-1H-pyrazol-4-yl]azo]-4- 75214-67-4 278-135-1 D D A 0.01%
sodium
Cobaltate(1-), bis[3-[[1-(3-
chlorophenyl)-4,5-dihydro-3-methyl-5-
45 oxo-1H-pyrazol-4-yl]azo]-4- 73612-40-5 277-554-7 D D A 0.01%
sodium
45 oxo-1H-pyrazol-4-yl]azo]-4-hydroxy-N- 71701-14-9 275-863-1 D D A 0.01%
methylbenzenesulfonamidato(2-)]-,
sodium
hydrogen
sodium
Cobaltate(1-), bis[3-[[4,5-dihydro-3-
methyl-1-(4-methylphenyl)-5-oxo-1H-
45 pyrazol-4-yl]azo]-4-hydroxy-N- 70281-40-2 274-528-7 D D A 0.01%
sodium
Cobaltate(1-), bis[3-[4-[(5-chloro-2-
Cobalt and its compounds, hydroxyphenyl)azo]-4,5-dihydro-3- See 1st line of "Cobalt and its
45 72403-34-0 276-646-4 D D A 0.01%
all members methyl-5-oxo-1H-pyrazol-1- compounds, all members"
yl]benzenesulfonamidato(2-)]-, sodium
Cobaltate(1-), bis[4-hydroxy-3-[(2-
hydroxy-1-naphthalenyl)amino]-N-(3-
45 methoxypropyl)benzenesulfonamidato( 71735-52-9 275-950-4 D D A 0.01%
2-)-N3,O3,O4]-, sodium
106
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobalt and its compounds, hydroxy-1- See 1st line of "Cobalt and its
45 63971-70-0 264-585-6 D D A 0.01%
all members naphthalenyl)azo]benzenesulfonamidat compounds, all members"
o(2-)]-, ammonium
45 50525-57-0 256-613-0 D D A 0.01%
o(2-)]-, hydrogen
hydroxy-1-
45 naphthalenyl)azo]benzenesulfonamidat 71839-84-4 276-069-8 D D A 0.01%
o(2-)]-, hydrogen, compound with 2-
propanamine (1:1)
hydroxy-1-
45 naphthalenyl)azo]benzenesulfonamidat 125252-57-5 D D A 0.01%
o(2-)]-, lithium
45 58302-43-5 261-204-5 D D A 0.01%
o(2-)]-, sodium
Cobalt and its compounds, hydroxy-1-naphthalenyl)azo]-N-(1- See 1st line of "Cobalt and its
45 72391-09-4 276-632-8 D D A 0.01%
all members methylethyl) compounds, all members"
benzenesulfonamidato(2-)]-, sodium
45 70247-76-6 274-505-1 D D A 0.01%
all members methoxyethyl) compounds, all members"
45 71735-61-0 275-959-3 D D A 0.01%
all members methoxypropyl) compounds, all members"
Cobalt and its compounds, hydroxy-1-naphthalenyl)azo]-N- See 1st line of "Cobalt and its
45 83847-06-7 281-082-7 D D A 0.01%
all members methylbenzenesulfonamidato (2-)]-, compounds, all members"
ammonium
45 83804-08-4 280-928-2 D D A 0.01%
lithium
45 83804-07-3 280-927-7 D D A 0.01%
sodium
Cobalt and its compounds, hydroxynaphth[2,1-d]-1,3-oxathiol-4- See 1st line of "Cobalt and its
45 83864-23-7 281-148-5 D D A 0.01%
all members yl)azo]benzenesulfon amide ,- compounds, all members"
dioxidato(2-)]-, ammonium
107
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
45 83817-79-2 280-981-1 D D A 0.01%
all members yl)azo]benzenesulfon amide ,- compounds, all members"
dioxidato(2-)]-, sodium
Cobalt and its compounds, hydroxyphenyl)azo]-6-hydroxy-N-(2- See 1st line of "Cobalt and its
45 70236-43-0 274-476-5 D D A 0.01%
all members hydroxyethyl)-N-methyl-2- compounds, all members"
naphthalenesulfonamidato(2-)]-, sodium
Cobaltate(1-), bis[6-amino-5-[(2-
45 hydroxy-4-nitrophenyl)azo]-N-methyl-2- 70236-59-8 D D A 0.01%
naphthalenesulfonamidato(2-)]-, sodium
Cobaltate(1-), bis[hydrogen 3-hydroxy-

45 4-[(2-hydroxy-1-naphthyl)azo]-7-nitro-1- 26921-01-7 248-109-4 D D A 0.01%
naphthalenesulfonato(2-)]-
Cobaltate(1-), bis[methyl [8-[[4-

Cobalt and its compounds, (aminosulfonyl)-2-hydroxy-5- See 1st line of "Cobalt and its
45 73507-63-8 277-507-0 D D A 0.01%
all members methoxyphenyl]azo]-7-hydroxy-1- compounds, all members"
naphthalenyl]carbamato(2-)]-, sodium
Cobaltate(1-), bis[N-(2-chlorophenyl)-2-
Cobalt and its compounds, [[2-hydroxy-5-[(methylamino)sulfonyl]ph See 1st line of "Cobalt and its
45 70247-73-3 271-352-2 D D A 0.01%
all members enyl]azo]-3-oxobutanamidato(2-)]-, compounds, all members"
sodium
Cobaltate(1-), bis[N-(2-chlorophenyl)-2-
Cobalt and its compounds, [[2-hydroxy-5- See 1st line of "Cobalt and its
45 70247-74-4 274-503-0 D D A 0.01%
all members [(methylamino)sulfonyl]phenyl]azo]-3- compounds, all members"
oxobutanamidato(2-)]-, sodium
Cobaltate(1-), bis[N-[(2-chlorophenyl)-2-
Cobalt and its compounds, [[2-hydroxy-5-[(methylamino)sulfonyl]p See 1st line of "Cobalt and its
45 55963-70-7 D D A 0.01%
all members henyl]phenyl]azo]-3- compounds, all members"
oxobutanamidato(2)]-, hydrogen
Cobaltate(1-), bis[N-[2-hydroxy-3-[(2-
45 hydroxy-5-nitrophenyl)azo]-5- 71735-59-6 D D A 0.01%
methylphenyl]acetamidato(2-)]-, sodium
Cobaltate(1-), bis[N-[7-hydroxy-8-[[2-
hydroxy-5-
Cobalt and its compounds, [(methylamino)sulfonyl]phenyl]azo]-1- See 1st line of "Cobalt and its
45 71839-76-4 276-063-5 D D A 0.01%
all members naphthalenyl]acetamidato(2-)]-, compounds, all members"
hydrogen, compound with 2-
propanamine (1:1)
Cobaltate(1-), bis[N-[8-[[5-
Cobalt and its compounds, (aminosulfonyl)-2-hydroxyphenyl]azo]- See 1st line of "Cobalt and its
45 68966-95-0 D D A 0.01%
all members 7-hydroxy-1- compounds, all members"
Cobaltate(2-), [[N,N'-1,2-
Cobalt and its compounds, ethanediylbis[N- See 1st line of "Cobalt and its
45 14931-83-0 239-001-8 D D A 0.01%
all members (carboxymethyl)glycinato]](4-)- compounds, all members"
N,N',O,O',ON,ON']-, (OC-6-21)-
Cobaltate(2-), [1-[(5-chloro-2-
hydroxyphenyl)azo]-2-
45 naphthalenolato(2-)][3-hydroxy-4-[(2-hy 125378-88-3 D D A 0.01%
droxy-1-naphthalenyl)azo]-7-nitro-1-
naphthalenesulfonato(3-)]-, disodium
108
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobaltate(2-), [1-[(5-chloro-2-
hydroxyphenyl)azo]-2-
Cobalt and its compounds, naphthalenolato(2-)][3-hydroxy-4-[(2- See 1st line of "Cobalt and its
45 71243-97-5 275-297-5 D D A 0.01%
all members hydroxy-1-naphthalenyl)azo]-7-nitro-1- compounds, all members"
naphthalenesulfonato(3-)]-, sodium
hydrogen
Cobalt and its compounds, phenyl-3H-pyrazol-3 -onato(2-)][2-[[[4- See 1st line of "Cobalt and its
45 82556-13-6 279-994-5 D D A 0.01%
all members hydroxy-3-[[2-(phenylamino)-1- compounds, all members"
naphthalenyl]azo]phenyl]sul
fonyl]amino]benzoato(3-)]-, disodium
Cobalt and its compounds, phenyl-3H-pyrazol-3-onato(2-)][2-[[[4- See 1st line of "Cobalt and its
45 73455-76-2 D D A 0.01%
all members hydroxy-3-[[2-(phenylamino)-1- compounds, all members"
naphthalenyl]azo]phenyl]sulfonyl]amino
]benzoato(3-)]-, sodium hydrogen
Cobalt and its compounds, phenyl-3H-pyrazol-3-onato(2-)][3- See 1st line of "Cobalt and its
45 72987-06-5 D D A 0.01%
naphthalenyl)azo]-7-nitro-1-
naphthalenesulfonato(3-)]-, dihydrogen
phenyl-3H-pyrazol-3-onato(2-)][3-
Cobalt and its compounds, hydroxy-4-[(2-hydroxy-1- See 1st line of "Cobalt and its
45 72987-07-6 D D A 0.01%
all members naphthalenyl)azo]-7-nitro-1- compounds, all members"
naphthalenesulfonato(3-)]-, dihydrogen,
compound with 2,2'-iminobis[ethanol]
(1:2)
Cobaltate(2-), [2,4-dinitro-6-[[2-
(phenylamino)-1-
naphthalenyl]azo]phenolato(2-)][3-
45 hydroxy-4-[(2-hydroxy-1- 72102-52-4 276-342-1 D D A 0.01%
naphthalenyl)azo]-7-nitro-1-
naphthalenesulfonato(3-)]-, sodium
hydrogen
Cobaltate(2-), [2-[[5-(aminosulfonyl)-2-
hydroxyphenyl]azo]-N-(2-ethylhexyl)-3-
Cobalt and its compounds, oxobutanamidato(2-)][4-[[1-[(2-hydroxy- See 1st line of "Cobalt and its
45 68928-31-4 272-999-3 D D A 0.01%
all members 3,5-dinitrophenyl)azo]-2- compounds, all members"
naphthalenyl]amino]benzenesulfonato(
3-)]-, dipotassium
45 phthalocyanine-C,C-disulfonato(4-)- 29383-29-7 249-591-9 D D A 0.01%
N29,N30,N31,N32]-, dihydrogen
45 phthalocyanine-C,C-disulfonato(4-)- 61045-13-4 D D A 0.01%
N29,N30,N31,N32]-, disodium
Cobaltate(2-), [6-amino-5-[(2-hydroxy-4-
nitrophenyl)azo]-N-methyl-2-
45 naphthalenesulfonamidato(2-)][6- 75314-27-1 278-189-6 D D A 0.01%
amino-5-[(2-hydroxy-4-nitrophenyl)azo]-
2-naphthalenesulfonato(3-)]-, disodium
109
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
phenylbutanamidato(2-)]-, dihydrogen
phenylbutanamidato(2-)]-, dilithium
45 2-hydroxyphenyl]azo]-3-oxo-N- 75522-91-7 D D A 0.01%
phenylbutanamidato(2-)]-, disodium
45 yl)azo]-4- 67906-23-4 267-695-2 D D A 0.01%
hydroxybenzenesulfonamidato(2)]-,
dilithium, (OC-6-22')-
45 yl)azo]-4- 72208-07-2 D D A 0.01%
disodium, (OC-6-22')-
45 yl)azo]-4- 75557-21-0 D D A 0.01%
lithium sodium, (OC-6-22')-
45 oxo-1H-pyrazol-4-yl]azo]-4- 70529-03-2 D D A 0.01%
disodium
45 71060-75-8 275-157-3 D D A 0.01%
o(2-)]-, disodium
Cobaltate(3-), [4-amino-3-[(2-hydroxy-
3,5-dinitrophenyl)azo]-1-
45 naphthalenesulfonato(3-)][5-amino-6- 82457-28-1 D D A 0.01%
[(2-hydroxy-3,5-dinitrophenyl)azo]-1-
naphthalenesulfonato(3-)]-, trisodium
45 bis(phosphonomethyl)glycinato(5-)]-, 67968-65-4 267-968-6 D D A 0.01%
triammonium, (T-4)-
tripotassium, (T-4)-
trisodium,(T-4)-
110
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobaltate(3-), bis[2-[[[3-[[1-[[(2-
chlorophenyl)amino]carbonyl]-2-
45 oxopropyl]azo]-4- 73612-41-6 D D A 0.01%
hydroxyphenyl]sulfonyl]amino]benzoato
(3-)]-, trisodium
Cobaltate(3-), bis[2-[[[4-hydroxy-3-[[2-
45 82556-12-5 279-992-4 D D A 0.01%
all members naphthalenyl]azo]phenyl]sulfonyl]am compounds, all members"
ino]benzoato(3-)]-, trisodium
Cobaltate(3-), bis[2-[[[4-hydroxy-3-[[2-
45 72829-33-5 276-918-2 D D A 0.01%
all members naphthalenyl]azo]phenyl]sulfonyl]amino compounds, all members"
]benzoato(3-)]-, sodium dihydrogen
Cobaltate(3-),bis[2-[[[4-hydroxy-3-[[2-
oxo-1-
45 [(phenylamino)carbonyl]propyl]azo]phe 73018-84-5 277-226-3 D D A 0.01%
nyl]sulfonyl]amino]benzoato(3-)]-,
sodium dihydrogen
Cobaltate(3-), bis[2-hydroxy-5-nitro-3-
[[2-oxo-1-
45 [(phenylamino)carbonyl]propyl]azo]ben 73507-73-0 D D A 0.01%
zenes ulfonato(3-)]-, sodium
dihydrogen
45 hydroxy-1-naphthalenyl)azo]-7-nitro-1- 125378-89-4 D D A 0.01%
naphthalenesulfona to(3-)]-, trisodium
45 hydroxy-1-naphthalenyl)azo]-7-nitro-1- 72797-08-1 D D A 0.01%
naphthalenesulfonato(3-)]-, trihydrogen
hydroxy-1-naphthalenyl)azo]-7-nitro-1-
45 naphthalenesulfonato(3-)]-, trihydrogen, 72797-09-2 D D A 0.01%
compound with 2,2'-iminobis[ethanol]
(1:3)
Cobaltate(3-), bis[3-hydroxy-7-nitro-4-
Cobalt and its compounds, [(1,2,3,4-tetrahydro-2,4-dioxo-3- See 1st line of "Cobalt and its
45 74196-11-5 D D A 0.01%
all members quinolinyl)azo]-1- compounds, all members"
Cobaltate(3-), bis[4-[[2-[(2-hydroxy-5-
nitrophenyl)azo]-1,3-dioxobutyl]amino]-
45 5-methoxy-2- 62598-42-9 263-622-3 D D A 0.01%
methylbenzenesulfonato(3-)]-,
trihydrogen
Cobaltate(3-), bis[4-[4-[[4-[[[3-[(4,5-
dihydro-3-methyl-5-oxo-1-phenyl-1H-
45 hydroxyphenyl]sulfonyl]amino]phenyl]a 75234-42-3 278-146-1 D D A 0.01%
zo]-4,5-dihydro-3-methyl-5-oxo-1H-
pyrazol-1-yl]benzenesulfonato(3-)]-,
trisodium
Cobaltate(3-), bis[4-[4-[[4-[4-[[5-
(aminosulfonyl)-2-hydroxyphenyl]azo]-
Cobalt and its compounds, 4,5-dihydro-3-methyl-5-oxo-1H-pyrazol- See 1st line of "Cobalt and its
45 75214-72-1 278-140-9 D D A 0.01%
all members 1-yl]phenyl]azo]-4,5-dihydro-3-methyl- compounds, all members"
5-oxo-1H-pyrazol-1-
yl]benzenesulfonato(3-)]-, trisodium
111
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobalt and its compounds, [[2-oxo-1- See 1st line of "Cobalt and its
45 73324-01-3 277-381-7 D D A 0.01%
all members [(phenylamino)carbonyl]propyl]azo]ben compounds, all members"
zenesulfonato(3-)]-,trisodium
Cobalt and its compounds, hydroxy-3,5-dinitrophenyl)azo]-1- See 1st line of "Cobalt and its
45 73297-10-6 D D A 0.01%
all members naphthalenesulfonato(3-)]-, sodium compounds, all members"
dihydrogen
45 hydroxy-4-nitrophenyl)azo]-2- 77630-54-7 D D A 0.01%
Cobalt and its compounds, Cobaltate(3-), hexakis(cyano-C)-, See 1st line of "Cobalt and its
45 14123-08-1 237-976-4 D D A 0.01%
all members cobalt(2+) (2:3), (OC-6-11)- compounds, all members"
Cobalt and its compounds, Cobaltate(3-), hexakis(cyano-C)-, zinc See 1st line of "Cobalt and its
45 14049-79-7 D D A 0.01%
all members (2:3), (OC-6-11)- compounds, all members"
Cobalt and its compounds, Cobaltate(3-), tris[6-hydroxy-5-nitroso- See 1st line of "Cobalt and its
45 67815-64-9 D D A 0.01%
all members 2-naphthalenesulfonato(2-)]-, trisodium compounds, all members"
Cobaltate(4-),
Cobalt and its compounds, [[[nitrilotris(methylene)]tris[phosphonato See 1st line of "Cobalt and its
45 63588-34-1 264-339-8 D D A 0.01%
all members ]](6-)-N,OP,OP',OP'']-, tetrapotassium, compounds, all members"
(T-4)-
Cobaltate(4-),
45 68000-01-1 268-068-6 D D A 0.01%
all members ]](6-)-N,OP,OP',OP'']-, tetrasodium, (T- compounds, all members"
4)-
Cobaltate(4-),
45 67968-64-3 267-967-0 D D A 0.01%
all members ]](6-)-N,OP,OP',OP'']-, triammonium compounds, all members"
hydrogen, (T-4)-
Cobalt and its compounds, phthalocyanine-2,9,16,23- See 1st line of "Cobalt and its
45 14285-59-7 238-200-7 D D A 0.01%
all members tetrasulfonato(6-)-N29,N30,N31,N32]-, compounds, all members"
tetrahydrogen, (SP-4-1)-
Cobaltate(4-), bis[2-[[[3-[[1-[[(2-
chlorophenyl)amino]carbonyl]-2-
45 oxopropyl]azo]-4- 70851-34-2 274-929-7 D D A 0.01%
hydroxyphenyl]sulfonyl]amino]benzoato
(3-)]-, tetrasodium
45 14564-70-6 238-606-4 D D A 0.01%
all members tetrapotassium, (OC-6-11)- compounds, all members"
45 14217-00-6 238-078-5 D D A 0.01%
all members tetrasodium, (OC-6-11)- compounds, all members"
Cobaltate(5-), bis[4-[(5-chloro-2,6-
difluoro-4-pyrimidinyl)amino]-2-[[4-
chloro-6-[[4-[4,5-dihydro-4-[(2-hydroxy-
45 5-sulfophenyl)azo]-3-methyl-5-oxo-1H- 83417-32-7 280-447-8 D D A 0.01%
pyrazol-1-yl]phenyl]amino]-1,3,5-triazin-
2-yl]amino]benzenesulfonato(4-)]-,
pentasodium
112
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobaltate(5-), bis[4-[[6-[[4-chloro-6-
(phenylamino)-1,3,5-triazin-2-yl]amino]-
Cobalt and its compounds, 1-hydroxy-3-sulfo-2-naphthalenyl]azo]- See 1st line of "Cobalt and its
45 75284-36-5 278-176-5 D D A 0.01%
all members 3-hydroxy-7-nitro-1- compounds, all members"
naphthalenesulfonato(4-)]-,
pentasodium
Cobaltate(5-), bis[4-[4-[[4-[[[3-[[4,5-
dihydro-3-methyl-5-oxo-1-(4-
sulfophenyl)-1H-pyrazol-4-yl]azo]-4-
45 hydroxyphenyl]sulfonyl]amino]phenyl]a 75214-71-0 278-139-3 D D A 0.01%
zo]-4,5-dihydro-3-methyl-5-oxo-1H-
pyrazol-1-yl]benzenesulfonato(4-)]-,
pentasodium
hydroxy-5-nitrophenyl)azo]-5-[(2,5,6-
45 trichloro-4-pyrimidinyl)amino]-2,7- 74196-19-3 D D A 0.01%
naphthalenedisulfonato(4-)]-,
pentasodium
Cobaltate(5-), bis[5-[(4,6-dichloro-1,3,5-
triazin-2-yl)amino]-4-hydroxy-3-[(2-h
45 ydroxy-5-nitrophenyl)azo]-2,7- 104815-53-4 D D A 0.01%
pentasodium
Cobaltate(5-), bis[5-[(4-amino-6-chloro-
1,3,5-triazin-2-yl)amino]-4-hydroxy-3-
45 [(2-hydroxy-5-nitrophenyl)azo]-2,7- 79817-88-2 279-311-0 D D A 0.01%
pentasodium
45 [(2-hydroxy-5-nitrophenyl)azo]-2,7- 73038-30-9 D D A 0.01%
tetrapotassium sodium
45 [(2-hydroxy-5-nitrophenyl)azo]-2,7- 70776-55-5 D D A 0.01%
tetrasodium hydrogen
methoxy-1,3,5-triazin-2-yl)amino]-4-
Cobalt and its compounds, hydroxy-3-[(2-hydroxy-5- See 1st line of "Cobalt and its
45 68132-93-4 268-657-8 D D A 0.01%
all members nitrophenyl)azo]-2,7- compounds, all members"
tetrasodium hydrogen
Cobaltate(5-), bis[6-[(5-chloro-2,6-
difluoro-4-pyrimidinyl)amino]-4-hydroxy-
Cobalt and its compounds, 3-[(2-hydroxy-5-nitro-3- See 1st line of "Cobalt and its
45 74196-12-6 277-756-5 D D A 0.01%
all members sulfophenyl)azo]-2- compounds, all members"
naphthalenesulfonato(4-)]-
,tetrapotassium sodium
Cobaltate(5-), bis[6-amino-5-[[2-
hydroxy-5-[[2-
45 (sulfooxy)ethyl]sulfonyl]phenyl]azo]-1- 72269-32-0 276-551-8 D D A 0.01%
naphthalenesulfonato(4-)]-, potassium
sodium
hydroxy-5-nitro-3-sulfophenyl)azo]-6-
45 [(2,5,6-trichloro-4-pyrimidinyl)amino]-2- 74196-13-7 D D A 0.01%
pentasodium
113
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobaltate(7-), [5-[[4-chloro-6-[[5-[(5-
chloro-2,6-difluoro-4-pyrimidinyl)amino]
-2-sulfophenyl]amino]-1,3,5-triazin-2-
Cobalt and its compounds, yl]amino]-4-hydroxy-3-[(2- hydroxy-5- See 1st line of "Cobalt and its
45 83417-33-8 D D A 0.01%
all members sulfophenyl)azo]-2,7- compounds, all members"
naphthalenedisulfonato(6-)][4-[(5 -
chloro-2,6-difluoro-4-pyrimidinyl)amino]-
2-[
hydroxy-5-nitrophenyl)azo]-7-[(3-
45 phosphonophenyl)amino]-2- 69898-68-6 274-210-8 D D A 0.01%
naphthalenesulfonato(5-)]-, disodium
pentahydrogen
hydroxy-1-naphthalenyl)azo]-3-[(2-
45 hydroxy-3-nitro-5-sulfophenyl)azo]-2,7- 74196-18-2 277-761-2 D D A 0.01%
heptasodium
hydroxy-5-nitrophenyl)azo]-7-[(3-
45 phosphonophenyl)amino]-2- 70833-34-0 D D A 0.01%
tetraammonium tetrahydrogen
Cobaltate(9-), bis[5-[[4-chloro-6-[[5-[(5-
chloro-2,6-difluoro-4-pyrimidinyl)amino]-
2-sulfophenyl]amino]-1,3,5-triazin-2-
45 yl]amino]-4-hydroxy-3-[(2-hydroxy-5- 83417-34-9 280-448-3 D D A 0.01%
sulfophenyl)azo]-2,7-
nonasodium
Carc. 1B
Muta. 2
Repr. 1B
45 Cobalt-dinitrate 10141-05-6 233-402-1 D D A 0.001% Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
45 Cobaltocene 1277-43-6 215-061-0 D D A 0.01%
Cobalt and its compounds, Cobaltocenium hexafluorophosphate(1- See 1st line of "Cobalt and its
45 12427-42-8 235-655-3 D D A 0.01%
all members ) compounds, all members"
Cobalt and its compounds, Cobaltocenium, (T-4)- See 1st line of "Cobalt and its
45 11077-19-3 D D A 0.01%
all members tetrachlorocobaltate(2-) (2:1) compounds, all members"
45 Cobaltous bromide 7789-43-7 232-166-7 D D A 0.01%
Carc. 1B
Muta. 2
Repr. 1B
Cobalt and its compounds, Acute Tox. 4 * See 1st line of "Cobalt and its
45 Cobaltous chloride 7646-79-9 231-589-4 D D A 0.001%
all members Resp. Sens. 1 compounds, all members"
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
45 Cobaltous sulfamate 14017-41-5 237-834-1 D D A 0.01%
114
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobalt and its compounds, Cyclohexanebutanoic acid, cobalt(2+) See 1st line of "Cobalt and its
45 38582-17-1 254-015-4 D D A 0.01%
Cobalt and its compounds, Di(acetato-O)(1,4- See 1st line of "Cobalt and its
45 68239-55-4 269-450-5 D D A 0.01%
all members diazabicyclo[2.2.2]octane-N1)cobalt compounds, all members"
Cobalt and its compounds, Di-.mu.-carbonyltetracarbonylbis See 1st line of "Cobalt and its
45 24212-54-2 246-081-8 D D A 0.01%
all members (triphenylphosphine)dicobalt compounds, all members"
Diammonium pentahydrogen bis[4-

hydroxy-3-[(2-hydroxy-5-
45 nitrophenyl)azo]-7-[(3- 83803-62-7 280-881-8 D D A 0.01%
phosphonophenyl)amino]naphthalene-
2-sulphonato(5-)]cobaltate(7-)
45 Diboron cobalt(2+) tetraoxide 38233-75-9 253-842-8 D D A 0.01%
Cobalt and its compounds, Dicarbonyl(.eta.5-2,4-cyclopentadien-1- See 1st line of "Cobalt and its
45 12078-25-0 235-139-8 D D A 0.01%
all members yl)cobalt compounds, all members"
Cobalt and its compounds, Dichloro(1,4-diazabicyclo[2.2.2]octane- See 1st line of "Cobalt and its
45 68239-57-6 269-451-0 D D A 0.01%
all members N1)cobalt compounds, all members"
Cobalt and its compounds, Dichlorobis(3-pyridylcarboxamide- See 1st line of "Cobalt and its
45 6856-47-9 229-954-8 D D A 0.01%
all members N1)cobalt compounds, all members"
45 Dicobalt edetate 36499-65-7 253-067-5 D D A 0.01%
45 Dicobalt orthosilicate 13455-33-9 236-654-0 D D A 0.01%
45 Dicobalt tris(sulphate) 13478-09-6 236-772-2 D D A 0.01%
Cobalt and its compounds, Dihydrogen See 1st line of "Cobalt and its
45 19224-80-7 242-896-8 D D A 0.01%
all members bis[L-glutamato(2-)-N,O1]cobaltate(2-) compounds, all members"
45 Diphosphoric acid, cobalt(2+) salt (1:2) 14640-56-3 238-689-7 D D A 0.01%
Dipotassium [[N,N'-ethylenebis[N-
45 (carboxymethyl)glycinato]](4-)- 14025-10-6 237-862-4 D D A 0.01%
N,N',O,O',ON,ON']cobaltate(2-)
45 Dipotassium disulphatocobaltate 13596-22-0 237-040-5 D D A 0.01%
Disodium [5-[[1-(anilinocarbonyl)-2-
oxopropyl]azo]-4-hydroxy-3-
45 nitrobenzenesulphonato(3-)][2-[(2- 76762-27-1 278-545-0 D D A 0.01%
hydroxy-5-nitrophenyl)azo]-3-oxo-N-
phenylbutyramidato(2-)]cobaltate(2-)
115
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Electrolytes, cobalt-manufacturing A
solution used in the electrolytic refining
of cobalt. The composition varies
45 according to the particular process 121053-28-9 D D A 0.01%
involved. The electrolyte generally
contains high levels of cob alt ions and
lower levels of impurity me
Fatty acids, soya, polymers with acetic

acid, fumaric acid, linseedoil, maleic
45 anhydride, pentaerythritol, rosin, tall oil, 70131-61-2 D D A 0.01%
tall-oil fatty acids and tripentaerythritol,
cobalt salts
45 Formic acid, cobalt salt 15731-88-1 239-824-2 D D A 0.01%
Heptahydrogen bis[4-hydroxy-3-[(2-
Cobalt and its compounds, hydroxy-5-nitrophenyl)azo]-7-[(3- See 1st line of "Cobalt and its
45 65335-15-1 265-702-3 D D A 0.01%
all members phosphonophenyl)amino]naphthalene- compounds, all members"
2-sulphonato(5-)]cobaltate(7-)
45 Hexa(cyano-c)cobaltate(4-) 23209-26-9 245-489-3 D D A 0.01%
Cobalt and its compounds, Hexanoic acid, 3,5,5-trimethyl-, See 1st line of "Cobalt and its
45 49676-83-7 256-426-4 D D A 0.01%
all members cobalt(2+) salt compounds, all members"
Hydrazinium(1+), (OC-6-21)-[[N,N'-1,2-
Cobalt and its compounds, ethanediylbis[N- See 1st line of "Cobalt and its
45 68201-98-9 269-248-7 D D A 0.01%
all members (carboxymethyl)glycinato]](4-)- compounds, all members"
N,N',O,O',ON,ON']cobaltate(2-) (2:1)
Hydrofluoric acid, reaction products

45 with alumina and cobalt chloride 68442-96-6 D D A 0.01%
(CoCl2)
Hydrogen [2,4-dihydro-4-[(2-hydroxy-4-
nitrophenyl)azo]-5-methyl-2-phenyl-3H-
45 pyrazol-3-onato(2-)][1-[(2-hydroxy-4- 52277-72-2 257-805-7 D D A 0.01%
nitrophenyl)azo]-2-naphtholato(2-
)]cobaltate(1-)
Hydrogen[2-[[5-(aminosulphonyl)-2-
hydroxyphenyl]azo]-3-oxo-N-
Cobalt and its compounds, phenylbutylamidato(2-)][3-[[1- See 1st line of "Cobalt and its
45 83249-70-1 280-339-0 D D A 0.01%
all members (benzothiazol-2-yl)-2-oxopropyl]azo]-4- compounds, all members"
hydroxybenzenesulphonamidato(2-)]
cobaltate(1-)
Hydrogen bis[1-[(2-hydroxy-4-
45 nitrophenyl)azo]naphthalen-2-olato(2- 32517-38-7 251-080-0 D D A 0.01%
)]cobaltate(1-)
Hydrogen bis[2,4-dihydro-4-[(2-
45 84030-59-1 281-834-4 D D A 0.01%
all members phenyl-3H-pyrazol-3-onato(2- compounds, all members"
)]cobaltate(1-)
Hydrogen bis[2,4-dihydro-4-[[2-hydroxy-
45 5-mesylphenyl]azo]-5-methyl-2-phenyl- 29998-71-8 249-997-6 D D A 0.01%
3H-pyrazol-3-onato(2-)]cobaltate(1-)
116
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Hydrogen bis[2-[(2-hydroxy-5-
nitrophenyl)azo]-3-oxo-N-
45 phenylbutyramidato(2-)]cobaltate(1-), 84030-58-0 281-833-9 D D A 0.01%
compound with 2,2'-
dodecyliminobis[ethanol] (1:1)
Hydrogen bis[3-[[1-(benzothiazol-2-yl)-
Cobalt and its compounds, 2-oxopropyl]azo]-4- See 1st line of "Cobalt and its
45 83249-73-4 280-342-7 D D A 0.01%
all members hydroxybenzenesulphonamidato(2-)] compounds, all members"
cobaltate(1-)
Hydrogen bis[5,8-dichloro-2-[(2-
Cobalt and its compounds, hydroxy-4-nitrophenyl)azo]-1- See 1st line of "Cobalt and its
45 82338-72-5 279-932-7 D D A 0.01%
all members naphtholato(2-)]cobaltate(1-), compounds, all members"
compound with cyclohexylamine (1:1)
Hydrogen bis[5,8-dichloro-2-[(2-
Cobalt and its compounds, hydroxy-5-nitrophenyl)azo]-1- See 1st line of "Cobalt and its
45 82338-74-7 279-933-2 D D A 0.01%
all members naphtholato(2-)]cobaltate(1-), compounds, all members"
compound with cyclohexylamine (1:1)
Hydrogen bis[N-[7-hydroxy-8-[[2-
45 hydroxy-5-mesylphenyl]azo]-1- 29616-23-7 249-729-8 D D A 0.01%
naphthyl]cobaltate(1-)
45 Isononanoic acid, cobalt salt 57364-75-7 260-700-9 D D A 0.01%
Cobalt and its compounds, Leach residues, zinc ore-calcine, See 1st line of "Cobalt and its
45 69012-71-1 273-767-4 D D A 0.01%
all members cobalt repulp compounds, all members"
Lithium[2-[[5-(aminosulphonyl)-2-
45 83270-30-8 280-353-7 D D A 0.01%
cobaltate(1-)
Lithium bis[2-[(2-hydroxy-5-
Lithium bis[2-[[5-(aminosulphonyl)-2-
45 hydroxyphenyl]azo]-3-oxo-N- 83249-68-7 280-336-4 D D A 0.01%
Lithium bis[3-[[1-(benzothiazol-2-yl)-2-
Cobalt and its compounds, oxopropyl]azo]-4- See 1st line of "Cobalt and its
45 83249-72-3 280-341-1 D D A 0.01%
cobaltate(1-)
45 Molybdate (Mo7O246-), cobalt(3+) (2:1) 68647-47-2 D D A 0.01%
45 N,N'-Ethylenebis(glycinato-O,N)cobalt 29977-10-4 249-986-6 D D A 0.01%
45 Neodecanoic acid, cobalt(2+) salt 52270-44-7 257-798-0 D D A 0.01%
117
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
45 Nitric acid, cobalt(3+) salt 15520-84-0 D D A 0.01%
45 Octadecanoic acid, cobalt salt 13586-84-0 237-016-4 D D A 0.001%
45 Octanoic acid, cobalt salt 6700-85-2 229-744-6 D D A 0.01%
Pentapotassium bis[5-[(4-amino-6-
chloro-1,3,5-triazin-2-yl)amino]-4-
45 hydroxy-3-[(2-hydroxy-5- 79817-89-3 279-312-6 D D A 0.01%
nitrophenyl)azo]naphthalene-2,7-
disulphonato(4-)]cobaltate(5-)
Phosphonic acid, (1-

45 hydroxyethylidene)bis-, ammonium 69178-34-3 273-899-2 D D A 0.01%
cobalt(2+) salt (1:2:1)

45 hydroxyethylidene)bis-, cobalt(2+) 69140-59-6 273-890-3 D D A 0.01%
potassium salt (1:1:2)

45 hydroxyethylidene)bis-, cobalt(2+) 69140-60-9 273-891-9 D D A 0.01%
sodium salt (1:1:2)
Cobalt and its compounds, Phosphoric acid, ammonium cobalt(2+) See 1st line of "Cobalt and its
45 14590-13-7 238-633-1 D D A 0.01%
all members salt (1:1:1) compounds, all members"
45 Phosphoric acid, cobalt(2+) salt (1:1) 13596-21-9 237-038-4 D D A 0.01%
45 Phosphoric acid, cobalt(2+) salt (2:1) 18718-10-0 242-521-8 D D A 0.01%
Cobalt and its compounds, Phosphoric acid, cobalt(2+) salt (2:3), See 1st line of "Cobalt and its
45 10101-56-1 D D A 0.01%
all members hydrate compounds, all members"
Cobalt and its compounds, Potassium [N,N-bis(carboxymethyl) See 1st line of "Cobalt and its
45 63640-17-5 264-375-4 D D A 0.01%
all members glycinato(3-)-N,O,O',O'']cobaltate(1-) compounds, all members"
Cobalt and its compounds, Propanoic acid, 2,2-dimethyl-, See 1st line of "Cobalt and its
45 15520-31-7 D D A 0.01%
all members cobalt(2+) salt compounds, all members"
Sodium [2-[[5-(aminosulphonyl)-2-
45 83249-69-8 280-338-5 D D A 0.01%
cobaltate(1-)
Sodium bis[1-[[5-(ethylsulphonyl)-2-
45 hydroxyphenyl]azo]-2-naphtholato(2- 55870-94-5 259-873-3 D D A 0.01%
)]cobaltate(1-)
Sodium bis[3-[[1-(benzothiazol-2-yl)-2-
Cobalt and its compounds, oxopropyl]azo]-4- See 1st line of "Cobalt and its
45 83249-71-2 280-340-6 D D A 0.01%
cobaltate(1-)
118
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Sodium bis[3-[[4,5-dihydro-3-methyl-1-
(4-nitrophenyl)-5-oxo-1H-pyrazol-4-
45 yl]azo]-4- 83803-65-0 280-884-4 D D A 0.01%
hydroxybenzenesulphonamidato(2)]cob
altate(1-)
Sodium bis[4-[(4-chloro-1-hydroxy-2-
Cobalt and its compounds, naphthyl)azo]-N,N'-diethyl-5- See 1st line of "Cobalt and its
45 24215-94-9 246-082-3 D D A 0.01%
all members hydroxybenzene-1,3- compounds, all members"
disulphonamidato(2-)]cobaltate(1-)
Sodium bis[4-hydroxy-3-[(5-
45 83817-78-1 280-980-6 D D A 0.01%
all members yl)azo]-N-methylbenzenesulphonamide compounds, all members"
S,S-dioxidato(2-)]cobaltate(1-)
Sodium bis[methyl [8-[[5-

(ethylsulphonyl)-2-hydroxyphenyl]azo]-
45 7-hydroxy-2- 55870-93-4 259-872-8 D D A 0.01%
naphthyl]methylcarbamato(2-
)]cobaltate(1-)
45 Sulfuric acid, ammonium cobalt(2+) salt 13586-38-4 D D A 0.01%
Cobalt and its compounds, Sulfuric acid, ammonium cobalt(2+) salt See 1st line of "Cobalt and its
45 13596-46-8 237-043-1 D D A 0.01%
all members (2:2:1) compounds, all members"
45 Sulfuric acid, cobalt salt, hydrate 65492-00-4 D D A 0.01%
Cobalt and its compounds, Tetrakis[(decanoato-O)cobalt]tetra- See 1st line of "Cobalt and its
45 84145-31-3 282-257-0 D D A 0.01%
all members .mu.-oxotitanium compounds, all members"
Cobalt and its compounds, Tetrakis[(octanoato-O)cobalt]tetra-.mu.- See 1st line of "Cobalt and its
45 84176-59-0 282-326-5 D D A 0.01%
all members oxotitanium compounds, all members"
45 Thiocyanic acid, cobalt(2+) salt 3017-60-5 221-156-8 D D A 0.01%
Tri-.mu.-
45 carbonyltetracarbonyl(pentacarbonyldic 50696-78-1 256-719-7 D D A 0.01%
obalt)dirhodium
45 Tricobalt bis(orthophosphate) 13455-36-2 236-655-6 D D A 0.01%
Cobalt and its compounds, Tricopper bis[hexa(cyano- See 1st line of "Cobalt and its
45 14518-26-4 238-524-9 D D A 0.01%
all members c)cobaltate(3-)] compounds, all members"
Trihydrogen bis
[5-[[[4-hydroxy-3-[[2-oxo-1-
45 [(phenylamino)carbonyl]propyl]azo]phe 72932-56-0 277-102-9 D D A 0.01%
nyl]sulphonyl]amino]naphthalene-2-
sulphonato(3-)]cobaltate(3-)
Triphenyl(p,p,p-triphenylphosphine
45 imidato-N)phosphorus(1+) 53433-12-8 258-552-5 D D A 0.01%
tetracarbonylcobaltate(1-)
45 Tris(heptane-3,5-dionato-O,O')cobalt 15188-91-7 239-240-8 D D A 0.01%
119
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Trisodium [N,N-bis[2-
45 [bis(carboxymethyl)amino]ethyl]glycinat 6255-07-8 D D A 0.01%
o(5-)]cobaltate(3-)
Trisodium bis[3-[(4,5-dihydro-3-methyl-
Cobalt and its compounds, 5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2- See 1st line of "Cobalt and its
45 84204-70-6 D D A 0.01%
all members hydroxy-5-nitrobenzenesulphonato(3- 282-438-4 compounds, all members"
)]cobaltate(3-)
Trisodium bis[3-[(5-amino-3-methyl-1-
phenyl-1H-pyrazol-4-yl)azo]-5-chloro-4-
45 hydroxy-N-[2- 83804-04-0 280-926-1 D D A 0.01%
(sulphooxy)ethyl]benzenesulphonamida
to(3-)]cobaltate(3-)
Trisodium bis[4-[4,5-dihydro-4-[(2-
45 79135-28-7 279-075-9 D D A 0.01%
all members oxo-1H-pyrazol-1-yl]benzene-1- compounds, all members"
Trisodium bis[4-hydroxy-3-nitro-5-
Cobalt and its compounds, [[2-oxo-1-[(phenylamino)carbonyl] See 1st line of "Cobalt and its
45 83733-22-6 280-675-8 D D A 0.01%
all members propyl]azo]benzenesulphonato(3-)] compounds, all members"
cobaltate(3-)
Trisodium bis[5-chloro-2-hydroxy-3-[(2-
45 6771-86-4 229-832-4 D D A 0.01%
all members naphthyl)azo]benzenesulphonato(3- compounds, all members"
)]cobaltate(3-)
Trisodium bis[6-amino-5-[(2-hydroxy-
45 3,5-dinitrophenyl)azo]naphthalene-1- 84057-73-8 281-891-5 D D A 0.01%
Trisodium bis[amino[(2-hydroxy-3,5-
45 dinitrophenyl)azo]naphthalenesulphona 74220-71-6 277-778-5 D D A 0.01%
to(3-)]cobaltate(3-)
Xanthylium, 9-(2-carboxyphenyl)-3,6-
bis(diethylamino)-, bis[3-[(4,5-dihydro-
Cobalt and its compounds, 3-methyl-5-oxo-1-phenyl-1H-pyrazol-4- See 1st line of "Cobalt and its
45 71566-55-7 275-640-9 D D A 0.01%
all members yl)azo]-4-hydroxy-N-[3-(1- compounds, all members"
methylethoxy)propyl]benzenesulfonami
dato(2-)]cobaltate(1-)
45 C.I. Acid Red 182 61901-42-6 256-613-0 D D A 0.01%
Cobalt and its compounds, 1-Propanamin, N,N-dipropyl-, See 1st line of "Cobalt and its
45 75101-45-0 D D A 0.01%
all members cobalt complex compounds, all members"
Cobalt and its compounds, Cobalt borate neodecanoate See 1st line of "Cobalt and its
45 68457-13-6 270-601-2 D D A 0.01%
all members complexes, compounds, all members"
45 C.I. Pigment Blue 28 1345-16-0 310-193-6 D D A 0.01%
45 Cobalt aluminate blue spinel 68186-86-7 310-193-6 D D A 0.01%
120
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
45 C.I. Acid Blue 51053-44-2 D D A 0.01%
45 C.I. Pigment Green 26 68187-49-5 269-101-7 D D A 0.01%
45 C.I. Pigment Violet 47 68610-13-9 271-849-4 D D A 0.01%

45 C.I. Pigment Green 50 68186-85-6 269-047-4 D D A 0.01% compounds, all members"
all members
PACT
45 C.I. Pigment Green 19 8011-87-8 232-381-6 D D A 0.01%
45 C.I. Pigment Black 27 68186-97-0 269-060-5 D D A 0.01%
45 Cobalt(II) isoalkanoates(C6-C19) 68409-81-4 270-066-5 D D A 0.001%
Cobalt and its compounds, (C9-C13) Neoalkanoic acids, cobalt(2+) See 1st line of "Cobalt and its
45 68955-83-9 273-293-8 D D A 0.01%
all members salts compounds, all members"
Trisodium bis(2-hydroxy-5-nitro-3-((2-
Cobalt and its compounds, oxo-1-((phenylamino)carbonyl)propyl) See 1st line of "Cobalt and its
45 85959-73-5 289-068-2 D D A 0.01%
all members azo)benzenesulphonato(3- compounds, all members"
))cobaltate(3-)
Cobalt and its compounds, Zinc chrome cobalt aluminate blue See 1st line of "Cobalt and its
45 74665-01-3 D D A 0.01%
all members spinel compounds, all members"
45 Cobalt cyanide (Co(CN)2) 542-84-7 D - B 0.01%
45 Cobalt cyanide (Co(CN)3) 14965-99-2 D - B 0.01%
45 Cobalt hydroxide (Co(OH)3) 1307-86-4 215-153-0 D - B 0.01%
45 Cobalt tungsten oxide (CoWO4) 10101-58-3 233-254-8 D - B 0.01%
45 Cobalt(2+) hydrogen citrate 18727-04-3 242-538-0 D - B 0.01%
45 Cobalt(II) molybdate 13762-14-6 237-358-4 D - B 0.01%
121
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Cobalt and its compounds, Cobalt, See 1st line of "Cobalt and its
45 14024-48-7 237-855-6 D - B 0.01%
all members bis(2,4-pentanedionato-O,O')-, (T-4)- compounds, all members"
45 13963-58-1 D - B 0.01%
all members tripotassium, (OC-6-11)- compounds, all members"
45 14039-23-7 D - B 0.01%
all members trisodium, (OC-6-11)- compounds, all members"
45 Cobalt diformate 544-18-3 D - B 0.01%
45 Ethanedioic acid, cobalt(2+) salt (1:1) 814-89-1 212-409-3 D - B 0.01%
Cobalt and its compounds, Leach residues, zinc ore-calcine, zinc See 1st line of "Cobalt and its
45 69012-72-2 273-769-5 D - B 0.01%
all members cobalt compounds, all members"
Molybdate(3-), tetracosa-.mu.-
Cobalt and its compounds, oxododecaoxo[.mu.12-[phosphato(3-)- See 1st line of "Cobalt and its
45 12263-08-0 D - B 0.01%
all members O:O:O:O':O':O':O'':O'':O'':O''':O''':O''']]d compounds, all members"
odeca-, cobalt(2+) (2:3)
45 Nitric acid, cobalt salt 14216-74-1 D - B 0.01%
Cobalt and its compounds, Tri-.mu.- See 1st line of "Cobalt and its
45 17786-31-1 D - B 0.01%
all members carbonylnonacarbonyltetracobalt compounds, all members"
45 Tricarbonylnitrosylcobalt 14096-82-3 D - B 0.01%
45 Cobalt selenide (CoSe) 1307-99-9 215-155-1 D D A 0.01%
45 Cobalt(2+) selenite 10026-23-0 233-064-5 D D A 0.01%
45 Selenic acid, cobalt(2+) salt (1:1) 14590-19-3 238-634-7 D D A 0.01%
Cobalt and its compounds, Cobaltate(3-), hexakis(nitrito-N)-, See 1st line of "Cobalt and its
45 13782-01-9 237-435-2 D D A 0.01%
all members tripotassium, (OC-6-11)- compounds, all members"
Cobalt and its compounds, Cobaltate(3-), hexakis(nitrito-O)-, See 1st line of "Cobalt and its
45 14649-73-1 D D A 0.01%
all members trisodium, (OC-6-11)- compounds, all members"
45 Trisodium hexanitritocobaltate 13600-98-1 237-077-7 D D A 0.01%
Cobalt and its compounds, Benzoic acid, 4-amino-, cobalt(2+) salt See 1st line of "Cobalt and its
45 68123-03-5 268-533-3 D D A 0.01%
ACGIH Worldwide
Documentation of the TLVs and
46 Colophony (Rosin), selected Rosin 8050-09-7 232-475-7 D D A 0.01% Soldering, adhesive, sealant Skin Sens. 1 BEIs with other Worldwide
Occupational Exposure Values;
2003.
122
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of "Colophony (Rosin),

46 Colophony (Rosin), selected Colophony resin 148499-15-4 D D A 0.01%
selected"
See 1st line of "Colophony (Rosin),

46 Colophony (Rosin), selected Resin acids and Rosin acids zinc salts 91081-53-7 293-659-0 D D A 0.01%
selected"
No current regulations but

Brake lining, wirings, alloy, Coughing, headache, shortness substance of concern in dispersive
47 Copper (metallic) 7440-50-8 231-159-6 D D A 0.01%
electronic material of breath, pharyngalgia friction material applications due to
environmental impact potential;
could be subject to future
Cyclododecane, hexabromo- Cyclododecane, hexabromo- REACH ANNEX XIV

48 25637-99-4 247-148-4 P D/P B X 0.01% 0.01% Flame retardant Repr. 2 Lact. 2015/8/21
(HBCDD) (HBCDD) JPN CSCL Class 1 substance
Cyclododecane, hexabromo- See 1st line of "Cyclododecane,

48 1,2,5,6,9,10-Hexabromocyclododecane 3194-55-6 221-695-9 P D/P B X 0.01% 0.01% Repr. 2 Lact. 2015/8/21
(HBCDD) hexabromo- (HBCDD)"
alpha-HBCDD
Cyclododecane, hexabromo- 247-148-4 See 1st line of "Cyclododecane,
48 hexabromocyclododecane 134237-50-6 P D/P B X 0.01% 0.01% 2015/8/21
(HBCDD) 221-695-9 hexabromo- (HBCDD)"
diastereoisomer
beta-HBCDD
diastereoisomer
Gamma-HBCDD
diastereoisomer
Cyclododecane, hexabromo- rel-(1R, 2S, 5R, 6S, 9R, 10S)- See 1st line of "Cyclododecane,
48 4736-49-6 P D/P B 0.1% 0.01%
(HBCDD) 1,2,5,6,9,10-Hexabromocyclododecane hexabromo- (HBCDD)"
Cyclododecane, hexabromo- rel-(1R, 2S, 5R, 6S, 9S, 10R)- See 1st line of "Cyclododecane,
48 65701-47-5 P D/P B 0.1% 0.01%
(HBCDD) 1,2,5,6,9,10-Hexabromocyclododecane hexabromo- (HBCDD)"
Cyclododecane, hexabromo- (1R, 2R, 5R, 6S, 9S, 10S)-1,2,5,6,9,10- See 1st line of "Cyclododecane,
48 138257-17-7 P D/P B 0.1% 0.01%
(HBCDD) Hexabromocyclododecane hexabromo- (HBCDD)"
Cyclododecane, hexabromo- (1R, 2R, 5R, 6S, 9R, 10S)-1,2,5,6,9,10- See 1st line of "Cyclododecane,
48 138257-18-8 P D/P B 0.1% 0.01%
Cyclododecane, hexabromo- (1R, 2S, 5S, 6R, 9S, 10S)-1,2,5,6,9,10- See 1st line of "Cyclododecane,
48 138257-19-9 P D/P B 0.1% 0.01%
Cyclododecane, hexabromo- (1R, 2S, 5S, 6S, 9S, 10R)-1,2,5,6,9,10- See 1st line of "Cyclododecane,
48 169102-57-2 P D/P B 0.1% 0.01%
Cyclododecane, hexabromo- (1R, 2R, 5S, 6R, 9R, 10S)-1,2,5,6,9,10- See 1st line of "Cyclododecane,
48 678970-15-5 P D/P B 0.1% 0.01%
Cyclododecane, hexabromo- (1R, 2S, 5R, 6S, 9S, 10S)-1,2,5,6,9,10- See 1st line of "Cyclododecane,
48 678970-16-6 P D/P B 0.1% 0.01%
Cyclododecane, hexabromo- (1R, 2R, 5R, 6S, 9S, 10R)-1,2,5,6,9,10- See 1st line of "Cyclododecane,
48 678970-17-7 P D/P B 0.1% 0.01%
123
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Flam. Liq. 2
Carc. 1A Published in Canada Gazette Part
Intermediates of agricultural
49 Chloromethyl methyl ether (CMME) 107-30-2 203-480-1 P - B 0.1% 0.01% Acute Tox. 4 * II, 2006-11-29 Vol. 140, No. 25
chemicals and medicines
Acute Tox. 4 *
50 Crude oil Crude oil 8002-05-9 232-298-5 D - B 0.01% Carc. 1B Reg. (EC) No 1272/2008
Carc. 1B (EC) No 1272/2008

Dye, color, paint, solvent,
204-273-9 STOT RE 1 The Canadian Prohibition of
51 Chlorobenzene Hexachlorobenzene 118-74-1 P D/P B - - cleaner, lubricant, synthetic
200-273-9 Aquatic Acute 1 Certain Toxic Substances
intermediate
Aquatic Chronic 1 Regulations 2012 JPN CSCL Class
1 substance.
Acute Tox. 4 *
Skin Irrit. 2 REACH SVHC proposal,
51 Chlorobenzene 1,2,4 Trichlorobenzene 120-82-1 204-428-0 P - B 0.1% 0.01%
Aquatic Acute 1 ANNEX XVII
Aquatic Chronic 1
51 Chlorobenzene 1,3,5-Trichlorobenzene 108-70-3 203-608-6 D - B 0.01% REACH SVHC proposal
51 Chlorobenzene 1,2,3-Trichlorobenzene 87-61-6 201-757-1 D - B 0.01% REACH SVHC proposal
REACH SVHC proposal

52 Cyclododecane 294-62-2 206-033-9 D - B 0.01% Intermediate
JPN CSCL Class 1 substance
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
53 Cyclohexane 110-82-7 203-806-2 D - B 0.01% - REACH ANNEX XVII
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
Muta. 2
REACH ANNEX XIV
Diamino-diphenylmethane　(4,4'- Resin intermediate, adhesive, STOT SE 1
54 101-77-9 202-974-4 P P A X 0.01% 0.01% Reg. (EC) No 1272/2008 2014/8/21
Diaminodiphenylmethane) dye STOT RE 2 *
Nissan voluntary regulation
Skin Sens. 1
Aquatic Chronic 2

Dimethylformamide Acute Tox. 4 * RECOMMENDATION
55 68-12-2 200-679-5 P D B X 0.01% 0.01% Solvent, catalyst
(N,NDimethylformamide) Acute Tox. 4 * Reg. (EC) No 1272/2008 Dir
Eye Irrit. 2 91/689/EC
Flam. Liq. 2
Ethylenediamine, synthetic
Carc. 1B
resin materials (polyamino acid
Acute Tox. 4 * REACH ANNEX XIV
56 1,2-Dichloroethane; ethylene dichloride 107-06-2 203-458-1 P - B X 0.01% 0.01% resin), film cleaning agent, 2017/11/22
Eye Irrit. 2 Reg. (EC) No 1272/2008
organic synthetic mixed
STOT SE 3
solvent,
Skin Irrit. 2
Flam. Liq. 2
REACH SVHC
57 1,2-Diethoxyethane 629-14-1 211-076-1 D - B 0.01% Ink, solvent for paint Repr. 1A
Reg. (EC) No 1272/2008
Eye Irrit. 2
124
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
58 1,3-diphenylguanidine (DPG) 102-06-7 203-002-1 D - B 0.01% Reg. (EC) No 1272/2008
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
3,8,10-Trioxa-9-stannatetradeca-5,12-
dien-14-oic acid, 9,9-dibutyl-2-methyl- Stabilizer, oxidation inhibitor, REACH Annex XVII Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 22535-42-8 245-061-6 R D/P A 0.1% 0.01% Irritation of eyes and skin
4,7,11-trioxo-, 1-methylethyl ester, antiaging agent 2009/425/EC with direct, prolonged skin contact
Diorganotin compounds,
(Z,Z)-
selected
3,8,10-Trioxa-9-stannatetradeca-5,12-
Diorganotin compounds, See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 dien-14-oic acid, 9,9-dibutyl-4,7,11- 13173-04-1 236-120-7 R D/P A 0.1% 0.01%
selected compounds, selected" with direct, prolonged skin contact
trioxo-, ethyl ester, (Z,Z)-
5,7,12-Trioxa-6-stannatetracosa-2,9-
59 dienoic acid, 6,6-dibutyl-4,8,11-trioxo-, 33466-31-8 251-531-1 R D/P A 0.1% 0.01%
dodecyl ester, (Z,Z)-
Diorganotin compounds, Acetate, S,S'-bisoctylmercapto-, See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 32011-18-0 R D/P A 0.1% 0.01%
selected dibutyltin compounds, selected" with direct, prolonged skin contact
59 Bis (acetato) dibutyltin 17523-06-7 241-521-5 R D/P A 0.1% 0.01%
59 Dibutyl tin 1002-53-5 P D/P B 0.1% 0.001%
Diorganotin compounds, Dibutyltinbis(2-ethylhexyl See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 10584-98-2 234-186-1 P D/P B 0.1% 0.001%
selected mercaptoacetate) compounds, selected" with direct, prolonged skin contact
59 Dibutylbis(octyl maleate)tin 17036-31-6 241-107-4 R D/P A 0.1% 0.01%
Diisooctyl 4,4'-
59 ((dibutylstannylene)bis(oxy))bis(4- 25168-21-2 246-701-7 R D/P A 0.1% 0.01%
oxoisocrotonate)
Diorganotin compounds, Dibutylbis((1- See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 25168-22-3 246-702-2 R D/P A 0.1% 0.01%
selected oxoneodecyl)oxy)stannane compounds, selected" with direct, prolonged skin contact
59 Dibutylbis(myristoyloxy)stannane 28660-67-5 249-134-3 P D/P B 0.1% 0.001%
59 Dibutylthioxostannane 4253-22-9 224-220-3 R D/P A 0.1% 0.01%
Dibutylbis[(1- Stabilizer, oxidation inhibitor, See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 59963-28-9 261-997-8 R D/P A 0.1% 0.01% Irritation of eyes and skin
oxoisooctadecyl)oxy]stannane antiaging agent compounds, selected" with direct, prolonged skin contact
selected
Silicic acid (H4SiO4), tetraethyl ester,

59 reaction products with 93925-42-9 300-344-4 R D/P A 0.1% 0.01%
bis(acetyloxy)dibutylstannane
Diorganotin compounds, Dibutylbis (ethyl 3-oxobutyrato- See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 54581-65-6 259-245-9 R D/P A 0.1% 0.01%
selected O1',O3)ltin compounds, selected" with direct, prolonged skin contact
125
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Diorganotin compounds, Dibutyltin bis(2-ethylhexyl-3- See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 53202-61-2 258-428-0 R D/P A 0.1% 0.01%
selected mercaptopropionate) compounds, selected" with direct, prolonged skin contact
59 Dibutyltin bis(benzyl maleate) 7324-74-5 230-797-2 R D/P A 0.1% 0.01%
59 Dibutyltin bis(cyclohexyl maleate) 5587-52-0 226-989-0 R D/P A 0.1% 0.01%
59 Dibutyltin bis(isooctyl mercaptoacetate) 25168-24-5 246-703-8 R D/P A 0.1% 0.01%
Diorganotin compounds, Dibutyltin bis(lauryl β- See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 51287-83-3 257-110-9 R D/P A 0.1% 0.01%
59 Dibutyltin bis(octylthioglycolate) 2781-09-1 R D/P A 0.1% 0.01%
59 Dibutyltin bis(oleyl maleate) 29881-72-9 249-923-2 R D/P A 0.1% 0.01%
Diorganotin compounds, Dibutyltin di(isooctyl 3- See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 26761-46-6 247-980-8 R D/P A 0.1% 0.01%
59 Dibutyltin diacetate 1067-33-0 213-928-8 R D/P A 0.1% 0.001%
Stabilizer, oxidation inhibitor, See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 Dibutyltin dibenzoate 5847-54-1 R D/P A 0.1% 0.01% Irritation of eyes and skin
antiaging agent compounds, selected" with direct, prolonged skin contact
selected
59 Dibutyltin dibutoxide 3349-36-8 222-103-1 P D/P B 0.1% 0.001%
Muta. 2
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 Dibutyltin dichloride 683-18-1 211-670-0 P D/P B 0.1% 0.001% Acute Tox. 4 *
compounds, selected" with direct, prolonged skin contact
Diorganotin compounds, STOT RE 1
selected Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
59 Dibutyltin dihexanoate 19704-60-0 243-240-3 R D/P A 0.1% 0.01%
59 Dibutyltin dilaurate 77-58-7 201-039-8 R D/P A 0.1% 0.001%
59 Dibutyltin dilauryl mercaptide 1185-81-5 214-688-7 R D/P A 0.1% 0.01%
59 Dibutyltin dimaleate 10192-92-4 R D/P A 0.1% 0.01%
59 Dibutyldimethoxystannane 1067-55-6 213-935-6 R D/P A 0.1% 0.01%
126
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
59 Dibutyltin dioctanoate 4731-77-5 225-236-3 P D/P B 0.1% 0.001%
59 Dibutyltin dioleate 13323-62-1 236-359-7 P D/P B 0.1% 0.001%
59 Dibutyltin dipalmitate 13323-63-2 236-360-2 P D/P B 0.1% 0.001%
59 Dibutyltin disalicylate 14214-24-5 238-067-5 R D/P A 0.1% 0.01%
Stabilizer, oxidation inhibitor, See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 Dibutyltin distearate 5847-55-2 227-438-7 P D/P B 0.1% 0.001% Irritation of eyes and skin
antiaging agent compounds, selected" with direct, prolonged skin contact
selected
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 Dibutyltin hydrogen borate 75113-37-0 401-040-5 P D/P B 0.1% 0.001% Acute Tox. 4 *
compounds, selected" with direct, prolonged skin contact
Diorganotin compounds, Eye Dam. 1
selected Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
59 Dibutyltin isooctanoate 85702-74-5 288-265-0 R D/P A 0.1% 0.01%
59 Dibutyltin linoleate 85391-79-3 288-265-0 R D/P A 0.1% 0.01%
59 Dibutyltin linolenate 95873-60-2 306-050-2 R D/P A 0.1% 0.01%
59 Dibutyltin maleate 78-04-6 201-077-5 P D/P B 0.1% 0.001%
59 Dibutyltin mercaptoacetate 78-20-6 201-093-2 R D/P A 0.1% 0.01%
59 Dibutyltin mercaptopropionate 78-06-8 201-079-6 R D/P A 0.1% 0.01%
59 Dibutyltin oxide 818-08-6 212-449-1 R D/P A 0.1% 0.001%
Diorganotin compounds, Dibutyltin S,S'-bis (isooctyl See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 26636-01-1 247-862-6 R D/P A 0.1% 0.01%
selected mercaptoacetate) compounds, selected" with direct, prolonged skin contact
59 Dibutytin di(2-ethylhexyl maleate) 15546-12-0 239-595-9 R D/P A 0.1% 0.01%
59 Di-n-butyltin bis(methyl maleate) 15546-11-9 239-594-3 R D/P A 0.1% 0.01%
Diorganotin compounds, Stabilizer, oxidation inhibitor, See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 Di-n-butyltin di(monobutyl)maleate 15546-16-4 239-596-4 P D/P B 0.1% 0.001% Irritation of eyes and skin
selected antiaging agent compounds, selected" with direct, prolonged skin contact
127
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
59 Di-n-butyltin di-2-ethylhexanoate 2781-10-4 220-481-2 P D/P B 0.1% 0.001%
Tin, dibutyl(1,2-ethanediamine-
59 N,N')bis(monoisooctyl 2-butenedioato- 163206-28-8 R D/P A 0.1% 0.01%
O')-
Diorganotin compounds, Tin, dibutyl[N-(carboxymethyl)-N-(2- See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 68239-46-3 269-443-7 R D/P A 0.1% 0.01%
selected hydroxyethyl)glycinato(2-)]- compounds, selected" with direct, prolonged skin contact
Tin, dibutylbis(2,4-pentanedionato-
59 O,O')-, 22673-19-4 245-152-0 R D/P A 0.1% 0.001%
(OC-6-11)-
Diorganotin compounds, Tin, dibutylbis(methyl 3- See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 32011-19-1 250-894-3 R D/P A 0.1% 0.01%
selected mercaptopropanoato-O,S)- compounds, selected" with direct, prolonged skin contact
Tin,
59 dibutylbis(N,N- 67924-24-7 R D/P A 0.1% 0.01%
diethylethanamine)difluoro-
Dioctyl tin; Acetic acid,2,2'-

59 [(dioctylstannylene)bis(thio)]bis-, 1,1'- 26401-97-8 247-666-0 R D/P A 0.1% 0.01%
diisooctyl ester
59 Dioctyltin bis(2-ethylhexyl thioglycolate) 15571-58-1 239-622-4 R D/P A 0.1% 0.001% Repr. 1B
59 Dioctyltin bis(isooctyl maleate) 33568-99-9 251-576-7 R D/P A 0.1% 0.01%
Acute Tox. 3 *
59 Dioctyltin dichloride 3542-36-7 222-583-2 R D/P A 0.1% 0.01% STOT RE 1
Aquatic Chronic 3
59 Dioctyltin maleate 16091-18-2 240-253-6 R D/P A 0.1% 0.01%
Diorganotin compounds, Stabilizer, oxidation inhibitor, See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 Dioctyltin oxide 870-08-6 212-791-1 R D/P A 0.1% 0.001% Irritation of eyes and skin
selected antiaging agent compounds, selected" with direct, prolonged skin contact
59 Dioctylbis(stearoyloxy)stannane 22205-26-1 244-840-8 R D/P A 0.1% 0.01%
59 Dioctyltin dilaurate 3648-18-8 222-883-3 R D/P A 0.1% 0.01%
59 Dioctylbis(pentane-2,4-dionato-O,O')tin 54068-28-9 483-270-6 R D/P A 0.1% 0.01%
59 Dioctyltindineodecanoate 68299-15-0 269-595-4 R D/P A 0.1% 0.01%
Silicic acid (H4SiO4), tetraethyl ester,

59 reaction products with 93925-43-0 300-346-5 R D/P A 0.1% 0.01%
bis(acetyloxy)dioctylstannane
128
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
59 Di-n-octyltin bis(2-ethylhexyl maleate) 10039-33-5 233-117-2 R D/P A 0.1% 0.01%
59 Diisobutyltin oxide 61947-30-6 263-343-7 R D B 0.1% 0.01%
Diorganotin compounds, Dimethoxybis(pentane-2,4-dionato- See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 66779-19-9 266-476-9 R D B 0.1% 0.01%
selected O,O')tin compounds, selected" with direct, prolonged skin contact
Tin, dichloro[29H,31H-
59 phthalocyaninato(2-)- 18253-54-8 R D B 0.1% 0.01%
N29,N30,N31,N32]-, (OC-6-12)-
Diorganotin compounds, Dibutyltin bis(C8 to C18 unsatd. fatty See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 85508-00-5 287-424-1 R D/P A 0.1% 0.01%
selected acyloxy) derivs. compounds, selected" with direct, prolonged skin contact
59 Dibutyltin diisothiocyanate 15719-34-3 R D/P A 0.1% 0.01% Irritation of eyes and skin
59 Bis(dodecylthio)dioctylstannane 22205-30-7 244-841-3 R D/P A 0.1% 0.01%
Diorganotin compounds, 2-Butenedioic acid, 1,1'- See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 68109-88-6 268-500-3 R D/P A 0.1% 0.01%
selected (dioctylstannylene) 4,4'-diethyl ester compounds, selected" with direct, prolonged skin contact
2-ethylhexyl 10-ethyl-4-[[2-[(2-
Diorganotin compounds, ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl- See 1st line of "Diorganotin Prohibit 0.1% by weight of Tin for fabrics or RTV-2 moulding kits etc
59 27107-89-7 248-227-6 R D/P A 0.1% 0.01%
selected 7-oxo-8-oxa-3,5-dithia-4- compounds, selected" with direct, prolonged skin contact
stannatetradecanoate (MOTE)
REACH ANNEX XIV

RECOMMENDATION
60 Disodiumtetraborates, selected Disodium tetraborates, anhydrous 1330-43-4 215-540-4 P D/P B X 0.01% 0.01% - Repr. 1B
Reg. (EU) No 528/2012
Reg. (EC) No 1272/2008
See line 1st of

60 Disodiumtetraborates, selected Disodium tetraborate, pentahydrate 12179-04-3 215-540-4 P D/P B X 0.001% 0.001% Repr. 1B
"Disodiumtetraborates, selected:"
See line 1st of

60 Disodiumtetraborates, selected Disodium Tetraborate, decahydrate 1303-96-4 215-540-4 P D/P B X 0.01% 0.01% Repr. 1B
"Disodiumtetraborates, selected:"
Tetraboron disodium heptaoxide, See line 1st of

60 Disodiumtetraborates, selected 12267-73-1 235-541-3 P D B 4.5% 0.01% Repr. 1B
hydrate "Disodiumtetraborates, selected:"
Carc. 2
Repr. 2 Reg. (EC) No 1272/2008
Dodecachloropentacyclo 1, 3, 4- Lact. Published in Canada
Agricultural chemicals,
61 Metheno-1H-cyclobuta(cd)pentalene, 2385-85-5 219-196-6 P P A - - Acute Tox. 4 * Gazette Part II, 2006-11-29
insecticides
Mirex Acute Tox. 4 * Vol. 140, No. 24
Aquatic Acute 1 JPN CSCL Class1 substance
Aquatic Chronic 1

Decanedioic acid, bis(1,2,2,6,6- Dye material, synthetic organic
62 41556-26-7 255-437-1 D - B 0.01% December 9, 2006 (Canadian
pentamethyl-4-piperidinyl)ester intermediate body
Challenge).
Solvent for fabric shrink Carc. 1B

Dichloropropanol (1,3-Dichloro-2-
63 96-23-1 202-491-9 D - B 0.01% resistant agent, fabric flame Acute Tox. 3 * Reg. (EC) No 1272/2008
propanol)
retardant, epoxy resin Acute Tox. 4 *
129
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
Muta. 1B
Dye, medical supply, Acute Tox. 4 * REACH SVHC
64 Diethyl sulphate 64-67-5 200-589-6 D - B 0.01%
agricultural chemicals Acute Tox. 4 * Reg. (EC) No 1272/2008
Acute Tox. 4 *
Skin Corr. 1B
Carc. 1B
Muta. 2
Solvent for extraction of
Acute Tox. 2 * REACH SVHC
65 Dimethyl sulphate 77-78-1 201-058-1 D - B 0.001% aromatic hydrocarbon, a
stabilizer
Skin Corr. 1B
Skin Sens. 1
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
66 dinitrotoluène 25321-14-6 246-836-1 D - B 0.01% Acute Tox. 3 * Reg. (EC) No 1272/2009
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
Repr. 2
Acute Tox. 2
Acute Tox. 3 PACT
67 dimethyltin dichloride dimethyltin dichloride 753-73-1 212-039-2 D - B 0.001%
Acute Tox. 3 Reg. (EC) No 1272/2008
STOT RE 1
Diazene-1,2-dicarboxamide (C,C'- Rubber or blowing agent for REACH ANNEX XIV

68 123-77-3 204-650-8 P - B X 0.01% 0.01% Resp. Sens. 1
azodi(formamide)) synthetic resin RECOMMENDATION
Repr. 1B
Phenol system weed killer, Acute Tox. 3 *
acaricide, agricultural Acute Tox. 3 * REACH SVHC
69 Dinoseb 88-85-7 201-861-7 D - B 0.01%
disinfectant medicine, Eye Irrit. 2 Reg. (EC) No 1272/2008
agricultural chemical material Aquatic Acute 1
Aquatic Chronic 1
70 dibutylbis(nonanoyloxy)stannane 25955-19-5 247-367-5 P - B 0.1% 0.001% REACH Annex XVII
Carc. 1B
Muta. 2
Repr. 2
Dye, organic synthetic raw Acute Tox. 3 * REACH ANNEX XIV
71 2,4-Dinitrotoluene 121-14-2 204-450-0 P - B X 0.01% 0.01% material, explosive Acute Tox. 3 * Chemical substances restriction 2015/8/21
intermediate Acute Tox. 3 * law class 2 monitoring substance
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 2 *
Acute Tox. 2 *
72 Endosulfan endosulfan 115-29-7 204-079-4 P - B - - Acute Tox. 4 * POPs substance
Aquatic Acute 1
Aquatic Chronic 1
alpha-endosulfan
72 Endosulfan (hexachloro-5-norbornene-2,3- 959-98-8 P - B - - POPs substance
dimethanol, cyclic sulfite, endo-)
beta-endosulfan
72 Endosulfan (hexachloro-5-norbornene-2,3- 33213-65-9 P - B - - POPs substance
dimethanol, cyclic sulfite, exo-)
130
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
72 Endosulfan endosulfan sulfate 1031-07-8 P - B - - POPs substance
Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Epichlorohydrin (1-chloro-2,3- Rubber raw material, Reg. (EC) No 1272/2008
73 106-89-8 203-439-8 D D A 0.01% Acute Tox. 3 *
epoxypropane) epoxy resin PACT
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
REACH ANNEX XVII

Reg. (EC) No 1272/2008
74 Ethanol, 2-(2-methoxyethoxy)- 111-77-3 203-906-6 D D A 0.01% Repr. 2 Canada Gazette Vol. 140, No. 49 -
intermediate body
December 9, 2006 (Canadian
Challenge).
Flam. Liq. 3
Dye material, synthetic organic Repr. 1B
REACH SVHC
75 Ethyl-/ Methyl-Glycols and their 2-Methoxyethanol 109-86-4 203-713-7 P P A 0.3% 0.01% intermediate body, battery Acute Tox. 4 *
Reg. (EC) No 1272/2008
Acetates: electrolyte Acute Tox. 4 *
Acute Tox. 4 *
Flam. Liq. 2 See line 1st of "

75 Ethyl-/ Methyl-Glycols and their EGDME 110-71-4 203-794-9 R D B 0.01% 0.01% Repr. 1B Ethyl-/ Methyl-Glycols and their
Acetates: Acute Tox. 4 * Acetates:"
Flam. Liq. 3
See line 1st of "
Repr. 1B
75 Ethyl-/ Methyl-Glycols and their 2-Ethoxyethanol 110-80-5 203-804-1 R D B 0.01% 0.01% Ethyl-/ Methyl-Glycols and their
Acute Tox. 3
Acetates: Acetates:"
Acute Tox. 4
Flam. Liq. 3
Repr. 1B See line 1st of "
75 Ethyl-/ Methyl-Glycols and their Propanol, 2-methoxy- 1589-47-5 216-455-5 P D B X 0.01% 0.01% STOT SE 3 Ethyl-/ Methyl-Glycols and their
Acetates: Skin Irrit. 2 Acetates:"
Eye Dam. 1
Repr. 1B
See line 1st of "
Acute Tox. 4 *
75 Ethyl-/ Methyl-Glycols and their 2-Methoxyethyl acetate 110-49-6 203-772-9 P D B 0.1% 0.01% Ethyl-/ Methyl-Glycols and their
Acute Tox. 4 *
Acetates: Acetates:"
Acute Tox. 4 *
Flam. Liq. 3
Repr. 1B See line 1st of "
75 Ethyl-/ Methyl-Glycols and their 2-Ethoxyethyl acetate 111-15-9 203-839-2 R - B 0.01% 0.01% Acute Tox. 4 * Ethyl-/ Methyl-Glycols and their
Acetates: Acute Tox. 4 * Acetates:"
Acute Tox. 4 *
Ethylene thiourea; imidazolidine-2- Repr. 1B REACH SVHC

76 96-45-7 202-506-9 D D A 0.01% Vulcanized accelerant
thione; 2-imidazoline-2-thiol Acute Tox. 4 * Reg. (EC) No 1272/2008
Flam. Liq. 2
Carc. 1B
Muta. 1B
Acute Tox. 2 *
77 ethyleneimine (aziridine) 151-56-4 205-793-9 D - B 0.01% Reg. (EC) No 1272/2008
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Chronic 2
Repr. 2
2-ethylhexyl 10-ethyl-4,4-dimethyl-7-
Acute Tox. 4 PACT
78 oxo-8-oxa-3,5-dithia-4- 57583-35-4 260-829-0 D - B 0.001%
STOT RE 1 Reg. (EC) No 1272/2008
stannatetradecanoate
Skin Sens. 1A
131
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1B
3-ethyl-2-methyl-2-(3-methylbutyl)-1,3- Skin Corr. 1B REACH SVHC
79 143860-04-2 421-150-7 D - B 0.01% -
oxazolidine Aquatic Acute 1 Reg. (EC) No 1272/2008
Aquatic Chronic 1
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 *
2,3-epoxypropanol
80 556-52-5 209-128-3 D - B 0.01% Acute Tox. 4 * Reg. (EC) No 1272/2008
(glycidol)
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Surface treatments for oil, soil,

Flurotelemers, selected and water repellency and
81 (Some substances may not 8-2 telomer alcohol: 678-39-7 D D A 0.01% stain/dirt resistance for textile Carcinogenic
have CAS#s) fabrics and carpet in the
automotive sector.
Flurotelemers, selected
81 (Some substances may not 8-2 telomer olefin: 21652-58-4 D D A 0.01%
have CAS#s)
2-(perflurooctyl)ethyl iodide, 8-2
81 (Some substances may not 2043-53-0 D D A 0.01%
telomer iodide:
have CAS#s)
C8 iodide:
(Octane,
1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-
have CAS#s)
heptadecafluoro-8-iodo- )
C10-2 Fluorotelomer alcohol; 1-

Dodecanol,
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,
have CAS#s)
12,12,12-heneicosafluoro-
81 (Some substances may not C10-2 telomer B iodide: 2043-54-1 D D A 0.01%
have CAS#s)
Carc. 1B
Muta. 2
Acute Tox. 3* Reg. (EC) No 1272/2008 Reg. (EU) Authorised if not used as a biocide. Authorised uses as biocide in
82 Formaldehyde 50-00-0 200-001-8 R D/P B 0.01% Adhesive, antiseptic Acute Tox. 3* No 528/2012 (BPR) product-type : 3. "P" as a biocide for other product types, please refer
Acute Tox. 3* PACT to the most recent regulation decisions.
Skin Corr. 1B
Skin Sens. 1
Fatty acids, C6-19-branched, Zinc

83 68551-44-0 271-378-4 D - B 0.01% -
salts
Formaldehyde, oligomeric reaction Dye material, synthetic organic

84 25214-70-4 500-036-1 P - B X 0.01% 0.01% REACH ANNEX XIV 2017/8/22
products with aniline (technical MDA) intermediate body
Solvent and surface-active

agent, medicine, medicine REACH SVHC
85 Formamide 75-12-7 200-842-0 D - B 0.01% Repr. 1B
intermediary body, synthetic Reg. (EC) No 1272/2008
intermediate
132
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Flam. Liq. 1
Carc. 1B
Muta. 2
Plastic material, organic
86 Furan 110-00-9 203-727-3 P - B 0.1% 0.01% synthesis material, solvent,
cleaning agent
STOT RE 2 *
Skin Irrit. 2
Aquatic Chronic 3
JPN CSCL Class 1 substance

POPs Substances
Prohibition of Certain Toxic
87 Hexachloro-1,3-butadiene (HCBD) 87-68-3 201-765-5 P P A 0.1% 0.01% Solvent Hepatic disorder, carcinogenic Substances Regulations, 2005
(SOR/SOR/2005-41. Published in
Canada Gazette Part II, 2006-11-
29 Vol. 140, No. 24
Acute Tox. 3 *
Acute Tox. 4 *
Reg. (EC) No 1272/2008
Acute Tox. 4 *
Hexachlorocyclohexane, gamma 200-401-2 Dye material, synthetic organic GefStoffV with Annex IV Nr. 5
88 Hexachlorocyclohexane 58-89-9 P D B - - STOT RE 2 *
isomer, Lindane 210-168-9 intermediate body JPN CSCL
Lact.
POPs substance
Aquatic Acute 1
Aquatic Chronic 1
Cyclohexane,1,2,3,4,5,6-hexachloro-
206-270-8 See 1st line of
88 Hexachlorocyclohexane (1.alpha,2.alpha,3.beta,4.alpha,5.beta, 319-84-6 P - B - -
200-401-2 "Hexachlorocyclohexane"
6.beta)-
Cyclohexane,1,2,3,4,5,6-hexachloro-
88 Hexachlorocyclohexane (1.alpha,2.beta,3.alpha,4.beta,5.alpha, 319-85-7 P - B - -
6.beta)-
hexachlorocyclohexane See 1st line of

88 Hexachlorocyclohexane 319-86-8 206-272-9 P - B - -
(delta-HCH) "Hexachlorocyclohexane"
technical 1,2,3,4,5,6-
88 Hexachlorocyclohexane hexachlorocyclohexane 608-73-1 P - B - -
(HCH mixed isomers)
Carc. 1B
89 Hexamethylphosphoric-triamide 680-31-9 211-653-8 D - B 0.001% Reg. (EC) No 1272/2008
Muta. 1B

Hexanedioic acid, bis(2-ethylhexyl) Synthetic resin Red flare, pain,
90 103-23-1 203-090-1 D D A 0.01% December 9, 2006 (Canadian
ester Resin additives diarrhea
Challenge)
Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Pigment monomer of plastic,
Acute Tox. 3 *
pigment, and adhesive; REACH SVHC
91 Hydrazine Hydrazine 302-01-2 206-114-9 P D B X 0.01% 0.01% Acute Tox. 3 *
amine oxidation inhibiting Reg. (EC) No 1272/2008
Skin Corr. 1B
stabilizer
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
91 Hydrazine Hydrazine hydrate 7803-57-8 206-114-9 P - B X 0.01% 0.01% Acute Tox. 3 * REACH SVHC
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
133
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Montreal Protocol;
Foaming agent,
Hydrobromofluorocarbons EU-R 2009/1005;
92 1,2-Dibromo-1,1-difluoroethane 75-82-1 200-905-2 P P A - - washing agent, Global warming substance
(HBFC's), all members US EPA Class Ⅰ
refrigerant
ODS
See 1st line of

Hydrobromofluorocarbons
92 Dibromofluoromethane 1868-53-7 P P A - - "Hydrobromofluorocarbons
(HBFC's), all members
(HBFC's), all members"
See 1st line of

Hydrobromofluorocarbons C2H2F2Br2: 1,1-Dibromo-2,2-
92 359-19-3 P P A - - "Hydrobromofluorocarbons
(HBFC's), all members difluoroethane
See 1st line of

92 Bromodifluoromethane 1511-62-2 216-149-1 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 1-Bromo-2-fluoroethane 762-49-2 212-100-3 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 1-Bromo-3-fluoropropane 352-91-0 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 3-Bromo-1,1,1-trifluoropropane 460-32-2 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 1,2-Dibromo-1-fluoroethane 358-97-4 206-621-5 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 1,3-Dibromo-1,1-difluoropropane 460-25-3 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 1,2-Dibromo-1,1,2-trifluoroethane 354-04-1 206-543-1 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 2,3-Dibromo-1,1,1-trifluoropropane 431-21-0 P P A - - "Hydrobromofluorocarbons
See 1st line of

Hydrobromofluorocarbons 1,1,1,2-tetrabromo-2-fluoro-ethane
(HBFC's), all members (C2HFBr4)
See 1st line of

Hydrobromofluorocarbons 1,1,2,2-tetrabromo-1-fluoro-ethane
(HBFC's), all members (C2HFBr4)
See 1st line of

Hydrobromofluorocarbons 1,1,1-tribromo-2,2-difluoroethane
(HBFC's), all members (C2HF2Br3)
See 1st line of

134
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of

See 1st line of

Hydrobromofluorocarbons 1,1,2-tribromo-2-fluoroethane
(HBFC's), all members (C2H2FBr3)
See 1st line of

Hydrobromofluorocarbons 1,1,2-tribromo-1-fluoroethane
See 1st line of

92 C2H3F2Br: Bromo-1,1-difluoroethane 359-07-9 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 C3HFBr6 P P A 0.1% 0.01% "Hydrobromofluorocarbons
See 1st line of

92 C3HF2Br5 P P A 0.1% 0.01% "Hydrobromofluorocarbons
See 1st line of

92 C3HF3Br4 P P A 0.1% 0.01% "Hydrobromofluorocarbons
See 1st line of

92 C3HF4Br3 666-48-8 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 C3H2FBr5 P P A 0.1% 0.01% "Hydrobromofluorocarbons
See 1st line of

92 C3H2F2Br4 148875-98-3 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 1,2,2-Tribromo-3,3,3-trifluoropropane 421-90-9 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 1,3-Dibromo-1,1,3,3-tetrafluoropropane 460-86-6 P P A - - "Hydrobromofluorocarbons
See 1st line of

Hydrobromofluorocarbons 1-bromo-1,1,2,2,2-pentafluoro-propane
(HBFC's), all members (C3H2F5Br)
See 1st line of

See 1st line of

135
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of

Foaming agent, See 1st line of

92 460-88-8 P P A - - washing agent, Global warming substance "Hydrobromofluorocarbons
refrigerant (HBFC's), all members"
See 1st line of

See 1st line of

Hydrobromofluorocarbons Propane, 3-bromo-1,1,1,2,3-
(HBFC's), all members pentafluoro-, (R*,S*)- (9CI) (C3H2F5Br)
See 1st line of

Hydrobromofluorocarbons Propane, 3-bromo-1,1,1,2,3-
(HBFC's), all members pentafluoro-, (R*,R*)- (9CI) (C3H2F5Br)
See 1st line of

92 C3H3FBr4 148875-95-0 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 1,2,3-Tribromo-3,3-difluoropropane 666-25-1 P P A - - "Hydrobromofluorocarbons
See 1st line of

Hydrobromofluorocarbons 2-bromo-1,1,3,3-tetrafluoro-propane
See 1st line of

Hydrobromofluorocarbons 2-bromo-1,3,3,3-tetrafluoropropane
See 1st line of

Hydrobromofluorocarbons 3-Bromo-1,1,2,2-tetrafluoropropane
See 1st line of

Hydrobromofluorocarbons 1-bromo-1,2,2,3-tetrafluoro-propane
See 1st line of

See 1st line of

See 1st line of

92 C3H4FBr3 75372-14-4 P P A - - "Hydrobromofluorocarbons
See 1st line of

Hydrobromofluorocarbons 1,2-Dibromo-3-fluoropropane
136
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of

See 1st line of

See 1st line of

Hydrobromofluorocarbons 1,2-Dibromo-1-fluoro-(R*,S*)-propane
See 1st line of

Hydrobromofluorocarbons 1,2-Dibromo-1-fluoro-(R*,R*)-propane
See 1st line of

Hydrobromofluorocarbons 1-bromo-2,3-difluoro-propane
See 1st line of

See 1st line of

See 1st line of

See 1st line of

See 1st line of

See 1st line of

92 1-Bromo-1,1-difluoroethane 420-47-3 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 1-Bromo-1,1,2,3,3,3-hexafluoropropane 2252-78-0 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 2-Bromo-1,1,1-trifluoroethane 421-06-7 207-001-7 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 Ethene, 2-bromo-1,1-difluoro- 359-08-0 206-624-1 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 Propane, 1-bromo-2-fluoro- 1871-72-3 P P A - - "Hydrobromofluorocarbons
137
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of

See 1st line of

92 Ethane, 1,2-dibromo-1,1,2-trifluoro- 354-06-3 206-544-7 P P A - - "Hydrobromofluorocarbons
See 1st line of

92 Tribromodifluoropropane 70192-80-2 P - B - - "Hydrobromofluorocarbons
Montreal Protocol;
Foaming agent,
Hydrochlorofluorocarbons 1,1-Dichloro-1,2,2-trifluoroethane EU-R 2009/1005;
93 812-04-4 P D/P B - - washing agent, Global warming substance
(HCFC's), all members (HCFC-123b) US EPA Class II
refrigerant
ODS
See 1st line of

Hydrochlorofluorocarbons
93 1,2,2-Trichloro-1,1-difluoroethane 354-21-2 206-548-9 P D/P B - - "Hydrochlorofluorocarbons
(HCFC's), all members
(HCFC's), all members"
See 1st line of

Hydrochlorofluorocarbons 1,2-Dichloro-1,1,2-trifluoroethane
93 354-23-4 206-549-4 P D/P B - - "Hydrochlorofluorocarbons
(HCFC's), all members (HCFC-123a)
See 1st line of

93 1,2-Dichloro-1,1-difluoroethane 1649-08-7 216-714-2 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1,2-Dichloro-1,2-difluoroethane 431-06-1 207-070-3 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 2-chloro-1,3-difluoropropane 102738-79-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

Hydrochlorofluorocarbons 1,1-Dichloro-1,2,3,3,3-
93 111512-56-2 P D/P B - - "Hydrochlorofluorocarbons
(HCFC's), all members pentafluoropropane
See 1st line of

93 Tetrachlorodifluoropropane 127564-82-3 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Trichlorodifluoropropane 127564-90-3 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Trichlorotetrafluoropropane 127564-91-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

See 1st line of

93 Chlorotrifluoroethane 1330-45-6 P D/P B - - "Hydrochlorofluorocarbons
138
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of

93 Tetrachlorofluoropropane 134190-49-1 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Trichlorofluoropropane 134190-51-5 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1,1,2,2-Tetrachloro-1-fluoroethane 134237-32-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Trichlorofluoroethane 134237-34-6 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Hexachlorofluoropropane 134237-35-7 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Pentachlorodifluoropropane 134237-36-8 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Tetrachlorotrifluoropropane 134237-37-9 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Trichlorotetrafluoropropane 134237-38-0 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Tetrachlorodifluoropropane 134237-39-1 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Trichlorotrifluoropropane 134237-40-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Chloropentafluoropropane 134237-41-5 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Trichlorodifluoropropane 134237-42-6 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Dichlorotrifluoropropane 134237-43-7 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Chlorotrifluoropropane 134237-44-8 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Dichlorofluoropropane 134237-45-9 P D/P B - - "Hydrochlorofluorocarbons
139
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of

See 1st line of

See 1st line of

93 1,1-Dichloro-1,2-difluoroethane 1842-05-3 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Dichlorofluoroethane 25167-88-8 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Dichlorodifluoroethane 25915-78-0 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Hexachlorofluoropropane 29470-94-8 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Tetrachlorotrifluoropropane 29470-95-9 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 2,3-Dichloro-1,1,1-trifluoropropane 338-75-0 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Trichlorodifluoroethane 41834-16-6 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 2-chloro-2-fluoropropane 420-44-0 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

See 1st line of

See 1st line of

See 1st line of

See 1st line of

93 3-Chloro-1,1,1-trifluoropropane 460-35-5 207-307-0 P D/P B - - "Hydrochlorofluorocarbons
140
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of

See 1st line of

93 1-chloro-1,1,3,3,3-pentafluoropropane 460-92-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

See 1st line of

93 Trichlorotrifluoropropane 61623-04-9 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 3-Chloro-1,1,2,2-tetrafluoropropane 679-85-6 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1,1,1-Trichloro-3,3,3-trifluoropropane 7125-83-9 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

See 1st line of

93 1,1-Dichloro-1-fluoropropane 7799-56-6 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1,1,3-trichloro-1-fluoropropane 818-99-5 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Dichlorodifluoropropane 134190-52-6 P P A - - "Hydrochlorofluorocarbons
See 1st line of

93 Dichlorofluropropane 127404-11-9 P P A - - "Hydrochlorofluorocarbons
See 1st line of

93 Dichlorotetrafluoropropane 127564-83-4 P P A - - "Hydrochlorofluorocarbons
See 1st line of

93 Dichlorotrifluoropropane 116890-51-8 P P A - - "Hydrochlorofluorocarbons
See 1st line of

93 1,2-Dichloro-1-fluoroethane 430-57-9 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1,2-Dichloro-1-fluoroethylene 430-58-0 207-065-6 P D/P B - - "Hydrochlorofluorocarbons
141
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of

Hydrochlorofluorocarbons 1-Chloro-1,1,2,2-tetrafluoroethane
(HCFC's), all members (HCFC-124a)
See 1st line of

93 1-Chloro-1,1-difluoroethane 75-68-3 200-891-8 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1-Chloro-1,2-difluoroethylene 359-04-6 206-622-0 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1-Chloro-1-fluoroethylene 2317-91-1 219-027-6 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1-Chloro-2-fluoroethylene 460-16-2 207-304-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 2-Chloro-1,1-difluoroethylene 359-10-4 206-625-7 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Chlorodifluoroethanes 25497-29-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Chlorodifluoromethane 75-45-6 200-871-9 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Chlorofluoromethane 593-70-4 209-803-2 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Chlorotetrafluoroethane 63938-10-3 264-567-8 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Dichlorofluoromethane 75-43-4 200-869-8 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Dichlorotrifluoroethane 34077-87-7 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Ethane, 1,1,1-trichloro-2-fluoro- 2366-36-1 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

See 1st line of

142
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of

Hydrochlorofluorocarbons Aquatic Chronic 3
93 Ethane, 1,1-dichloro-1-fluoro- 1717-00-6 404-080-1 P D/P B - - "Hydrochlorofluorocarbons
(HCFC's), all members Ozone 1
See 1st line of

93 Ethane, 1,2-difluoro-1,1,2-trichloro- 354-15-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Ethane, 1-chloro-1,2-difluoro- 338-64-7 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Ethane, 2,2-dichloro-1,1,1-trifluoro- 306-83-2 206-190-3 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Ethane, 2-chloro-1,1,1,2-tetrafluoro- 2837-89-0 220-629-6 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Ethane, chloro-1,1-difluoro- 55949-44-5 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Ethane, monochlorodifluoro- 338-65-8 688-133-6 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Trichlorofluoroethane 27154-33-2 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 chloroodifluoropropanee 134190-53-7 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 chloroofluoroethanee 110587-14-9 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 chloroofluoroopropanee 134190-54-8 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 chlorohexafluoropropane 28987-04-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 chloropentafluoropropane 108662-83-5 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 chlorotetrafluoropropane 134190-50-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 chlorotrifluoropropane 26588-23-8 P D/P B - - "Hydrochlorofluorocarbons
143
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
See 1st line of

93 chloro-1,1,1-trifluoroethane 75-88-7 200-912-0 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Pentachlorodifluoropropane 116867-32-4 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 Pentachlorofluoropropane 134190-48-0 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1-chloro-1,1,2-trifluoroethane 421-04-5 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1-chloro-1,2,2-trifluoroethane 431-07-2 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1,1-Dichloro-2-fluoroethane 430-53-5 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1,1-Dichloro-2,2-difluoroethane 471-43-2 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1,1,1,2-Tetrachloro-2-fluoroethane 354-11-0 206-545-2 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1,1,2,2-Tetrachloro-1-fluoroethane 354-14-3 206-546-8 P D/P B - - "Hydrochlorofluorocarbons
See 1st line of

93 1,2-dichloro-2-fluoropropane 420-97-3 206-999-1 P - B - - "Hydrochlorofluorocarbons
See 1st line of

Hydrochlorofluorocarbons 1,3,3-trichloro-1,1,2,2-
93 422-54-8 207-014-8 P - B - - "Hydrochlorofluorocarbons
(HCFC's), all members tetrafluoropropane
See 1st line of

93 1-chloro-1,1,2,2,3,3-hexafluoropropane 422-55-9 207-015-3 P - B - - "Hydrochlorofluorocarbons
See 1st line of

93 2-chloro-1,1,1,3,3,3-hexafluoropropane 431-87-8 207-078-7 P - B - - "Hydrochlorofluorocarbons
Kyoto Protocol
Air-conditioning refrigerant,
Hydrofluorocarbons (HFC's), all Danish decree
94 1,1,1,2,2,3,3-Heptafluoropropane 2252-84-8 D D/P B 0.01% adhesive foam, Global warming substance
members 02/7/2 No552
spray can
2006/40/EC
Hydrofluorocarbons (HFC's), all See 1st line of "Hydrofluorocarbons

94 1,1,1,2,3,3-Hexafluoropropane 431-63-0 207-076-6 D D/P B 0.01%
members (HFC's), all members"
144
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

94 1,1,1,2-Tetrafluoroethane 811-97-2 212-377-0 D D/P B 0.01%

94 1,1,2,2-Tetrafluoroethane 359-35-3 206-628-3 D D/P B 0.01%

94 1,1,2-Trifluoroethane 430-66-0 207-066-1 D D/P B 0.01%

94 1,1-Difluoroethane 75-37-6 200-866-1 D D/P B 0.01%

94 1,2-Difluoroethane 624-72-6 D D/P B 0.01%

94 Difluoroethane 25497-28-3 D D/P B 0.01%

94 Difluoromethane 75-10-5 200-839-4 D D/P B 0.01%

94 Ethane, 1,1,1-trifluoro- 420-46-2 206-996-5 D D/P B 0.01%

94 Ethane, pentafluoro- 354-33-6 206-557-8 D D/P B 0.01%

94 Ethyl fluoride 353-36-6 206-531-6 D D/P B 0.01%

94 Methyl fluoride 593-53-3 209-796-6 D D/P B 0.01%

94 1,1,1,2,2-Pentafluoropropane 1814-88-6 D D/P B 0.01%

94 1,1,1,3,3-Pentafluoropropane 460-73-1 D D/P B 0.01%

94 1,1,1,3,3-Pentafluorobutane 406-58-6 430-250-1 D D/P B 0.01% Flam. Liq. 2
Hydrofluorocarbons (HFC's), all Pentane, 1,1,1,2,2,3,4,5,5,5- See 1st line of "Hydrofluorocarbons

94 138495-42-8 D D/P B 0.01%
members decafluoro- (HFC's), all members"

94 Propane, 1,1,1,2,3,3,3-heptafluoro- 431-89-0 207-079-2 D D/P B 0.01%

94 Propane, 1,1,1,3,3,3-hexafluoro- 690-39-1 D D/P B 0.01%

94 Propane, hexafluoro- 27070-61-7 D D/P B 0.01%

94 Trifluoroethane 27987-06-0 248-764-6 D D/P B 0.01%
145
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

94 Trifluoromethane 75-46-7 200-872-4 D D/P B 0.01%

94 Vinylidene fluoride 75-38-7 200-867-7 D D/P B 0.01%

94 Hexafluoropropane 359-58-0 D - B 0.01%

94 1,1,2,2-tetrafluoropropane 40723-63-5 D - B 0.01%

94 fluoro acetylene 2713-09-9 D - B 0.01%
EU-D 2000/53/EEC
Repr. 1A
Paint, Reg. (EC) No 1272/2008
Acute Tox. 4 *
PVC stabilizer, rubber Reg. (EC) No 552/2009
Lead and its compounds, (2-Ethylhexanoato-O)(isodecanoato- Acute Tox. 4 *
95 94246-92-1 231-100-4 P D/P B 0.1% 0.01% stabilizer, free cutting steel, JAMA voluntary regulation
all members O)lead STOT RE 2 *
bearing, Korean Recycling Law
Aquatic Acute 1
lubrication Voluntary restraint by Taiwan scrap
Aquatic Chronic 1
vehicle recycling industry
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, (2-Ethylhexanoato-O)(isononanoato- Acute Tox. 4 * See 1st line of "Lead and its
95 94246-91-0 231-100-4 P D/P B 0.1% 0.01%
all members O)lead STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, (2-Ethylhexanoato-O)(isooctanoato- Acute Tox. 4 * See 1st line of "Lead and its
95 94246-90-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, (2-Ethylhexanoato-O)(neodecanoato- Acute Tox. 4 * See 1st line of "Lead and its
95 94246-93-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Acute Tox. 4 * See 1st line of "Lead and its
95 (Isodecanoato-O)(isononanoato-O)lead 94246-86-3 231-100-4 P D/P B 0.1% 0.01%
all members STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 (Isodecanoato-O)(isooctanoato-O)lead 94246-85-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, (Isodecanoato-O)(neodecanoato- Acute Tox. 4 * See 1st line of "Lead and its
95 94246-87-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
146
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 (Isononanoato-O)(isooctanoato-O)lead 94246-84-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, (Isononanoato-O)(neodecanoato- Acute Tox. 4 * See 1st line of "Lead and its
95 94481-58-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, (Neononanoato-O)(neoundecanoato- Acute Tox. 4 * See 1st line of "Lead and its
95 93894-64-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, .alpha.-D-Glucopyranose, 1- Acute Tox. 4 * See 1st line of "Lead and its
95 68901-12-2 231-100-4 P D/P B 0.1% 0.01%
all members (dihydrogen phosphate), lead salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, [.mu.-(4,6-Dinitroresorcinolato(2-)- Acute Tox. 4 * See 1st line of "Lead and its
95 84837-22-9 231-100-4 P D/P B 0.1% 0.01%
all members O1,O3)]dihydroxydilead STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, [.mu.-[[5,5'-Azobis[1H-tetrazolato]](2- Acute Tox. 4 * See 1st line of "Lead and its
95 94015-57-3 231-100-4 P D/P B 0.1% 0.01%
all members )]]dihydroxydilead STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 1,2,3-Propanetricarboxylic acid, 2- Acute Tox. 4 * See 1st line of "Lead and its
95 14450-60-3 231-100-4 P D/P B 0.1% 0.01%
all members hydroxy-, lead salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 512-26-5 231-100-4 P D/P B 0.1% 0.01%
all members hydroxy-, lead(2+) salt (2:3) STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 6107-83-1 231-100-4 P D/P B 0.1% 0.01%
all members hydroxy-, lead(2+) salt (2:3), trihydrate STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
147
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 1,2-Benzenedicarboxylic acid, lead(2+) Acute Tox. 4 * See 1st line of "Lead and its
95 18608-34-9 231-100-4 P D/P B 0.1% 0.01%
all members salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 1,2-Benzenedicarboxylic acid, lead(2+) Acute Tox. 4 * See 1st line of "Lead and its
95 90193-83-2 231-100-4 P D/P B 0.1% 0.01%
all members salt, basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
1,3,5,7,9-Pentaoxa- Acute Tox. 4 *
Lead and its compounds, 2.lambda.2,4.lambda.2,6.lambda.2,8.la Acute Tox. 4 * See 1st line of "Lead and its
95 12275-07-9 235-549-7 P D/P B 0.1% 0.01%
all members mbda.2-tetraplumbacyclotridec-11-ene- STOT RE 2 * compounds, all members"
10,13-dione, (Z)- Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, Acute Tox. 4 *
95 54554-36-8 259-227-0 P D/P B 0.1% 0.01%
all members lead salt STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
See 1st line of "Lead and its
Lead and its compounds, 1,3-Benzenediol, 2,4,6-trinitro-, lead Acute Tox. 4 *
95 15245-44-0 239-290-0 P D/P B 0.1% 0.001% compounds, all members"
all members salt STOT RE 2 *
REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 1,3-Benzenediol, nitro-, lead(2+) salt Acute Tox. 4 * See 1st line of "Lead and its
95 70268-38-1 231-100-4 P D/P B 0.1% 0.01%
all members (1:1) STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
2,4-Cyclohexadien-1-one, 3,5,6-
95 trihydroxy-4,6-bis(3-methyl-2-butenyl)- 68901-11-1 231-100-4 P D/P B 0.1% 0.01%
2-(3-methyl-2-oxobutyl)-, lead salt, (R)-
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 2-Butenedioic acid (E)-, lead salt 13698-55-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 2-Butenedioic acid (E)-, lead(2+) salt, Acute Tox. 4 * See 1st line of "Lead and its
95 90268-59-0 290-862-6 P D/P B 0.1% 0.01%
all members basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
148
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 2-Butenedioic acid (Z)-, lead(2+) salt, Acute Tox. 4 * See 1st line of "Lead and its
95 90268-66-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 2-Propenoic acid, 2-methyl-, lead salt, Acute Tox. 4 * See 1st line of "Lead and its
95 90552-19-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
2-Propenoic acid, 2-methyl-, methyl Repr. 1A

ester, polymer with ethenylbenzene, Acute Tox. 4 *
Lead and its compounds, lead(2+) bis(2-methyl-2-propenoate) Acute Tox. 4 * See 1st line of "Lead and its
95 68155-47-5 231-100-4 P D/P B 0.1% 0.01%
all members and .alpha.-(2-methyl-1-oxo-2- STOT RE 2 * compounds, all members"
propenyl)-.omega.-[(2-methyl-1-oxo-2- Aquatic Acute 1
propenyl)oxy]poly(oxy-1,2-ethanediyl) Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 3-(Triphenylplumbyl)-1H-pyrazole 51105-45-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
7,11-Metheno-11H,13H-tetrazolo[1,5- Acute Tox. 4 *
Lead and its compounds, c][1,7,3,5,2,6]dioxadiazadiplumbacyclo Acute Tox. 4 * See 1st line of "Lead and its
95 19651-80-0 231-100-4 P D/P B 0.1% 0.01%
all members dodecine, 5,5,13,13-tetradehydro-4,5- STOT RE 2 * compounds, all members"
dihydro-4,8,10,15-tetranitro- Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 7-Methyloctanoic acid, lead salt 97952-39-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 9-Hexadecenoic acid, lead(2+) salt,(Z)- Acute Tox. 4 * See 1st line of "Lead and its
95 90388-15-1 231-100-4 P D/P B 0.1% 0.01%
all members ,basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 9-Octadecenoic acid (Z)-, lead salt 15347-55-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 9-Octadecenoic acid (Z)-, lead salt, Acute Tox. 4 * See 1st line of "Lead and its
95 90459-88-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
149
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 * See 1st line of "Lead and its
Lead and its compounds, 231-100-4 Acute Tox. 4 * compounds, all members"
95 Acetic acid, lead salt, basic 51404-69-4 P D/P B X 0.1% 0.001%
all members 257-175-3 STOT RE 2 * REACH ANNEX XIV
Aquatic Acute 1 RECOMMENDATION
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Acetoxytributylplumbane 2587-82-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Acetoxytrimethylplumbane 5711-19-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Acetoxytriphenylplumbane 1162-06-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Basic lead sulfite 12608-25-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Benzenesulfonic acid, 4-C10-13-sec- Acute Tox. 4 * See 1st line of "Lead and its
95 84961-75-1 231-100-4 P D/P B 0.1% 0.01%
all members alkyl derivitives, lead(2+) salts STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Bis(diethyldithiocarbamato-S,S')lead 17549-30-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Bis(o-acetoxybenzoato)lead 62451-77-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Bis(pentane-2,4-dionato-O,O')lead 15282-88-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
150
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Bismuth lead ruthenium oxide 65229-22-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Bismuth, compound with lead (1:1) 12048-28-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Butanedioic acid, 2,3-dihydroxy- Acute Tox. 4 * See 1st line of "Lead and its
95 815-84-9 231-100-4 P D/P B 0.1% 0.01%
all members [R-(R*,R*)]-, lead(2+) salt (1:1) STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Carbamodithioic acid, ethylphenyl-, Acute Tox. 4 * See 1st line of "Lead and its
95 93892-65-0 231-100-4 P D/P B 0.1% 0.01%
all members lead(2+) salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Carbonic acid, lead(2+) salt 25510-11-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Castor oil, dehydrated, polymer with Acute Tox. 4 * See 1st line of "Lead and its
95 68604-05-7 231-100-4 P D/P B 0.1% 0.01%
all members rosin, calcium lead zinc salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Chlorotrimethylplumbane 1520-78-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Chlorotriphenylplumbane 1153-06-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Chromium lead oxide sulfate, silica- Acute Tox. 4 * See 1st line of "Lead and its
95 116565-74-3 231-100-4 P D/P B 0.1% 0.01%
all members modified STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
151
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Copper, .beta.-resorcylate salicylate 231-100-4 Acute Tox. 4 * See 1st line of "Lead and its
95 68411-07-4 P D/P B 0.1% 0.01%
all members lead complexes 614-455-3 STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Cyclohexanebutanoic acid, lead(2+) Acute Tox. 4 * See 1st line of "Lead and its
95 62637-99-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Decanoic acid, branched, lead salts 90342-24-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Decanoic acid, lead salt 20403-42-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Diacetoxydiphenylplumbane 6928-68-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Diamyldithiocarbamate, lead 109707-90-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Diantimony lead tetroxide 16450-50-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Dibasic lead stearate 56189-09-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Dibismuth dilead tetraruthenium Acute Tox. 4 * See 1st line of "Lead and its
95 11116-83-9 231-100-4 P D/P B 0.1% 0.01%
all members tridecaoxide STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
152
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Dilead dirhodium heptaoxide 37240-96-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Diphenyllead dichloride 2117-69-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Diplumbane, hexaethyl- 2388-00-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Diplumbane, hexaphenyl- 3124-01-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Docosanoic acid, lead salt 3249-61-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Dodecanoic acid, lead salt, basic 90342-56-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Dodecanoic acid, lead(2+) salt 15773-55-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Fatty acids, C12-18, lead salts 68131-60-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
153
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 231-100-4 Acute Tox. 4 *
95 Fatty acids, C16-18, lead salts 91031-62-8 P D/P B 0.1% 0.001% compounds, all members"
all members 292-966-7 STOT RE 2 *
REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Fatty acids, C4- 20-branched, lead Acute Tox. 4 * See 1st line of "Lead and its
95 125328-49-6 231-100-4 P D/P B 0.1% 0.01%
all members salts STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Fatty acids, C6- 19-branched, lead Acute Tox. 4 * See 1st line of "Lead and its
95 91002-20-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Fatty acids, C8-10-branched, lead salts 85049-42-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Fatty acids, C8-10-branched, lead Acute Tox. 4 * See 1st line of "Lead and its
95 68409-79-0 231-100-4 P D/P B 0.1% 0.01%
all members salts, basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Fatty acids, C8-18 and C18-
95 unsaturated, 84776-36-3 231-100-4 P D/P B 0.1% 0.01%
lead salts
Aquatic Acute 1
Aquatic Chronic 1
154
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Fatty acids, C9-11-branched, lead salts 81412-57-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Fatty acids, castor-oil, hydrogenated, Acute Tox. 4 * See 1st line of "Lead and its
95 91697-36-8 231-100-4 P D/P B 0.1% 0.01%
all members lead salts STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Fatty acids, coco, lead salts 92044-89-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Fatty acids, tall-oil, lead manganese Acute Tox. 4 * See 1st line of "Lead and its
95 61788-53-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Fatty acids, tall-oil, lead salts 61788-54-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Fatty acids, tallow, reaction products Acute Tox. 4 * See 1st line of "Lead and its
95 94349-78-7 231-100-4 P D/P B 0.1% 0.01%
all members with lead oxide STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Flue dust, lead blast furnace 70514-05-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Formic acid, lead salt 7056-83-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
155
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Gilsonite, polymer with linseed oil, Acute Tox. 4 * See 1st line of "Lead and its
95 68989-89-9 231-100-4 P D/P B 0.1% 0.01%
all members lead salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Glycine, N,N'-1,2-ethanediylbis[N-
95 (carboxymethyl)-, lead(2+) sodiumsalt 22904-40-1 231-100-4 P D/P B 0.1% 0.01%
(1:1:2)
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Hafnium lead trioxide 12029-23-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Hexacosanoic acid, lead salt 94006-20-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Hexadecanoic acid, lead salt, basic 90388-09-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Hexadecanoic acid, lead(2+) salt, basic 90388-10-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Hexanoic acid, 2-ethyl-, lead(2+) salt 301-08-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Hexanoic acid, 3,5,5-trimethyl-, lead Acute Tox. 4 * See 1st line of "Lead and its
95 23621-79-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Hydroxy(neodecanoato-O)lead 71753-04-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
156
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Iron lead oxide (Fe12PbO19) 12023-90-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Isodecanoic acid, lead salt, basic 90431-14-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Isodecanoic acid, lead(2+) salt, basic 91671-82-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Isononanoic acid, lead salt 27253-41-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Isononanoic acid, lead salt, basic 90431-21-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Isooctanoic acid, lead salt 64504-12-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Isooctanoic acid, lead salt, basic 90431-26-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Isooctanoic acid, lead(2+) salt, basic 91671-83-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Isoundecanoic acid, lead(2+) salt, basic 91671-84-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
157
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lauric acid, lead salt 15306-30-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Leach residues, lead slag 69029-71-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Acute Tox. 4 *
95 Lead 7439-92-1 231-100-4 P D/P B 0.1% 0.001% compounds, all members"
all members STOT RE 2 *
REACH ANNEX XVII
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead (II) acetate, trihydrate 6080-56-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead (II) methylthiolate 35029-96-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead (IV) acetate 546-67-8 208-908-0 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 12-hydroxyoctadecanoate 65127-78-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 2,4-dihydroxybenzoate 20936-32-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 202 15752-86-0 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
158
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead 205 14119-28-9 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 210 14255-04-0 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 2-ethylhexoate 16996-40-0 241-076-7 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 3-(acetamido)phthalate 93839-98-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 5-nitroterephthalate 60580-60-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead acetate 15347-57-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead acetate 301-04-2 206-104-4 P D/P B 0.1% 0.001% compounds, all members"
REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead acrylate 14466-01-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead alloy, dross 69011-59-2 P D/P B 0.1% 0.01% compounds, all members"
REACH ANNEX XVII
Aquatic Acute 1
Aquatic Chronic 1
159
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 231-100-4 Acute Tox. 4 * See 1st line of "Lead and its
95 Lead alloy, Pb,Sn, dross 69011-60-5 P D/P B 0.1% 0.01%
all members 273-701-4 STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead antimonate 13510-89-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead antimonide 12266-38-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead azide 13424-46-9 236-542-1 P D/P B 0.1% 0.001% compounds, all members"
REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead benzoate 15907-04-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(12-hydroxystearate) 58405-97-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(2-ethylhexanolate) 93840-04-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(3,5,5-trimethylhexanoate) 35837-70-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(5-oxo-DL-prolinate) 85392-78-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
160
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead bis(5-oxo-L-prolinate) 85392-77-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(isononanoate) 52847-85-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(isoundecanoate) 93965-29-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(nonylphenolate) 72586-00-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(piperidine-1-carbodithioate) 41556-46-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(p-octylphenolate) 84394-98-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(tetracosylbenzenesulphonate) 85865-91-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis(tricosanoate) 93966-37-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bis[didodecylbenzenesulphonate] 85865-92-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
161
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead borate 14720-53-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead b-resorcylate 41453-50-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead bromide (PbBr2) 10031-22-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead carbonate 598-63-0 209-943-4 P D/P B 0.1% 0.001% compounds, all members"
REACH ANNEX XVII
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead carbonate hydroxide 1319-46-6 215-290-6 P D/P B 0.1% 0.001% compounds, all members"
REACH ANNEX XVII, SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead chloride 7758-95-4 231-845-5 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead chloride (V.A.N.) 12612-47-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead chloride oxide 12205-72-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead cyanamidate 20890-10-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
162
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead cyanamide 20837-86-9 244-073-9 P D/P B 0.1% 0.001% compounds, all members"
REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead cyanamide 35112-70-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead cyanide 592-05-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dibenzoate 873-54-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dibromate 34018-28-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dibutanolate 65119-94-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dibutyrate 819-73-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead didocosanoate 29597-84-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dihexanoate 15773-53-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
163
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead dilactate 18917-82-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dilinoleate 33627-12-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dimethyldithiocarbamate 19010-66-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dimyristate 32112-52-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dipalmitate 15773-56-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead diphosphinate 10294-58-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dipicrate 6477-64-1 229-335-2 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead dipropionate 814-70-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead disulphamidate 13767-78-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
164
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead disulphide 12137-74-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead diundec-10-enoate 94232-40-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead fluoborate 13814-96-5 237-486-0 P D/P B 0.1% 0.001% compounds, all members"
REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead fluoride 7783-46-2 231-998-8 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead fluoride hydroxide 97889-90-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead fluorosilicate 25808-74-6 247-278-1 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead formate 811-54-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead germanate 12435-47-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead hexafluorosilicate 1310-03-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
165
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead hydroxide 19783-14-3 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead hydroxide 39345-91-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead hydroxide nitrate 12268-84-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead hydroxysalicylate 87903-39-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead icosanoate 94266-32-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead icosanoate (1:2) 94266-31-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead iodate 25659-31-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead iodide 10101-63-0 233-256-9 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead isophthalate 38787-87-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
166
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead linoleate 16996-51-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead malate 816-68-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead maleate 19136-34-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead methacrylate 1068-61-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead methacrylate 52609-46-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead molybdate 10190-55-3 233-459-2 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Lead and its compounds, Acute Tox. 4 * compounds, all members"
95 Lead monoxide 1317-36-8 215-267-0 P D/P B X 0.1% 0.001%
all members STOT RE 2 * REACH ANNEX XIV
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead myristate 20403-41-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead naphthalate 50825-29-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
167
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead naphthenate 61790-14-5 263-109-4 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead neobate 12034-88-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead neodecanoate 27253-28-7 231-100-4 P D/P B 0.1% 0.01% compounds, all members"
REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead nitrate 10099-74-8 233-245-9 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead nitroresorcinate 51317-24-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead oleate 1120-46-3 214-310-0 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead oxalate 814-93-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead oxide 1335-25-7 231-100-4 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead oxide (Pb2O) 12059-89-1 235-036-8 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
168
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead oxide (PbO), lead-contg. 68411-78-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead oxide (PbO), retort 69029-53-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead oxide phosphonate Acute Tox. 4 *
95 12141-20-7 235-252-2 P D/P B 0.1% 0.001% compounds, all members"
all members (Pb3O2(HPO3)) STOT RE 2 *
REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead oxide phosphonate, hemihydrate 1344-40-7 231-100-4 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead oxide sulfate 12765-51-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead oxide sulfate (Pb2O(SO4)) 12036-76-9 234-853-7 P D/P B 0.1% 0.001% compounds, all members"
REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
95 Lead oxide sulfate (Pb4O3(SO4)) 12202-17-4 235-380-9 P D/P B X 0.1% 0.001%
Aquatic Chronic 1
Repr. 1A
95 Lead oxide sulfate (Pb5O4(SO4)) 12065-90-6 235-067-7 P D/P B X 0.1% 0.001%
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead palmitate 19528-55-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
169
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead pentadecanoate 93966-74-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead peroxide 1309-60-0 215-174-5 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead phosphate 7446-27-7 231-205-5 P D/P B 0.1% 0.001% Reg. (EC) No 1272/2008
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead phthalate 16183-12-3 240-321-5 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead phthalate 6838-85-3 229-927-0 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead picrate 25721-38-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead propionate 42558-73-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead pyrophosphate 13453-66-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead ruthenium oxide (PbRuO3) 37194-88-0 253-389-6 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
170
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead sebacate 29473-77-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Acute Tox. 4 * REACH ANNEX XIV
95 Lead silicate 11120-22-2 234-363-3 P D/P B X 0.1% 0.001%
all members STOT RE 2 * RECOMMENDATION
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead silicate 13566-17-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead silicate 22569-74-0 245-090-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead silicate sulfate 12687-78-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead silicate sulfate 67711-86-8 266-962-0 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead stearate 7428-48-0 231-068-1 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead stearate dibasic 52652-59-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead subacetate 1335-32-6 215-630-3 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
171
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead succinate 1191-18-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead sulfate 15739-80-7 239-831-0 P D/P B 0.1% 0.001% REACH ANNEX XVII
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead sulfate 7446-14-2 231-198-9 P D/P B 0.1% 0.001% REACH ANNEX XVII
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead sulfate, tribasic 12397-06-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead sulfide (PbS) 1314-87-0 215-246-6 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead sulfomolybdochromate, silica Acute Tox. 4 * See 1st line of "Lead and its
95 116565-73-2 231-100-4 P D/P B 0.1% 0.01%
all members encapsulated STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead tantalate 12065-68-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead telluride 1314-91-6 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead tellurite 13845-35-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
172
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead tetrachloride 13463-30-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead tetracosanoate 93966-38-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Acute Tox. 4 * REACH ANNEX XIV
95 Lead tetraoxide 1314-41-6 215-235-6 P D/P B X 0.1% 0.001%
all members STOT RE 2 * RECOMMENDATION
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead thiocyanate 592-87-0 209-774-6 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead thiosulfate 13478-50-7 236-780-6 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead tin oxide (PbSnO3) 12036-31-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Acute Tox. 4 * REACH SVHC
95 Lead titanium oxide (PbTiO3) 12060-00-3 235-038-9 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead titanium zirconium oxide Acute Tox. 4 *
95 12626-81-2 235-727-4 P D/P B 0.1% 0.001% REACH SVHC
all members (Pb(Ti,Zr)O3) STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead trioxide 1314-27-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
173
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead tungsten oxide 7759-01-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead tungsten oxide 12737-98-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead uranate pigment 85536-79-4 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead vanadate 10099-79-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead zirconate 12060-01-4 235-039-4 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) (R)-12-hydroxyoleate 13094-04-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) (Z)-hexadec-9-enoate 93858-24-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) 2,4-dinitroresorcinolate 13406-89-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) 4-(1,1-dimethylethyl)benzoate 85292-77-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
174
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead(2+) 4,4'- Acute Tox. 4 * See 1st line of "Lead and its
95 93858-23-2 231-100-4 P D/P B 0.1% 0.01%
all members isopropylidenebisphenolate STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) 4,6-dinitro-o-cresolate 65121-76-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) acrylate 867-47-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) decanoate 15773-52-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) heptadecanoate 63399-94-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) isohexadecanoate 95892-13-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) isooctadecanoate 70727-02-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) neodecanoate 71684-29-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) neononanoate 93894-48-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
175
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) neoundecanoate 93894-49-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(2+) octanoate 7319-86-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(4+) stearate 7717-46-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(II) fumarate 71686-03-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(II) isodecanoate 84852-34-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(II) isooctanoate 93981-67-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(II) maleate 17406-54-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead(IV) fluoride 7783-59-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead, (2-methyl-4,6-dinitrophenolato-
95 O1)(nitrato-O)-.mu.-oxodi-, 79357-62-3 231-100-4 P D/P B 0.1% 0.01%
monohydrate
Aquatic Acute 1
Aquatic Chronic 1
176
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead, [.mu.-[1,2-
95 benzenedicarboxylato(2-)-O1:O2]]di- 17976-43-1 241-894-4 P D/P B 0.1% 0.01%
.mu.-oxotri-, cyclo-
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, [1,2-benzenedicarboxylato(2- Acute Tox. 4 *
95 69011-06-9 273-688-5 P D/P B 0.1% 0.001% REACH SVHC
all members )]dioxotri- STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, [1,2-benzenedicarboxylato(2- Acute Tox. 4 * See 1st line of "Lead and its
95 57142-78-6 260-590-2 P D/P B 0.1% 0.01%
all members )]oxodi- STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, [29H,31H-phthalocyaninato(2-)- Acute Tox. 4 * See 1st line of "Lead and its
95 15187-16-3 231-100-4 P D/P B 0.1% 0.01%
all members N29,N30,N31,N32]-, (SP-4-1)- STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,2-ethylhexanoate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-30-4 231-100-4 P D/P B 0.1% 0.01%
all members isodecanoate complexes, basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, 2-ethylhexanoate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-31-5 231-100-4 P D/P B 0.1% 0.01%
all members isononanoate complexes, basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 90431-32-6 231-100-4 P D/P B 0.1% 0.01%
all members isooctanoate complexes, basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, 2-ethylhexanoate naphthenate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-33-7 231-100-4 P D/P B 0.1% 0.01%
all members complexes STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 90431-34-8 231-100-4 P D/P B 0.1% 0.01%
all members naphthenate complexes, basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
177
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 90431-35-9 231-100-4 P D/P B 0.1% 0.01%
all members neodecanoate complexes, basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 68187-37-1 231-100-4 P D/P B 0.1% 0.01%
all members tall-oil fatty acids complexes STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead, alkyls, manufacturing wastes 70513-89-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead, antimonial 69029-50-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead, antimonial, dross 69029-51-2 P D/P B 0.1% 0.01% REACH ANNEX XVII
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, bis(2-hydroxybenzoato-O1,O2)- Acute Tox. 4 * See 1st line of "Lead and its
95 15748-73-9 231-100-4 P D/P B 0.1% 0.01%
all members ,(T-4)- STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, bis(dipentylcarbamodithioato- Acute Tox. 4 * See 1st line of "Lead and its
95 36501-84-5 253-068-0 P D/P B 0.1% 0.01%
all members S,S')-,(T-4)- STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, bis(diphenylcarbamodithioato- Acute Tox. 4 * See 1st line of "Lead and its
95 75790-73-7 231-100-4 P D/P B 0.1% 0.01%
all members S,S')-,(T-4)- STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead, bis(octadecanoato)dioxotri- 12565-18-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
178
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead, bis(octadecanoato)dioxotri- 12578-12-0 235-702-8 P D/P B 0.1% 0.001% REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead, bullion 97808-88-3 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, C3-13-fatty acid naphthenate Acute Tox. 4 * See 1st line of "Lead and its
95 79803-79-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, C4-10-fatty acid naphthenate Acute Tox. 4 * See 1st line of "Lead and its
95 84067-00-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, C4-10-fatty acid octanoate Acute Tox. 4 * See 1st line of "Lead and its
95 92200-92-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, C5-23-branched carboxylate C4- Acute Tox. 4 * See 1st line of "Lead and its
95 84066-98-8 231-100-4 P D/P B 0.1% 0.01%
all members 10-fatty acid complexes STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, C5-23-branched carboxylate C4- Acute Tox. 4 * See 1st line of "Lead and its
95 83711-45-9 231-100-4 P D/P B 0.1% 0.01%
all members 10-fatty acid naphthenate complexes STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, C5-23-branched carboxylate Acute Tox. 4 * See 1st line of "Lead and its
95 83711-46-0 231-100-4 P D/P B 0.1% 0.01%
all members naphthenate complexes STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 83711-47-1 231-100-4 P D/P B 0.1% 0.01%
all members naphthenate octanoate complexes STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
179
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 84066-99-9 231-100-4 P D/P B 0.1% 0.01%
all members octanoate complexes STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 70084-67-2 231-100-4 P D/P B 0.1% 0.01%
all members naphthenate complexes STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead, C8-10-branched fatty acids C9-
95 11-neofatty acids naphthenate 90431-28-0 231-100-4 P D/P B 0.1% 0.01%
complexes
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead, C8-10-branched fatty acids C9-
95 11-neofatty acids naphthenate 90431-27-9 231-100-4 P D/P B 0.1% 0.01%
complexes, overbased
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,C9- 28-neocarboxylate 2- Acute Tox. 4 * See 1st line of "Lead and its
95 125494-56-6 231-100-4 P D/P B 0.1% 0.01%
all members ethylhexanoate complexes, basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead,decanoate octanoate complexes 70321-55-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,di-.mu.-hydroxy(2-methyl-4,6- Acute Tox. 4 * See 1st line of "Lead and its
95 96471-22-6 231-100-4 P D/P B 0.1% 0.01%
all members dinitrophenolato-O1)(nitrato-O)di- STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,dihydroxy[2,4,6-trinitro-1,3- Acute Tox. 4 * See 1st line of "Lead and its
95 12403-82-6 231-100-4 P D/P B 0.1% 0.01%
all members benzenediolato(2-)]di- STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead,dross 69029-52-3 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
180
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead,dross, antimony-rich 69029-45-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead,dross, bismuth-rich 69029-46-5 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead,dross, copper-rich 69227-11-8 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead,dross, vanadium-zinc-containing 100656-49-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isodecanoate isononanoate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-36-0 231-100-4 P D/P B 0.1% 0.01%
all members complexes, basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead, isodecanoate isooctanoate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-37-1 231-100-4 P D/P B 0.1% 0.01%
all members complexes,basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isodecanoate naphthenate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-38-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isodecanoate naphthenate Acute Tox. 4 * See 1st line of "Lead and its
95 101012-92-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isodecanoate neodecanoate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-39-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
181
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isononanoate isooctanoate Acute Tox. 4 * See 1st line of "Lead and its
95 84929-94-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isononanoate naphthenate Acute Tox. 4 * See 1st line of "Lead and its
95 84929-97-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isononanoate naphthenate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-40-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isononanoate neodecanoate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-41-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isooctanoate naphthenate Acute Tox. 4 * See 1st line of "Lead and its
95 68515-80-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isooctanoate naphthenate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-42-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isooctanoate neodecanoate Acute Tox. 4 * See 1st line of "Lead and its
95 101013-06-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,isooctanoate neodecanoate Acute Tox. 4 * See 1st line of "Lead and its
95 84929-95-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,naphthenate neodecanoate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-43-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
182
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,naphthenate neodecanoate Acute Tox. 4 * See 1st line of "Lead and its
95 84929-96-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead,neononanoate neoundecanoate Acute Tox. 4 * See 1st line of "Lead and its
95 90431-44-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead,zinc dross 94551-60-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Linseed oil, polymer with tung oil, lead Acute Tox. 4 * See 1st line of "Lead and its
95 68990-75-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Linseed oil, reaction products with lead Acute Tox. 4 * See 1st line of "Lead and its
95 68152-99-8 231-100-4 P D/P B 0.1% 0.01%
all members oxide (Pb3O4) and mastic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Acute Tox. 4 * REACH SVHC
95 Methanesulfonic acid, lead(2+) salt 17570-76-2 401-750-5 P D/P B 0.1% 0.001%
all members STOT RE 2 * Reg. (EC) No 1272/2008
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Naphthalenesulfonic acid, diisononyl- Acute Tox. 4 * See 1st line of "Lead and its
95 63568-30-9 231-100-4 P D/P B 0.1% 0.01%
all members ,lead(2+) salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Naphthalenesulfonic acid, dinonyl-, Acute Tox. 4 * See 1st line of "Lead and its
95 61867-68-3 231-100-4 P D/P B 0.1% 0.01%
all members lead(2+) salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Naphthenic acids, lead (2+) salts 91078-81-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
183
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Naphthenic acids, lead manganese Acute Tox. 4 * See 1st line of "Lead and its
95 61788-52-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Naphthenic acids, lead salts, basic 92045-67-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Neodecanoic acid, lead salt, basic 90459-25-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Neononanoic acid, lead salt, basic 90459-26-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Neoundecanoic acid, lead salt, basic 90459-28-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Nitric acid, lead(2+) salt,reaction Acute Tox. 4 * See 1st line of "Lead and its
95 97953-08-7 231-100-4 P D/P B 0.1% 0.01%
all members products with sodium tin oxide STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Octadecanoic acid, lead salt, basic 90459-51-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Octadecanoic acid, lead(2+) salt, basic 90459-52-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Octadecanoic acid, lead(2+) salt, Acute Tox. 4 * See 1st line of "Lead and its
95 52080-60-1 231-100-4 P D/P B 0.1% 0.01%
all members tribasic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
184
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Octanoic acid, lead salt 15696-43-2 239-790-9 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Orthoboric acid, lead(2+) salt 35498-15-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Petrolatum, petroleum, oxidized, lead Acute Tox. 4 * See 1st line of "Lead and its
95 67674-14-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Phenol, 2-methyldinitro-, lead salt 50319-14-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Phenol, dodecyl-, lead(2+) salt 68586-21-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Phenol, tetrapropylene-, lead(2+) salt 122332-23-4 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Phosphonic acid, lead salt 16038-76-9 240-176-8 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Phosphonic acid, lead salt, basic 53807-64-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Phosphonic acid, lead(2+) salt 24824-71-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
185
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Phosphonic acid, lead(2+) salt (1:1) 13453-65-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Phosphonic acid, lead(2+) salt (2:1) 15521-60-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Phosphoric acid, lead(2+) salt (1:1) 15845-52-0 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Phosphoric acid, mixed butyl Acute Tox. 4 * See 1st line of "Lead and its
95 93925-27-0 231-100-4 P D/P B 0.1% 0.01%
all members and hexyl diesters, lead(2+) salts STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Phosphorodithioate Acute Tox. 4 * See 1st line of "Lead and its
95 20383-42-0 231-100-4 P D/P B 0.1% 0.01%
all members O,O-bis(1,3-dimethylbutyl), lead salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Phosphorodithioic acid, mixed O,O- Acute Tox. 4 * See 1st line of "Lead and its
95 91783-10-7 231-100-4 P D/P B 0.1% 0.01%
all members bis(bu and pentyl) esters, lead(2+) salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Plumbane, chlorotriethyl- 1067-14-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Plumbane, diethyldimethyl- 1762-27-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Plumbane, ethyl methyl derivitives 68610-17-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
186
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Plumbane, ethyltrimethyl- 1762-26-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Plumbane, tetrabutyl- 1920-90-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Plumbane, tetrakis(1-methylethyl)- 14846-40-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Plumbane, tetrakis(1-methylpropyl)- 65151-08-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Plumbane, triethylmethyl- 1762-28-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Plumbate (PbO22-), disodium 12034-30-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Plumbate (PbO44-), calcium (1:2), (T- Acute Tox. 4 * See 1st line of "Lead and its
95 12013-69-3 234-591-3 P D/P B 0.1% 0.01%
all members 4)- STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Potassium
95 pentadecaoxodiplumbatepentaniobate( 12372-45-1 231-100-4 P D/P B 0.1% 0.01%
1-)
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Salicylate, lead (II) 6107-93-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
187
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Silicic acid (H2sio3), calcium salt (1:1), Acute Tox. 4 * See 1st line of "Lead and its
95 100402-96-8 231-100-4 P D/P B 0.1% 0.01%
all members lead and manganese-doped STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Silicic acid (H2SiO3), lead(2+) salt (1:1) 10099-76-0 233-246-4 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Silicic acid (H4SiO4), lead salt 15906-71-5 240-047-6 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Silicic acid, calcium salt, Acute Tox. 4 * See 1st line of "Lead and its
95 102110-36-1 231-100-4 P D/P B 0.1% 0.01%
all members lead and manganese-doped STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Slimes and sludges, lead sinter dust Acute Tox. 4 * See 1st line of "Lead and its
95 70514-37-3 231-100-4 P D/P B 0.1% 0.01%
all members scrubber STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Speiss, lead-zinc 93821-72-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Spiro[isobenzofuran-1(3H),9'-
95 [9H]xanthen]-3-one, 2',4',5',7'- 1326-05-2 231-100-4 P D/P B 0.1% 0.01%
tetrabromo-3',6'-dihydroxy-, lead salt
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Stearic acid, lead (2+) salt 1072-35-1 214-005-2 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Sulfuric acid, barium lead salt 42579-89-5 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
188
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Sulfuric acid, barium salt (1:1), lead- Acute Tox. 4 * See 1st line of "Lead and its
95 99328-54-8 231-100-4 P D/P B 0.1% 0.01%
all members doped STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Sulfuric acid, lead salt, tetrabasic 52732-72-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Sulfuric acid, lead(2+) salt, basic 90583-07-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Sulfurous acid, lead salt, basic 52231-92-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Sulfurous acid, lead salt, dibasic 62229-08-7 P D/P B 0.1% 0.001% REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Sulfurous acid, lead(2+) salt, basic 90583-37-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Sulfurous acid, lead(2++) salt (1:1) 7446-10-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Telluric acid (H2TeO3), lead(2+) salt Acute Tox. 4 * See 1st line of "Lead and its
95 15851-47-5 231-100-4 P D/P B 0.1% 0.01%
all members (1:1) STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Tetradecanoic acid, lead salt, basic 90583-65-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
189
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Tetraethyllead 78-00-2 201-075-4 P D/P B 0.1% 0.001% REACH SVHC
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Tetramethyl lead 75-74-1 200-897-0 P D/P B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Tetraphenyllead 595-89-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Tetrapropyl lead 3440-75-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Thiosulphuric acid, lead salt 26265-65-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead/Tin alloy 39412-44-7 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Trinitrophloroglucinol, lead salt 51325-28-1 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Boric acid (HBO2), lead(2+) salt, Acute Tox. 4 * See 1st line of "Lead and its
95 10214-39-8 231-100-4 P D/P B 0.1% 0.01%
all members monohydrate (8CI, 9CI) STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Fatty acids, C6-19-branched, lead Acute Tox. 4 * See 1st line of "Lead and its
95 68603-83-8 271-675-9 P D/P B 0.1% 0.01%
all members salts, basic STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
190
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Pigment Lightfast Lead-Molybdate Acute Tox. 4 * See 1st line of "Lead and its
95 78690-68-3 231-100-4 P D/P B 0.1% 0.001%
all members Orange OS (9CI) STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Arsenic acid, lead (4+) salt 53404-12-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead arsenate 3687-31-8 222-979-5 P D/P B 0.1% 0.001% compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead arsenate 7784-40-9 232-064-2 P D/P B 0.1% 0.001% compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
231-901-9 Acute Tox. 4 *
95 Lead arsenate (Pb3(AsO4)2) 10102-48-4 P D/P B 0.1% 0.01%
231-100-4 Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead arsenate, unspecified 7645-25-2 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead arsenite 10031-13-7 233-083-9 P D/P B 0.1% 0.01% compounds, all members"
REACH ANNEX XVII
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead sulfochromate yellow (C.I. 0,001% and Acute Tox. 4 *
95 1344-37-2 215-693-7 P D/P B X 0.001% compounds, all members" 2015/5/21
all members Pigment Yellow 34) 0,01µg/cm2 STOT RE 2 *
REACH ANNEX XIV
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Molybdate orange (Lead chromate 0,001% and Acute Tox. 4 *
95 12656-85-8 235-759-9 P D/P B X 0.001% compounds, all members" 2015/5/21
all members pigment) 0,01µg/cm2 STOT RE 2 *
REACH ANNEX XIV
Aquatic Acute 1
Aquatic Chronic 1
191
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Chromium lead oxide 11119-70-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Dilead chromate dihydroxide 12017-86-6 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, 0,001% and Acute Tox. 4 *
95 Lead chromate 7758-97-6 231-846-0 P D/P B X 0.001% compounds, all members" 2015/5/21
all members 0,01µg/cm2 STOT RE 2 *
REACH ANNEX XIV
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead chromate oxide 18454-12-1 242-339-9 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead chromate silicate 11113-70-5 234-347-6 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead chromate Acute Tox. 4 * See 1st line of "Lead and its
95 69011-07-0 231-100-4 P D/P B 0.1% 0.01%
all members silicate(Pb3(CrO4)(SiO4)) STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Lead chromate Acute Tox. 4 * See 1st line of "Lead and its
95 51899-02-6 231-100-4 P D/P B 0.1% 0.01%
all members sulfate(Pb9(CrO4)5(SO4)4) STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Naphthenic acid, cobalt lead Acute Tox. 4 * See 1st line of "Lead and its
95 61789-50-2 231-100-4 P D/P B 0.1% 0.001%
all members manganese salt STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 198 16646-00-7 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
192
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead 199 27486-00-6 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 200 16645-99-1 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 201 17239-87-1 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 203 14687-25-3 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 209 14119-30-3 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 211 15816-77-0 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 212 15092-94-1 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead 214 15067-28-4 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead styphnate 63918-97-8 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
193
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead, bis(carbonato(2-))dihydroxytri 1344-36-1 231-100-4 P - B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead selenate 7446-15-3 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead selenide 12069-00-0 235-109-4 P P A 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead selenite 7488-51-9 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Residues, copper-iron-lead-nickel 231-100-4 Acute Tox. 4 *
95 102110-49-6 P D/P B 0.1% 0.01% compounds, all members"REACH
all members matte, sulfuric acid-insol. 310-050-8 STOT RE 2 *
Annex XVII
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Silicic acid, lead nickel salt 68130-19-8 231-100-4 P D/P B 0.1% 0.01% compounds, all members"
REACH Annex XVII
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Nitrous acid, lead(2+) salt 13826-65-8 231-100-4 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead perchlorate 13637-76-8 237-125-7 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
Lead and its compounds, Perchloric acid, reaction products with Acute Tox. 4 * See 1st line of "Lead and its
95 99749-31-2 231-100-4 P D/P B 0.1% 0.01%
all members lead oxide (pbo) and triethanolamine STOT RE 2 * compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
194
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Repr. 1A
Acute Tox. 4 *
95 Lead Molybdate Orange YE 428D (9CI) 37268-42-1 231-100-4 P - B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1
Repr. 1A
Acute Tox. 4 *
95 Lead Molybdate Orange YEE 98D (9CI) 50935-72-3 231-100-4 P - B 0.1% 0.001%
Aquatic Acute 1
Aquatic Chronic 1

Lead and its compounds, Pyrochlore, antimony lead yellow; C.I. compounds, all members"
95 8012-00-8 232-382-1 P - B X 0.1% 0.001%
all members Pigment Yellow 41 REACH ANNEX XIV
RECOMMENDATION
Irritation of skin and eyes.;

High intensity discharge (HID)
cardiovascular,
(2',7'-Dibromo-3',6'-dihydroxy-3- 231-106-7 lamps, electric switches, EU-D 2000/53/EEC
Mercury and its compounds, nervous system, kidney and
96 oxospiro [isobenzofuran-1(3H),9'- 55728-51-3 200-532-5 P P A 0.1% 0.01% luminescent material for REACH Annex XVII
all members brain disorder;
[9H]xanthen]-4'-yl)hydroxymercury 247-783-7 instrument lighting, pyrotechnic Reg. (EC) No 1272/2008
initiators etc.
disruptors
231-106-7
Mercury and its compounds, (2-Carboxy-m- See 1st line of "Mercury and its
96 52795-88-7 200-532-5 P D/P B 0.1% 0.01%
all members tolyl)hydroxymercury,monosodium salt compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, See 1st line of "Mercury and its
96 (2-Carboxyphenyl)hydroxymercury 14066-61-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 (Acetato-O)ethylmercury 109-62-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 (Acetato-O)methylmercury 108-07-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 (Bromodichloromethyl)phenylmercury 3294-58-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 (Dihydroxyphenyl)phenylmercury 27360-58-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 (Lactato-O1,O2)mercury 18918-06-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 (Maleoyldioxy)bis[phenylmercury] 2701-61-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 (Metaborato-O)phenylmercury 31224-71-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
195
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
231-106-7
96 (Phenylmercurio)urea 2279-64-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, [(2-Hydroxyethyl)amino]phenylmercury See 1st line of "Mercury and its
96 61792-06-1 200-532-5 P D/P B 0.1% 0.01%
all members acetate compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, [.mu.-[(Oxydiethylene but-2- See 1st line of "Mercury and its
96 94070-92-5 200-532-5 P D/P B 0.1% 0.01%
all members enedioato)(2-)]]diphenyldimercury compounds, all members"
247-783-7
[.mu.-[[4,4'-(Oxydiethylene) 231-106-7
96 bis(dodecenylsuccinato)](2- 93882-20-3 200-532-5 P D/P B 0.1% 0.01%
)]]diphenyldimercury 247-783-7
231-106-7
Mercury and its compounds, [.mu.-[Metasilicato(2-)-O:O]]bis(2- See 1st line of "Mercury and its
96 19367-79-4 200-532-5 P D/P B 0.1% 0.01%
all members methoxyethyl)dimercury compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, [.mu.-[Orthoborato(2-)- See 1st line of "Mercury and its
96 6273-99-0 200-532-5 P D/P B 0.1% 0.01%
all members O:O']]diphenyldimercury compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, [2,2',2''-Nitrilotri(ethanol)- See 1st line of "Mercury and its
96 23319-66-6 200-532-5 P D/P B 0.1% 0.01%
all members N,O,O',O'']phenylmercury lactate compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, [2-Ethylhexyl hydrogen maleato-O'] See 1st line of "Mercury and its
96 27605-30-7 200-532-5 P D/P B 0.1% 0.01%
all members phenylmercury compounds, all members"
247-783-7
231-106-7
96 [Benzoato(2-)-C2,O1]mercury 5722-59-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 [Naphthoato(1-)-O]phenylmercury 31632-68-5 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 2-(Ethylmercuriothio)benzoic acid 148-61-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 2-Ethoxyethylmercury acetate 124-08-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 2-Ethoxyethylmercury chloride 124-01-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, 2-Hydroxy-5-(1,1,3,3- See 1st line of "Mercury and its
96 584-18-9 200-532-5 P D/P B 0.1% 0.01%
all members tetramethylbutyl)phenylmercury acetate compounds, all members"
247-783-7
Acute Tox. 3 *
STOT RE 1
96 2-Methoxyethylmercury chloride 123-88-6 204-659-7 P D/P B 0.1% 0.01% Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
196
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
231-106-7
96 6-Methyl-3-nitrobenzoxamercurate 133-58-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Barium tetraiodomercurate 10048-99-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Bis(5-oxo-DL-prolinato-N1,O2)mercury 94276-38-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Bis(5-oxo-L-prolinato-N1,O2)mercury 94481-62-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Bis(acetato-O)[.mu.-[1,3-dioxane-2,5- See 1st line of "Mercury and its
96 84029-43-6 200-532-5 P D/P B 0.1% 0.01%
all members diylbis(methylene)-c:c',O,O']]dimercury compounds, all members"
247-783-7
231-106-7
96 Bis(lactato-O1,O2)mercury 18917-83-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Bis(trichloromethyl)mercury 6795-81-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Bis[(+)-lactato]mercury 33724-17-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Bis[(trimethylsilyl)methyl]mercury 13294-23-0 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Bromo(2-hydroxypropyl)mercury 18832-83-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Bromoethylmercury 107-26-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Bromomethylmercury 506-83-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Bromophenylmercury 1192-89-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Chlormerodrin 62-37-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Chloro(hydroxyphenyl)mercury 1320-80-5 200-532-5 P D/P B 0.1% 0.01%
247-783-7
197
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
231-106-7
96 Chloro(o-hydroxyphenyl)mercury 90-03-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Chloro[p-[(2-hydroxy-1- See 1st line of "Mercury and its
96 3076-91-3 200-532-5 P D/P B 0.1% 0.01%
all members naphthyl)azo]phenyl]mercury compounds, all members"
247-783-7
231-106-7
96 Chloro-2-thienylmercury 5857-39-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Chloro-m-tolylmercury 5955-19-1 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Chloro-o-tolylmercury 2777-37-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Cobaltate(2-), tetrakis(thiocyanato-N)-, See 1st line of "Mercury and its
96 27685-51-4 200-532-5 P D/P B 0.1% 0.01%
all members mercury(2+) (1:1), (T-4)- compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Cyclohexanebutanoic acid, See 1st line of "Mercury and its
96 62638-02-2 200-532-5 P D/P B 0.1% 0.01%
all members mercury(2+) salt compounds, all members"
247-783-7
231-106-7
96 Diammonium tetrachloromercurate 33445-15-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
Acute Tox. 2 *
Acute Tox. 1
Mercury and its compounds, Acute Tox. 2 * See 1st line of "Mercury and its
96 Diethylmercury 627-44-1 211-000-7 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
231-106-7
Mercury and its compounds, Dihydrogen [orthoborato(3-)- See 1st line of "Mercury and its
96 102-98-7 200-532-5 P D/P B 0.1% 0.01%
all members O]phenylmercurate(2-) compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Diiodo(5-iodopyridin-2-amine- See 1st line of "Mercury and its
96 93820-20-3 200-532-5 P D/P B 0.1% 0.01%
all members N1)mercury compounds, all members"
247-783-7
231-106-7
96 Dimercury amidatenitrate 1310-88-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Dimercury difluoride 13967-25-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Dimercury diiodide 15385-57-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
198
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
231-106-7
96 Dimercury(I) oxalate 2949-11-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Dimethyl[.mu.-[sulphato(2-)- See 1st line of "Mercury and its
96 3810-81-9 200-532-5 P D/P B 0.1% 0.01%
all members O:O']]dimercury compounds, all members"
247-783-7
Acute Tox. 2 *
Acute Tox. 1
Mercury and its compounds, Acute Tox. 2 * See 1st line of "Mercury and its
96 Dimethylmercury 593-74-8 209-805-3 P D/P B 0.1% 0.01%
Aquatic Acute 1
Aquatic Chronic 1
231-106-7
96 Di-o-tolylmercury 616-99-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
Diphenyl[.mu.-
96 [(tetrapropenyl)succinato(2-)- 27236-65-3 248-355-2 P D/P B 0.1% 0.01%
O:O']]dimercury
231-106-7
96 Diphenylmercury 587-85-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Disodium tetra(cyano-C)mercurate(2-) 15682-88-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Disuccinimidomercury 584-43-0 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Ethyliodomercury 2440-42-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Ethylmercuric chloride 107-27-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Ethylmercuric phosphate 2235-25-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Fluorescein mercuric acetate 3570-80-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Hexanoic acid, 2-ethyl-, mercury(2+) See 1st line of "Mercury and its
96 13170-76-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Hydrargaphen 14235-86-0 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Hydrogen [metasilicato(2-)-O](2- See 1st line of "Mercury and its
96 64491-92-5 200-532-5 P D/P B 0.1% 0.01%
all members methoxyethyl)mercurate(1-) compounds, all members"
247-783-7
199
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Hydrogen .mu.-hydroxy[.mu.- 231-106-7

96 [orthoborato(3-)- 94277-53-9 200-532-5 P D/P B 0.1% 0.01%
O:O']]diphenyldimercurate(1-) 247-783-7
Hydrogen [3-[(.alpha.-carboxylato-o- 231-106-7

96 anisoyl)amino]-2- 26552-50-1 200-532-5 P D/P B 0.1% 0.01%
hydroxypropyl]hydroxymercurate(1-) 247-783-7
231-106-7
96 Iodomethylmercury 143-36-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Lactatophenylmercury 122-64-5 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Meralein sodium 4386-35-0 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercaptomerin sodium 21259-76-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercuderamide 525-30-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Mercurate(1-),(4- See 1st line of "Mercury and its
96 59-85-8 200-532-5 P D/P B 0.1% 0.01%
all members carboxylatophenyl)chloro-, hydrogen compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercurate(1-),(4- See 1st line of "Mercury and its
96 138-85-2 200-532-5 P D/P B 0.1% 0.01%
all members carboxylatophenyl)hydroxy-, sodium compounds, all members"
247-783-7
Mercurate(1-),triiodo-, hydrogen, 231-106-7

96 compound with 3-methyl-2(3H)- 72379-35-2 200-532-5 P D/P B 0.1% 0.01%
benzothiazolimine (1:1) 247-783-7
231-106-7
Mercury and its compounds, Mercurate(2-),tetrachloro-, dipotassium, See 1st line of "Mercury and its
96 20582-71-2 200-532-5 P D/P B 0.1% 0.01%
all members (T-4)- compounds, all members"
247-783-7
Mercurate(2-), tetraiodo-, (T-4)-, 231-106-7

96 dihydrogen, compound with 5-iodo-2- 63325-16-6 200-532-5 P D/P B 0.1% 0.01%
pyridinamine (1:2) 247-783-7
231-106-7
Mercury and its compounds, Mercurate(2-), tetraiodo-, dicopper(1+), See 1st line of "Mercury and its
96 13876-85-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercuric acetate 1600-27-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercuric benzoate 583-15-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
200
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
96 Mercuric bromide 7789-47-1 232-169-3 P D/P B 0.1% 0.01%
Muta. 2
0.1% Repr. 2
(0.0005% Acute Tox. 2 *
96 Mercuric chloride 7487-94-7 231-299-8 P D/P B for batteries, 0.001% STOT RE 1
2% in button Skin Corr. 1B
cells) Aquatic Acute 1
Aquatic Chronic 1
231-106-7
96 Mercuric cyanide 592-04-1 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercuric iodide 7774-29-0 200-532-5 P D/P B 0.1% 0.01%
247-783-7
96 Mercuric nitrate 10045-94-0 233-152-3 P D/P B 0.1% 0.01%
0.1%
(0.0005%
96 Mercuric oxide 21908-53-2 244-654-7 P D/P B for batteries, 0.001%
2% in button
cells)
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
96 Mercuric oxycyanide 1335-31-5 215-629-8 P D/P B 0.1% 0.01% Acute Tox. 3 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
96 Mercuric potassium cyanide 591-89-9 209-735-3 P D/P B 0.1% 0.01%
231-106-7
96 Mercuric subsulfate 1312-03-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercuric sulfate 7783-35-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercuric thiocyanate 592-85-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercurobutol 498-73-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercurous acetate 631-60-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercurous azide 38232-63-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercurous chloride 7546-30-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
201
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
231-106-7
96 Mercurous iodide 7783-30-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercurous nitrate 10415-75-5 200-532-5 P D/P B 0.1% 0.01%
247-783-7
0.1%
(0.0005%
96 Mercurous oxide 15829-53-5 239-934-0 P D/P B for batteries, 0.001%
2% in button
cells)
231-106-7
96 Mercurous sulfate 7783-36-0 200-532-5 P D/P B 0.1% 0.01%
247-783-7
0.1% Repr. 1B
(0.0005% Acute Tox. 2 *
96 Mercury 7439-97-6 231-106-7 P D/P B for batteries, 0.001% STOT RE 1
2% in button Aquatic Acute 1
cells) Aquatic Chronic 1
231-106-7
96 Mercury (I) nitrate 14836-60-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury (II) nitrate, monohydrate 7783-34-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury acetate 592-63-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury acetylide 68833-55-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury ammonium chloride 10124-48-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury bis(4-chlorobenzoate) 15516-76-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury bis(trifluoroacetate) 13257-51-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury bromide (Hg2Br2) 15385-58-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury bromide (HgBr) 10031-18-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
Acute Tox. 4 *
Eye Irrit. 2
Mercury and its compounds, STOT SE 3 See 1st line of "Mercury and its
96 Mercury chloride 10112-91-1 233-307-5 P D/P B 0.1% 0.01%
all members Skin Irrit. 2 compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
231-106-7
96 Mercury diiodate 7783-32-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
202
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
231-106-7
96 Mercury dipotassium tetrathiocyanate 14099-12-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury disilver tetraiodide 7784-03-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury distearate, pure 645-99-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury fluoride 27575-47-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury fluoride (HgF2) 7783-39-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury gluconate 63937-14-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury nitride 12136-15-1 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury oleate 1191-80-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury salicylate 5970-32-1 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury silver iodide 12344-40-0 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury succinate 589-65-1 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury sulfide (HgS) 1344-48-5 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury telluride (HgTe) 12068-90-5 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury thallium dinitrate 94022-47-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury(1+) bromate 13465-33-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
203
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
231-106-7
96 Mercury(1+) ethyl sulphate 71720-55-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury(1+) trifluoroacetate 2923-15-1 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury(1+), amminephenyl-, acetate 22450-90-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Mercury(2+) (9Z,12Z)-octadeca-9,12- See 1st line of "Mercury and its
96 7756-49-2 200-532-5 P D/P B 0.1% 0.01%
all members dienoate compounds, all members"
247-783-7
231-106-7
96 Mercury(2+) chloroacetate 26719-07-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Mercury(2+), bis(2,4,6-tri-2-pyridinyl- See 1st line of "Mercury and its
96 53010-52-9 200-532-5 P D/P B 0.1% 0.01%
all members 1,3,5-triazine-N1,N2,N6)-, (OC-6-1'2)- compounds, all members"
247-783-7
231-106-7
96 Mercury(II) oxalate 3444-13-1 200-532-5 P D/P B 0.1% 0.01%
247-783-7
96 Mercury(II) potassium iodide 7783-33-7 231-990-4 P D/P B 0.1% 0.01%
231-106-7
Mercury and its compounds, Mercury, (2-ethylhexanoato-O)(1- See 1st line of "Mercury and its
96 103332-13-4 200-532-5 P D/P B 0.1% 0.01%
all members methoxycyclohexyl)- compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercury, (1- See 1st line of "Mercury and its
96 103369-15-9 200-532-5 P D/P B 0.1% 0.01%
all members methoxycyclohexyl)(neodecanoato-O)- compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercury, (1-methoxyethyl)(9- See 1st line of "Mercury and its
96 104325-07-7 200-532-5 P D/P B 0.1% 0.01%
all members octadecenoato-O)-, compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercury, (1-methoxycyclohexyl)(9- See 1st line of "Mercury and its
96 104325-08-8 200-532-5 P D/P B 0.1% 0.01%
all members octadecenoato-O)-, compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercury, (1- See 1st line of "Mercury and its
96 104335-53-7 200-532-5 P D/P B 0.1% 0.01%
all members methoxyethyl)(neodecanoato-O)- compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercury, (2-ethylhexanoato-O)(1- See 1st line of "Mercury and its
96 104339-46-0 200-532-5 P D/P B 0.1% 0.01%
all members methoxyethyl) compounds, all members"
247-783-7
Mercury, (2',7'-dibromo-3',6'-dihydroxy-
231-106-7
Mercury and its compounds, 3-oxospiro[isobenzofuran-1(3H),9'- See 1st line of "Mercury and its
96 129-16-8 200-532-5 P D/P B 0.1% 0.01%
all members [9H]xanthen ]-4'-yl)hydroxy-, disodium compounds, all members"
247-783-7
salt
204
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
231-106-7
Mercury and its compounds, 236-326-7 See 1st line of "Mercury and its
96 Mercury, (2-ethylhexanoato-O)phenyl- 13302-00-6 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Mercury, (9-octadecenoato-O)phenyl-, See 1st line of "Mercury and its
96 104-60-9 200-532-5 P D/P B 0.1% 0.01%
all members (Z)- compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercury, (acetato-O)(2-hydroxy-5- See 1st line of "Mercury and its
96 63468-53-1 200-532-5 P D/P B 0.1% 0.01%
all members nitrophenyl)- compounds, all members"
247-783-7
231-106-7
96 Mercury, (acetato-O)(4-aminophenyl)- 6283-24-5 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Mercury, (acetato-O)[3- See 1st line of "Mercury and its
96 5954-14-3 200-532-5 P D/P B 0.1% 0.01%
all members (chloromethoxy)propyl-C,O]- compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercury, (acetato-O)[4-[[4- See 1st line of "Mercury and its
96 19447-62-2 200-532-5 P D/P B 0.1% 0.01%
all members (dimethylamino)phenyl]azo]phenyl]- compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercury, (acetato-O)diamminephenyl-, See 1st line of "Mercury and its
96 68201-97-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
96 Mercury, (neodecanoato-O)phenyl- 26545-49-3 247-783-7 P D/P B 0.1% 0.01%
231-106-7
Mercury and its compounds, Mercury, [.mu.-[dodecylbutanedioato(2- See 1st line of "Mercury and its
96 24806-32-4 200-532-5 P D/P B 0.1% 0.01%
all members )-O:O']]diphenyldi- compounds, all members"
247-783-7
Mercury, [2,5-dichloro-3,6-dihydroxy- 231-106-7

96 2,5-cyclohexadiene-1,4-dionato(2-)- 33770-60-4 200-532-5 P D/P B 0.1% 0.01%
O1,O6]- 247-783-7
231-106-7
96 Mercury, bis(4-methylphenyl)- 537-64-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury, bis(acetato-O)(benzenamine)- 63549-47-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Mercury, bis(phenyldiazenecarbothioic See 1st line of "Mercury and its
96 14783-59-6 200-532-5 P D/P B 0.1% 0.01%
all members acid 2-phenylhydrazidato-N2,S)-, (T-4)- compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercury, chloro(2-hydroxy-5- See 1st line of "Mercury and its
96 24579-90-6 200-532-5 P D/P B 0.1% 0.01%
all members nitrophenyl)- compounds, all members"
247-783-7
231-106-7
96 Mercury, chloro(4-hydroxyphenyl)- 623-07-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
205
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
231-106-7
96 Mercury, chloro(4-methylphenyl)- 539-43-5 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury, chloro(ethanethiolato)- 1785-43-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Mercury, chloro[2-(2-cyclohexen-1-yl)- See 1st line of "Mercury and its
96 90584-88-6 200-532-5 P D/P B 0.1% 0.01%
all members 3-benzofuranyl]- compounds, all members"
247-783-7
231-106-7
Mercury and its compounds, Mercury, chloro[p-(2,4- See 1st line of "Mercury and its
96 15785-93-0 200-532-5 P D/P B 0.1% 0.01%
all members dinitroanilino)phenyl]- compounds, all members"
247-783-7
231-106-7
96 Mercury, compound with sodium (2:1) 12055-37-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury, compound with sodium (4:1) 57363-77-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury, compound with titanium (1:3) 11083-41-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury, dibutyl- 629-35-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury, iodo(iodomethyl)- 141-51-5 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Mercury, methyl(8-quinolinolato- See 1st line of "Mercury and its
96 86-85-1 200-532-5 P D/P B 0.1% 0.01%
all members N1,O8)- compounds, all members"
247-783-7
Mercury, 231-106-7
96 phenyl(phenyldiazenecarbothioic acid 56724-82-4 200-532-5 P D/P B 0.1% 0.01%
2-phenylhydrazidato)- 247-783-7
231-106-7
96 Mercury, phenyl(propanoato-O)- 103-27-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Mercury, phenyl(trichloromethyl)- 3294-57-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
96 Mercurymethylchloride 115-09-3 204-064-2 P D/P B 0.1% 0.01%
231-106-7
96 Mersalyl 492-18-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
206
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
231-106-7
96 Mersalyl acid 486-67-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Methoxyethylmercuric acetate 151-38-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
96 Methyl mercury dicyandiamide 502-39-6 207-935-5 P D/P B 0.1% 0.01%
231-106-7
96 Methyl(pentachlorophenolato)mercury 5902-76-1 200-532-5 P D/P B 0.1% 0.01%
247-783-7
0.1%
231-106-7 (0.0005%
96 Methylmercury 22967-92-6 200-532-5 P D/P B for batteries, 0.001%
247-783-7 2% in button
cells)
231-106-7
96 Methylmercury benzoate 3626-13-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Methylmercury hydroxide 1184-57-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, N-(Ethylmercuric)-p- See 1st line of "Mercury and its
96 517-16-8 200-532-5 P D/P B 0.1% 0.01%
all members toluenesulphonannilide compounds, all members"
247-783-7
231-106-7
96 Naphthenic acids, mercury salts 1336-96-5 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Nitric acid, mercury(2+) salt, See 1st line of "Mercury and its
96 13465-31-1 200-532-5 P D/P B 0.1% 0.01%
all members hemihydrate compounds, all members"
247-783-7
231-106-7
96 Otimerate sodium 16509-11-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Phenyl(quinolin-8-olato-N1,O8)mercury 14354-56-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Phenyl(tribromomethyl)mercury 3294-60-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
0.1% Acute Tox. 3 *

(0.0005% STOT RE 1
96 Phenylmercuric acetate 62-38-4 200-532-5 P D/P B for batteries, 0.001% Skin Corr. 1B
2% in button Aquatic Acute 1
cells) Aquatic Chronic 1
207
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Acute Tox. 3 *
202-866-7
STOT RE 1
96 Phenylmercuric hydroxide 100-57-2 P D/P B 0.1% 0.01% Skin Corr. 1B
Aquatic Acute 1
247-783-7
Aquatic Chronic 1
Acute Tox. 3 *
200-242-9
STOT RE 1
96 Phenylmercuric nitrate 55-68-5 P D/P B 0.1% 0.01% Skin Corr. 1B
Aquatic Acute 1
247-783-7
Aquatic Chronic 1
231-106-7
96 Phenylmercury benzoate 94-43-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Phenylmercury chloride 100-56-1 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Phenylmercury See 1st line of "Mercury and its
96 32407-99-1 200-532-5 P D/P B 0.1% 0.01%
all members dimethyldithiocarbamate compounds, all members"
247-783-7
Acute Tox. 3 *
231-106-7 STOT RE 1
Mercury and its compounds, Phenylmercury hydroxide-- See 1st line of "Mercury and its
96 8003-05-2 200-532-5 P D/P B 0.1% 0.01% Skin Corr. 1B
all members phenylmercury nitrate compounds, all members"
Aquatic Chronic 1
231-106-7
96 Phenylmercury salicylate 28086-13-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Phenylmercury stearate 104-59-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Phosphoric acid, mercury salt 10451-12-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Potassium triiodomercurate(1-) 22330-18-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
Sodium [3-[[(3-
231-106-7
Mercury and its compounds, carboxylatopropionamido)carbonyl]ami See 1st line of "Mercury and its
96 7620-30-6 200-532-5 P D/P B 0.1% 0.01%
all members no]-2- compounds, all members"
247-783-7
methoxypropyl]hydroxymercurate(1-)
231-106-7
96 Sodium 4-chloromercuriobenzoate 3198-04-7 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Sodium o-(ethylmercurithio)benzoate 54-64-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Sodium timerfonate 5964-24-9 200-532-5 P D/P B 0.1% 0.01%
247-783-7
208
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Tetrakis(acetato-O)[.mu.4-(3',6'-
231-106-7
Mercury and its compounds, dihydroxy-3-oxospiro[isobenzofuran- See 1st line of "Mercury and its
96 54295-90-8 200-532-5 P D/P B 0.1% 0.01%
all members 1(3H),9'-[9H]xanthene]-2',4',5',7'- compounds, all members"
247-783-7
tetrayl)]tetramercury
231-106-7
96 Trimercury biscitrate 18211-85-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
Mercury and its compounds, Mercury, (2-mercaptoacetamidato- See 1st line of "Mercury and its
96 7548-26-7 200-532-5 P D/P B 0.1% 0.01%
all members O,S)methyl compounds, all members"
247-783-7
Unst. Expl.
Acute Tox. 3 *
Acute Tox. 3 *
96 Mercury-difulminate 628-86-4 211-057-8 P D/P B 0.1% 0.01% Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
Mercury, bromo[1-
231-106-7
Mercury and its compounds, (methoxyphenylmethyl)-2-oxo-2-[(1,7,7- See 1st line of "Mercury and its
96 5326-00-1 200-532-5 P D/P B 0.1% 0.01%
all members trimethylbicyclo[2.2.1]hept-2- compounds, all members"
247-783-7
yl)oxy]ethyl]-
231-106-7
96 Mercuric arsenate 7784-37-4 P D/P B 0.1% 0.01%
247-783-7
Carc. 1B
231-106-7
Mercury and its compounds, Skin Sens. 1 See 1st line of "Mercury and its
96 Mercury (I) chromate 13465-34-4 200-532-5 P D/P B 0.1% 0.01%
247-783-7
Aquatic Chronic 1
Carc. 1B
231-106-7
96 Mercury (II) chromate 13444-75-2 200-532-5 P D/P B 0.1% 0.01%
247-783-7
Aquatic Chronic 1
Carc. 1B
231-106-7
96 Mercury dichromate 7789-10-8 200-532-5 P D/P B 0.1% 0.01%
247-783-7
Aquatic Chronic 1
96 Phenylmercuric octanoate 13864-38-5 P - B 0.1% 0.01%
231-106-7
96 Mercury selenide (HgSe) 20601-83-6 200-532-5 P D/P B 0.1% 0.01%
247-783-7
231-106-7
96 Perchloric acid, mercury(2+) salt 7616-83-3 200-532-5 P D/P B 0.1% 0.01%
247-783-7
209
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Flam. Liq. 2 PACT

Coolant, Acute Tox. 3 * Norway, Sweden (SFS 1985:840;
97 Methanol 67-56-1 200-659-6 R D B 0.1% 0.01% window washer fluid, Acute Tox. 3 * SFS 1986:8), Prohibit in EU, Russia, Ukraine
washing agent Acute Tox. 3 * Denmark, Finland
STOT SE 1 Russia, Ukraine
Carc. 1B
Methyl acrylamidomethoxyacetate Muta. 1B
98 77402-03-0 401-890-7 D - B 0.01% Polymer product Reg. (EC) No 1272/2008
(containing > 0,1 % acrylamide) Acute Tox. 4 *
Eye Irrit. 2
REACH Annex XIV

recommendation
World Health Organization
Mineral fibres (Natural or Friction material, reinforcement for definition of respirable fiber,
99 Synthetic) except Continuous Ceramic Fibers 142844-00-6 604-314-4 P D B X 0.01% 0.01% material, insulation material, Carc. 1B and IARC monograph
Filament Fibres, all members cable 81,2002,for Man-Made vitreous
fibers Canada Gazette Vol. 140,
No. 49 - December 9, 2006
(Canadian Challenge).
Mineral fibres (Natural or

Calcium-Magnesium-Zirconium-Silicate See 1st line of "Mineral fibres, all
99 Synthetic) except Continuous 329211-92-9 P D B X 0.1% 0.01%
Mixture members"
Filament Fibres, all members

Aluminium Chloride, Basic reaction See 1st line of "Mineral fibres, all
99 Synthetic) except Continuous 675106-31-7 614-074-2 D D A 0.01%
products with Silica members"

See 1st line of "Mineral fibres, all
99 Synthetic) except Continuous Cristobalite 14464-46-1 238-455-4 D - B 0.01%
members"

Zirconia Aluminosilicate Refractory EU Index See 1st line of "Mineral fibres, all
99 Synthetic) except Continuous P - B 0.1% 0.01%
Ceramic Fibres 650-017-00-8 members"

Aluminosilicate, Refractory Ceramic See 1st line of "Mineral fibres, all
99 Synthetic) except Continuous 66402-68-4 266-340-9 P - B X 0.01% 0.01% Carc. 1B
Fibres members"
STOT RE 2 *
402-210-1 Residual monomer in Skin Sens. 1
100 Monomethyldibromodiphenylmethane 99688-47-8 P P A - - REACH ANNEX XVII
401-210-1 manufacture of polymer Aquatic Acute 1
Aquatic Chronic 1
Residual monomer in Possibility of dioxin generation at EU-D 76/769/EEC

101 Monomethyldichlorodiphenylmethane 81161-70-8 P P A - -
manufacture of polymer burning Gefstoff V Annex IV No. 18
278-404-3
Monomethyltetrachlorodiphenylmethan Residual monomer in Aquatic Acute 1
102 76253-60-6 287-477-0 P P A - - REACH ANNEX XVII
e manufacture of polymer Aquatic Chronic 1
287-476-5
Repr. 1B
REACH SVHC
103 Methoxy acetic acid 625-45-6 210-894-6 D - B 0.01% Organic synthesis material Acute Tox. 4 *
Reg. (EC) No 1272/2008
Skin Corr. 1B
2-methoxy-1-propanol acetate Flam. Liq. 3

104 (2-methoxypropyl acetate ; 70657-70-4 274-724-2 D - B 0.01% Repr. 1B Reg. (EC) No 1272/2008
propyleneglycol methylether acetate) STOT SE 3
210
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 2
Reg. (EC) No 1272/2008
Dye material, synthetic organic Acute Tox. 4 *
105 Naphthalene 91-20-3 202-049-5 D D A 0.01% Canadian Challenge
intermediate body Aquatic Acute 1
Batch 1
Aquatic Chronic 1

2-Naphthalenol, 1-[(4-methyl-2-
106 2425-85-6 219-372-2 D D A 0.01% Ink, paint, pigment, fabric Challenge). Environmental
nitrophenyl)azo]- (Pigment Red 3)
Protection Ac t, 1999 (CEPA,
1999).
202-080-4
232-443-2
272-185-8
285-510-3
265-066-7
271-267-0
265-042-6
265-067-2
295-431-6
309-945-6
265-041-0
295-433-7
265-185-4
265-178-6
295-434-2 Paint for fabric and leather,
285-511-9 oxidation inhibitor in lubricating Carc. 1A
2-Naphthylamine and its salts, REACH ANNEX XVII
107 2-Naphthylamine 91-59-8 265-150-3 P - B 0.1% 0.001% oil,impurities in rubber/latex Acute Tox. 4 *
265-151-9 and plastic,oxidation inhibitor Aquatic Chronic 2
265-073-5 intermediate, dye
295-440-5
265-068-8
265-056-2
295-441-0
270-993-5
265-071-4
265-046-8
295-447-3
295-442-6
272-206-0
265-086-6
265-089-2
309-976-5
272-186-3
232-443-2
272-185-8
285-510-3
265-066-7
271-267-0
265-042-6
265-067-2
295-431-6
309-945-6
265-041-0
295-433-7
265-185-4
265-178-6
295-434-2
285-511-9
265-150-3
2-Naphthylamine and its salts,
107 2-Naphthylammoniumacetat 553-00-4 265-151-9 P P A 0.1% 0.001% NG REACH ANNEX XVII
all members
265-073-5
295-440-5
265-068-8
265-056-2
295-441-0
270-993-5
265-071-4
265-046-8
295-447-3
295-442-6
272-206-0
265-086-6
265-089-2
309-976-5
272-186-3
209-030-0
211
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
Welding electrodes, flame
Nickel and its compounds, Skin Sens. 1 Reg. (EC) No 552/2009
108 Chromium nickel oxide (Cr2NiO4) 12018-18-7 234-636-7 P D B 0.1% 0.01% spraying, special materials,
all members Aquatic Acute 1 REACH Annex XVII
component in metals
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, (2-Ethylhexanoato-O)(isodecanoato- STOT RE 1 See 1st line of "Nickel and its
108 84852-39-1 284-351-7 D D A 0.01%
all members O)nickel Resp. Sens. 1 compounds, all members"
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, (2-Ethylhexanoato-O)(isononanoato- STOT RE 1 See 1st line of "Nickel and its
108 85508-45-8 287-470-2 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Nickel and its compounds, (2-Ethylhexanoato-O)(isooctanoato- See 1st line of "Nickel and its
108 84852-38-0 284-350-1 D D A 0.01%
all members O)nickel compounds, all members"
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, (2-Ethylhexanoato-O)(neodecanoato- STOT RE 1 See 1st line of "Nickel and its
108 85135-77-9 285-698-7 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, (Isodecanoato-O)(isononanoato- STOT RE 1 See 1st line of "Nickel and its
108 84852-36-8 284-348-0 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, (Isodecanoato-O)(isooctanoato- STOT RE 1 See 1st line of "Nickel and its
108 85166-19-4 285-909-2 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Nickel and its compounds, (Isodecanoato-O)(neodecanoato- See 1st line of "Nickel and its
108 85508-42-5 287-467-6 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, (Isononanoato-O)(isooctanoato- STOT RE 1 See 1st line of "Nickel and its
108 85508-46-9 287-471-8 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
212
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, (Isononanoato-O)(neodecanoato- STOT RE 1 See 1st line of "Nickel and its
108 85551-28-6 287-592-6 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, (Isooctanoato-O)(neodecanoato- STOT RE 1 See 1st line of "Nickel and its
108 84852-35-7 284-347-5 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Nickel and its compounds, (Neononanoato-O)(neoundecanoato- See 1st line of "Nickel and its
108 93920-08-2 300-092-5 D D A 0.01%
[.mu.-[[1,1',1'',1'''-[Benzene-1,2,4,5-
Nickel and its compounds, See 1st line of "Nickel and its
108 tetrayltetrakis(nitromethylidyne)]naphth- 22484-07-7 245-028-6 D D A 0.01%
2-olato](4-)]]dinickel
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Nickel and its compounds, [.mu.-[Carbonato(2-)- See 1st line of "Nickel and its
108 65405-96-1 265-748-4 D D A 0.01% Acute Tox. 4 *
all members O:O']]dihydroxydinickel compounds, all members"
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
[[2,2'-(4,8-Dichlorobenzo[1,2-d:4,5-
108 d']bisoxazole-2,6-diyl)bis[4,6- 47726-62-5 256-331-8 D D A 0.01%
dichlorophenolato]](2-)]nickel
Nickel and its compounds, [[2,2'-Thiobis[3-octylphenolato]](2-)- See 1st line of "Nickel and its
108 33882-09-6 251-715-1 D D A 0.01%
all members O,O',S]nickel compounds, all members"
[[N,N',N'',N'''-[29H,31H-
Phthalocyaninetetrayltetrakis(sulphonyli
108 mino-3,1-phenylene)]tetrakis[3- 97404-22-3 306-785-9 D D A 0.01%
oxobutyramidato]](2-)-
N29,N30,N31,N32]nickel
[[N,N',N''-[29H,31H-
Phthalocyaninetriyltris(sulphonylimino-
108 3,1-phenylene)]tris[3- 97404-21-2 306-784-3 D D A 0.01%
oxobutyramidato]](2-)-
1,2,3-Propanetricarboxylic acid, 2-
108 hydroxy-, ammonium nickel(2+) salt 68025-13-8 268-176-3 D D A 0.01%
(2:2:1)
Nickel and its compounds, 1,2,3-Propanetriol, 1-(dihydrogen See 1st line of "Nickel and its
108 68391-37-7 269-946-1 D D A 0.01%
all members phosphate), nickel(2+) salt (1:1) compounds, all members"
Nickel and its compounds, 1,2,3-Propanetriol, mono(dihydrogen See 1st line of "Nickel and its
108 67952-69-6 267-923-0 D D A 0.01%
all members phosphate), nickel(2+) salt (1:1) compounds, all members"
213
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Nickel and its compounds, 1,2-Benzenedicarboxylic acid, 3,4,5,6- See 1st line of "Nickel and its
108 18824-79-8 D D A 0.01%
all members tetrabromo-, nickel(2+) salt (1:1) compounds, all members"
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, 2,7-Naphthalenedisulfonic acid, STOT RE 1 See 1st line of "Nickel and its
108 72319-19-8 D D A 0.01%
all members nickel(2+) salt (1:1) Resp. Sens. 1 compounds, all members"
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, STOT RE 1 See 1st line of "Nickel and its
108 2-Ethylhexanoic acid, nickel salt 7580-31-6 231-480-1 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Acetic acid, nickel(2+) salt, polymer

108 with formaldehyde and 4-(1,1,3,3- 71050-57-2 D D A 0.01%
tetramethylbutyl)phenol
Carc. 1A
108 Aluminum nickel oxide (Al2NiO4) 12004-35-2 234-454-8 D D A 0.01% STOT RE 1
Skin Sens. 1
108 Aluminum, compound with nickel (1:1) 12003-78-0 234-439-6 D D A 0.01%
Nickel and its compounds, Aluminum, triethyl-, reaction products See 1st line of "Nickel and its
108 79357-65-6 D D A 0.01%
all members with nickel(2+) bis(2-ethylhexanoate) compounds, all members"
Antimony oxide (Sb2O3), solid solution Acute Tox. 4 *

108 with nickel oxide (NiO) and titanium 73892-02-1 277-627-3 D D A 0.01% Acute Tox. 4 *
oxide (TiO2) Aquatic Chronic 2
108 Antimony, compound with nickel (1:1) 12035-52-8 234-827-5 D D A 0.01%
108 Antimony, compound with nickel (1:3) 12503-49-0 235-676-8 D D A 0.01%
Benzenepropanoic acid, 3,5-bis(1,1-

108 dimethylethyl)-4-hydroxy-, nickel(2+) 55868-93-4 D D A 0.01%
salt (2:1)
Carc. 1A
Muta. 2
Repr. 1B
Benzoic acid, 3,5-bis(1,1-
108 dimethylethyl)-4-hydroxy-, nickel(2+) 52625-25-9 258-051-1 D D A 0.01%
salt (2:1)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Nickel and its compounds, Bis(1,1,1,5,5,5-hexafluoropentane-2,4- See 1st line of "Nickel and its
108 14949-69-0 239-028-5 D D A 0.01%
all members dionato-O,O')nickel compounds, all members"
108 Bis(1,5-cyclooctadiene)nickel 1295-35-8 215-072-0 D D A 0.01%
214
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Nickel and its compounds, Bis(1H-1,2,4-triazole-3-sulphonato- See 1st line of "Nickel and its
108 85586-46-5 287-849-2 D D A 0.01%
all members N2,O3)nickel compounds, all members"
108 Bis(1-nitroso-2-naphtholato)nickel 12794-26-2 235-829-9 D D A 0.01%
Bis(4-benzoyl-2,4-dihydro-5-methyl-2-
phenyl-3H-pyrazol-3-onato-
108 O,O')(2,2,4,4-tetramethyl-7-oxa-3,20- 79121-51-0 279-067-5 D D A 0.01%
diazadispiro[5.1.11.2]henicosan-21-
one-O21)nickel
Nickel and its compounds, Bis(4-benzoyl-2,4-dihydro-5-methyl-2- See 1st line of "Nickel and its
108 69524-96-5 274-027-3 D D A 0.01%
all members phenyl-3H-pyrazol-3-onato-O,O')nickel compounds, all members"
108 Bis(5-oxo-DL-prolinato-N1,O2)nickel 85026-81-9 285-069-7 D D A 0.01%
108 Bis(5-oxo-L-prolinato-N1,O2)nickel 70824-02-1 274-912-4 D D A 0.01%
108 Bis(butanedione dioximato)nickel 13478-93-8 236-782-7 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Bis(D-gluconato-O1,O2)nickel 71957-07-8 276-205-6 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Bis(diethyldithiocarbamato-S,S')nickel 52610-81-8 258-044-3 D D A 0.01%
108 Bis(quinolin-8-olato-N1,O8)nickel 14100-15-3 237-950-2 D D A 0.01%
Nickel and its compounds, Bis[(2-hydroxyethyl)dithiocarbamato- See 1st line of "Nickel and its
108 52486-98-3 257-953-2 D D A 0.01%
all members S,S']nickel compounds, all members"
Nickel and its compounds, Bis[2-hydroxy-4- See 1st line of "Nickel and its
108 15843-91-1 239-949-2 D D A 0.01%
all members (octyloxy)benzophenonato]nickel compounds, all members"
Nickel and its compounds, Bis[bis(2-hydroxyethyl)dithiocarbamato- See 1st line of "Nickel and its
108 52486-99-4 257-954-8 D D A 0.01%
all members S,S']nickel compounds, all members"
Bis[di(3,5,5-
108 trimethylhexyl)dithiocarbamato- 84604-95-5 283-380-2 D D A 0.01%
S,S']nickel
Bis[N-(2,4-dimethoxyphenyl)-2,3-
108 bis(hydroxyimino)butyramidato- 85269-39-2 286-563-5 D D A 0.01%
N2,N3]nickel
Nickel and its compounds, Bis[N-(2-hydroxyethyl)-N- See 1st line of "Nickel and its
108 76625-10-0 278-504-7 D D A 0.01%
all members methylglycinato-N,O,on]nickel compounds, all members"
215
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
108 Bismuth, compound with nickel (1:1) 12688-64-1 235-773-5 D D A 0.01%
Nickel and its compounds, Butanedioic acid, 2,3-dihydroxy- [R- See 1st line of "Nickel and its
108 67952-41-4 267-894-4 D D A 0.01%
all members (R*,R*)]-, nickel(2+) salt (2:1) compounds, all members"
108 C.I. Reactive green 12 72152-45-5 276-399-2 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
108 Carbonic acid, nickel salt 16337-84-1 240-408-8 D D A 0.01% Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Carbonic acid, nickel(2+) salt (2:1) 17237-93-3 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Chloric acid, nickel(2+) salt 67952-43-6 267-897-0 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Citric acid , ammonium nickel salt 18283-82-4 242-161-1 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Copper(2+), bis(1,2-ethanediamine-
108 N,N')-, (SP-4-1)-tetrakis(cyano- 63427-32-7 264-136-4 D D A 0.01%
C)nickelate(2-) (1:1)
Nickel and its compounds, Copper, compound with lanthanum and See 1st line of "Nickel and its
108 51912-52-8 257-510-3 D D A 0.01%
all members nickel (4:1:1) compounds, all members"
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, Cyclohexanebutanoic acid, nickel(2+) STOT RE 1 See 1st line of "Nickel and its
108 3906-55-6 223-463-2 D D A 0.01%
all members salt Resp. Sens. 1 compounds, all members"
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Diammonium tetrachloronickelate(2-) 99587-11-8 308-989-3 D D A 0.01%
108 Diiron nickel tetraoxide 12168-54-6 235-335-3 D D A 0.01%
216
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
108 Diiron nickel zinc tetraoxide 97435-21-7 306-902-3 D D A 0.01%
Dimethoxy[29H,31H-
108 phthalocyaninato(2-)- 83898-70-8 281-282-4 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Dimethylhexanoic acid, nickel salt 93983-68-7 301-323-2 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Dinickel orthosilicate 13775-54-7 237-411-1 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
Nickel and its compounds, Resp. Sens. 1 See 1st line of "Nickel and its
108 Diphosphoric acid, nickel(2+) salt 19372-20-4 D D A 0.01%
all members Skin Sens. 1 compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Diphosphoric acid, nickel(2+) salt (1:2) 14448-18-1 238-426-6 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
108 Dipotassium tetrafluoronickelate(2-) 13859-60-4 237-595-3 D D A 0.01%
108 Dipotassium tris(cyano-c)nickelate(2-) 39049-81-5 254-261-2 D D A 0.01%
Nickel and its compounds, Dysprosium, compound with nickel See 1st line of "Nickel and its
108 12175-27-8 235-341-6 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Ethyl hydrogen sulphate, nickel(2+) salt 71720-48-4 275-897-7 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
Nickel and its compounds, Fatty acids, C6-19-branched, nickel STOT RE 1 See 1st line of "Nickel and its
108 91697-41-5 294-302-1 D D A 0.01%
all members salts Resp. Sens. 1 compounds, all members"
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
217
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1A
Muta. 2
Repr. 1B
Fatty acids, C8-18 and C18-
108 unsaturated, 84776-45-4 283-972-0 D D A 0.01%
nickel salts
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Nickel and its compounds, Hexaamminenickel(2+) See 1st line of "Nickel and its
108 13877-20-8 237-638-6 D D A 0.01%
all members bis[tetrafluoroborate(1-)] compounds, all members"
Carc. 1A
Muta. 2
Repr. 1B
108 Hexanoic acid, 2-ethyl-, nickel(2+) salt 4454-16-4 224-699-9 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Iron alloy, base,(Fe.Ni)(ferronickel) 11133-76-9 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Isononanoic acid, nickel(2+) salt 84852-37-9 284-349-6 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Lanthanum, compound with nickel (1:5) 12196-72-4 235-372-5 D D A 0.01%
Leach residues, nickel-vanadium ore -

Residues from basic leaching of nickel-
bearing vanadium ores. Composed
108 primarily of silica and insoluble 84144-92-3 282-214-6 D D A 0.01%
compounds of nickel and vanadium
with minor quantities of other metals,
such as arsenic, lead, tin and zinc.
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
Carc. 1A
Nickel and its compounds, 235-008-5 See 1st line of "Nickel and its
108 Lithium nickel oxide (LiNiO2) 12031-65-1 D D A 0.01% STOT RE 1
Skin Sens. 1
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
Carc. 1A
108 Molybdenum nickel oxide 12673-58-4 D D A 0.01% STOT RE 1
Skin Sens. 1
108 Naphthenic acids, nickel salts 61788-71-4 263-000-1 D D A 0.01%
218
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1A
Muta. 2
Repr. 1B
108 Neodecanoic acid, nickel salt 51818-56-5 257-447-1 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 2
108 Nickel 7440-02-0 231-111-4 D D A 0.01% STOT RE 1
Skin Sens. 1
108 Nickel [R(R*,R*)]-tartrate 52022-10-3 257-610-7 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Nickel and its compounds, Acute Tox. 4 * See 1st line of "Nickel and its
108 Nickel acetate 14998-37-9 239-086-1 D D A 0.01%
all members Acute Tox. 4 * compounds, all members"
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Nickel acetate tetrahydrate 6018-89-9 D D A 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
108 Nickel acrylate 51222-18-5 257-066-0 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
108 Nickel ammonium sulfate 15699-18-0 239-793-2 D D A 0.01%
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Nickel and its compounds, C.I. Pigment Yellow 157 ( Nickel See 1st line of "Nickel and its
108 68610-24-2 271-853-6 D D A 0.01% STOT RE 1
all members barium titanium priderite) compounds, all members"
Skin Sens. 1
219
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel bis(benzenesulphonate) 39819-65-3 254-642-3 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel bis(dihydrogen phosphate) 18718-11-1 242-522-3 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel bis(phosphinate) 14507-36-9 238-511-8 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel bis(piperidine-1-carbodithioate) 41476-75-9 255-387-0 D D A 0.01%
Carc. 1A
STOT RE 1
108 Nickel bisphosphinate 36026-88-7 252-840-4 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel boride 12619-90-8 235-723-2 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel boride (Ni2B) 12007-01-1 234-494-6 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel boride (Ni3B) 12007-02-2 234-495-1 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel boride (NiB) 12007-00-0 234-493-0 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel bromide (NiBr2) 13462-88-9 236-665-0 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
220
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
108 Nickel bromide (NiBr2), trihydrate 7789-49-3 D D A 0.01%
108 Nickel carbide 12710-36-0 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
108 Nickel carbonate 3333-67-3 222-068-2 D D A 0.01% Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel carbonyl 12612-55-4 236-669-2 D D A 0.01%
Flam. Liq. 2
Carc. 2
Nickel and its compounds, Repr. 1B See 1st line of "Nickel and its
108 Nickel carbonyl 13463-39-3 236-669-2 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel chloride 37211-05-5 231-743-0 D D A 0.01%
Carc. 1A
STOT RE 1
108 Nickel cyanide 557-19-7 209-160-8 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel dibenzoate 553-71-9 209-046-8 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel dibromate 14550-87-9 238-596-1 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
221
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Nickel dihydroxide hydrate 36897-37-7 D D A 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
108 Nickel dimethyldithiocarbamate 15521-65-0 239-560-8 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
108 Nickel dipotassium bis(sulphate) 13842-46-1 237-563-9 D D A 0.01%
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel dithiocyanate 13689-92-4 237-205-1 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel fluoride (NiF2) 10028-18-9 233-071-3 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel fluoride (NiF2), tetrahydrate 13940-83-5 D D A 0.01%
Carc. 1A
STOT RE 1
108 Nickel hydrogen phosphate 14332-34-4 238-278-2 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
108 Nickel hydroxide 11113-74-9 234-348-1 D D A 0.01% Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
222
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1A
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
108 Nickel hydroxide 12054-48-7 235-008-5 D D A 0.01% Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel hydroxide 12125-56-3 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel isooctanoate 27637-46-3 248-585-3 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel methacrylate 94275-78-2 304-466-9 D D A 0.01%
Ox. Sol. 2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
108 Nickel nitrate 14216-75-2 238-076-4 D D A 0.01% Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Ox. Sol. 2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
108 Nickel nitrate (2+ salt) 13138-45-9 236-068-5 D D A 0.01% Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
108 Nickel oxide 11099-02-8 234-323-5 D D A 0.01%
Aquatic Chronic 4
Carc. 1A
108 Nickel oxide 1313-99-1 215-215-7 D D A 0.01%
Aquatic Chronic 4
223
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1A
108 Nickel oxide (Ni2O3) 1314-06-3 215-217-8 D D A 0.01%
Aquatic Chronic 4
Carc. 1A
108 Nickel oxide (NiO2) 12035-36-8 234-823-3 D D A 0.01%
Aquatic Chronic 4
Carc. 1A
STOT RE 1
108 Nickel phosphide (Ni2P) 12035-64-2 234-828-0 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel potassium cyanide 14220-17-8 238-082-7 D D A 0.01%
Carc. 1A
STOT RE 1
108 Nickel silicide (Ni2Si) 12059-14-2 235-033-1 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel silicide (NiSi) 12035-57-3 D D A 0.01%
Carc. 1A
STOT RE 1
108 Nickel silicide (NiSi2) 12201-89-7 235-379-3 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
108 Nickel subsulfide 12035-72-2 234-829-6 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
108 Nickel sulfate 7786-81-4 232-104-9 D D A 0.01% Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel sulfide (Ni2S3) 12259-56-2 D D A 0.01%
Carc. 1A
Muta. 2
108 Nickel sulfide (NiS) 16812-54-7 240-841-2 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
224
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1A
STOT RE 1
108 Nickel telluride 12142-88-0 235-260-6 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
108 Nickel tin trioxide 12035-38-0 234-824-9 D D A 0.01% STOT RE 1
Skin Sens. 1
Carc. 1A
108 Nickel titanium oxide 12035-39-1 234-825-4 D D A 0.01% STOT RE 1
Skin Sens. 1
Carc. 1A
108 Nickel titanium oxide 12653-76-8 235-752-0 D D A 0.01% STOT RE 1
Skin Sens. 1
Nickel and its compounds, Nickel titanium tungsten oxide See 1st line of "Nickel and its
108 69011-05-8 273-686-4 D D A 0.01%
all members (NiTi20W2O47) compounds, all members"
Carc. 1A
108 Nickel uranium oxide (NiU3O10) 15780-33-3 239-876-6 D - B 0.01% STOT RE 1
Skin Sens. 1
Nickel and its compounds, Nickel uranyl tetraacetate, See 1st line of "Nickel and its
108 71767-12-9 275-994-4 D - B 0.01%
all members of uranium depleted in uranium-235 compounds, all members"
Carc. 1A
108 Nickel vanadium oxide (NiV2O6) 52502-12-2 257-970-5 D D A 0.01% STOT RE 1
Skin Sens. 1
Carc. 1A
108 Nickel zirconium oxide (NiZrO3) 70692-93-2 274-755-1 D D A 0.01% STOT RE 1
Skin Sens. 1
Nickel(1+), [1-(2-amino-4-imino-5(4H)-
Nickel and its compounds, thiazolylidene)-N-[1-(2-amino-4-imino- See 1st line of "Nickel and its
108 53199-85-2 D D A 0.01%
all members 5(4H)-thiazolylidene)-1H-isoindol-3-yl]- compounds, all members"
1H-isoindol-3-aminato]-, chloride
108 Nickel(2+) acrylate 60700-37-0 262-383-2 D D A 0.01%
108 Nickel(2+) methacrylate 52496-91-0 257-963-7 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(2+) neodecanoate 85508-44-7 287-469-7 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
225
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(2+) neononanoate 93920-10-6 300-094-6 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(2+) neoundecanoate 93920-09-3 300-093-0 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel(2+) oleate 13001-15-5 235-832-5 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(2+) palmitate 13654-40-5 237-138-8 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel(2+) silicate 21784-78-1 244-578-4 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel(2+) sulphite 7757-95-1 231-827-7 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(2+) trifluoroacetate 16083-14-0 240-235-8 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Nickel and its compounds, Nickel(2+), bis(1,2-ethanediamine- See 1st line of "Nickel and its
108 68958-89-4 273-379-5 D D A 0.01%
Nickel(2+), bis(1,2-ethanediamine-
108 N,N')-, salt with 71215-98-0 D D A 0.01%
dimethylbenzenesulfonic acid (1:2)
Nickel and its compounds, Nickel(2+), bis(1,2-propanediamine)-, See 1st line of "Nickel and its
108 18972-69-5 D D A 0.01%
all members bis[dicyanoaurate(1-)] compounds, all members"
Nickel and its compounds, Nickel(2+), bis(ethylenediamine)-, See 1st line of "Nickel and its
108 21264-77-7 244-300-1 D D A 0.01%
all members sulfate (1:1) compounds, all members"
226
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Nickel(2+), hexakis(1H-imidazole-N3)-,
108 (OC-6-11)-, 1,2-benzenedicarboxylate 108818-89-9 D D A 0.01%
(1:1)
Nickel(2+), tris(1,2-ethanediamine-
108 N,N')-, (OC-6-11)-, salt with 71215-97-9 D D A 0.01%
dimethylbenzenesulfonic acid (1:2)
Nickel(2+), tris(4,7-diphenyl-1,10-
108 phenanthroline-N1,N10)-, (OC-6-11)-, 68309-97-7 269-684-8 D D A 0.01%
bis[tetrafluoroborate(1-)]
Nickel(2+), tris(4,7-diphenyl-1,10-
108 phenanthroline-N1,N10)-, (OC-6-11)-, 38780-90-4 254-127-3 D D A 0.01%
dinitrate
Nickel and its compounds, Nickel(2++), hexaammine-, (OC-6-11)-, See 1st line of "Nickel and its
108 67806-76-2 D D A 0.01%
all members carbonate (1:1) compounds, all members"
Nickel and its compounds, Nickel(2++), hexaammine-, See 1st line of "Nickel and its
108 51467-07-3 D D A 0.01%
all members dihydroxide, (OC-6-11)- compounds, all members"
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
108 Nickel(II) acetate 373-02-4 206-761-7 D D A 0.01%
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
108 Nickel(II) chloride 7718-54-9 231-743-0 D D A 0.01% STOT RE 1
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Nickel(II) chloride hexahydrate (1:2:6) 7791-20-0 D D A 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
227
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(II) fluoborate 14708-14-6 238-753-4 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel(II) fumarate 6283-67-6 228-501-1 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(II) iodide 13462-90-3 236-666-6 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(II) isodecanoate 85508-43-6 287-468-1 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(II) isooctanoate 29317-63-3 249-555-2 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Nickel(II) nitrate, hexahydrate (1:2:6) 13478-00-7 D D A 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
228
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Nickel(II) sulfate hexahydrate (1:1:6) 10101-97-0 D D A 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
Nickel and its compounds, Nickel, (2-ethylhexanoato- See 1st line of "Nickel and its
108 70776-98-6 D D A 0.01%
all members O)(trifluoroacetato-O)- compounds, all members"
Nickel, (2-propanol)[[2,2'-thiobis[4-
108 (1,1,3,3-tetramethylbutyl)phenolato]](2- 67763-27-3 267-045-8 D D A 0.01%
)-O,O',S]-
Nickel and its compounds, Nickel, (carbonato(2-))tetrahydroxytri-, See 1st line of "Nickel and its
108 39430-27-8 D D A 0.01%
all members tetrahydrate compounds, all members"
Nickel and its compounds, Nickel, [(2-amino-2- See 1st line of "Nickel and its
108 68133-84-6 268-711-0 D D A 0.01%
all members oxoethoxy)acetato(2-)]- compounds, all members"
Nickel, [.mu.-(piperazine-N1:N4)]bis[3-
Nickel and its compounds, [1-[(4,5,6,7-tetrachloro-1-oxo-1H- See 1st line of "Nickel and its
108 71889-22-0 276-168-6 D D A 0.01%
all members isoindol-3-yl)hydrazono]ethyl]- compounds, all members"
2,4(1H,3H)-quinolinedionato(2-)]di-
Nickel, [[1,1'-[1,2-
Nickel and its compounds, phenylenebis(nitrilomethylidyne)]bis[2- See 1st line of "Nickel and its
108 20437-10-9 243-820-6 D D A 0.01%
all members naphthalenolato]](2-)-N,N',O,O']-, (SP- compounds, all members"
4-2)-
Nickel and its compounds, Nickel, [[2,2'- See 1st line of "Nickel and its
108 71215-73-1 D D A 0.01%
all members [methylenebis(thio)]bis[acetato]](2-)]- compounds, all members"
Nickel, [[2,2'-sulfonylbis[4-(1,1,3,3-
108 tetramethylbutyl)phenolato]](2-)- 16432-37-4 240-485-8 D D A 0.01%
O1,O1',O2]-
Nickel, [[2,2'-thiobis[4-(1,1,3,3-
108 tetramethylbutyl)phenolato]](2-)- 27574-34-1 248-536-6 D D A 0.01%
O,O',S]-
Nickel, [1,3-dihydro-5,6-bis[[(2-hydroxy-
Nickel and its compounds, 1-naphthalenyl)methylene]amino]-2H- See 1st line of "Nickel and its
108 42844-93-9 255-965-2 D D A 0.01%
all members benzimidazol-2-onato(2-)- compounds, all members"
N5,N6,O5,O6]-, (SP-4-2)-
Nickel and its compounds, Nickel, [29H,31H-phthalocyaninato(2-)- See 1st line of "Nickel and its
108 14055-02-8 237-893-3 D D A 0.01%
all members N29,N30,N31,N32]-, (SP-4-1)- compounds, all members"
229
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Nickel, [29H,31H-phthalocyaninato(2-)-
N29,N30,N31,N32]-, [[3-[(5-chloro-2,6-
108 difluoro-4- 90459-35-1 291-678-9 D D A 0.01%
pyrimidinyl)amino]phenyl]amino]sulfony
l sulfo derivitives, sodium salts
Nickel, [29H,31H-phthalocyaninato(2-)-
N29,N30,N31,N32]-, chlorosulfonyl
Nickel and its compounds, derivitives, reaction products with 2-[(4- See 1st line of "Nickel and its
108 93573-17-2 297-551-4 D D A 0.01%
all members aminophenyl)sulfonyl]ethyl hydrogen compounds, all members"
sulfate monosodium salt, potassium
sodium salts, compounds with pyridine
Nickel, [29H,31H-phthalocyanine-
108 C,C,C,C-tetrasulfonyl tetrachloridato(2)- 28680-76-4 249-155-8 D D A 0.01%
N29,N30,N31,N32]-
Nickel, [2-hydroxybenzoic acid [3-[1-

Nickel and its compounds, cyano-2-(methylamino)-2- See 1st line of "Nickel and its
108 85958-80-1 288-967-7 D D A 0.01%
all members oxoethylidene]-2,3-dihydro-1H-isoindol- compounds, all members"
1-ylidene]hydrazidato(2-)]-
Nickel and its compounds, Nickel, [carbonato(2- See 1st line of "Nickel and its
108 12334-31-5 D D A 0.01%
all members )]hexahydroxytetra- compounds, all members"
Nickel, [N-(4-chlorophenyl)-2-[3-[[[1-(4-
108 oxo-1H-pyrazol-4- 71889-20-8 D D A 0.01%
yl]methylene]hydrazino]-1H-isoindol-1-
ylidene]-2-cyanoacetamidato(2-)]-
Nickel and its compounds, Nickel, [N-(carboxymethyl)glycinato(2-)- See 1st line of "Nickel and its
108 13869-33-5 237-618-7 D D A 0.01%
all members N,O,ON]- compounds, all members"
Nickel, [N,N',N'',N'''-tetrakis[4-(4,5-
dihydro-3-methyl-5-oxo-1H-pyrazol-1-
108 yl)phenyl]-29H,31H-phthalocyanine- 72986-45-9 277-174-1 D D A 0.01%
C,C,C,C-tetrasulfonamidato(2-)-
N29,N30,N31,N32]-
Nickel, [N,N',N''-tris[4-(4,5-dihydro-3-
Nickel and its compounds, methyl-5-oxo-1H-pyrazol-1-yl)phenyl]- See 1st line of "Nickel and its
108 72252-57-4 D D A 0.01%
all members 29H,31H-phthalocyanine-C,C,C- compounds, all members"
trisulfonamidato(2-)-N29,N30,N31,N32]-
Nickel and its compounds, Nickel, 2,2'-thiobis[4-nonylphenol] See 1st line of "Nickel and its
108 85480-75-7 287-356-2 D D A 0.01%
all members complexes compounds, all members"
Nickel, acetate carbonate C8-10-

108 branched fatty acids C9-11-neofatty 90459-30-6 291-673-1 D D A 0.01%
acids complexes
Nickel and its compounds, Nickel, acetylacetone 6-methyl-2,4- See 1st line of "Nickel and its
108 90459-34-0 291-677-3 D D A 0.01%
all members heptanedione complexes compounds, all members"
Nickel and its compounds, Nickel, aqua[2-[(4,5-dihydro-3-methyl-5- See 1st line of "Nickel and its
108 106316-55-6 D D A 0.01%
all members oxo-1H-pyrazol-4-yl)azo]benzoato(2-)]- compounds, all members"
Nickel and its compounds, Nickel, bis(2,4-pentanedionato-O,O')-, See 1st line of "Nickel and its
108 3264-82-2 221-875-7 D D A 0.01%
all members (SP-4-1)- compounds, all members"
230
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Nickel and its compounds, Nickel, bis(2-heptadecyl-1H-imidazole- See 1st line of "Nickel and its
108 68912-08-3 272-799-6 D D A 0.01%
all members N3)bis(octanoato-O)- compounds, all members"
Nickel and its compounds, Nickel, bis(3-amino-4,5,6,7-tetrachloro- See 1st line of "Nickel and its
108 70833-37-3 274-916-6 D D A 0.01%
all members 1H-isoindol-1-one oximato-N2,O1)- compounds, all members"
Nickel and its compounds, Nickel, bis(dibutylcarbamodithioato- See 1st line of "Nickel and its
108 13927-77-0 237-696-2 D D A 0.01%
all members S,S')-, (SP-4-1)- compounds, all members"
Nickel and its compounds, Nickel, bis(diethylcarbamodithioato- See 1st line of "Nickel and its
108 14267-17-5 238-157-4 D D A 0.01%
Nickel and its compounds, Nickel, bis(diisononylcarbamodithioato- See 1st line of "Nickel and its
108 85298-61-9 D D A 0.01%
all members ,')- compounds, all members"
Nickel and its compounds, Nickel, bis(dipentylcarbamodithioato- See 1st line of "Nickel and its
108 36259-37-7 252-937-1 D D A 0.01%
Nickel and its compounds, Nickel, bis(phenyldiazenecarbothioic See 1st line of "Nickel and its
108 36545-21-8 D D A 0.01%
all members acid 2-phenylhydrazidato)- compounds, all members"
Nickel and its compounds, Nickel, bis[(2-hydroxy-4- See 1st line of "Nickel and its
108 68189-15-1 D D A 0.01%
all members octylphenyl)phenylmethanonato-O,O']- compounds, all members"
Nickel and its compounds, Nickel, bis[(cyano-C)triphenylborato(1- See 1st line of "Nickel and its
108 83864-02-2 D D A 0.01%
all members )-N]bis(hexanedinitrile-N,N')- compounds, all members"
Nickel and its compounds, Nickel, bis[[didecyl (1,2-dicyano-1,2- See 1st line of "Nickel and its
108 77245-35-3 D D A 0.01%
all members ethenediyl)bis[carbamato]](2-)]- compounds, all members"
Nickel, bis[1,2-bis(4-methoxyphenyl)-
108 1,2-ethenedithiolato(2-)-S,S']-, (SP-4- 38951-97-2 254-212-5 D D A 0.01%
1)-
Nickel and its compounds, Nickel, bis[1,2-diphenyl-1,2- See 1st line of "Nickel and its
108 28984-20-5 249-353-4 D D A 0.01%
all members ethenedithiolato(2-)-S,S']-, (SP-4-1)- compounds, all members"
Nickel and its compounds, Nickel, bis[1-[4-(diethylamino)phenyl]-2- See 1st line of "Nickel and its
108 51449-18-4 D D A 0.01%
all members phenyl-1,2-ethenedithiolato(2-)-S,S']- compounds, all members"
Nickel and its compounds, Nickel, bis[1-[4-(dimethylamino)phenyl]- See 1st line of "Nickel and its
108 38465-55-3 253-958-9 D D A 0.01%
all members 2-phenyl-1,2-ethenedithiolato(2-)-S,S']- compounds, all members"
Nickel and its compounds, Nickel, bis[2,3-bis(hydroxyimino)-N-(2- See 1st line of "Nickel and its
108 42739-61-7 255-924-9 D D A 0.01%
all members methoxyphenyl)butanamidato]- compounds, all members"
Nickel and its compounds, Nickel, bis[2,3-bis(hydroxyimino)-N- See 1st line of "Nickel and its
108 29204-84-0 249-503-9 D D A 0.01%
all members phenylbutanamidato-N2,N3]- compounds, all members"
Nickel, bis[2,4-dihydro-5-methyl-4-(1-
108 oxodecyl)-2-phenyl-3H-pyrazol-3-onato- 56557-00-7 260-258-7 D D A 0.01%
O,O']-
231
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Nickel and its compounds, Nickel, bis[2-butene-2,3-dithiolato(2-)- See 1st line of "Nickel and its
108 38951-94-9 254-210-4 D D A 0.01%
all members S,S']-, (SP-4-1)- compounds, all members"
Nickel and its compounds, Nickel, bis[3-[(4-chlorophenyl)azo]- See 1st line of "Nickel and its
108 51931-46-5 257-521-3 D D A 0.01%
all members 2,4(1H,3H)-quinolinedionato]- compounds, all members"
Nickel and its compounds, Nickel, bis[bis(2-methylpropyl) See 1st line of "Nickel and its
108 15317-78-9 239-354-8 D D A 0.01%
all members carbamodithioato-S,S']-, (SP-4-1)- compounds, all members"
Nickel, bis[N-hydroxy-3-(hydroxyimino)-
Nickel and its compounds, N'-(2- See 1st line of "Nickel and its
108 71605-83-9 D D A 0.01%
all members methoxyphenyl)butanimidamidato- compounds, all members"
N',N3]-
Nickel and its compounds, Nickel, borate C8-10-branched See 1st line of "Nickel and its
108 90459-31-7 291-674-7 D D A 0.01%
all members carboxylate complexes compounds, all members"
Nickel and its compounds, Nickel, borate neodecanoate See 1st line of "Nickel and its
108 92502-55-1 296-343-0 D D A 0.01%
Nickel,
108 C4-10 fatty acids naphthenate 93573-15-0 297-549-3 D D A 0.01%
complexes
Nickel and its compounds, Nickel, See 1st line of "Nickel and its
108 93573-16-1 297-550-9 D D A 0.01%
all members C4-10 fatty acids octanoate complexes compounds, all members"
Nickel and its compounds, Nickel, C5-23-branched carboxylate See 1st line of "Nickel and its
108 93762-59-5 297-774-7 D D A 0.01%
all members C4-10 fatty acids complexes compounds, all members"
Nickel, C5-23-branched carboxylate

108 C4-10-fatty acids naphthenate 93573-14-9 297-548-8 D D A 0.01%
complexes
108 92200-98-1 295-925-1 D D A 0.01%
all members naphthenate complexes compounds, all members"
108 92200-99-2 295-926-7 D D A 0.01%
all members naphthenate octanoate complexes compounds, all members"
Nickel and its compounds, Nickel, C5-C23-branched carboxylate See 1st line of "Nickel and its
108 90459-32-8 291-675-2 D D A 0.01%
all members octanoate complexes compounds, all members"
108 Nickel, compound with niobium (1:1) 12034-55-8 234-807-6 D D A 0.01%
108 Nickel, compound with tin (3:1) 12059-23-3 235-034-7 D D A 0.01%
108 Nickel, compound with zirconium (1:2) 12142-92-6 235-261-1 D D A 0.01%
Nickel and its compounds, Nickel, isodecanoate naphthenate See 1st line of "Nickel and its
108 85585-97-3 287-800-5 D D A 0.01%
Nickel and its compounds, Nickel, isononanoate naphthenate See 1st line of "Nickel and its
108 85585-98-4 287-801-0 D D A 0.01%
232
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Nickel and its compounds, Nickel, isooctanoate naphthenate See 1st line of "Nickel and its
108 90459-33-9 291-676-8 D D A 0.01%
Nickel and its compounds, Nickel, naphthenate neodecanoate See 1st line of "Nickel and its
108 85585-99-5 287-802-6 D D A 0.01%
Nickel and its compounds, Nickel, tetrakis(triphenyl phosphite-P)-, See 1st line of "Nickel and its
108 14221-00-2 D D A 0.01%
Nickel,[6,8,16,18-tetrachloro-1,11-bis(2-
furanylmethyl)-1,10,11, 20-
Nickel and its compounds, tetrahydrodibenzo[c,j]dipyrazolo[3,4- See 1st line of "Nickel and its
108 79745-01-0 D D A 0.01%
all members f:3',4'-m][1,2,5,8,9,12] compounds, all members"
hexaazacyclotetradecinato(2-)-
N5,N10,N15,N20]-
Nickelate(1-), [[N,N'-1,2-
ethanediylbis[N-
N,N',O,O',ON,ON']-, potassium, (OC-6-
21)-
Nickelate(1-), [3,4-bis[[(2-hydroxy-1-
108 naphthalenyl)methylene]amino]benzoat 61300-98-9 262-703-0 D D A 0.01%
o(3-)-N3,N4,O3,O4]-, hydrogen
Nickelate(1-), [N,N-
N,O,O',O'']-, hydrogen, (T-4)-
108 Nickelate(1-), trichloro-, ammonium 24640-21-9 246-378-2 D D A 0.01%
Nickelate(2-), [[N,N'-1,2-
ethanediylbis[N-
N,N',O,O',ON,ON']-, dihydrogen, (OC-
6-21)-
Nickelate(3-), [22-[[[3-[(5-chloro-2,6-
difluoro-4-
Nickel and its compounds, pyrimidinyl)amino]phenyl]amino]sulfony See 1st line of "Nickel and its
108 71243-96-4 D D A 0.01%
all members l]-29H,31H-phthalocyanine-1,8,15- 275-295-4 compounds, all members"
trisulfonato(5-)-N29,N30,N31,N32]-,
trisodium, (SP-4-2)-
Nickelate(3-), [5-[(4,5-dihydro-3-methyl-
108 hydroxy-3-[( 2-hydroxy-3-nitro-5- 79817-91-7 279-314-7 D D A 0.01%
sulfophenyl)azo]-2,7-
naphthalenedisulfonato(5-)]-, trisodium
Nickelate(3-), [C-[[[3-[(4-amino-6-
chloro-1,3,5-triazin-2-
Nickel and its compounds, yl)amino]phenyl]amino]sulfonyl]-C,C,C- See 1st line of "Nickel and its
108 72229-81-3 276-491-2 D D A 0.01%
all members tris(aminosulfonyl)-29H,31H- compounds, all members"
phthalocyanine-C,C,C-trisulfonato(5-)-
N29,N30,N31,N32]-, trisodium
triammonium, (T-4)-
233
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
tripotassium, (T-4)-
trisodium,(T-4)-
Nickelate(4-),
Nickel and its compounds, [[[nitrilotris(methylene)]tris[phosphonato See 1st line of "Nickel and its
108 63588-33-0 264-338-2 D D A 0.01%
all members ]](6-)-N,OP,OP',OP'']-, tetrapotassium, compounds, all members"
(T-4)-
Nickelate(4-),
[[[nitrilotris(methylene)]tris[phosphonato
108 ]](6-)-N,OP,OP',OP'']-, tetrasodium, (T- 68052-00-6 268-296-6 D D A 0.01%
4)-
Nickelate(4-),
Nickel and its compounds, [[[nitrilotris(methylene)]tris[phosphonato See 1st line of "Nickel and its
108 67968-22-3 267-961-8 D D A 0.01%
all members ]](6-)-N,OP,OP',OP'']-, triammonium compounds, all members"
hydrogen, (T-4)-
Nickelate(4-), [22-[[(4-
sulfophenyl)amino]sulfonyl]-29H,31H-
108 phthalocyanine-1,8,15-trisulfonato(6-)- 70729-79-2 D D A 0.01%
N29,N30,N31,N32]-, tetrahydrogen,
(SP-4-2)-
Nickelate(4-), [bis[[[3-[[4,5-dihydro-3-
methyl-5-oxo-1-[4-[[2-
Nickel and its compounds, (sulfooxy)ethyl]sulfonyl]phenyl]-1H- See 1st line of "Nickel and its
108 90459-36-2 291-679-4 D D A 0.01%
all members pyrazol-4-yl]azo]phenyl]amino]sulfonyl]- compounds, all members"
29H,31H-phthalocyaninedisulfonato(6-)-
N29,N30,N31,N32]-, sodium
Nickelate(6-), [4-[[5-[[(3,6-dichloro-4-
pyridazinyl)carbonyl]amino]-2-
sulfophenyl]azo]-4,5-dihydro-5-oxo-1-
Nickel and its compounds, Pneumonia, skin inflammation, See 1st line of "Nickel and its
108 [2-sulfo-5-[[(trisulfo-29H,31H- 93891-86-2 299-467-3 D D A 0.01% Alloy, plating
all members asthma, carcinogenic compounds, all members"
phthalocyaninyl)sulfonyl]amino]phenyl]-
1H-pyrazole-3-carboxylato(8-)-
N29,N30,N31,N32]-, hexasodium
Nickelate(6-), [4-[[5-[[(3,6-dichloro-4-
pyridazinyl)carbonyl]amino]-2-
sulfophenyl]azo]-4,5-dihydro-5-oxo-1-
Nickel and its compounds, [5-[[(trisulfo-29H,31H- See 1st line of "Nickel and its
108 68698-80-6 272-095-9 D D A 0.01%
all members phthalocyaninyl)sulfonyl]amino]-2- compounds, all members"
sulfophenyl]-1H-pyrazole-3-
carboxylato(8-)-N29,N30,N31,N32]-
,hexahydrogen
Nickelate(6-), [C-[[[3-[[4,5-dihydro-3-
methyl-5-oxo-1-[3-sulfo-4-[2-[2-sulfo-4-
[(2,5,6-trichloro-4-
Nickel and its compounds, pyrimidinyl)amino]phenyl]ethenyl]pheny See 1st line of "Nickel and its
108 72453-55-5 D D A 0.01%
all members l]-1H-pyrazol-4-yl]azo]-4- compounds, all members"
sulfophenyl]amino]sulfonyl]-29H,31H-
phthalocyanine-C,C,C-trisulfonato(8-)-
N29,N30,N31,N32]-,
234
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Nickelate(6-),[[[1,2-
Nickel and its compounds, ethanediylbis[nitrilobis(methylene)]]tetr See 1st line of "Nickel and its
108 68958-86-1 273-375-3 D D A 0.01%
all members akis[phosphonato]](8-)], compounds, all members"
pentaammonium hydrogen,(OC-6-21)-
108 68958-87-2 273-376-9 D D A 0.01%
all members akis[phosphonato]](8-)], compounds, all members"
pentapotassium hydrogen,(OC-6-21)-
108 68958-88-3 273-377-4 D D A 0.01%
all members akis[phosphonato]](8-)], pentasodium compounds, all members"
hydrogen,(OC-6-21)-
Nickelate(8-), bis[3-[(2-amino-8-
Nickel and its compounds, hydroxy-6-sulfo-1-naphthalenyl)azo]-2- See 1st line of "Nickel and its
108 72139-08-3 276-364-1 D D A 0.01%
all members hydroxy-5-sulfobenzoato(5-)]-, compounds, all members"
hexasodium dihydrogen
108 Nickelocene 1271-28-9 215-039-0 D D A 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Octadecanoic acid, nickel(2+) salt 2223-95-2 218-744-1 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
108 Octanoic acid, nickel(2+) salt 4995-91-9 225-656-7 D D A 0.01% Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Oxalic acid, nickel salt 20543-06-0 243-867-2 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Phosphonic acid, [[3,5-bis(1,1-

Nickel and its compounds, dimethylethyl)-4- See 1st line of "Nickel and its
108 30947-30-9 250-401-1 D D A 0.01%
all members hydroxyphenyl]methyl]-, monoethyl compounds, all members"
ester, nickel(2+) salt (2:1)
Carc. 1A
STOT RE 1
108 Phosphoric acid, calcium nickel salt 17169-61-8 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Phosphoric acid, nickel(2+) salt (2:3) 10381-36-9 233-844-5 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
235
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Potassium [N,N-
N,O,O',O'']nickelate(1-)
Carc. 1A
STOT RE 1
Nickel and its compounds, Silicic acid (H2SiO3), nickel(2+) salt See 1st line of "Nickel and its
108 31748-25-1 250-788-7 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Sulfamic acid, nickel(2+) salt (2:1) 13770-89-3 237-396-1 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Sulfuric acid, ammonium nickel(2+) salt 7785-20-8 D D A 0.01%
Sulfuric acid, nickel salt, reaction

108 products with sulfurized calcium 72162-32-4 D D A 0.01%
phenolate
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
235-008-5
Nickel and its compounds, Sulfuric acid, nickel(2+) salt (1:1), See 1st line of "Nickel and its
108 10101-98-1 236-068-5 D D A 0.01%
all members heptahydrate compounds, all members"
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
600-153-9
Sulfuric acid, nickel(2+) salt (1:1),

108 reaction products with nickel and nickel 68585-48-8 D D A 0.01%
oxide (NiO)
Carc. 1A
STOT RE 1
Nickel and its compounds, Telluric acid (H2TeO3), nickel(2+) salt Resp. Sens. 1 See 1st line of "Nickel and its
108 15851-52-2 239-967-0 D D A 0.01%
all members (1:1) Skin Sens. 1 compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
Nickel and its compounds, Telluric acid (H2TeO4), nickel(2+) salt Resp. Sens. 1 See 1st line of "Nickel and its
108 15852-21-8 239-974-9 D D A 0.01%
all members (1:1) Skin Sens. 1 compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Tetrahydrogen [[[(3-amino-4-
sulphophenyl)amino]sulphonyl]-
108 29H,31H- 79102-62-8 279-060-7 D D A 0.01%
phthalocyaninetrisulphonato(6-)-
N29,N30,N31,N32]nickelate(4-)
236
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Tetrasodium [[[(3-amino-4-
sulphophenyl)amino]sulphonyl]-
108 29H,31H- 93939-76-5 300-365-9 D D A 0.01%
phthalocyaninetrisulphonato(6-)-
Tetrasodium [bis[[[4-[[2-
(sulphooxy)ethyl]sulphonyl]phenyl]amin
108 o]sulphonyl]-29H,31H- 97280-68-7 306-462-2 D D A 0.01%
phthalocyaninedisulphonato(6)-
Nickel and its compounds, Titanate(2-), hexafluoro-, See 1st line of "Nickel and its
108 34109-80-3 D D A 0.01%
all members nickel(2+), (1:1), (OC-6-11)- compounds, all members"
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
Nickel and its compounds, Aluminiummagnesiumnickelsiliziumoxid 235-008-5 See 1st line of "Nickel and its
108 198831-12-8 D D A 0.01%
all members e 236-068-5 compounds, all members"
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
Acute Tox. 4 *
108 Antimony nickel titanium oxide yellow 8007-18-9 232-353-3 D D A 0.01% Acute Tox. 4 *
Aquatic Chronic 2
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Iron nickel zinc oxide 12645-50-0 D D A 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
Nickel and its compounds, methyl 3-chlorobenzothiophene-2- 235-008-5 See 1st line of "Nickel and its
108 14406-71-4 D D A 0.01%
all members carboxylate 236-068-5 compounds, all members"
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
Nickel and its compounds, 5,5-Azobis(2,4,6-pyrimidinetriol), nickel See 1st line of "Nickel and its
108 68511-62-6 270-944-8 D D A 0.01%
all members complex compounds, all members"
108 Chrome iron nickel black spinel 71631-15-7 275-738-1 D D A 0.01%
237
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
108 Nickel niobium titanium yellow rutile 68611-43-8 271-892-9 D D A 0.01%
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Nickel phosphate 14396-43-1 D D A 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
Carc. 1A
Muta. 2
108 Nickel sulfide 11113-75-0 234-349-7 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
Nickel and its compounds, Phosphoric acid,compounds,nickel(2+) 235-008-5 See 1st line of "Nickel and its
108 90053-13-7 D D A 0.01%
all members zinc salt (2:1:2) 236-068-5 compounds, all members"
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
Nickel and its compounds, Phosphoric acid,compounds,nickel(2+) 235-008-5 See 1st line of "Nickel and its
108 501953-51-1 D D A 0.01%
all members zinc salt (2:1:2) tetrahydrate 236-068-5 compounds, all members"
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
Carc. 1A
STOT RE 1
108 Nickel arsenide (NiAs) 27016-75-7 248-169-1 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel diarsenide 12068-61-0 235-103-1 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
238
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
108 Rammelsbergite (NiAs2) 1303-22-6 D D A 0.01%
Carc. 1A
STOT RE 1
108 Trinickel bis(arsenate) 13477-70-8 236-771-7 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
Nickel and its compounds, Aluminum boron cobalt lithium nickel 235-008-5 See 1st line of "Nickel and its
108 207803-51-8 D D A 0.01%
all members oxide 236-068-5 compounds, all members"
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Aluminum cobalt lithium nickel oxide 193214-24-3 D D A 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
Nickel and its compounds, Cassiterite, cobalt manganese nickel See 1st line of "Nickel and its
108 99749-23-2 309-018-6 D D A 0.01%
all members grey compounds, all members"
Carc. 1A
Nickel and its compounds, Cobalt molybdenum nickel oxide See 1st line of "Nickel and its
108 68016-03-5 268-169-5 D D A 0.01% STOT RE 1
all members (CoMo2NiO8) compounds, all members"
Skin Sens. 1
Carc. 1A
108 Cobalt nickel oxide (CoNiO2) 58591-45-0 261-346-8 D D A 0.01% STOT RE 1
Skin Sens. 1
Nickel and its compounds, Cobalt(2+) dinickel(2+) bis[2- See 1st line of "Nickel and its
108 94232-44-7 303-972-7 D D A 0.01%
all members hydroxypropane-1,2,3-tricarboxylate] compounds, all members"
Nickel and its compounds, Dicobalt(2+) nickel(2+) bis[2- See 1st line of "Nickel and its
108 94232-84-5 304-013-5 D D A 0.01%
all members hydroxypropane-1,2,3-tricarboxylate] compounds, all members"
108 Spinels, cobalt nickel zinc grey 95046-47-2 305-835-7 D D A 0.01%
[2,3'-Bis[[(2-
Nickel and its compounds, hydroxyphenyl)methylene]amino]but-2- See 1st line of "Nickel and its
108 64696-98-6 265-022-7 D - B 0.01%
all members enedinitrilato(2-)-N2,N3,O2,O3]nickel; compounds, all members"
C.I. Solvent Brown 53
239
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Nickel and its compounds, 1,2,3-Propanetricarboxylic acid, 2- See 1st line of "Nickel and its
108 6018-92-4 227-873-2 D - B 0.01%
all members hydroxy-, nickel(2+) salt (2:3) compounds, all members"
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Cobalt lithium manganese nickel oxide 182442-95-1 D - B 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Cobalt lithium manganese nickel oxide 346417-97-8 D - B 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
Carc. 1A
Muta. 2
Repr. 1B
108 Citric acid, nickel salt 22605-92-1 245-119-0 D - B 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Nickel and its compounds, Di-.mu.-carbonylbis(.eta.5-2,4- See 1st line of "Nickel and its
108 12170-92-2 235-339-5 D - B 0.01%
all members cyclopentadien-1-yl)dinickel compounds, all members"
Carc. 1A
STOT RE 1
108 Dinickel hexacyanoferrate 14874-78-3 238-946-3 D - B 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Ethanedioic acid, nickel(2+) salt (1:1) 547-67-1 208-933-7 D - B 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Formic acid, copper nickel salt 68134-59-8 268-755-0 D - B 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
240
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1A
Muta. 2
Repr. 1B
108 Formic acid, nickel(2+) salt 3349-06-2 222-101-0 D - B 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
108 Molybdenum nickel oxide (MoNiO4) 14177-55-0 238-034-5 D - B 0.01% STOT RE 1
Skin Sens. 1
108 Nickel alloy, base , Ni,Al 12635-29-9 D - B 0.01%
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel formate 15843-02-4 239-946-6 D - B 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
108 Nickel tungsten oxide (NiWO4) 14177-51-6 238-032-4 D - B 0.01% STOT RE 1
Skin Sens. 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(2+) hydrogen citrate 18721-51-2 242-533-3 D - B 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(2+) propionate 3349-08-4 222-102-6 D - B 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Nickel and its compounds, Nickel(2+), hexaammine-, (OC-6-11)-, See 1st line of "Nickel and its
108 68758-60-1 D - B 0.01%
all members diformate compounds, all members"
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel(II) fluosilicate 26043-11-8 247-430-7 D - B 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
108 Nickel, dichlorobis(triphenylphosphine)- 14264-16-5 238-154-8 D - B 0.01%
Nickel and its compounds, Nickel, tetrakis[tris(methylphenyl) See 1st line of "Nickel and its
108 35884-66-3 252-777-2 D - B 0.01%
all members phosphite-P]- compounds, all members"
241
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Nickel and its compounds, Nickelate(2-), tetrakis(cyano-C)-, See 1st line of "Nickel and its
108 14038-85-8 D - B 0.01%
all members disodium, (SP-4-1)- compounds, all members"
108 Tetrakis(trifluorophosphine)nickel 13859-65-9 237-597-4 D - B 0.01%
Nickel and its compounds, Zirconate(2-), hexafluoro-, See 1st line of "Nickel and its
108 30868-55-4 D - B 0.01%
all members nickel(2+) (1:1), (OC-6-11)- compounds, all members"
Nickel and its compounds, Zirconium alloy, base, Zr 40-82, Ni 18- See 1st line of "Nickel and its
108 42612-06-6 D - B 0.01%
all members 60 compounds, all members"
Carc. 1A
Muta. 2
Repr. 1B
108 Nickel selenate 15060-62-5 239-125-2 D D A 0.01%
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel selenide 1314-05-2 215-216-2 D D A 0.01% Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1A
STOT RE 1
108 Nickel(2+) selenite 10101-96-9 233-263-7 D D A 0.01%
Aquatic Acute 1
Aquatic Chronic 1
235-715-9
222-068-2
240-841-2
206-761-7
231-743-0
233-071-3
108 Nickel nitrite 17861-62-0 D D A 0.01%
231-111-4
215-215-7
237-396-1
232-104-9
234-349-7
234-829-6
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
108 Nickel perchlorate 13637-71-3 237-124-1 D D A 0.01% Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Nickel and its compounds, Perchloric acid, nickel(2+) salt, See 1st line of "Nickel and its
108 13520-61-1 D D A 0.01%
all members hexahydrate compounds, all members"
242
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Additive for engine coolant, Delirium, spasms, dizziness,

vulcanizing agent for rubber headache, sweating, nausea,
109 Nitrites, all members Ammonium nitrite 13446-48-5 236-598-7 D D A 0.01% Reg. (EC) No 1272/2008
product, loss of consciousness, vomiting,
corrosion preventive additive facial flush
Flam. Liq. 2
109 Nitrites, all members Amyl nitrite 110-46-3 203-770-8 D D A 0.01% Acute Tox. 4 * Reg. (EC) No 1272/2008
Acute Tox. 4 *
Acute Tox. 4 *
109 Nitrites, all members Barium nitrite hydrate 115216-77-8 D D A 0.01% Reg. (EC) No 1272/2008
Acute Tox. 4 *
Flam. Liq. 2
109 Nitrites, all members Butyl nitrite 544-16-1 208-862-1 D D A 0.01% Acute Tox. 3 * Reg. (EC) No 1272/2008
Acute Tox. 3 *
109 Nitrites, all members Calcium nitrite 13780-06-8 237-424-2 D D A 0.01% Reg. (EC) No 1272/2008
109 Nitrites, all members Calcium nitrite hydrated 10031-34-2 D D A 0.01% Reg. (EC) No 1272/2008
Flam. Gas 1
Press. Gas
109 Nitrites, all members Ethyl nitrite 109-95-5 203-722-6 D D A 0.01% Acute Tox. 4 * Reg. (EC) No 1272/2008
Acute Tox. 4 *
Acute Tox. 4 *
Flam. Liq. 2
Carc. 1B
109 Nitrites, all members Isobutyl nitrite 542-56-3 208-819-7 D D A 0.01% Muta. 2 Reg. (EC) No 1272/2008
Acute Tox. 4 *
Acute Tox. 4 *
109 Nitrites, all members Magnesium nitrite 15070-34-5 D D A 0.01% Reg. (EC) No 1272/2008
Ox. Sol. 2
109 Nitrites, all members Potassium nitrite 7758-09-0 231-832-4 D D A 0.01% Acute Tox. 3 * Reg. (EC) No 1272/2008
Aquatic Acute 1
109 Nitrites, all members Silver nitrite 7783-99-5 232-041-7 D D A 0.01% Reg. (EC) No 1272/2008
Ox. Sol. 3
109 Nitrites, all members Sodium nitrite 7632-00-0 231-555-9 D D A 0.01% Acute Tox. 3 * Reg. (EC) No 1272/2008
Aquatic Acute 1
Flam. Liq. 2
109 Nitrites, all members tert-Butyl nitrite 540-80-7 208-757-0 D D A 0.01% Acute Tox. 4 * Reg. (EC) No 1272/2008
Acute Tox. 4 *
Acute Tox. 4 *
109 Nitrites, all members Dicyclohexylammonium nitrite 3129-91-7 221-515-9 D D A 0.01% Reg. (EC) No 1272/2008
Acute Tox. 4 *
Diethyldihexadecylammonium nitrite
109 Nitrites, all members 105841-28-9 D D A 0.01% Reg. (EC) No 1272/2008
(6CI, 7CI)
109 Nitrites, all members Diisopropylammonium nitrite 34915-40-7 252-285-8 D D A 0.01% Reg. (EC) No 1272/2008
109 Nitrites, all members Morpholin, Nitrite (9CI) 62076-93-1 D D A 0.01% Reg. (EC) No 1272/2008
243
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Flam. Liq. 2
109 Nitrites, all members Pentyl nitrite 463-04-7 207-332-7 D D A 0.01% Acute Tox. 4 * Reg. (EC) No 1272/2008
Acute Tox. 4 *
Flam. Liq. 2
109 Nitrites, all members butan-2-yl nitrite 924-43-6 213-104-8 D D A 0.01% Acute Tox. 4 * Reg. (EC) No 1272/2008
Acute Tox. 4 *
Paint for fabric and leather, REACH ANNEX XVII

oxidation inhibitor in lubricating Carc. 1B Reg. (EC) No 1272/2008
110 4-Nitrobiphenyl (4-Nitrodiphenyl) 92-93-3 202-204-7 P P A 0.1% 0.01%
oil,impurities in rubber/latex Aquatic Chronic 2 Industrial Safety and Health Law:
and plastic,dye intermediate Production prohibited substance
Reg. (EC) No 1272/2008

Explosive material, high
111 Nitrocellulose 9004-70-0 D D A 0.01% Visceral disorders Dir. 2007/23/EC
explosives
TSCA
Carc. 1B
Reg. (EC) No 1272/2008
Acute Tox. 2 *
Published in Canada Gazette Part
112 N-Nitrosamines, selected N-Nitroso dimethyl amine 62-75-9 200-549-8 P P A X - - Rubber material Acute Tox. 3 *
II, 2006-11-29 Vol. 140, No. 25
STOT RE 1
TRGS 552, TRGS 615 TRGS 905
Aquatic Chronic 2
112 N-Nitrosamines, selected N-Nitroso diethanol amine 1116-54-7 214-237-4 D D A 0.01% Carc. 1B TRGS 552, TRGS 615 TRGS 905
Carc. 1B
112 N-Nitrosamines, selected N-Nitrosodi-n-propyl amine 621-64-7 210-698-0 D D A 0.0001% Acute Tox. 4 * TRGS 552, TRGS 615 TRGS 905
Aquatic Chronic 2
112 N-Nitrosamines, selected N-Nitroso diethyl amine 55-18-5 200-226-1 D D A 0.01% TRGS 552, TRGS 615 TRGS 905
112 N-Nitrosamines, selected N-Nitroso ethyl phenyl amine 612-64-6 D D A 0.01% TRGS 552, TRGS 615 TRGS 905
112 N-Nitrosamines, selected N-Nitroso methyl ethyl amine 10595-95-6 D D A 0.01% TRGS 552, TRGS 615 TRGS 905
112 N-Nitrosamines, selected N-Nitroso methyl phenyl amine 614-00-6 210-366-5 D D A 0.01% TRGS 552, TRGS 615 TRGS 905
112 N-Nitrosamines, selected N-Nitroso morpholine 59-89-2 D D A 0.01% TRGS 552, TRGS 615 TRGS 905
112 N-Nitrosamines, selected N-Nitroso pyrrolidine 930-55-2 213-218-8 D D A 0.01% TRGS 552, TRGS 615 TRGS 905
112 N-Nitrosamines, selected N-Nitrosodi-i-propyl amine 601-77-4 D D A 0.01% TRGS 552, TRGS 615 TRGS 905
112 N-Nitrosamines, selected N-Nitrosodi-n-butylamine 924-16-3 213-101-1 D D A 0.01% TRGS 552, TRGS 615 TRGS 905
112 N-Nitrosamines, selected N-Nitrosopiperidine 100-75-4 202-886-6 D D A 0.01% TRGS 552, TRGS 615 TRGS 905
Repr. 2
Paint for fabric and leather,
oxidation inhibitor in lubricating
113 Nonylphenol, selected Nonylphenol 25154-52-3 246-672-0 P D B X 0.01% 0.01% Skin Corr. 1B Reg. (EC) No 552/2009 Prohibit for Texitile article
oil,impurities in rubber/latex
and plastic,dye intermediate
Aquatic Chronic 1
113 Nonylphenol, selected p-nonylphenol 104-40-5 203-199-4 R D B 0.01% 0.01% See 1st line of "Nonylphenol" Prohibit for Texitile article
113 Nonylphenol, selected p-Isononylphenol 26543-97-5 247-770-6 R D B 0.1% 0.01% See 1st line of "Nonylphenol" Prohibit for Texitile article
244
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
113 Nonylphenol, selected p-(1-Methyloctyl)phenol 17404-66-9 241-427-4 R D B 0.1% 0.01% See 1st line of "Nonylphenol" Prohibit for Texitile article
113 Nonylphenol, selected p-(1,1-Dimethylheptyl)phenol 30784-30-6 250-339-5 R D B 0.1% 0.01% See 1st line of "Nonylphenol" Prohibit for Texitile article
113 Nonylphenol, selected 4-(1-Ethyl-1-methylhexyl)phenol 52427-13-1 257-907-1 R D B 0.1% 0.01% See 1st line of "Nonylphenol" Prohibit for Texitile article
113 Nonylphenol, selected 4-(1-Ethyl-1,3-dimethylpentyl)phenol 186825-36-5 R D B 0.1% 0.01% See 1st line of "Nonylphenol" Prohibit for Texitile article
113 Nonylphenol, selected 4-(1-Ethyl-1,4-dimethylpentyl)phenol 142731-63-3 R D B 0.1% 0.01% See 1st line of "Nonylphenol" Prohibit for Texitile article
Repr. 2
Acute Tox. 4 *
113 Nonylphenol, selected Branched 4-nonylphenol 84852-15-3 284-325-5 R D B 0.1% 0.01% Skin Corr. 1B See 1st line of "Nonylphenol" Prohibit for Texitile article
Aquatic Acute 1
Aquatic Chronic 1
Nonylphenol ethoxylates, all 14-(Nonylphenoxy)-3,6,9,12- Surface active agent,

114 26264-02-8 247-555-7 D D A 0.01% Irritation of eyes Reg. (EC) No 1907/2006 (REACH)
members tetraoxatetradecan-1-ol leather treatment agent
3,6,9,12,15,18,21,24,27-
Nonylphenol ethoxylates, all See 1st line of ”Nonylphenol
114 Nonaoxanonacosan-1-ol,29- 27177-08-8 248-294-1 D D A 0.01%
members ethoxylates, all members”
(nonylphenoxy)-
3,6,9,12,15,18,21,24-
114 Octaoxahexacosan-1-ol, 26- 26571-11-9 247-816-5 D D A 0.01%
(nonylphenoxy)-
Nonylphenol ethoxylates, all 3,6,9,12,15,18,21-Heptaoxatricosan-1- See 1st line of ”Nonylphenol

114 27177-05-5 248-293-6 D D A 0.01%
members ol, 23-(nonylphenoxy)- ethoxylates, all members”
Nonylphenol ethoxylates, all Decaethylene glycol, isononylphenyl See 1st line of ”Nonylphenol
114 65455-72-3 D D A 0.01%
members ether ethoxylates, all members”

114 Ethanol, 2-[2-(nonylphenoxy)ethoxy]- 27176-93-8 248-291-5 D D A 0.01%
Nonylphenol ethoxylates, all Ethanol, 2-[2-[2-[2-(4- See 1st line of ”Nonylphenol

114 7311-27-5 230-770-5 D D A 0.01%
members nonylphenoxy)ethoxy]ethoxy]ethoxy]- ethoxylates, all members”
500-024-6
246-672-0
See 1st line of ”Nonylphenol
Nonylphenol ethoxylates, all 284-325-5
114 Ethylene oxide-Nonylphenol polymer 9016-45-9 R D B 0.01% 0.01% ethoxylates, all members” Prohibit for Texitile article
members 234-284-4
REACH Annex XVII
291-844-0
203-199-4

114 Nonylphenol polyethylene glycol ether 20636-48-0 D D A 0.01%
245
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

114 Nonylphenol polyethylene glycol ether 27177-01-1 D D A 0.01%
246-672-0
284-325-5
Nonylphenol ethoxylates, all Poly(oxy-1,2-ethanediyl), alpha-(4- See 1st line of ”Nonylphenol
114 27942-26-3 234-284-4 D D A 0.01%
members nonylphenyl)-omega-hydroxy ethoxylates, all members”
291-844-0
203-199-4
246-672-0
Poly(oxy-1,2-ethanediyl), .alpha.-(1- 284-325-5
114 oxo-2-propenyl)-.omega.- 50974-47-5 234-284-4 D D A 0.01%
(nonylphenoxy)- 291-844-0
203-199-4
246-672-0
Poly(oxy-1,2-ethanediyl), alpha- 284-325-5
114 (nonylphenyl)-omega-hydroxy-, 51811-79-1 234-284-4 D D A 0.01%
phosphate 291-844-0
203-199-4
246-672-0
284-325-5
Nonylphenol ethoxylates, all Nonylphenylpolyoxyethylene See 1st line of ”Nonylphenol
114 54612-36-1 234-284-4 D D A 0.01%
members sulfosuccinate ethoxylates, all members”
291-844-0
203-199-4
246-672-0
614-460-0
Poly(oxy-1,2-ethanediyl), alpha- See 1st line of ”Nonylphenol
114 (nonylphenyl)-omega-hydroxy-, 68412-53-3 R D B 0.01% 0.01% ethoxylates, all members” Prohibit for Texitile article
members 234-284-4
branched, phosphates REACH Annex XVII
291-844-0
203-199-4
246-672-0
Poly(oxy-1,2-ethanediyl), alpha-sulfo- 284-325-5
114 omega-(nonylphenoxy)-, branched, 68649-55-8 234-284-4 D D A 0.01%
ammonium salt 291-844-0
203-199-4
246-672-0
Poly(oxy-1,2-ethanediyl), alpha- 284-325-5
114 (nonylphenyl)-omega-(sulfooxy)-, 9014-90-8 234-284-4 D D A 0.01%
sodium salt 291-844-0
203-199-4
246-672-0
Poly(oxy-1,2-ethanediyl), alpha-sulfo- 284-325-5
114 omega-(nonylphenoxy)-, ammonium 9051-57-4 234-284-4 D D A 0.01%
salt 291-844-0
203-199-4
246-672-0
500-045-0
Poly (oxy-1,2-ethanediyl), See 1st line of ”Nonylphenol
114 alpha –(4-nonylphenyl)-omega-hydroxy 26027-38-3 R D B 0.01% 0.01% ethoxylates, all members” Prohibit for Texitile article
members 234-284-4
- REACH Annex XVII
291-844-0
203-199-4
246
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
500-209-1
246-672-0
Poly (oxy-1,2-ethanediyl), alpha – See 1st line of ”Nonylphenol
114 (nonylphenyl)-omega-hydroxy-, 68412-54-4 R D B 0.01% 0.01% ethoxylates, all members” Prohibit for Texitile article
members 234-284-4
branched REACH Annex XVII
291-844-0
203-199-4
246-672-0
500-315-8
Poly (oxy-1,2-ethanediyl),alpha-(4- See 1st line of ”Nonylphenol
114 nonylphenyl)-omega-hydroxy-, 127087-87-0 R D B 0.01% 0.01% ethoxylates, all members” Prohibit for Texitile article
members 234-284-4
branched REACH Annex XVII
291-844-0
203-199-4
Nonylphenol ethoxylates, all Poly(oxy-1,2-ethanediyl), .alpha.-(2- See 1st line of ”Nonylphenol

114 51938-25-1 D D A 0.01%
members nonylphenyl)-.omega.-hydroxy- ethoxylates, all members”
246-672-0
609-346-2
See 1st line of ”Nonylphenol
Nonylphenol ethoxylates, all Poly(oxy-1,2-ethanediyl), .alpha.- 284-325-5
114 37205-87-1 R D B 0.01% 0.01% ethoxylates, all members” Prohibit for Texitile article
members (isononylphenyl)-.omega.-hydroxy- 234-284-4
REACH Annex XVII
291-844-0
203-199-4

114 Ethanol, 2-[2-(4-Nonylphenoxy)Ethoxy]- 20427-84-3 243-816-4 D D A 0.01%
3,6,9,12,15-Pentaoxaheptadecan-1-ol,
114 17-(4-onylphenoxy)-; p-Nonylphenol 34166-38-6 D D A 0.01%
hexaethoxylate
Nonylphenol ethoxylates, all 3,6,9,12,15,18-Hexaoxaeicosan-1-ol, See 1st line of ”Nonylphenol

114 27942-27-4 248-743-1 D D A 0.01%
members 20-(4-nonylphenoxy)- ethoxylates, all members”

114 4-t-Nonylphenol-diethoxylate 156609-10-8 D D A 0.01%

114 Ethanol, 2-(4-nonylphenoxy)- 104-35-8 D D A 0.01%
3,6,9,12,15,18,21,24-
114 Octaoxahexacosan-1-ol,26-(4- 14409-72-4 D - B 0.01%
nonylphenoxy)-
Reaction solvent (elimination

reaction), refining solvent, Repr. 1B REACH ANNEX XIV
115 N,N-dimethylacetamide (DMAC) 127-19-5 204-826-4 P - B X 0.01% 0.01% resin solvent, paint remover, Acute Tox. 4 * RECOMMENDATION
pharmaceutical products Acute Tox. 4 * Reg. (EC) No 1272/2008
(insoluble compound solvent)
Carc. 1B
N,N,N',N'-tetramethyl-4,4'- Dye material, synthetic organic REACH SVHC
116 101-61-1 202-959-2 D - B 0.01% Aquatic Acute 1
methylenedianiline (Michler's base) intermediate body Reg. (EC) No 1272/2008
Aquatic Chronic 1
247
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Hinderd amine light stabilizer

7-Oxa-3,20-diazadispiro[5.1.11.2]- JPN CSCL Class 2 monitored
Car refinish coating, Plastics or
117 heneicosan-21-one, 2,2,4,4- 64338-16-5 264-780-6 D D A 0.01% chemical substances
Wood coating and Binder of
tetramethyl- Canadian Priority List in 2008
Acryl or Polyester resin
Ozone depletion,
Chloro-fluoro-carbons (CFC) Digestive, global warming substance,
EU-R 2009/1005
118 and other Ozone depleting 1,1,1,2-Tetrachlor-2,2-difluorethane 76-11-9 200-934-0 P P A - - foaming agent, Irritation of skin,
EPA ODP class 1
substances, all members washing agent anesthetic effect,
central nervous disorder
Chloro-fluoro-carbons (CFC)
1,1,1,3,3,3-Hexachlor-2,2-
118 and other Ozone depleting 3182-26-1 P P A - - See 1st line of "CFC all members"
difluorpropane
substances, all members
1,1,1,3,3-Pentachlor-2,2,3-
trifluorpropane
118 and other Ozone depleting 1,1,1,3-Tetrachlortetrafluorpropane 2268-46-4 218-868-6 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting 1,1,1-Trichlorpentafluorpropane 4259-43-2 P P A - - See 1st line of "CFC all members"
200-936-1
118 and other Ozone depleting 1,1,2-trichloro-1,2,2-trifluoroethane 76-13-1 P P A - - See 1st line of "CFC all members"
200-893-9
118 and other Ozone depleting 1,1-Dichlor-1,2,2,2-tetrafluorethane 374-07-2 206-774-8 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting 1,2,2-Trichloropentafluoropropane 1599-41-3 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting 1,2,3-Trichloropentafluoropropane 76-17-5 616-299-1 P P A - - See 1st line of "CFC all members"
1,2-Dichloro-1,1,2,3,3,3-
118 and other Ozone depleting 661-97-2 211-551-3 P P A - - See 1st line of "CFC all members"
hexafluoropropane
118 and other Ozone depleting 1,2-Difluorotetrachloroethane 76-12-0 200-935-6 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Bromofluoromethane 373-52-4 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting chlorotrifluoroethylene 79-38-9 201-201-8 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Chlorotrifluoromethane 75-72-9 200-894-4 P P A - - See 1st line of "CFC all members"
248
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
118 and other Ozone depleting Cryofluorane 76-14-2 200-937-7 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Decafluorobutane 355-25-9 206-580-3 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Dichlorodifluoromethane 75-71-8 200-893-9 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting dichlorotetrafluoroethane 1320-37-2 215-300-9 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Heptachlorofluoropropane 135401-87-5 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Heptachlorofluoropropane 422-78-6 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Heptafluoropropyl chloride 422-86-6 207-024-2 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Hexachlorodifluoropropane 134452-44-1 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Hexachloroethane 67-72-1 200-666-4 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Monochloropentafluoroethane 76-15-3 200-938-2 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Octafluoropropane 76-19-7 200-941-9 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Pentachlorofluoroethane 354-56-3 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Pentachlorotrifluoropropane 134237-31-3 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Perfluoroethane 76-16-4 200-939-8 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Tetrachlorotetrafluoropropane 29255-31-0 P P A - - See 1st line of "CFC all members"
249
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
118 and other Ozone depleting Trichlorofluoromethane 75-69-4 200-892-3 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Trichlorotrifluoroethane 26523-64-8 247-758-0 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Trichlorotrifluoroethane 354-58-5 206-564-6 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting 1,1,1-Tribromo-2,2,2-trifluoroethane 354-48-3 206-560-4 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting 1,1-Dibromo-1,2,2,2-tetrafluoroethane 27336-23-8 248-414-2 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting 1,1-Dibromo-2,2-difluoroethylene 430-85-3 207-068-2 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting 1,2-Dibromo-1,1,2-trichloroethane 13749-38-7 237-330-1 P P A 0.1% 0.01% See 1st line of "CFC all members"
1,2-Dibromo-1-chloro-1,2,2-
118 and other Ozone depleting 354-51-8 206-562-5 P P A 0.1% 0.01% See 1st line of "CFC all members"
trifluoroethane
118 and other Ozone depleting 1,2-Dibromotetrachloroethane 630-25-1 211-136-7 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting 1-Bromo-1-chloro-2,2-difluoroethylene 758-24-7 212-062-8 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting 2-Bromo-1,1-dichloroethylene 5870-61-1 227-523-9 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Bromodichlorofluoromethane 353-58-2 206-536-3 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Bromopentafluoroethane 354-55-2 206-563-0 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Bromotrifluoroethylene 598-73-2 209-948-1 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Carbon tetrabromide 558-13-4 209-189-6 P P A 0.1% 0.01% See 1st line of "CFC all members"
250
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
118 and other Ozone depleting Chlorobromomethane 74-97-5 200-826-3 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Chlorobromotrifluoroethane 74925-63-6 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Chlorodibromomethane 124-48-1 204-704-0 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Bromochlorodifluoromethane 353-59-3 206-537-9 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Dibromodichloromethane 594-18-3 209-829-4 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Dibromotetrafluoroethane 25497-30-7 247-042-8 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Dibromotetrafluoroethane (Halon 2402) 124-73-2 204-711-9 P P A - - See 1st line of "CFC all members"
Ethane, 2-bromo-1-chloro-1,1,2-
118 and other Ozone depleting 354-20-1 P P A 0.1% 0.01% See 1st line of "CFC all members"
trifluoro-
trifluoro-, (R)-
trifluoro-, (S)-
118 and other Ozone depleting Ethane, tribromo- 598-16-3 209-920-9 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Ethene, tetrabromo- 79-28-7 201-192-0 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Methane, bromotrichloro- 75-62-7 200-886-0 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Methane, tribromofluoro- 353-54-8 206-535-8 P P A 0.1% 0.01% See 1st line of "CFC all members"
251
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Press. Gas
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
118 and other Ozone depleting Methyl bromide (Bromomethane) 74-83-9 200-813-2 P P A - - See 1st line of "CFC all members"
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Ozone
118 and other Ozone depleting Pentabromoethane 75-95-6 200-918-3 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Tribromochloromethane 594-15-0 209-827-3 P P A 0.1% 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting Trifluorobromomethane 75-63-8 200-887-6 P P A - - See 1st line of "CFC all members"
118 and other Ozone depleting Difluorodibromomethane 75-61-6 200-885-5 P P A - - See 1st line of "CFC all members"
1,2-Dichloro-1,1,3,3,3-
pentafluoropropane
1,3-dichloro-1,1,2,2,3,3-
118 and other Ozone depleting 662-01-1 211-552-9 P - B - - See 1st line of "CFC all members"
hexafluoropropane
2-chloro-1,1,1,2,3,3,3-
118 and other Ozone depleting 76-18-6 200-940-3 P - B - - See 1st line of "CFC all members"
heptafluoropropane
118 and other Ozone depleting Dichlorohexafluorocyclobutane 356-18-3 206-599-7 P - B - - See 1st line of "CFC all members"
118 and other Ozone depleting Chloroheptafluorocyclobutane 377-41-3 P - B - - See 1st line of "CFC all members"
118 and other Ozone depleting octafluorocyclobutane 115-25-3 204-075-2 D - B 0.01% See 1st line of "CFC all members"
118 and other Ozone depleting tetradecafluorohexane 355-42-0 206-585-0 D - B 0.01% See 1st line of "CFC all members"

Flam. Sol. 1
Substances Regulations,2005
210-172-0 Acute Tox. 4 *
119 Pentachlorobenzene 608-93-5 P P A - - Flame retardant (SOR/SOR/2005-41.Published in
Aquatic Chronic 1
29 Vol. 140, No. 24
252
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Pentachlorophenol (PCP) Dye material, synthetic organic REACH ANNEX XVII
120 Pentachlorophenol 87-86-5 201-778-6 P P A 0.1% 0.01% Eye Irrit. 2
and its salts, all members intermediate body Reg. (EC) No 1272/2008
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Pentachlorophenol (PCP)
120 Potassium pentachlorophenate 7778-73-6 231-911-3 P P A 0.1% 0.01% Eye Irrit. 2 REACH ANNEX XVII
and its salts, all members
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
120 Zinc bis(pentachlorophenolate) 2917-32-0 220-847-1 P P A 0.1% 0.01% REACH ANNEX XVII
Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
120 Sodium Pentachlorophenate 131-52-2 205-025-2 P P A 0.1% 0.01% Eye Irrit. 2 REACH ANNEX XVII
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
121 Perchlorates, all members Lithium Perchlorate 7791-03-9 232-237-2 D D A 0.01% California Assemby Bill No. 826
121 Perchlorates, all members Magnesium Perchlorate 10034-81-8 233-108-3 D D A 0.01% California Assemby Bill No. 826
Ox. Sol. 1 California Assemby Bill No. 826

121 Perchlorates, all members Potassium Perchlorate 7778-74-7 231-912-9 D D A 0.01%
California Assemby Bill No. 826

Ox. Sol. 1
121 Perchlorates, all members Sodium Perchlorate 7601-89-0 231-511-9 D D A 0.01% Reg. (EC) No 1272/2008
Acute Tox. 4 *
PACT
121 Perchlorates, all members Thallium(3+) perchlorate 15596-83-5 239-677-4 D D A 0.01% California Assemby Bill No. 826
121 Perchlorates, all members Perchloric acid, cobalt (2+) salt 13455-31-7 236-653-5 D D A 0.01% California Assemby Bill No. 826
California Assemby Bill No. 826

Air bag, pretensioner, Expl. 1.1
121 Perchlorates, all members Ammonium perchlorate 7790-98-9 232-235-1 D D A 0.01% Reg. (EC) No 1272/2008
coin type battery Ox. Sol. 1
PACT
Carc. 2
Perfluorooctane sulfonates Repr. 1B
76/769/EEC
C8F17SO2X (X = OH, Metal STOT RE 1
Fluorine surface coating agent, 2006/122EEC
122 salt, halide, amide, and other Perfluoroctane sulfonate acid 1763-23-1 217-179-8 P P A 0.001% 0.0001% Acute Tox. 4 *
surface active agent (Prohibited from July 1st 2008)
derivatives including polymers) Acute Tox. 4 *
Canada Gazette Part II,2008.6.11
(PFOS), all members Lact.
Aquatic Chronic 2
253
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Perfluorooctane sulfonates
C8F17SO2X (X = OH, Metal
See 1st line of "PFOS all
122 salt, halide, amide, and other Perfluoroctane sulfonate anion 45298-90-6 P P A 0.001% 0.0001%
members"
derivatives including polymers)
(PFOS), all members
206-200-6
217-179-8
220-527-1
274-460-8 See 1st line of "PFOS all
122 salt, halide, amide, and other Perfluorooctane-1-sulfonyl fluoride 307-35-7 P P A 0.001% 0.0001%
260-375-3 members"
223-980-3
(PFOS), all members
260-837-4
268-357-7
217-179-8
Perfluorooctane sulfonates 2-Propenoic acid, 2-methyl-, dodecyl 220-527-1
C8F17SO2X (X = OH, Metal ester, polymers with 2- 274-460-8
122 salt, halide, amide, and other [methyl[(perfluoro-C4-8-alkyl)- 306975-62-2 260-375-3 P P A 0.001% 0.0001%
members"
derivatives including polymers) sulfonyl]amino]ethyl acrylate and 223-980-3
(PFOS), all members vinylidene chloride 260-837-4
268-357-7
C8F17SO2X (X = OH, Metal Glycine,N-ethyl-N-
122 salt, halide, amide, and other [(heptadecafluorooctyl)sulfonyl]-, 2991-51-7 221-062-7 P P A 0.001% 0.0001%
members"
derivatives including polymers) potassium salt
(PFOS), all members
Carc. 2
122 salt, halide, amide, and other Perfluorooctane sulfonate potasium salt 2795-39-3 220-527-1 P P A 0.001% 0.0001% Acute Tox. 4 *
members"
Aquatic Chronic 2
Carc. 2
Perfluorooctane sulfonate ammonium See 1st line of "PFOS all
122 salt, halide, amide, and other 29081-56-9 249-415-0 P P A 0.001% 0.0001% Acute Tox. 4 *
salt members"
Aquatic Chronic 2
Carc. 2
122 salt, halide, amide, and other Perfluorooctane sulfonate lithium salt 29457-72-5 249-644-6 P P A 0.001% 0.0001% Acute Tox. 4 *
members"
Aquatic Chronic 2
Tetraethylammoniumheptade See 1st line of "PFOS all
122 salt, halide, amide, and other 56773-42-3 260-375-3 P P A 0.001% 0.0001%
cafluoroctansulfonate members"
(PFOS), all members
Carc. 2
PFOA and its salts, Repr. 1B Lact.
Perfluorooctanoic acids Fuel hose, gasket, wire Acute Tox. 4 REACH SVHC
123 PFOA - perfluorooctanoic acid 335-67-1 206-397-9 R D/P A 0.1% 0.01% Prohibit in Norway
C8F15O2X (X = H, NH4, and insulator, bearings Acute Tox. 4 Reg. (EC) No 1272/2008
Metal salts), all members STOT RE 1
Eye Dam. 1
254
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 2
PFOA and its salts, Repr. 1B Lact.
Perfluorooctanoic acids Acute Tox. 4
123 Ammonium salt of PFOA 3825-26-1 223-320-4 R D/P A 0.1% 0.01% See 1st line of "PFOA and its salts" Prohibit in Norway
C8F15O2X (X = H, NH4, and Acute Tox. 4
Metal salts), all members STOT RE 1
Eye Dam.1
PFOA and its salts,

Perfluorooctanoic acids
123 Sodium salt of PFOA 335-95-5 206-404-5 R D/P A 0.1% 0.01% See 1st line of "PFOA and its salts" Prohibit in Norway
C8F15O2X (X = H, NH4, and
Metal salts), all members
PFOA and its salts,

123 Potassium salt of PFOA 2395-00-8 219-248-8 R D/P A 0.1% 0.01% See 1st line of "PFOA and its salts" Prohibit in Norway
PFOA and its salts,

123 Silver salt of PFOA 335-93-3 206-402-4 R D/P A 0.1% 0.01% See 1st line of "PFOA and its salts" Prohibit in Norway
PFOA and its salts,

123 Ethylperfluorooctanoate 3108-24-5 221-468-4 R D/P A 0.1% 0.01% See 1st line of "PFOA and its salts" Prohibit in Norway
PFOA and its salts,

123 Methylperfluorooctanoate 376-27-2 206-808-1 R D/P A 0.1% 0.01% See 1st line of "PFOA and its salts" Prohibit in Norway
PFOA and its salts,

123 Pentadecafluorooctyl fluoride 335-66-0 206-396-3 R D/P A 0.1% 0.01% See 1st line of "PFOA and its salts" Prohibit in Norway
Muta. 2
Residual monomer of phenol
Acute Tox. 3 *
resin and epoxy resin,
124 Phenol 108-95-2 203-632-7 D D A 0.01% impurities of phenolic oxidation
Acute Tox. 3 * PACT
inhibitor,
STOT RE 2 *
synthetic resin and plasticizer
Skin Corr. 1B
Phenol, 2-(2H-benzotriazol-2-yl)-4,6- REACH SVHC

125 3846-71-7 223-346-6 P P A 0.1% 0.01% Ultraviolet degradation inhibitor Poisonous to liver
bis(1,1-dimethlethyl)-(UV-320) JPN CSCL Class 1 substance
2-(2H-benzotriazol-2-yl)-4-(tert-butyl)-6- REACH SVHC

126 36437-37-3 253-037-1 D D A 0.01% Ultraviolet rays absorbent vPvB
(sec-butyl)phenol (UV-350) PACT
Additives for fabric

REACH SVHC
Phenol, 2-(5-chloro-2H-benzotriazol-2- Additives for rubber Substance judged as persistent
127 3864-99-1 223-383-8 D D A 0.01% PACT
yl)-4,6-bis(1,1'-dimethylethyl)- (UV-327) Additives for resin and concentrative
JPN CSCL
Ultraviolet absorber
Oxidation inhibitor for

128 Phenol, 2,4,6-tris(1,1-dimethylethyl)- 732-26-3 211-989-5 R D B 0.1% 0.01% Liver and kidney disorder JPN CSC Class 1 substances Prohibit in Japan
lubricating oil and fuel
Phenylendiamines and its salts, Dye material, synthetic organic Liver, spleen and adrenal Reg. (EC) No 1272/2008
129 2,6-Dichloro-p-phenylenediamine 609-20-1 210-184-6 D D A 0.01%
all members intermediate body disorder Japan CSCL class 1 substance
255
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Phenylendiamines and its salts, 2-Ethoxy-N4,N4-diethyl-p-

129 2359-46-8 219-103-9 D D A 0.01% Reg. (EC) No 1272/2008
all members phenylenediamine
Phenylendiamines and its salts, 2-Methoxy-5-methyl-p-

129 5307-00-6 D D A 0.01% Reg. (EC) No 1272/2008
all members phenylenediamine
Phenylendiamines and its salts,

129 2-Nitro-p-phenylenediamine 5307-14-2 D D A 0.01% Reg. (EC) No 1272/2008
all members 226-164-5

129 4-Chloro-o-phenylenediamine 95-83-0 202-456-8 D D A 0.01% Reg. (EC) No 1272/2008
all members
Acute Tox. 3 *
129 Dimethyl-p-phenylenediamine 99-98-9 202-807-5 D D A 0.01% Acute Tox. 3 * Reg. (EC) No 1272/2008
all members
Acute Tox. 3 *
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Phenylendiamines and its salts, Acute Tox. 3 *
129 m-phenylenediamine 108-45-2 203-584-7 D D A 0.01% Reg. (EC) No 1272/2008
all members Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Phenylendiamines and its salts, Acute Tox. 3 *
129 m-phenylenediamine dihydrochloride 541-69-5 208-790-0 D D A 0.01% Reg. (EC) No 1272/2008
all members Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Phenylendiamines and its salts, Skin Sens. 1

129 N,N'-Diphenyl-p-phenylenediamine 74-31-7 200-806-4 D D A 0.01% Reg. (EC) No 1272/2008
all members Aquatic Chronic 3
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
129 o-Phenylenediamine 95-54-5 202-430-6 D D A 0.01% Acute Tox. 4 * Reg. (EC) No 1272/2008
all members
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
129 o-phenylenediamine dihydrochloride 615-28-1 210-418-7 D D A 0.01% Acute Tox. 4 * Reg. (EC) No 1272/2008
all members
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

129 Phenylenediamines 25265-76-3 D D A 0.01% Reg. (EC) No 1272/2008
all members
256
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Phenylendiamines and its salts, Reg. (EC) No 1272/2008
129 p-Phenylenediamine 106-50-3 203-404-7 D D A 0.01% Eye Irrit. 2
all members PACT
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
129 p-Phenylenediamine dihydrochloride 624-18-0 210-834-9 D D A 0.01% Eye Irrit. 2 Reg. (EC) No 1272/2008
all members
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

129 p-Phenylenediamine hydrochloride 55972-71-9 259-926-0 D D A 0.01% Reg. (EC) No 1272/2008
all members
Phenylendiamines and its salts, N,N'-ditolyl-p-phenylenediamine; N,N'- Reg. (EC) No 1272/2008

129 27417-40-9 R - B 0.1% 0.01% Prohibit in Japan
all members bis(methylphenyl)-1,4-Benzenediamine Japan CSCL class 1 substance
N,N'-dixylyl-p-phenylenediamine; 1,4- Reg. (EC) No 1272/2008

129 Benzenediamine, N,N'- 28726-30-9 R - B 0.1% 0.01% Japan CSCL class 1 substance Prohibit in Japan
all members
bis(dimethylphenyl)- (9CI)
N-toly-N'-xylyl-p-phenylenediamine;
Reg. (EC) No 1272/2008
Phenylendiamines and its salts, 1,4-Benzenediamine, N-
129 70290-05-0 R - B 0.1% 0.01% Japan CSCL class 1 substance Prohibit in Japan
all members (dimethylphenyl)-N'-(methylphenyl)-
(9CI)
Component in lubricants for

Phosphoric acid, tris(2-methylphenyl) STOT SE 1
130 78-30-8 201-103-5 D D A 0.01% hydraulics, engines, gears, Reg. (EC) No 1272/2008
ester Aquatic Chronic 2
pumps
Bis(2-methoxyethyl) phthalate(1,2- REACH ANNEX XIV

131 Phthalates, selected Benzenedicarboxylic acid, 1,2-bis(2- 117-82-8 204-212-6 P D B X 0.01% 0.01% Plasticizer Repr. 1B RECOMMENDATION
methoxyethyl) ester) (DMEP) Reg. (EC) No 1272/2008

131 Phthalates, selected Benzylbutylphthalate (BBP) 85-68-7 201-622-7 P D/P B X 0.01% 0.01% Aquatic Acute 1 REACH ANNEX XVII 2015/2/21
Aquatic Chronic 1 Reg. (EC) No 1272/2008
REACH ANNEX XIV

131 Phthalates, selected Di(2-ethylhexyl)phthalate (DEHP) 117-81-7 204-211-0 P D/P B X 0.01% 0.01% Repr. 1B REACH ANNEX XVII 2015/2/21
Reg. (EC) No 1272/2008
REACH ANNEX XIV

Repr. 1B
131 Phthalates, selected Dibutylphthalate (DBP) 84-74-2 201-557-4 P D/P B X 0.01% 0.01% REACH ANNEX XVII 2015/2/21
Aquatic Acute 1
Reg. (EC) No 1272/2008
REACH ANNEX XIV

131 Phthalates, selected Diisobutylphthatlate (DIBP) 84-69-5 201-553-2 P D/P B X 0.01% 0.01% Repr. 1B 2015/2/21
Reg. (EC) No 1272/2008
Repr. 1B REACH SVHC

131 Phthalates, selected Diisopentylphthalate (DIPP) 605-50-5 210-088-4 D D A 0.01%
Heptyl undecyl phthalate

REACH ANNEX XIV
(1,2-Benzenedicarboxylic acid di-C7-
131 Phthalates, selected 68515-42-4 271-084-6 P D B X 0.01% 0.01% Repr. 1B RECOMMENDATION
11-branched and linear alkyl-esters)
Reg. (EC) No 1272/2008
(DHNUP)
257
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
(1,2-Benzenedicarboxylic acid,
131 Phthalates, selected 3648-20-2 222-884-9 D D A 0.01% Canadian Chemical Challenge
diundecyl ester)
REACH ANNEX XIV

1,2-Benzenedicarboxylic acid; di-C6-8-
131 Phthalates, selected 71888-89-6 276-158-1 P D B X 0.01% 0.01% Repr. 1B RECOMMENDATION
branched alkylesters, C7-rich (DIHP)
Reg. (EC) No 1272/2008
131 Phthalates, selected 68515-44-6 271-086-7 D D A 0.01%
diheptyl ester, branched and linear)
dinonyl ester, branched and linear)
131 Phthalates, selected 111381-89-6 D D A 0.01%
heptyl nonyl ester, branched and linear)
131 Phthalates, selected heptyl undecyl ester, branched and 111381-90-9 D D A 0.01%
linear)
131 Phthalates, selected nonyl undecyl ester, branched and 111381-91-0 D D A 0.01%
linear)

131 Phthalates, selected Dipentylphthalate 131-18-0 205-017-9 R D B 0.1% 0.01% Prohibit in USA
131 Phthalates, selected Di-isodecyl phthalate 26761-40-0 247-977-1 D D A 0.01% US EPA Chemical Action Plan.
131 Phthalates, selected Di-n-octylphthalate 117-84-0 204-214-7 D D A 0.01% US EPA Chemical Action Plan.
Di-isononylphthalate; Di-(C9-rich REACH ANNEX XVII

branched C8-C10alkyl) phthalate US EPA Chemical Action Plan.
REACH SVHC
131 Phthalates, selected Dihexyl phthalate 84-75-3 201-559-5 D D A 0.01% Repr. 1B
Reg. (EC) No 1272/2008
1,2-benzenedicarboxylic acid, di-C6-10-

131 Phthalates, selected 68515-51-5 271-094-0 D D A 0.01% PACT
alkyl esters
1,2-benzenedicarboxylic acid, mixed

131 Phthalates, selected decyl and hexyl and octyl diesters with 68648-93-1 272-013-1 D D A 0.01%
≥ 0.3% of dihexyl phthalate
REACH ANNEX XVII

131 Phthalates, selected Di-isononyl phthalate 28553-12-0 249-079-5 D D A 0.01%
US EPA Chemical Action Plan
131 Phthalates, selected Di-isononyl phthalate 8553-12-0 D - B 0.01% US EPA Chemical Action Plan
REACH SVHC
131 Phthalates, selected diisohexyl phthalate (DIHP) 68515-50-4 271-093-5 D - B 0.01% Repr. 1B
Reg. (EC) No 1272/2008
131 Phthalates, selected Diethyl phthalate 84-66-2 201-550-6 D - B 0.01%
REACH ANNEX XIV

131 Phthalates, selected N-pentyl-isopentylphtalate 776297-69-9 P - B X 0.3% 0.01%
RECOMMENDATION
258
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
1,2-Benzenedicarboxylic acid, Repr. 1B REACH ANNEX XIV

131 Phthalates, selected 84777-06-0 284-032-2 D - B 0.01%
dipentylester, branched and linear Aquatic Acute 1 RECOMMENDATION
Polyamine Curing Agents,

132 bis-Hexamethylenetriamine 143-23-7 205-593-1 D D A 0.01% Interior trim Abdominalgia, nausea, vomiting TSCA
selected

132 Triethyleneglycoldiamine 929-59-9 213-203-6 D D A 0.01%
selected

132 Poly(propyleneglycol)triamine 64852-22-8 D D A 0.01%
selected

132 Poly(propyleneglycol)diamine 9046-10-0 618-561-0 D D A 0.01%
selected
Skin Corr. 1B
Polyamine Curing Agents, Skin Sens. 1
132 Pentaethylenehexamine 4067-16-7 223-775-9 D D A 0.01%
selected Aquatic Acute 1
Aquatic Chronic 1
Polyamine Curing Agents, Flam. Sol. 2

132 Hexamethylenetetramine 100-97-0 202-905-8 D D A 0.01%
selected Skin Sens. 1
[1,1'-Biphenyl]-ar,ar'-diol, tetrabromo-, Skin disorder, carcinogenic,

Polybrominated biphenyls
133 polymer with (chloromethyl)oxirane and 68758-75-8 P P A 0.1% 0.01% Flame retardant possibility of endocrine Reg. (EC) No 552/2009
(PBB), all members
4,4'-(1-methylethylidene)bis[phenol] disruptors
Polybrominated biphenyls See 1st line of "Polybrominated

133 1,1'-Biphenyl, 2,2',3,4',5'-pentabromo- 73141-48-7 P P A 0.1% 0.01%
(PBB), all members biphenyls (PBB), all members"

133 1,1'-Biphenyl, 2,2',3,4,6-pentabromo- 77910-04-4 P P A 0.1% 0.01%

133 1,1'-Biphenyl, 2,2',3,5',6-pentabromo- 88700-05-4 P P A 0.1% 0.01%



133 1,1'-Biphenyl, 2,2',4,4'-tetrabromo- 66115-57-9 P P A 0.1% 0.01%

133 1,1'-Biphenyl, 2,2',4,5,5'-pentabromo- 67888-96-4 P P A 0.1% 0.01%




259
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement




133 1,1'-Biphenyl, 2,2',5-tribromo- 59080-34-1 P P A 0.1% 0.01%


133 1,1'-Biphenyl, 2,2'-dibromo- 13029-09-9 P P A 0.1% 0.01%

133 1,1'-Biphenyl, 2,3,4,4',5-pentabromo- 96551-70-1 P P A 0.1% 0.01%

133 1,1'-Biphenyl, 2',3,4,4',5-pentabromo- 74114-77-5 P P A 0.1% 0.01%


133 1,1'-Biphenyl, 2,3,4,5,6-pentabromo- 38421-62-4 P P A 0.1% 0.01%

133 1,1'-Biphenyl, 2,3',4',5-tetrabromo- 59080-38-5 P P A 0.1% 0.01%



133 1,1'-Biphenyl, 2,4,4',6-tetrabromo- 64258-02-2 P P A 0.1% 0.01%


133 1,1'-Biphenyl, 2,4,6-tribromo- 59080-33-0 P P A 0.1% 0.01%



133 1,1'-Biphenyl, 2,4-dibromo- 53592-10-2 P P A 0.1% 0.01%
260
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement







133 1,1'-Biphenyl, 3,4,4',5-tetrabromo- 59589-92-3 P P A 0.1% 0.01%



133 1,1'-Biphenyl, 4,4'-dibromo- 92-86-4 202-198-6 P P A 0.1% 0.01%
Polybrominated biphenyls 2,2',3,3',5,5',6,6'-Octabromo-4- See 1st line of "Polybrominated

133 83929-69-5 281-362-9 P P A 0.1% 0.01%
(PBB), all members phenoxy-1,1'-biphenyl biphenyls (PBB), all members"
Polybrominated biphenyls 4,4',6,6'-Tetrabromo[1,1'-biphenyl]-2,2'- See 1st line of "Polybrominated

133 14957-65-4 239-029-0 P P A 0.1% 0.01%
(PBB), all members diol biphenyls (PBB), all members"

133 Decabromobiphenyl 13654-09-6 237-137-2 P P A 0.1% 0.01%
See 1st line of "Polybrominated

Polybrominated biphenyls 237-137-2
133 Firemaster BP-6 59536-65-1 P P A 0.1% 0.01% biphenyls (PBB), all members"
(PBB), all members 248-696-7
REACH ANNEX XVII
Polybrominated biphenyls 237-137-2 See 1st line of "Polybrominated

133 Firemaster FF-1 67774-32-7 P P A 0.1% 0.01%
(PBB), all members 248-696-7 biphenyls (PBB), all members"

133 Hexabromobiphenyl 36355-01-8 252-994-2 P P A 0.1% 0.01%

133 Octabromobiphenyl 27858-07-7 248-696-7 P P A 0.1% 0.01%

133 Octabromodiphenyl (Bromkal 80) 61288-13-9 P P A 0.1% 0.01%

133 1,1'-Biphenyl, 2,3,3',4'-tetrabromo- 40088-45-7 P P A 0.1% 0.01%
261
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

133 1,1'-Biphenyl, 2,2',4,4',5,5'-hexabromo- 59080-40-9 P P A 0.1% 0.01%

133 3-bromobiphenyl 2113-57-7 218-304-9 P - B 0.1% 0.01%

133 2-bromobiphenyl 2052-07-5 218-141-3 P - B 0.1% 0.01%
REACH ANNEX XIV

Polybrominated diphenyl ethers Decabromodiphenyl ether Possibility of dioxin generation at RECOMMENDATION
134 1163-19-5 214-604-9 P D/P B X 0.01% 0.01% Flame retardant
(PBDE), all members ('Deca'; Decabromodiphenyl oxide) burning Dec 2013 voluntary phase out US
EPA. P by July 2015 in D.C.
Polybrominated diphenyl ethers

134 Octabromodiphenyl ether ('Octa') 32536-52-0 251-087-9 P P A 0.1% 0.01% Repr. 1B Reg. (EC) No 1272/2008
(PBDE), all members
STOT RE 2 *
Reg. (EC) No 1272/2008
Polybrominated diphenyl ethers Lact.
134 Pentabromodiphenyl ether ('Penta') 32534-81-9 251-084-2 P P A 0.001% 0.0001% JPN CSCL Class 1 substances
(PBDE), all members Aquatic Acute 1
POPs substance
Aquatic Chronic 1
Polybrominated diphenyl ethers JPN CSCL Class 1 substances

134 Diphenyl ether,hexabromo derivative 36483-60-0 253-058-6 P P A 0.1% 0.01%
(PBDE), all members POPs substance

134 Diphenyl ether,heptabromo derivative 68928-80-3 273-031-2 P P A 0.001% 0.0001%

134 Diphenyl ether,tetrabromoderivative 40088-47-9 254-787-2 P P A 0.001% 0.0001%
Polybrominated diphenyl ethers Benzen,1,2,4,5-tetrabromo-3-(2,4- JPN CSCL Class 1 substances

134 116995-33-6 P - B 0.1% 0.01%
(PBDE), all members dibromophenoxy)- POPs substance

134 2,2',4,4',5,5'-Hexabromodiphenyl ether 68631-49-2 P - B 0.001% 0.0001%
Polybrominated diphenyl ethers 2,2',4 JPN CSCL Class 1 substances

134 207122-15-4 P - B 0.001% 0.0001%
(PBDE), all members ,4',5,6'-hexabromodiphenyl ether POPs substance
Polybrominated diphenyl ethers 2,2',3,3',4,5',6-heptabromodiphenyl JPN CSCL Class 1 substances

134 446255-22-7 P - B 0.001% 0.0001%
(PBDE), all members ether POPs substance
Polybrominated diphenyl ethers 2,2',3,4,4',5',6-Heptabromodiphenyl JPN CSCL Class 1 substances

134 207122-16-5 P - B 0.001% 0.0001%
(PBDE), all members ether POPs substance

134 2,2',4,4'-tetrabromodiphenyl ether 5436-43-1 P - B 0.001% 0.0001%

134 2,2',4,4',5-Pentabromodiphenyl ether 60348-60-9 P - B 0.001% 0.0001%
Polybrominated Terphenyls
135 Dodecabromoterphenyl 79596-31-9 279-193-0 P D B 0.1% 0.01% Capacitor Skin disorder, carcinogenic TSCA
( PBT ), all members
Polybrominated Terphenyls See 1st line of "Polybrominated

135 Undecabromoterphenyl 83929-80-0 281-374-4 P D B 0.1% 0.01%
( PBT ), all members Terphenyls ( PBT ), all members"
262
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

135 4-bromo-p-terphenyl 1762-84-1 P D B 0.1% 0.01%



135 4,4'-Dibromo-p-terphenyl 17788-94-2 P D B 0.1% 0.01%

Irritation of eyes,
Insulating fluid for electric skin and liver disorder,
Polychlorinated Biphenyls
136 1,1'-Biphenyl, 2,4',5-trichloro- 16606-02-3 215-648-1 P P A 0.005% 0.0002% system, switchboard, carcinogenic, Reg. (EC) No 552/2009
( PCB ), all members
transformer and condenser possibility of endocrine
disruptors
See 1st line of "Polychlorinated

136 2,2',4,4'-Tetrachlorobiphenyl 2437-79-8 215-648-1 P P A 0.1% 0.01%
Biphenyls ( PCB ), all members"

136 2,3',4,4',5,5'-HEXACHLOROBIPHENYL 52663-72-6 215-648-1 P P A 0.1% 0.01%

136 2,4,5,2',4',5'-Hexachlorobiphenyl 35065-27-1 215-648-1 P P A 0.1% 0.01%

136 3,3',4,4'-TETRACHLOROBIPHENYL 32598-13-3 215-648-1 P P A 0.1% 0.01%

136 3,4,5,3',4',5'-Hexachlorobiphenyl 32774-16-6 215-648-1 P P A 0.1% 0.01%

136 Aroclor 1016 12674-11-2 215-648-1 P P A 0.1% 0.01%

136 Aroclor 1221 11104-28-2 215-648-1 P P A 0.1% 0.01%

136 Aroclor 1232 11141-16-5 215-648-1 P P A 0.1% 0.01%

136 Aroclor 1242 53469-21-9 215-648-1 P P A - -

136 Aroclor 1248 12672-29-6 215-648-1 P P A 0.1% 0.01%

136 AROCLOR 1254 11097-69-1 215-648-1 P P A 0.1% 0.01%

136 Aroclor 1260 11096-82-5 215-648-1 P P A 0.1% 0.01%
263
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

136 Heptachloro-1,1'-biphenyl 28655-71-2 215-648-1 P P A 0.1% 0.01%

136 Nonachloro-1,1'-biphenyl 53742-07-7 215-648-1 P P A 0.1% 0.01%

136 pentachloro[1,1'-biphenyl] 25429-29-2 215-648-1 P P A 0.1% 0.01%
STOT RE 2 *
136 Polychlorinated biphenyls 1336-36-3 215-648-1 P P A - - Aquatic Acute 1
Aquatic Chronic 1

136 Tetrachloro(tetrachlorophenyl)benzene 31472-83-0 250-646-4 P P A 0.1% 0.01%
hexachlorobiphenyl See 1st line of "Polychlorinated

136 33979-03-2 251-773-8 P - B - -
(2,2',4,4',6,6'-PCB) Biphenyls ( PCB ), all members"
CAN Prohibition of Certain Toxic

Polychlorinated Naphthalenes, Solvent, Skin disorder, Substances Regulations
137 Naphthalene, chloro derivatives 70776-03-3 274-864-4 P P A - -
all members plasticizer carcinogenic JPN CSCL Class 1
POPs substance

137 Naphthalene, trichloro- 1321-65-9 215-321-3 P P A - -
Naphthalenes, all members"
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2 See 1st line of "Polychlorinated
137 Pentachloronaphthalene 1321-64-8 215-320-8 P P A - -
Skin Irrit. 2 Naphthalenes, all members"
Aquatic Acute 1
Aquatic Chronic 1
Polychlorinated naphthalene;
137 Cyclohexanecarboxylic acid, 4-propyl-, 38289-27-9 P - B - - POPs substance
trans- (9CI)
hexachloronaphthalene
137 1335-87-1 215-641-3 P - B - - POPs substance
(Halowax 1014)
137 tetrachloronaphthalene 1335-88-2 215-642-9 P - B - - POPs substance
137 octachloronaphthalene 2234-13-1 218-778-7 P - B - - POPs substance
137 chloronaphthalene 25586-43-0 247-120-1 P - B - - POPs substance
137 dichloronaphthalene 28699-88-9 249-165-2 P - B - - POPs substance
137 heptachloronaphthalene 32241-08-0 250-969-0 P - B - - POPs substance
Insulating fluid for electric Irritation of eyes,

Polychlorinated Terphenyls ( ChemVerbotsV
138 Terphenyl, chlorinated 61788-33-8 262-968-2 P P A 0.005% 0.0001% system, switchboard, skin and liver disorder,
PCT ), all members EU-D 2005/69/EC
transformer and condenser carcinogenic
264
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
Muta. 1B
Polycyclic aromatic REACH ANNEX XVII, SVHC
Repr. 1B
139 hydrocarbons (PAH; PCAH), Benzo(a)pyrene 50-32-8 200-028-5 P D B X 0.001% 0.001% Tire extender oil intention
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
Polycyclic aromatic Carc. 1B

REACH ANNEX XVII
139 hydrocarbons (PAH; PCAH), Benzo(e)pyrene 192-97-2 205-892-7 P D B 0.1% 0.01% Aquatic Acute 1
Reg. (EC) No 1272/2008
Polycyclic aromatic
139 Anthracene 120-12-7 204-371-1 P D B 0.1% 0.01% Carc. 1B REACH SVHC
hydrocarbons (PAH; PCAH),
selected

REACH ANNEX XVII
139 hydrocarbons (PAH; PCAH), Benz(a)anthracene 56-55-3 200-280-6 P D B X 0.001% 0.001% Aquatic Acute 1
Reg. (EC) No 1272/2008
Carc. 1B
Polycyclic aromatic
Muta. 2 REACH ANNEX XVII
139 hydrocarbons (PAH; PCAH), Chrysene 218-01-9 205-923-4 P D B 0.1% 0.01%
selected
Aquatic Chronic 1

REACH ANNEX XVII
139 hydrocarbons (PAH; PCAH), Benz(j)fluoranthene 205-82-3 205-910-3 P D B X 0.01% 0.01% Aquatic Acute 1
Reg. (EC) No 1272/2008

REACH ANNEX XVII
139 hydrocarbons (PAH; PCAH), Benz(k)fluoranthene 207-08-9 205-916-6 P D B X 0.01% 0.01% Aquatic Acute 1
Reg. (EC) No 1272/2008

REACH ANNEX XVII
139 hydrocarbons (PAH; PCAH), Dibenz(a,h)anthracene 53-70-3 200-181-8 P D B X 0.001% 0.001% Aquatic Acute 1
Reg. (EC) No 1272/2008

REACH ANNEX XVII
139 hydrocarbons (PAH; PCAH), Benz(e)acephenanthrylene 205-99-2 205-911-9 P D B X 0.01% 0.01% Aquatic Acute 1
Reg. (EC) No 1272/2008
Polycyclic aromatic Carc. 1A Muta. 1B Repr. 1B REACH ANNEX XIV

139 hydrocarbons (PAH; PCAH), Coal tar pitch, high temperature 65996-93-2 266-028-2 D - B 0.01% Aquatic Acute 1 RECOMMENDATION
selected Aquatic Chronic 1 Reg. (EC) No 1272/2008
REACH ANNEX XIV

Polycyclic aromatic
RECOMMENDATION, ANNEX
139 hydrocarbons (PAH; PCAH), Anthracene oil 90640-80-5 292-602-7 D - B 0.01% Carc. 1B
XVII
selected
Reg. (EC) No 1272/2008
Polycyclic aromatic
Anthracene oil, anthracene paste, Carc. 1B REACH SVHC
139 hydrocarbons (PAH; PCAH), 91995-17-4 295-278-5 D - B 0.01%
distn. Lights Muta. 1B Reg. (EC) No 1272/2008
selected
Polycyclic aromatic
Anthracene oil, anthracene paste, Carc. 1B REACH SVHC
139 hydrocarbons (PAH; PCAH), 91995-15-2 295-275-9 D - B 0.01%
anthracene fraction Muta. 1B Reg. (EC) No 1272/2009
selected
Polycyclic aromatic
Carc. 1B REACH SVHC
139 hydrocarbons (PAH; PCAH), Anthracene oil, anthracene-low 90640-82-7 292-604-8 D - B 0.01%
Muta. 1B Reg. (EC) No 1272/2010
selected
Polycyclic aromatic Carc. 1B REACH SVHC

139 Anthracene oil, anthracene paste 90640-81-6 292-603-2 D - B 0.01%
hydrocarbons (PAH; PCAH), Muta. 1B Reg. (EC) No 1272/2011
selected
265
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Phosphonium, triphenyl(phenylmethyl)-,
Chemical Substances Control Law:
salt with 4,4'-[2,2,2-trifluoro-1-
140 75768-65-9 278-305-5 D - B 0.01% － Class 2 specified chemical
(trifluoromethyl)ethylidene]bis[phenol]
substances
(1:1)
Carc. 1B
Neutralization titration REACH SVHC
141 Phenolphthalein 77-09-8 201-004-7 D - B 0.01% Muta. 2
indicator, adsorption indicator Reg. (EC) No 1272/2008
Repr. 2
Carc. 1B
Reg. (EC) No 1272/2008
142 1,3-Propanesultone 1120-71-4 214-317-9 D - B 0.001% Acute Tox. 4 *
PACT
Acute Tox. 4 *
2-Propanone, reaction products with additive in rubber parts, paint

143 68412-48-6 270-192-0 D D A 0.01%
diphenylamine (PREPOD) additive, plasticizer
Repr. 1B
1-Methylpyrrolidin-2-one Dye material, synthetic organic Eye Irrit. 2 REACH SVHC
144 Pyrrolidones, selected 872-50-4 212-828-1 D D A 0.01%
(2-Pyrrolidinone, 1-methyl ) (NMP) intermediate body STOT SE 3 Reg. (EC) No 790/2009
Skin Irrit. 2
144 Pyrrolidones, selected N-Ethyl-2-pyrrolidone (NEP) 2687-91-4 220-250-6 D D A 0.01% Repr. 1B Reg. (EC) No 1272/2008
Poly(oxy-1,2-ethanediyl), α-[4-(1,1,3,3-
145 9002-93-1 D - B 0.01% 2000/60/EU.
tetramethylbutyl)phenyl]-ω-hydroxy-
Flam. Liq. 1
Carc. 1B
Muta. 1B
Acute Tox. 4 *
Propylene oxide; 1,2-epoxypropane; Lubricating oil, surface-active REACH SVHC
146 75-56-9 200-879-2 P - B X 0.001% 0.001% Acute Tox. 4 *
methyloxirane agent, oil-separating chemicals Reg. (EC) No 1272/2008
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Carc. 1B
Muta. 2
Acute Tox. 4 *
phenyl glycidyl ether
147 122-60-1 204-557-2 D - B 0.01% STOT SE 3 Reg. (EC) No 1272/2008
(1,2-epoxy-3-phenoxypropane)
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
Carc. 2
Repr. 1B
Perfluorooctanesulphonate, compound
STOT RE 1
with diethanolamine
148 70225-14-8 274-460-8 P - B 0.001% 0.0001% Acute Tox. 4 * PFOS
(Heptadecafluorooctanesulphonate,
Acute Tox. 4 *
compound with 2,2'-iminodiethanol)
Lact.
Aquatic Chronic 2
Carc. 1B
Muta. 2
Acute Tox. 4 *
PACT
149 quinoline 91-22-5 202-051-6 D - B 0.01% Acute Tox. 4 *
Reg. (EC) No 1272/2008
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
Radioactive substances
(including scrap metal Carcinogenic
150 Plutonium 7440-07-5 D D A 0.01% High-intensity discharge lamp 2013/59/EURATOM
contaminants), Endocrine disruption
all members
266
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
(including scrap metal See 1st line of "Radioactive
150 Radium 7440-14-4 231-122-4 D D A 0.01%
contaminants), substances, all members"
all members
150 Thorium 7440-29-1 231-139-7 D D A 0.01%
all members
150 Thorium Dioxide 1314-20-1 215-225-1 D D A 0.01%
all members
Radioactive substances Acute Tox. 2 *

(including scrap metal Acute Tox. 2 * See 1st line of "Radioactive
150 Uranium 7440-61-1 231-170-6 D D A 0.01%
contaminants), STOT RE 2 * substances, all members"
all members Aquatic Chronic 4
150 Uranium Compounds D - B 0.01%
all members
Glass stainer, color-dulling Urtication, coughing, feeling of

Selenium and its compounds, all agent for lead glass, red suffocation, nausea,
151 Barium selenite 13718-59-7 237-280-0 D D A 0.01% Waste Disposal and Public
members pigments, electronic part, pharyngalgia, feeling of
Cleaning Law
rectifier listlessness
Acute Tox. 3 *
Acute Tox. 3 *
Selenium and its compounds, all See 1st line of "Selenium and its
151 Hydrogen selenide 7783-07-5 231-978-9 D D A 0.01% STOT RE 2
members compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
151 Iron selenide 1310-32-3 215-177-1 D D A 0.01%
Acute Tox. 3 *
Acute Tox. 3 *
151 Sodium-selenite 10102-18-8 233-267-9 D D A 0.01% STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 3 *
Acute Tox. 3 *
151 Selenium oxide 12640-89-0 235-738-4 D D A 0.01% STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 3 *
Acute Tox. 3 *
Selenium and its compounds, all Bis(ethylselenyl)diiron tetranitrosyl See 1st line of "Selenium and its
151 15025-89-5 D D A 0.01% STOT RE 2
members (6CI) compounds, all members"
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 3 *
Acute Tox. 3 *
151 Dimethylselenide 593-79-3 209-807-4 D D A 0.01% STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 3 *
Acute Tox. 3 *
151 Selenium sulfide 7446-34-6 D D A 0.01% STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
267
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
151 Selenic acid 7783-08-6 D D A 0.01%
151 Selenious acid 7783-00-8 231-974-7 D D A 0.01%
Acute Tox. 3 *
Selenium and its compounds, all Acute Tox. 3 * See 1st line of "Selenium and its
151 Selenium 7782-49-2 231-957-4 D D A 0.01%
members STOT RE 2 * compounds, all members"
Aquatic Chronic 4
Acute Tox. 3 *
Acute Tox. 3 *
151 Selenium dioxide 7446-08-4 231-194-7 D D A 0.01% STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
Acute Tox. 3 *
Acute Tox. 3 *
151 Selenium hexafluoride 7783-79-1 D D A 0.01% STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
151 Zinc selenide 1315-09-9 215-259-7 D D A 0.01%
151 Thallium selenide (Tl2Se) 15572-25-5 239-627-1 D D A 0.01%
151 Thallium(I) selenide 12039-52-0 234-895-6 D D A 0.01%
Raw materials for ceramic

IARC Group 1 Carcinogen,
industry, raw materials for Coughing,
152 Silica, Crystalline 14808-60-7 238-878-4 D D A 0.01% US National Toxicology Program
solium silicate, for casting and carcinogenic
Probable Human carcinogen
molding

153 Sodium azide 26628-22-8 247-852-1 R D B 0.1% 0.01% Aquatic Acute 1 Poisonous and Deleterious Prohibit in Japan
intermediate body
Aquatic Chronic 1 Substances Control Law
Flam. Liq. 3
Repr. 2
Residual monomer such as Reg. (EC) No 1272/2008
Acute Tox. 4*
154 Styrene ( Vinyl benzene ) 100-42-5 202-851-5 D D A 0.01% ABS resin, polystyrene resin, PACT
STOT RE 1
or SMC EU Risk Assessment
Skin Irrit. 2
Eye Irrit. 2
Carc. 1B
Residual
155 Styrene oxide (Epoxy styrene) 96-09-3 202-476-7 D D A 0.001% Acute Tox. 4 * Reg. (EC) No 1272/2008
monomer
Eye Irrit. 2
EC No. 842/2006
Automobile tire, window glass, Global warming
156 Sulfur Hexafluoride 2551-62-4 219-854-2 P D/P B 0.1% 0.01% Substance of concern due to global
refrigerant substance
warming potential
Oxid. Sol. 2
Repr. 1B
157 Sodium peroxometaborate 7632-04-4 231-556-4 D - B 0.01% Acute Tox. 4 * REACH SVHC
STOT SE 3
Eye Dam. 1
158 Silicic acid, barium salt, lead-doped 68784-75-8 272-271-5 P - B 0.1% 0.001% Lamp fluorescent material Reproductive toxicity REACH SVHC
268
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 1B
sulfallate (ISO);
Acute Tox. 4 *
159 2-chloroallyl N,N- 95-06-7 202-388-9 D - B 0.01% Reg. (EC) No 1272/2008
Aquatic Acute 1
dimethyldithiocarbamate
Aquatic Chronic 1
Carc. 1B REACH ANNEX XVII

160 tar acids, coal, crude 65996-85-2 266-019-3 D - B 0.01%
Muta. 1B Reg. (EC) No 1272/2008
1,2-bis(2-methoxyethoxy)ethane Solvent, coolant, absorbent, REACH SVHC

161 112-49-2 203-977-3 D - B 0.01% Repr. 1B
［TEGDME，triglyme］ acid gas, cleaning agent Reg. (EC) No 1272/2008
162 tetrabromophthalic anhydride 632-79-1 211-185-4 D - B 0.01% PACT
Oil soluble phenol resin Skin Irrit. 2

4-(1,1,3,3-tetramethylbutyl)phenol, (4- (tackifier, printing ink, varnish), Eye Dam. 1 REACH SVHC
163 140-66-9 205-426-2 D - B 0.01%
tert-Octylphenol) surface active agent (textile oil, Aquatic Acute 1 PACT
for polymer, for agrichemicals) Aquatic Chronic 1
Expl. 1.1
5-tert-butyl-2,4,6-trinitro-m-xylene Carc. 2 REACH ANNEX XIV
164 81-15-2 201-329-4 P - B X 0.01% 0.01% Perfume 2014/8/21
(musk xylene) Aquatic Acute 1 Reg. (EC) No 1272/2008
Aquatic Chronic 1
Dye material, synthetic organic Aquatic Acute 1 PACT

165 Tetrabromobisphenol A(TBBPA) 79-94-7 201-236-9 D D A 0.01%
intermediate body Aquatic Chronic 1 EU risk assessment

Substances Regulations, 2005
Tetrachlorobenzene, all Coughing,
166 1,2,3,4-tetrachlorobenzene 634-66-2 211-214-0 P P A 0.1% 0.01% Agricultural chemicals (SOR/SOR/2005-41. Published in
members hepatic disorder
29 Vol. 140, No. 24
Tetrachlorobenzene, all See 1st line of

166 1,2,3,5- tetrachlorobenzene 634-90-2 211-217-7 P P A 0.1% 0.01%
members "Tetrachlorobenzene, all members"

166 Benzene, tetrachloro- 12408-10-5 235-643-8 P P A 0.1% 0.01%

166 1,2,4,5- tetrachlorobenzene 95-94-3 202-466-2 P P A 0.1% 0.01%
Reg. (EC) No 1272/2008

Materials for electronics
Confusion, dizziness, Statutory Order no. 552 of 2 July
167 Tetrafluromethane 75-73-0 200-896-5 P D/P B 0.1% 0.01% industry (semiconductors),
headache 2002 of the Danish Ministry of the
refrigerant, etching gas
Environment
Acute Tox. 2 *
Acute Tox. 2 *
168 Thallium 7440-28-0 231-138-1 D D A 0.01% Reg. (EC) No 1272/2008
STOT RE 2 *
Aquatic Chronic 4
269
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 * Reg. (EC) No 1272/2008
Thioperoxydicarbonicdiamide([(H2N)C(
Eye Irrit. 2 PACT
169 S)]2S2),tetramethyl-; Thiram; 137-26-8 205-286-2 D D/P B 0.01% Rubber vulcanizing accelerator
Skin Irrit. 2 Japan Waste management and
Tetramethylthiuram disulphide
Skin Sens. 1 public cleansing law
Aquatic Acute 1
Aquatic Chronic 1
Muta. 1B
Powder paint, solder resist ink, Acute Tox. 3 *
optical semiconductor sealing Acute Tox. 3 * REACH SVHC
TGIC (1,3,5-tris(oxiranylmethyl)-1,3,5-
170 TGIC 2451-62-9 219-514-3 D - B 0.01% resin, epoxy-resin reforming STOT RE 2 * Reg. (EC) No 1272/2008
triazine-2,4,6(1H,3H,5H)-trione)
material, stabilizer of a Eye Dam. 1 PACT
resistance-to-flame plastics Skin Sens. 1
Aquatic Chronic 3
Muta. 1B
Acute Tox. 3 *
β-TGIC (1,3,5-tris[(2S and 2R)-2,3-
169 TGIC epoxypropyl]-1,3,5-triazine-2,4,6- 59653-74-6 423-400-0 D - B 0.01% Resin and hardener of coating
STOT RE 2 * Reg. (EC) No 1272/2008
(1H,3H,5H)-trione); Teroxirone
Eye Dam. 1
Skin Sens. 1
Flam. Liq. 2
Repr. 2
REACH ANNEX XVII
Asp. Tox. 1
171 Toluene 108-88-3 203-625-9 D D A 0.01% Solvent Reg. (EC) No 1272/2008
STOT RE 2 *
PACT
Skin Irrit. 2
STOT SE 3
DOTG is a non-regulated, FDA

compliant substance for food
contact but also a possible source
o-Toluidine generating ACM rubber (in gasket, bracket, o-ring, etc.), AEM rubber, EPDM
172 1,2-Di-o-tolylguanidine, DOTG 97-39-2 202-577-6 D D A 0.01% of o-Toluidine in rubber products.
substances, selected rubber
Listed to identify products to
evaluate for possible o-Toluidine
formation. Temporary listing.
o-Toluidine generating Dye material, synthetic organic REACH SVHC

172 o-Toluidine 95-53-4 202-429-0 P - B 0.1% 0.01% Carc. 1B
substances, selected intermediate body (EC) No 1272/2008
Acute Tox. 4 *
Eye Irrit. 2
173 Trichlorophenol and its salts, all 2,4,5 -Trichlorophenol 95-95-4 202-467-8 D D A 0.01% Dye intermediate, antiseptic Skin Irrit. 2 (EC) No 1272/2008
members Aquatic Acute 1
Aquatic Chronic 1
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
173 Trichlorophenol and its salts, all 2,4,6 -Trichlorophenol 88-06-2 201-795-9 D D A 0.01% Dye intermediate, antiseptic (EC) No 1272/2008
Skin Irrit. 2
members
Aquatic Acute 1
Aquatic Chronic 1
Carc. 1B
Repr. 1B
Trichloropropane( 1,2,3 - REACH SVHC
174 96-18-4 202-486-1 D D A 0.01% Solvent, cross-linker Acute Tox. 4 *
Trichloropropane) Reg. (EC) No 1272/2008
Acute Tox. 4 *
Acute Tox. 4 *
270
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Solvent, coloring inhibitor in Shortness of breath, feeling of

175 Trimethylphosphate 512-56-1 208-144-8 D D A 0.01% manufacture of polymer, flame listlessness, over-irritation, Reg. (EC) No 552/2009
retardant tremors
Triorganotin Corrosive to eyes, skin and

Pollution
176 compounds,selected (trialkyl- (Chloroacetoxy)triphenylstannane 7094-94-2 230-401-8 P P A 0.1% 0.01% airway, possibility of endocrine REACH Annex XVII
inhibition paint
and　triaryltin compounds) disruptors
[1R-
Triorganotin (1.alpha.,4a.beta.,4b.alpha.,10a.alpha.) See 1st line of "Triorganotin
176 compounds,selected (trialkyl- ]-Tributyl[[[1,2,3,4,4a,4b,5,6,10,10a- 26239-64-5 247-531-6 P P A 0.1% 0.01% compounds,selected (trialkyl- and
and　triaryltin compounds) decahydro-7-isopropyl-1,4a-dimethyl-1- triaryltin compounds)
phenanthryl]carbonyl]oxy]stannane
Triorganotin Acetic acid, 2,2',2''- See 1st line of "Triorganotin

176 compounds,selected (trialkyl- [(methylstannylidyne)tris(thio)]tris-, 54849-38-6 259-374-0 P P A 0.1% 0.01% compounds,selected (trialkyl- and
and　triaryltin compounds) triisooctyl ester triaryltin compounds)
Acute Tox. 2 *
Triorganotin Eye Irrit. 2 See 1st line of "Triorganotin
Bis(tris(2-methyl-2-phenylpropyl)tin)
176 compounds,selected (trialkyl- 13356-08-6 236-407-7 P P A 0.1% 0.001% Skin Irrit. 2 compounds,selected (trialkyl- and
oxide
and　triaryltin compounds) Aquatic Acute 1 triaryltin compounds)
Aquatic Chronic 1
Triorganotin See 1st line of "Triorganotin

176 compounds,selected (trialkyl- Bis(tributyltin) maleate 14275-57-1 238-166-3 P P A 0.1% 0.01% compounds,selected (trialkyl- and
and　triaryltin compounds) triaryltin compounds)

176 compounds,selected (trialkyl- Bis(tributyltin)phthalate 4782-29-0 225-327-8 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Bis(tributylstannyl)Fumarate 6454-35-9 229-262-6 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Bromotrimethylstannane 1066-44-0 213-916-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and
Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
See 1st line of "Triorganotin
Triorganotin Acute Tox. 3 *
compounds,selected (trialkyl- and
176 compounds,selected (trialkyl- Stannane, acetoxytriphenyl- 900-95-8 212-984-0 P P A 0.1% 0.001% STOT RE 1
triaryltin compounds)
and　triaryltin compounds) STOT SE 3
Reg. (EC) No 1272/2008
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

176 compounds,selected (trialkyl- Stannane, bromotriethyl- 2767-54-6 220-443-5 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Stannane, fluorotriphenyl- 379-52-2 206-833-8 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Stannane, tributylfluoro- 1983-10-4 217-847-9 P P A 0.1% 0.01% compounds,selected (trialkyl- and
271
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

176 compounds,selected (trialkyl- Tributyl(lauroyloxy)stannane 3090-36-6 221-434-9 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyl(neodecanoyloxy)stannane 28801-69-6 249-232-6 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyl(oleoyloxy)stannane 3090-35-5 221-433-3 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin (and salts and esters) 688-73-3 211-704-4 P P A 0.1% 0.001% compounds,selected (trialkyl- and

Tributyltin .alpha.-(2,4,5-
176 compounds,selected (trialkyl- 73940-89-3 P P A 0.1% 0.01% compounds,selected (trialkyl- and
trichlorophenoxy) propionate

176 compounds,selected (trialkyl- Tributyltin .beta.-iodopropionate 73927-95-4 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin acetate 56-36-0 200-269-6 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin Acrylate 13331-52-7 236-381-7 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin benzoate 4342-36-3 224-399-8 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin bromide 1461-23-0 215-959-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin chloride 1461-22-9 215-958-7 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin dimethyldithiocarbamate 20369-63-5 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin hydroxide 1067-97-6 213-939-8 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin iodide 7342-47-4 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin iodoacetate 73927-91-0 P P A 0.1% 0.01% compounds,selected (trialkyl- and
272
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

176 compounds,selected (trialkyl- Tributyltin isooctylthioacetate 73927-97-6 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin isothiocyanate 681-99-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin linoleate 24124-25-2 246-024-7 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin methacrylate 2155-70-6 218-452-4 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin methoxide 1067-52-3 213-933-5 P P A 0.1% 0.01% compounds,selected (trialkyl- and

Tributyltin monopropylene glycol
maleate

176 compounds,selected (trialkyl- Tributyltin nonanoate 4027-14-9 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin sulfamate 6517-25-5 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Triethyltin acetate 1907-13-7 217-609-4 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Triethyltin chloride 994-31-0 213-616-1 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Triethyltin hydroxide 994-32-1 213-617-7 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Triethyltin iodide 2943-86-4 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Triethyltin phenoxide 1529-30-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Trimethyltin acetate 1118-14-5 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Trimethyltin azide 1118-03-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and
273
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

176 compounds,selected (trialkyl- Trimethyltin chloride 1066-45-1 213-917-8 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Trimethyltin hydroxide 56-24-6 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Trimethyltin iodide 811-73-4 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Trimethyltin sulphate 63869-87-4 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Trimethyltin thiocyanate 4638-25-9 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tri-n-butyl tin salicylate 4342-30-7 224-397-7 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Triphenylstannyl decanoate 47672-31-1 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Triphenyl tin chloride 639-58-7 211-358-4 P P A 0.1% 0.001% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Triphenyltin dimethyldithiocarbamate 1803-12-9 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Triphenyltin hydride 892-20-6 212-967-8 P P A 0.1% 0.01% compounds,selected (trialkyl- and
Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Triorganotin Acute Tox. 3 * See 1st line of "Triorganotin
176 compounds,selected (trialkyl- Triphenyltin hydroxide 76-87-9 200-990-6 P P A 0.1% 0.001% STOT RE 1 compounds,selected (trialkyl- and
and　triaryltin compounds) STOT SE 3 triaryltin compounds)
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

176 compounds,selected (trialkyl- Triphenyltin iodide 894-09-7 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tripropyltin acetate 3267-78-5 221-879-9 P P A 0.1% 0.01% compounds,selected (trialkyl- and
274
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

176 compounds,selected (trialkyl- Tripropyltin bromide 2767-61-5 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tripropyltin chloride 2279-76-7 218-910-3 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tripropyltin iodide 7342-45-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tripropyltin iodoacetate 73927-92-1 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tripropyltin laurate 57808-37-4 260-965-0 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tripropyltin methacrylate 4154-35-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and
Triorganotin Corrosive to eyes, skin and See 1st line of "Triorganotin

Pollution
176 compounds,selected (trialkyl- (2-BIPHENYLOXY)TRIBUTYLTIN 3644-37-9 P P A 0.1% 0.01% airway, possibility of endocrine compounds,selected (trialkyl- and
inhibition paint
and　triaryltin compounds) disruptors triaryltin compounds)

1,3,5-TRIS(TRIBUTYLTIN)-S-
TRIAZINE-2,4,6-TRIONE

2-BUTENOIC ACID, 4-OXO-4-[
176 compounds,selected (trialkyl- 4027-18-3 223-701-5 P P A 0.1% 0.01% compounds,selected (trialkyl- and
(TRIBUTYLSTANNYL)OXY]-

176 compounds,selected (trialkyl- BIS(TRIBUTYLTIN) ITACONATE 25711-26-6 247-200-6 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- P-NITROPHENOXYTRIBUTYLTIN 3644-32-4 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- Tributyltin 56573-85-4 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- TRIBUTYLTIN 2-ETHYLHEXANOATE 5035-67-6 225-726-7 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- TRIBUTYLTIN CHLOROACETATE 5847-52-9 P P A 0.1% 0.01% compounds,selected (trialkyl- and
Triorganotin Corrosive to eyes, skin and See 1st line of "Triorganotin

Pollution
176 compounds,selected (trialkyl- Tributyltin cinnamate 27147-18-8 P P A 0.1% 0.01% airway, possibility of endocrine compounds,selected (trialkyl- and
inhibition paint
and　triaryltin compounds) disruptors triaryltin compounds)
275
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

176 compounds,selected (trialkyl- TRIBUTYLTIN CYANATE 4027-17-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- TRIBUTYLTIN CYANIDE 2179-92-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and

TRIBUTYLTIN GAMMA-
CHLOROBUTYRATE

TRIBUTYLTIN
176 compounds,selected (trialkyl- 53404-82-3 258-537-3 P P A 0.1% 0.01% compounds,selected (trialkyl- and
ISOPROPYLSUCCINATE

TRIBUTYLTIN
METHANESULPHONATE

176 compounds,selected (trialkyl- TRIBUTYLTIN NAPHTHENATE 36631-23-9 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- TRIBUTYLTIN O-IODOBENZOATE 73927-93-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- TRIBUTYLTIN P-IODOBEMZOATE 73940-88-2 P P A 0.1% 0.01% compounds,selected (trialkyl- and

176 compounds,selected (trialkyl- TRIBUTYLTIN UNDECYLENATE 69226-47-7 P P A 0.1% 0.01% compounds,selected (trialkyl- and
Acute Tox. 2 *
Acute Tox. 3 *
Triorganotin STOT SE 3 See 1st line of "Triorganotin
1-(Tricyclohexylstannyl)-1H-1,2,4-
176 compounds,selected (trialkyl- 41083-11-8 255-209-1 P P A 0.1% 0.01% Skin Irrit. 2 compounds,selected (trialkyl- and
triazole
and　triaryltin compounds) Eye Dam. 1 triaryltin compounds)
Aquatic Acute 1
Aquatic Chronic 1

EU Index
176 compounds,selected (trialkyl- Tricyclohexyl Tin Compounds P - B 0.1% 0.01% compounds,selected (trialkyl- and
050-012-00-5

EU Index
176 compounds,selected (trialkyl- Triethyl Tin Compounds P - B 0.1% 0.01% compounds,selected (trialkyl- and
050-006-00-2

EU Index
176 compounds,selected (trialkyl- Trihexyl Tin Compounds P - B 0.1% 0.01% compounds,selected (trialkyl- and
050-010-00-4

EU Index
176 compounds,selected (trialkyl- Trimethyl Tin Compounds P - B 0.1% 0.01% compounds,selected (trialkyl- and
050-005-00-7
276
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement

EU Index
176 compounds,selected (trialkyl- Trioctyl Tin Compounds P - B 0.1% 0.01% compounds,selected (trialkyl- and
050-013-00-0

EU Index
176 compounds,selected (trialkyl- Tripentyl Tin Compounds P - B 0.1% 0.01% compounds,selected (trialkyl- and
050-009-00-9

EU Index
176 compounds,selected (trialkyl- Triphenyl Tin Compounds P - B 0.1% 0.01% compounds,selected (trialkyl- and
050-011-00-X

EU Index
176 compounds,selected (trialkyl- Tripropyl Tin Compounds P - B 0.1% 0.01% compounds,selected (trialkyl- and
050-007-00-8
Triorganotin Bis(tributyltin) oxide; 1,1,1,3,3,3- See 1st line of "Triorganotin

176 compounds,selected (trialkyl- Hexabutyldistannoxane; Tributyltin 56-35-9 200-268-0 P P A 0.1% 0.001% compounds,selected (trialkyl- and
and　triaryltin compounds) oxide (TBTO) triaryltin compounds)

176 compounds,selected (trialkyl- Tributyltin naphthenate 85409-17-2 287-083-9 P P A 0.1% 0.001% compounds,selected (trialkyl- and
Flame retardant
177 Phosphate Flame Retardants Triphenylphosphate 115-86-6 204-112-2 D D A 0.01% Flame retardant Blood disorders
under review
Reg. (EC) No 1272/2008

US California Prop 65
177 Phosphate Flame Retardants Tris(1,3-dichloro-2-propyl)phosphate 13674-87-8 237-159-2 D D A 0.01% Flame retardan Carc. 2
notify/labelling will be required, but
not eliminated at this time
Dye material, synthetic organic Cauterization of skin, eyes,

177 Phosphate Flame Retardants Tris-(1-aziridinyl) phosphine oxide 545-55-1 208-892-5 P P A 0.1% 0.01% REACH ANNEX XVII
intermediate body and mucosa
REACH ANNEX XVII

Tris(2,3-dibromopropyl)phosphate
177 Phosphate Flame Retardants 126-72-7 204-799-9 P P A - - Flame retardant Carcinogenic TSCA Article 5
[TRIS]
79/633/EEC
Carc. 2
177 Phosphate Flame Retardants Tris(2-chloroethyl)phosphate 115-96-8 204-118-5 P D/P B X 0.01% 0.01% Flame retardant 2015/8/21
Acute Tox. 4 * (EC) No 1272/2008
Aquatic Chronic 2
REACH SVHC
Fire retardant, plasticizer, oil
177 Phosphate Flame Retardants Trixylyl phosphate 25155-23-1 246-677-8 D D A 0.01% Repr. 1B Reg. (EC) No 1272/2008
pressure hydraulic oil
PACT
Material of medicine and an Red flare, tumefaction, Poisonous and Deleterious

178 Tributylamine 102-82-9 203-058-7 R - B 0.1% 0.01% Prohibit in Japan
agricultural chemical corrosion, necrosis Substances Control Law
179 trichlorobenzene all isomers trichlorobenzene all isomers 12002-48-1 234-413-4 P - B 0.1% 0.01% POPs substance
180 2,4,6-tribromophenol 118-79-6 204-278-6 D - B 0.01% PACT
277
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Muta. 2
Dye, medicines, intermediates Repr. 2
Reg. (EC) No 1272/2008
of medicines, STOT RE 1
181 Vanadium(V) oxide 1314-62-1 215-239-8 D - B 0.01% synthetic intermediate, Acute Tox. 4 *
catalyst, pottery tinting, Acute Tox. 4 *
Challenge).
ultraviolet rays cut glass STOT SE 3
Aquatic Chronic 2
Press. Gas
REACH ANNEX XVII
182 Vinyl chloride 75-01-4 200-831-0 P P A 0.1% 0.01% Residual monomer in polymer Flam. Gas 1
Reg. (EC) No 1272/2008
Carc. 1A
Eye Dam. 1
Hexahydromethylphathalic
183 Hexahydromethylphathalic anhydride 25550-51-0 247-094-1 D - B 0.01% Hardener of epoxy-resin Resp. Sens. 1 REACH SVHC
anhydride
Skin Sens. 1
Eye Dam. 1
183 Hexahydro-4-methylphathalic anhydride 19438-60-9 243-072-0 D - B 0.01% Resp. Sens. 1 REACH SVHC
anhydride
Skin Sens. 1
Eye Dam. 1
anhydride
Skin Sens. 1
Eye Dam. 1
anhydride
Skin Sens. 1
Cyclohexane-1,2-dicarboxylic Alkyd resin, material of Eye Dam. 1

Cyclohexane-1,2-dicarboxylic
184 anhydride (Hexahydrophthalic 85-42-7 201-604-9 D - B 0.01% plasticizer, hardener of epoxy- Resp. Sens. 1 REACH SVHC
anhydride
anhydride - HHPA) resin Skin Sens. 1
Cyclohexane-1,2-dicarboxylic Eye Dam. 1

cis-cyclohexane-1,2-dicarboxylic
184 anhydride (Hexahydrophthalic 13149-00-3 236-086-3 D - B 0.01% Resp. Sens. 1 REACH SVHC
anhydride
anhydride - HHPA) Skin Sens. 1
Cyclohexane-1,2-dicarboxylic Eye Dam. 1

trans-cyclohexane-1,2-dicarboxylic
184 anhydride (Hexahydrophthalic 14166-21-3 238-009-9 D - B 0.01% Resp. Sens. 1 REACH SVHC
anhydride
anhydride - HHPA) Skin Sens. 1
Oxid. Sol. 2
Repr. 1B
Sodium perborate, perboric acid,
185 Sodium perborate 15120-21-5 239-172-9 D - B 0.01% Acute Tox. 4 * REACH SVHC
sodium salt
STOT SE 3
Eye Dam. 1
Oxid. Sol. 3
Repr. 1B
Sodium perborate, perboric acid,
185 perboric acid, sodium salt 11138-47-9 234-390-0 D - B 0.01% Acute Tox. 4 * REACH SVHC
sodium salt
STOT SE 3
Eye Dam. 1
bisphenol A Repr. 2
(p,p'- STOT SE 3
186 Bispenol 80-05-7 201-245-8 R - B 0.01% 0.01% Reg. (EC) No 1272/2008 Prohibit for thermal paper
dihydroxydiphenyldimethylmethane ; Eye Dam. 1
4,4 -Isopropylidenediphenol) Skin Sens. 1
REACH SVHC intension

186 Bispenol bisphenol F 620-92-8 210-658-2 D - B 0.01% Carc. 1B
PACT
278
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
186 Bispenol bisphenol S 80-09-1 201-250-5 D - B 0.01% Carc. 1B PACT
232-443-2
272-185-8
285-510-3
265-066-7
271-267-0
265-042-6
265-067-2
295-431-6
309-945-6
265-041-0
295-433-7
265-185-4
265-178-6
295-434-2
Heavy Aromatic Distillates and Distillates (petroleum), heavy 285-511-9
187 64741-53-3 D - B 0.01% Carc. 1A Reg. (EC) No 1272/2008
Extracts naphthenic 265-150-3
265-151-9
265-073-5
295-440-5
265-068-8
265-056-2
295-441-0
270-993-5
265-071-4
265-046-8
295-447-3
295-442-6
272-206-0
265-086-6
265-089-2
309 976 5
Heavy Aromatic Distillates and Extracts (petroleum), heavy paraffinic
187 64742-04-7 265-103-7 D - B 0.01% Carc. 1B Reg. (EC) No 1272/2008
Extracts distillate solvent
265-111-0
232-443-2
272-185-8
285-510-3
265-066-7
271-267-0
265-042-6
265-067-2
295-431-6
309-945-6
265-041-0
295-433-7
265-185-4
265-178-6
Heavy Aromatic Distillates and Extracts (petroleum), heavy naphthenic 295-434-2
187 64742-11-6 D - B 0.01% Carc. 1B Reg. (EC) No 1272/2008
Extracts distillate solvent 285-511-9
265-150-3
265-151-9
265-073-5
295-440-5
265-068-8
265-056-2
295-441-0
270-993-5
265-071-4
265-046-8
295-447-3
295-442-6
272-206-0
265-086-6
265 089 2
279
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
265-117-3
232-443-2
272-185-8
285-510-3
265-066-7
271-267-0
265-042-6
265-067-2
295-431-6
309-945-6
265-041-0
295-433-7
265-185-4
265-178-6
Heavy Aromatic Distillates and Distillates (petroleum), acid-treated 295-434-2
187 64742-18-3 D - B 0.01% Carc. 1A Reg. (EC) No 1272/2008
Extracts heavy naphthenic 285-511-9
265-150-3
265-151-9
265-073-5
295-440-5
265-068-8
265-056-2
295-441-0
270-993-5
265-071-4
265-046-8
295-447-3
295-442-6
272-206-0
265-086-6
265 089 2

188 Cyclotetrasiloxane Cyclotetrasiloxane, heptamethylphenyl- 10448-09-6 233-931-8 D - B 0.01% December 9, 2006 (Canadian
Challenge).
Reg. (EC) No 1272/2008

Resin, antifoaming agent, PACT
Repr. 2
188 Cyclotetrasiloxane Cyclotetrasiloxane, octamethyl- 556-67-2 209-136-7 D - B 0.01% lubricant, brightener, dielectric Canada Gazette Vol. 140, No. 49 -
Aquatic Chronic 4
fluid, adhesives December 9, 2006 (Canadian
Challenge).

189 Cosafluorotridecanoic acid Pentacosafluorotridecanoic acid 72629-94-8 276-745-2 D - B 0.01% REACh SVHC
intermediate body
Surface-active agent, water

189 Cosafluorotridecanoic acid Tricosafluorododecanoic acid 307-55-1 206-203-2 D - B 0.01% repellant, clothing, architectural REACh SVHC
material
189 Cosafluorotridecanoic acid Henicosafluoroundecanoic acid 2058-94-8 218-165-4 D - B 0.01% Organic synthesis material REACh SVHC
189 Cosafluorotridecanoic acid Heptacosafluorotetradecanoic acid 376-06-7 206-803-4 D - B 0.01% Organic synthesis material REACh SVHC

Siloxanes and Silicones, di-Me, Siloxanes and Silicones, di-Me,
190 70900-21-9 D - B 0.01% - Eye, genital system December 9, 2006 (Canadian
hydrogen-terminated hydrogen-terminated
Challenge).
Siloxanes and Silicones, Me 3,3,3- Canada Gazette Vol. 140, No. 49 -

Siloxanes and Silicones, di-Me,
190 trifluoropropyl, Me vinyl,hydroxy- 68952-02-3 D - B 0.01% - Eye, genital system December 9, 2006 (Canadian
hydrogen-terminated
terminated Challenge).
Carc. 2
Acute Tox. 3 * POPs substance
Wood antiseptic, paint for Acute Tox. 3 * Reg. (EC) No 1272/2008
191 Other POPs Aldrin 309-00-2 206-215-8 P - B - -
insect repellent and fungicide STOT RE 1 Chemical Substances Control Law:
Aquatic Acute 1 Class 1 specified chemical
Aquatic Chronic 1
280
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
Carc. 2
Acute Tox. 1 POPs substance
191 Other POPs Dieldrin 60-57-1 200-484-5 P - B - -
insect repellent and fungicide STOT RE 1 Chemical Substances Control Law:
Aquatic Chronic 1

191 Other POPs Endrin 72-20-8 200-775-7 P - B - -
insect repellent and fungicide Aquatic Acute 1 Chemical Substances Control Law:
Aquatic Chronic 1 Class 1 specified chemical
Carc. 2
POPs substance
Acute Tox. 3 *
1,1,1-Trichloro-2,2-bis(4- Dye material, synthetic organic Reg. (EC) No 1272/2008
191 Other POPs 50-29-3 200-024-3 P - B - - STOT RE 1
chlorophenyl)ethane; 4,4'-DDT intermediate body Chemical Substances Control Law:
Aquatic Acute 1
Class 1 specified chemical
Aquatic Chronic 1
Carc. 2 Reg. (EC) No 1272/2008

Acute Tox. 4 * Chemical Substances Control Law:
Wood antiseptic, paint for
191 Other POPs Chlordanes 57-74-9 200-349-0 P - B - - Acute Tox. 4 * Class 1 specified chemical
insect repellent and fungicide
Aquatic Acute 1 substances
Aquatic Chronic 1 POPs Substances
Carc. 2
Acute Tox. 4 * Chemical Substances Control Law:
Agricultural chemicals,
191 Other POPs Toxaphene 8001-35-2 232-283-3 P - B - - STOT SE 3 Class 1 specified chemical
insecticide
Skin Irrit. 2 substances
Aquatic Acute 1 POPs Substances
Aquatic Chronic 1
Acute Tox. 4 *
Agricultural chemicals, Skin Irrit. 2 Reg. (EC) No 1272/2008
191 Other POPs Dicofol 115-32-2 204-082-0 P - B 0.1% 0.01%
insecticide Skin Sens. 1 Chemical Substances Control Law:
Aquatic Chronic 1
Carc. 2
Acute Tox. 3 *
Reg. (EC) No 1272/2008
190 Other POPs chlordecone 143-50-0 205-601-3 P - B - - Acute Tox. 3 *
POPs Substances
Aquatic Acute 1
Aquatic Chronic 1
Carc. 2
Acute Tox. 3 *
heptachlor
191 Other POPs (1,4,5,6,7,8,8a-heptachloro-3a,4,7,7a- 76-44-8 200-962-3 P - B - -
STOT RE 2 * POPs Substances
tetrahydro-4,7-methanoindene)
Aquatic Acute 1
Aquatic Chronic 1
ugilec 121
191 Other POPs (p,p'-dichlorodiphenyl ethane); 3547-04-4 P - B - - POPs Substances
Benzene, 1,1 -ethylidenebis(4-chloro-
4-(1,1,3,3-tetramethylbutyl)phenol,
ethoxylated - covering well-defined 2315-67-5 REACH ANNEX XIV
192 D - B 0.01% Surface-active agent
substances and UVCB substances, RECOMMENDATION
polymers and homologues
ethoxylated - covering well-defined REACH ANNEX XIV
192 2315-61-9 D - B 0.01% Surface-active agent
281
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Comparison
with GADSL
NISSAN (wt%)
B: Specific
requirement
192 9002-93-1 D - B 0.01% Surface-active agent
192 2497-59-8 219-682-8 D - B 0.01% Surface-active agent
282
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Standard revision record
Issue
Date Revision sections Background
classification
Sep. 8, M0301-1994
1994 New issue
Section 4.3 (Substances with category 3 usage 1) Application to Danish government
restriction) Table 5 partially revised. for (1-year) exemption of CFC-113
Products used in CFC/washing in Europe and 1,1,1-trichloroethane was
approved on December 27, 1994.
→ Implementation date amended.
Jan. 16, M0301-1995 2) EU Regulation
HCFC in Europe
1995 Revision 94/3903/EEC (HCFC regulations
→ Newly added and implementation date etc.)
amended. 94.12
3) Swedish HCFC regulation
revision, October 1994
Section 3 (Regulation categories) Table 1 partially Increasing moves and studies to
revised. restrict and terminate the use of
mercury in automotive components,
→ Individual country definitions and compliance
centering on Michigan State. The
Feb. 21, M0301-1996 with voluntary regulations added to category 2.
"Big 3" manufacturers vowed to
1996 Revision Section 4.2 (Category 2 usage restriction voluntarily terminate the use of
substances) Table 3 partially revised. switches containing mercury from
→ Added US voluntary measures from 1997 1997. Clarify Nissan's voluntary
models to mercury section. measures.
Feb. 27, M0301-1997 Section 3 (Regulation categories) Table 1 partially 1) Clarified lead reduction targets
1997 Revision revised. and voluntary regulations in
"Recycling targets for end-of-life
→ Added category 4.
vehicles" in Department of Trade
Section 4.2 (Category 2 usage restriction and Industry Industrial Structure
substances) Table 3 partially revised. Council Scrap Vehicle Disposal
→ Added Japanese, EU, and US voluntary and Recycling Subcommittee.
measures from 1999 to mercury section. 2) Clarified specified substances
→ Added components in which use of lead is covered in "European Council and
prohibited. Board Draft Directive on End-of-life
Vehicles", including voluntary
Section 4.4 (Category 4 usage restriction
regulations.
substances) Table 6 partially revised.
→ Added obligation to report usage.
Appendix Table 1 partially revised.
→ Added specific examples of brominated flame
retardants.
Added annex.
→ Added Industrial Structure Council voluntarily
regulated substances and substances covered
by draft EU directive.
- 283 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Mar. 12, M0301-1998 Section 4.1 (Category 1 usage restriction 1) Added substances identified
1998 Revision substances) Table 2 partially revised. worldwide as toxic to category 1.
→ Added polychlorinated terphenyl, 2) Added five substances covered by
polybrominated biphenyl, polybrominated Nissan toxic substance reduction
terphenyl, monomethyl-tetrachloro-diphenyl guidelines (cadmium, mercury,
methane, monomethyl-dichloro-diphenyl lead, hexavalent chromium, and
methane, monomethyl-dibromo-diphenyl brominated flame retardants) to
methane, dioxins, carbon tetrachloride, category 2.
1,1,1-trichloroethane, and bromofluorocarbons 3) Added substances regulated by
as halide phenyls. German chemical laws to category
Section 4.2 (Category 2 usage restriction 2.
substances) Table 3 partially revised. 4) Added certain substances
→ Added usage prohibition for five substances voluntarily regulated by German
covered by Nissan toxic substance reduction Association of Automotive Industry
guidelines. to category 2, and added all to
Appendix.
→ Added German regulations to mercury
section.
- 284 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Standard revision record (continued)
Issue
classification
Section 4.2 (Category 2 usage restriction
substances) Table 3 partially revised.
→ Added German lead pigment usage
prohibition regulation.
→ Added Japan and Europe to regions
prohibiting use of nitrosating agents.
→ Added usage prohibition of pentachloroethane
in Europe.
→ Added German pentachlorophenol sale
prohibition regulation.
→ Added usage prohibition of certain arsenides
in Japan and Europe. Added related German
regulation.
→ Added usage prohibition of hydrogen sulfide
Mar. 12, M0301-1998 and formaldehyde in Japan and Europe,
1998 Revision substances voluntarily regulated by German
Association of Automotive Industry.
→ Added usage prohibition of triorganotin
compounds in Japan and Europe.
→ Added usage restrictions for halogenated
organic solvents in Europe.
→ Added usage prohibition of azo dyes in Japan
and Europe.
→ Added usage prohibition of benzopyrene in
Japan and Europe.
Revised section 5 (Related regulatory
organizations).
Revised Appendix Tables 1 and 2.
Added new Contents.
(Definitions) 1) Move substance list to top to
→ Abolish existing dividing categories, and divide make easier to use.
into three: "Usage prohibited substances and
2) Eliminate category 3 related to
usage restricted substances" divided into
Montreal Protocol and move to
general components and bulk materials, and
usage prohibited substances.
"Substances not prohibited but requiring
caution in future". 3) Clarify Nissan definition of usage
→ Reorganized definition of usage restriction and prohibition.
related regulations.
→ Definition of specified substance content in
materials, components, and products.
→ Change property list to index format.
Mar. 24, M0301-1999 → Add English names.
1999 Revision → Add section on toxicity.
→ Delete atmospheric emission standards from
substances requiring future caution as not
relevant to components.
(Substances covered)
→ Add 16th revision of 76/769/EEC.
→ Amended lead and hexavalent chromium usage
restrictions in line with revision of draft EU
end-of-life vehicle disposal directive.
(Related regulations)
→ Reorganize related regulations.
(Index by application)
→ Add new index.
- 285 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Issue
classification
(Substances covered)
→ Amended "Japan and Europe" to "Europe" only No Japanese regulatory moves.
in line with revised reduction guidelines for
specified brominated flame retardant .
polybrominated diphenyl ether (PBDE)
[Substance No. P7].
→ Added 23 substances whose usage is restricted Study Swiss/French regulations

by European regulations, particularly in
Switzerland and France.
[Additional substance numbers]
B19,C22,C23,C24,C25,D34,D35,
D36,E12,H13,H14,I2,K1,M15,M16
N12,P19,S6,T23,T24,T25,T26,
T27
May 18, M0301-2000 → Added 16 substances whose usage is restricted In accordance with revisions to
2000 Revision
in 99/43/EC, the 17th revision of EU directive regulations already mentioned.
76/769/EEC.
A17,A18,A19,B20,B21,C26,D37,
D38,D39,H10,P20,P21,S7,S8,T28
T29
→ Added 4 substances with addition of In accordance with revisions to

substances whose usage is restricted by regulations already mentioned.
revision to German hazardous substance
regulation TRGS614 (usage restrictions on azo
dyes).
Added 4 substances to A6.
(Layout)
→ New index in alphabetical order.
→ Added list of EU end-of-life vehicle directive and In accordance with EU end-of-life

exemption components. vehicle directive.
Added C1, L1, M1.
Upgraded H10 usage prohibited substances.
→ Include revision details of EU directive on 2037/2000/EC ← 3093/94/EC
ozone layer depleting substances.
Dec. 26, [Change substance number]
2000 H5
M0301-2000
Revision [Additional substance numbers]
B22 (bromochloromethane)
→ Added substances covered by Montreal Montreal Protocol
Protocol.
M17 (methyl bromide),
→ Added Japanese chemical law class1 Added chemical law class 1.
substances.
M18, T30
- 286 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
[Change substance number]
Integrated M16 and E6 into E6.
M17 was duplicated, so changed M16 to methyl
bromide and M17 to N-mono (or di) methyl phenyl-N'
-mono (or di) methyl phenyl para-phenylenediamine.
B22 Canadian basic environmental law
H14 76/769/EEC In compliance with 8th
→ Prohibited even in manufacturing processes for revision
nonferrous metals.
A20 76/769/EEC 20th revision
C17,R2,E13 76/769/EEC 21th revision
C27 76/769/EEC In compliance with 7th
revision
P22 Nissan voluntary measures
H10 In accordance with EU end-of-life
→ Changed start of prohibition for uses other than vehicle directive
corrosion protection to July 1, 2007.
Aug. 1, M0301-2002 N12 → Added supplement and amended CAS No.
2002 Revision
M1
→ Added Massachusetts State regulation. Massachusetts State regulation
L1 76/769/EEC 12th revision
→ Deleted substance covered.
→ Final version of 13.3 EU directive on end-of-life
vehicles and exemptions
→ Revised annex (lead, PVC).
P7
→ Added to Table 10.
→ Only pentabromo diphenyl ether (PeBDPE) use
prohibited in Japan and N. America.
B21,C12,P18,T20,P5,C1,P9,M6,
M7,H10 → Amended CAS No.
P1,T2,D34,D35,K1,P19,T27,
C7,C21,C24 → Added CAS No.
B6 → Revised substances covered.
D33 → Combined from Table 10 to C24.
[Added substances covered by regulations.]
H15, P17, S19
→ Danish regulation Danish regulation 2002/7/2 No552
M0301-2003
Nov., 2003 Added directive on greenhouse effect gases.
Revision
[Partially revised regulations on Pb, Hg, Cd, Cr6+.]
→ Added revised details of JAMA recycling JAMA 2002 recycling initiative
initiative targets.
- 287 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
[Changed classification]
Changed "substances not subject to prohibition
restrictions but requiring caution in the future" to
"substances requiring attention with regulations
and social climate". Revised Table 10 details
accordingly.
[Changed regulation details.]
C1, H10, L1, M1,
→ Added regulation (voluntary measure) covering
all destination regions from July 2007.
Regulation outline in accordance with EU
end-of-life vehicle directive.
P7
→ Added regulation for US market from January New York, Maine, California state
2006 (New York, Maine, California states). regulations
Added regulation (voluntary measure) covering
all destination regions from July 2007.
[Added regulated substances.]
A6
→ Added relevant substances following
introduction of 2002/61/EC and 2003/3/EC. 2002/61/EC 19th revision
Revised information on related regulation 2003/3/EC In compliance with
accordingly. 12th revision
T31, T32
→ Added "substances requiring attention with
M0301-2005 regulations and social climate" in response to
Mar. 11, Revision 28th revised directive (draft) of 76/769/EC. 76/769/EC 28th revision (draft stage)
2005 S4
→ Incorporated from "substances requiring
attention with regulations and social climate" to
"substances whose use is prohibited or
restricted (general components)" following JAMA
voluntary initiative. JAMA initiative
Individual volatile organic compounds identified

by Ministry of Health, Labour and Welfare as
guidelines relating to indoor pollutants.
→ Clarified handling in remark 4 for scope.
Added 8 out of 13 substances to "substances
requiring attention with regulations and social
climate". 8 substances added:
acetaldehyde (A21), chlorpyrifos (C28), diazinon
(D40), paradichlorobenzene (D41),
ethylbenzene (E14), fenobucarb (F3),
tetradecan (T33), and xylene (X1).
(Formaldehyde (F1) is already included in
"substances whose use is prohibited or
restricted (general components)". Styrene (S5),
di-2-ethylyhexyl phthalate (D31), and di-n-butyl
phthalate (D32) are already included in
and social climate". Toluene (T31) is included in
and social climate" here.) JAMA initiative
- 288 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
[Added regulated substances.]
T32 (trichlorobenzen)
→ Added "substances whose use is prohibited or 76/769/EC 28th revision
restricted" in accordance with 76/769/EC 28th
revision. Previously categorized in "substances
requiring attention with regulations and social
climate", but this was deleted.
[Changed regulation details.]

Table 13.3
→ Incorporated details of EU ELV ANNEX II 2005/673/EC European Parliament

implemented on September 20, 2005. and Council directive on end-of-life
vehicles
2000/53/EC revision to Annex II
C1 (cadmium and its compounds)

→ Brought details of Nissan voluntary regulations 2005/673/EC European Parliament
from July 1, 2007, in line with ANNEX II and Council directive on end-of-life
following revision. (Deleted "provided it is not vehicles
used intentionally".) 2000/53/EC revision to Annex II
→ Regulation of "Usage prohibited from January 1, Nissan voluntary regulation

2001" previously for EU market changed to
cover both EU and non-EU European market
based on actual situation. Legal regulations take
priority for back-dated sections.
M0301
Nov. 30, → Reorganized details for each destination market
[2005-1] and indicated Nissan initiatives in box for
2005
Revision clarification.
L1 (lead and its compounds)
→ Brought details of Nissan voluntary regulations 2005/673/EC European Parliament

from July 1, 2007, in line with ANNEX II and Council directive on end-of-life
following revision. (Deleted "provided it is not vehicles
used intentionally".) 2000/53/EC revision to Annex II
→ Regulation of "Usage prohibited from January 1,
2003" previously for EU market changed to
cover both EU and non-EU European market Nissan voluntary regulation
based on actual situation. Legal regulations take
priority for back-dated sections.
→ Deleted discontinued EU destination regulation
"To be reduced to less than 1/3 of 1996 by end
of 2002"
→ Reorganized details for each destination market
and indicated Nissan initiatives in box for
clarification.
- 289 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
M1 (Mercury and mercury compounds)
→ Coordinated details of Nissan voluntary 2005/673/EC European Parliament
regulations implemented from July 1, 2007 with and Council directive on end-of-life
post-revision ANNEX II. (Deleted "provided use vehicles
is not intentional".) 2000/53/EC Amendment to ANNEX
II
→ Applied previous EU market regulation of "use Nissan voluntary regulation
prohibited from 1999 except in fluorescent tubes
and lamps" to EU and non-EU European nations
based on current situation. Legal regulations
take priority for older components.
→ Details of regulations for US market revised to Connecticut and Rhode Island State
coincide with state legal regulations introduced regulations
the earliest.
→ Details revised for each destination market and
Nissan initiatives summarized within box for
improved clarity.
H10 (Hexavalent chromium)

→ Coordinated details of Nissan voluntary 2005/673/EC European Parliament
regulations implemented from July 1, 2007 with and Council directive on end-of-life
post-revision ANNEX II. (Deleted "provided use vehicles
is not intentional".) 2000/53/EC Amendment to ANNEX
→ Incorporated details "anti-corrosive coatings for II
chassis nut and bolt assemblies" into regulation
details due to EU directives on end-of-life
M0301 vehicles.
Nov. 30, [2005-1] → Use was prohibited for EU and non-EU Nissan voluntary regulation
2005 European destination markets from January 1,
revision
2007 and from July 2007 for all other
(continued) destinations for new vehicles as a Nissan
voluntary regulation even for "anti-corrosive
coatings for chassis nut and bolt assemblies".
→ Applied previous EU market regulation of "use
prohibited in anti-corrosive coatings from
January 1, 2007" to EU and non-EU European
nations based on current situation. Legal
regulations take priority for older components.
improved clarity.
P7 (Polybrominated diphenyl ether: PBDE)
→ Expanded scope of previous US market Nissan voluntary regulation

regulation "use of pentabromo diphenyl ether
(PeBDPE) and octabromo diphenyl ether
(OBDPE) exceeding 0.1% of material weight is
prohibited from January 1, 2006" as a Nissan
voluntaryregulation to include Canada.
improved clarity.
- 290 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
[Clarification of vehicles covered]
H10 (Hexavalent chromium)
→ Clarified scope of "use prohibited from July
2007" voluntary measure for Japanese market
(new vehicles).
[Miscellaneous]
M0301 1. Scope reference 4
→ Clarified reference NES for VOCs.
Nov. 30, [2005-1]
2005 revision 2. Entries on drawings
(continued) → Entries on drawings include this NES number
and change number.
Amendment to "Voluntary regulation" notation

→ Previous "Voluntary regulation" changed to
"Nissan voluntary regulation".
M0301 1. SCOPE
In Nissan, specified substances and applicable
Nov. 28, [2007-N]
2007 regions are regulated in principle in accordance
revision
with each country’s regulations; thus, regarding
nonregulated regions, expression was changed
from “Prohibit usage in principle” to “It is desirable
to prohibit usage in principle”.
3. DEFINITIONS OF SPECIFIED SUBSTANCES

In the past, Nissan has independently regulated
specified substances in accordance with each
country’s regulations. In recent years, however,
industry in general has complied with GADSL.
Thus, this time, it was decided to make GADSL +
Class 1 specified chemical substances under the
Japan Chemical Substances Control Law the basis
for specified substances.
Newly added chemical substances are shown in

Table 6.
Table 3
Added exemption rules from South Korean laws.
Table 4
Added exemption rules from voluntary regulation by
Taiwan scrap vehicle recycling industry.
Table 5
Described the details of Nissan global policy.
- 291 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
4. Control of restricted substances
Due to the ever increasing importance of
understanding the conditions in which restricted
substances are used and controlled, material and
parts suppliers have been additionally requested to
submit data via IMDS, etc.
Table. 1
As the number of prohibited/declarable chemical
substances is likely to rise in the future, Nissan has
added tables that show the groups of restricted
substances to be prohibited and declarable and the
regulation level for each substance.
Table. 2
In the old NESM0301 [2007-1], prohibited and
declarable substances were listed separately.
However, depending on the chemical substances,
there were both prohibited and declarable regions,
resulting in the same chemical substances being on
the prohibited and declarable substance lists,
Oct. 29, M0301 making it difficult to judge at a glance whether it
2008 [2008-N] was a prohibited substance or a declarable
substance. To avoid this confusion, prohibited and
declarable substances are included on one list and
the declarable level for each region is indicated
beside each substance in [2008-N].
Moreover, according to the current revisions to the

NES, chemical substances added or with changes
in the declarable standards are shown in the right
column of Table. 2 such that the changes from
[2007-N] can be easily clarified.
Table. 3
As the revision 2008/689/EC of the EU ELV
Directive was issued and ANNEX II was revised,
this review has been conducted including their
contents.
Table. 4
The exemption provisions provided by the South
Korean recycling law have been separated and
made into Table. 4.
- 292 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Table. 1 and Table. 2
Addition of prohibited /declarable substance GADSL2009 Version1.0
by the GADSL2009 Version1.0
Change of declarable standard of arsenic and

its compounds (Japan Europe: prohibited,
Other areas: declarable → All areas:
declarable)
Europe REACH restriction ECHA The officially REACH restriction

announced SVHC15 candidate substance are
added as a declarable standard on
September, 2009.
12 restricted substances are added as Stockholm Convention

Oct. M0301 prohibited substances on POPs convention*4
2009 [2009-N]
Change of declarable standard of diorganotin 2009/425/EC
compounds, selected (All areas: declarable →
Europe: prohibited, Other areas: declarable)
Dimethylfumarate was added as a prohibited

substance. 2009/251/EC
Table. 3
Exemption requirement correction due to EU
Directive on end-of-life vehicles
Table. 5
Taiwan scrap vehicle recycling· Review of
exemption requirement regarding the industry
voluntary requirement
Table. 1 and Table. 2

by the GADSL2010 Version1.0
Europe REACH restriction REACH restriction

The officially-announced SVHC 38 substances
by ECHA in March, 2010 were added as
specified substances.
Prohibition of use of methanol in Russia and

Ukraine was added.
Prohibition by voluntary regulation of

Jul. M0301 Deca-BDE in North America was added.
2010 [2010-N]
For Europe and Israel, prohibition of use of air
conditioner refrigerant HFC134a was added.
Table. 3
Exemption requirement (lead) revision due to
EU Directive on end-of-life vehicles
Table. 6
Exemption requirement addition due to China
- 293 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Table. 2, Table. 3
by the GADSL2011 Version 1.0.
Europe REACH restriction

The officially-announced SVHC 53 substances REACH restriction
by ECHA in June, 2011 were added as
specified substances.
Of them, 6 substances were added as
certification substances and 20 substances
(18 substances + 2 substances subject to
condition change) were added as candidate
substances.
Addition of NES M0302 "Reference for

substance data input by IMDS"
Oct. M0301 Revision of HBCDD restriction contents

2011 [2011-N]
Revision of contents of European restriction to
cadmium and its compounds
Table. 1
Addition of restricted substance chronology
Table. 3
Addition of differences from GADSL
Addition of REACH restriction column
Table. 4
Exemption requirement correction due to EU
Table. 5
Revision of voluntary restriction by Taiwan
scrap vehicle recycling industry
Page 2
-> Correct Line1, Table 1 and 2, to Table 2
and 3
Table 2:
Nov. M0301 -> Page Number correction
2011 [2011-1] -> P7, 151, 152, 158 Group name correction
Table 3:
Addition of P8, 6 Group, Azo-dyes
4,4'-Methylenedianiline (CAS No, 101-77-9)
as SVHC approval substances covered
Table. 1 Table.3 REACH restriction
->Addition of 8 substances as certification
Feb. M0301 substances
2012 [2012-N]
Table 4:
->Correct Group name
- 294 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Table.1
CAS Nos. are indicated.
Table.2, Table. 3
Addition of prohibited/controlled substances GADSL2012 Version1.0
by GADSL20112 Version1.0
Table.3
Sequence of substance group listing was
changed to the same sequence of GADSL.
REACH regulation
European REACH regulation Addition of the
SVHC 13 substances announced by ECHA in
June, 2012 as the designated substances.
Addition of the SVHC 54 substances

announced by ECHA in September, 2012 as
the candidate substances.
Change of the plasticizer (DEHP, BBP, DBP,

DIBP) management standard.
Europe => All vehicles in and after February,
Dec. M0301
2015
2012 [2012-1]
Japan, U.S., and other regions
=> New models in and after February, 2015
Change of the tris phosphate management

standard. Significant New Use Rule
Europe => All vehicles in and after February, (SNUR)
2015
Japan, U.S., and other regions
=> New models in and after February, 2015
Change of the di-n-pentyl phthalate (DnPP)

management standard.
=> Prohibited in North America.
Table.4
Change of exemption period for lead (8i) in
EU directive on end of life vehicle disposal
(Notice)
Table.8
Addition of substances restricted on the use in
Nissan global policy
- 295 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Correction of errors in Table 1.

->Correction of year in which 1163-19-5
regulations begin (2010 -> 2015).
Table.2, Table. 3
GADSL2013 Version1.0
Addition of prohibited/controlled substances
Table.3 REACH regulation

European REACH regulations Addition of 6
SVHC*3 substances announced by ECHA*2 in
June 2013 as designated substances
Addition of 7 SVHC substances announced by

ECHA in September, 2013 as candidate
substances
Check conformity with the Candidate list.

->Addition of 10 substances for which data
has not yet been entered.
M0301
Nov.
[2013-N]
2013 Revision of threshold values for applicable
substances with mercury and hexavalent
chromium as detailed below.
Hexavalent chromium
->Prohibition of use alongside use of leather
Prohibition of BNST in Canada (North

Canadian Environmental
America)
Protection Act, 1999(CEPA)
->Prohibition of usage excluding for rubber.
Correction of errors
Correction of errors in the Differences with
GADSL column
->96551-70-1 Blank ->A
Table.7
Addition of exemption regulations for
prohibition of harmful substances usage and
recoverability management rules
- 296 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
Table.2, table.3, table.8, Nissan global policy
Deca-BDE
*New vehicles after July, 2017 a ban on use
⇒ It is applied by specific car model
According to a specific schedule for
earliest elimination
By July, 2017 that can be supported.
*All vehicles after April, 2018 a ban on use of

PAHs
⇒ POPs treaty, will become law in each
country
Chemical Substances Control Law
Table .3
M0301 Added 1 substance to nonylphenol REACH regulation
Mar.
[2014-N] (6 substances)
2014
following the ninth SVHC revision of the
European REACH regulation
Table .7
Revision of PRC ELV regulation,
a moratorium on certain toxic substances and
correction of the exemptions in the
recovery rate management rule
Table .3 error in writing correction

⇒Short chain, middle chain chlorination
paraffin,
Global D/P of the regulation area column is
corrected when D/P((P:C10-C13,) is included
- 297 -
RNES-B-00027 v1.0
00-10-050 / - - N
M0301 [2016-N]
5. European biocidal products regulation
active substance
Add the explanation of regulation according to
the FAQ by IMDS steerling committee.
Table.1
GADSL2015 Version1.0
Change contents, the constitution of the table
Table.2, Table. 3
Addition of prohibited/controlled substances
Biocidal coatings / biocidal additives, selected

⇒207 Substances addition
The management of Biocidal coatings /
biocidal additives, selected obeys it as follows
Authorisation required：The target product
type isn't registered for biocide use.
Approval acquisition is needed (until approval
is acquired, prohibited).
Mar. M0301
D：Approved to the target product type and is
2015 [2015-N]
practicable.
P：Prohibited on use for a target product type
Table.3
European REACH regulation material addition REACH regulation
・SVHC: 13 substances
・SVHC approval substances covered
1 substances
・SVHC study substance：5 substances
・Annex17: 1 substance
Correction of errors in Table.3

Cas No, 8553-12-0 are corrected to
28553-12-0
Table.7
Addition of exemption regulations for
prohibition of harmful substances usage and
recoverability management rules
Implementation of whole revision with

reflection of RNES-B00027v1.0 that
Jul. M0301 established as Renault/Nissan common
2016 [2016-N]
standard.
- 298 -

名 称（Title） 2016-N M0301: M0403 M0402 M0302 D0031

Uploaded by

Copyright:

Available Formats

You might also like

名 称（Title） 2016-N M0301: M0403 M0402 M0302 D0031

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

名 称（Title） 2016-N M0301: M0403 M0402 M0302 D0031

Uploaded by

Copyright:

Available Formats

M0301 [2016-N]

規格番号 変 番 区分 承認日 ﾌｧｲﾙ分類番号

Substance Use Restrictions

制定日 最新変番の承認日 重保重要識別 英訳ﾗﾝｸ 分類(製造)

ｺﾓﾝｽﾀﾝﾀﾞｰﾄﾞ 日産自動車株式会社 NES 委員会

承認者１ 福井 孝之 分科会 材料技術(高分 専門委員会 環境材料

地区 課ｺｰﾄﾞ 作成者 TEL(内線）

Title: Prohibited or restricted substances in parts – List and

Signature (Alliance Single Technical Leader)

Signature (Renault validator) Signature (Nissan validator)

 "This document is a compilation of RENAULT document No 00-10-050 and Nissan document No

Issued by : Philippe ROLLAND

Issued by : Naoki HATTORI

Renault Nissan Internal

Renault Nissan Internal

Renault Nissan Internal

List and declaration modes

1.1 SCOPE (Field of application)

The Standard established requirements are applicable for :

1.1.2. GEOGRAPHIC FIELD OF APPLICATION

1.1.3 .DRAWING NOTATION

2 Normative and informative references

3 Terms and definitions:

4 Symbols and abbreviations:

5.2. SPECIFIC CASES

Renault Nissan Internal

Renault Nissan Internal

6.2. MANDATORY DECLARATION & PROHIBITION TRESHOLDS

Renault Nissan Internal

Renault Nissan Internal

Annex 1: List of substances with P / R / D classification

See file “RNES-B00027_V1.0_Annex1.xlsx” included below

Renault Nissan Internal

To be labeled or made identifiable using

[Lead as an alloying element]

[Lead and lead compounds in components]

[Lead and lead compounds in components] continued

Renault Nissan Internal

[Lead and lead compounds in components] continued

14. As an anti-corrosion agent of the carbon

Renault Nissan Internal

(1) This exemption shall be reviewed in 2015.

Renault Nissan Internal

EXHAUSTIVE LIST OF EXEMPTIONS

1) Lead as an alloying element

a) Steel for machining purposes and galvanized

2) Lead and lead compounds in components

New type whose dimension

Renault Nissan Internal

Ranges and expiry dates of Changes from

Renault Nissan Internal

Ranges and expiry dates of Changes from

New type whose dimension

C. Hexavalent Chromium (Cr6+)

As an anti-corrosion agent of the carbon steel

Spare parts for vehicles put on the

Renault Nissan Internal

Renault Nissan Internal

名称（Title） 2016-N M0301: M0403 M0402 M0302 D0031

名称（Title） 2016-N M0301: M0403 M0402 M0302 D0031

名称（Title） 2016-N M0301: M0403 M0402 M0302 D0031

規格番号変番区分承認日ﾌｧｲﾙ分類番号

制定日最新変番の承認日重保重要識別英訳ﾗﾝｸ分類(製造)

ｺﾓﾝｽﾀﾝﾀﾞｰﾄﾞ日産自動車株式会社 NES 委員会

承認者１福井孝之分科会材料技術(高分専門委員会環境材料

地区課ｺｰﾄﾞ作成者 TEL(内線）